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P r o s ta c y c l in  (PGI2 ) i s  a po ten t  v a s o d i l a t o r  and a n t i - p la te le t  
prostaglandin which i s  the major  product o f  a ra ch id o n ic  ac id 
metabol ism in  va s c u la r  t i s s u e .  I t  is  thought to  funct ion as a 
loca l  v a s o p ro te c t iv e  agent,  p r o te c t i n g  blood vesse ls from 
p l a t e l e t  deposit ion and subsequent damage. Thromboxane A2 (TxA2 ) 
is  the major product of arachidonic acid metabolism in p la te le ts ,  
and has a c t io ns  d i r e c t l y  opposed to  those of p rostacyc l in  as i t  
is a potent vasod i la to r  and p la te le t  aggregating agent, which is  
syn thes ised and re leased when p la te le t  aggregation occurs. I t  
has been proposed t h a t  a balance e x i s t s  between these two 
substances to  ma in ta in  vascular i n t e g r i t y .  Disturbance of t h i s  
balance may be important in  d iseases assoc ia ted  w i th  p l a t e l e t  
consumption and v a s o c o n s t r i c t i o n  such as pregnancy induced 
hyper tens ion  (PIH) and p ro s ta c y c l in  def ic iency and excess TXA2 
production have both been impl icated in  the  pa thophys io logy  o f  
t h i s  c o n d i t i o n .  Recent ly,  adrenoceptor antagonists and calcium 
channel blocking agents have been used in the t re a tm e n t  o f PIH. 
The aims o f  t h i s  t h e s i s  were f i r s t l y  to  study th e  e f fec ts  of 
these drugs on p la te le t  funct ion and PGI2 and TxA2 production in 
v i t r o , and second ly ,  to  study plasma le v e l s  o f  PGI2 and TXA2 
metabol i tes in  normal pregnancy and PIH, and assess the e f fec t  of 
treatment with an adrenoceptor antagonist ( l a b e t a l o l )  on le v e l s  
of these substances and p la te le t  consumption in  PIH.
The e f f e c t s  o f  seven adrenoceptor  a n ta g o n is ts  on p l a t e l e t  
aggrega t ion  and TxA2 p roduc t ion  in  p l a t e l e t  r i c h  plasma were 
s tud ied  i n v i t r o .  Labetalo l ,  pindolol  and propranolol  inh ib i ted
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p l a t e l e t  aggregat ion  and TxÂ2 genera t ion  in  a dose dependent 
manner, probably by preventing release of a ra ch id o n ic  ac id  from 
membrane p h o s p h o l ip id s .  Th is  e f f e c t  was independent o f  any 
adrenoceptor blocking p ro p e r t y ,  as several o th e r  adrenoceptor  
an tagon is ts  - a t e n o lo l ,  m e to p r o lo l ,  t im o lo l  and prazosin were 
without e f fe c t .  This p la te le t  i n h ib i t o r y  e f f e c t  may be re la te d  
to  membrane s t a b i l i  s i  ng a c t i v i t y  or l i p i d  s o l u b i l i t y  as these 
propert ies were common to a l l  three e f fe c t iv e  agents.
The e f f e c t s  o f  l a b e t a l o l ,  p indo lo l  and propranolol  on vascular 
PGI2 p roduc t ion  was s tu d ied  using u m b i l i c a l  a r t e r y ,  however, 
these agents had l i t t l e  e f f e c t ,  causing only s l ig h t  i n h ib i t i o n  of 
PGI2 p roduc t ion  at high drug c o n c e n t ra t io n s .  These 3 agents 
acted synergi s t i c a l  l y  w i th  PGI2 - e i t h e r  exogenous or derived 
from vessel wal l - to  i n h i b i t  p l a t e l e t  aggrega t ion  in  p l a t e l e t  
r ich  plasma.
I t  has re c e n t l y  become possible to  measure p la te le t  aggregation 
in whole blood. This may be more physiological than t r a d i t i o n a l  
t u r b id o m e t r i c  techniques using p la te le t  r ich  plasma as i t  leaves 
p la te le t  in  t h e i r  na tu ra l  m i l i e u  surrounded by red and wh i te  
c e l l s  which can themselves inf luence p la te le t  aggregation. The 
e f f e c t s  o f  l a b e t a l o l ,  p i n d o l o l ,  p rop rano lo l  and a te n o lo l  on 
p l a t e l e t  aggrega t ion  in  whole blood was s tu d ie d .  Labeta lo l ,  
p in d o lo l  and p rop rano lo l  i n h i b i t e d  aggregat ion  in  a dose 
dependent manner and acted syn e rg is t i c a l l y  with exogenous PGI2 to 
i n h i b i t  p la te le t  aggregation. They also in h ib i ted  PGI2 and TXA2 
production from whole blood. Ateno lo l  had no e f f e c t  on e i t h e r  
aggregat ion  or TxA2 o r  PGI2 p ro d u c t io n .  The calcium channel
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b lo ck in g  agent n i c a r d ip i n e  was s im i la r l y  assessed and found to  
i n h i b i t  aggregat ion  but i t  had no e f f e c t  on TxA2 or PGI2 
production. Labetalol  and n i c a r d ip i n e  were a lso  found to  act 
s y n e r g i s t i c a l l y  w i th  low c o n c e n t ra t io n s  of asp i r in  to i n h ib i t  
p la te le t  aggregation in  whole blood.
Cross-sectional and long i tud ina l  studies of plasma levels  of PGI2 
and TxA2 metabol i tes throughout normal pregnancy were performed. 
Prostacycl in  metabol ites were found to  be increased in the f i r s t  
t r i m e s t e r  compared to  the  non-pregnant s t a te ,  w h i le  TxA2 
metabol i te levels  were s l i g h t l y  reduced in  the  second and t h i r d  
t r i m e s t e r s .  C ross -se c t io n a l  and long i tud ina l  studies of these 
substances in  PIH were also performed and plasma P6 I 2 metabol i tes 
were found to  be reduced, providing fu r th e r  evidence t h a t  PIH is  
assoc ia ted  w i th  PGI2 de f ic iency .  No change in TxA2 metabol i tes 
was noted in  PIH. The e f f e c t s  o f  t re a tm e n t  w i th  l a b e t a l o l  on 
plasma le v e l s  o f  PGI2 and TxA2 m e ta b o l i t e s ,  and on p l a t e l e t  
consumption were s tud ied  in  PIH. L a be ta lo l  the rapy  d id  not 
a f f e c t  l e v e l s  o f  TxA2 m e ta b o l i te s  but seemed to  increase PGI2 
m e ta b o l i te  le v e l s  i f  these were i n i t i a l l y  low, a l though no 
c o n s is te n t  e f f e c t  on plasma PGI2 metabol i te levels was noted i f  
these were i n i t i a l l y  w ith in  the normal range. Fol lowing therapy  
w i th  l a b e t a l o l  p l a t e l e t  consumption was s ig n i f i c a n t l y  reduced 
espec ia l ly  in severe PIH. This reduct ion in  p la te le t  consumption 
suggests t h a t  the a n t i - p l a te le t  proper t ies o f labeta lo l  studied 
in  v i t r o  may wel l  e x i s t  in  v i v o , and such p la te le t  pro tect ive  
therapy may be of value in  the treatment of t h i s  disease.
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The a n t i - p l a t e l e t  p ro p e r t ie s  o f  adrenoceptor antagonists, used 
e i the r  alone o r  in  combinat ion w i th  p r o s ta c y c l i n  or  a s p i r i n ,  
which have been descr ibed in  t h i s  t h e s i s ,  re q u i re  f u r t h e r  
c l i n i c a l  evaluat ion, but o f f e r  new therapeut ic p o s s i b i l i t i e s  not 
on ly  in  PIH but also in  other vascular disorders associated with 




1.1 DISCOVERY OF PROSTAGLANDINS PROSTACYCLIN AND THROMBOXANE 
The f i r s t  obse rva t ions  on the b io l o g i c a l  e f f e c t s  o f  
p ros ta g la n d in s  were made by Raphael Kurzok, a New York 
gynaeco log is t  w i th  an i n t e r e s t  in a r t i f i c i a l  inseminat ion. He 
noted that when seminal f l u i d  was i n j e c te d  i n t o  the  u te rus  i t  
caused u te r i n e  co n t ra c t io n  and immediate expulsion o f  the f l u i d  
(Kurzrok and Lieb, 1930).
The f i n d in g s  o f  Kurzrok and Lieb were quickly extended by other 
i n v e s t i g a t o r s .  In 1935 G o ld b la t t  d iscovered th a t  t h i s  
b i o l o g i c a l l y  a c t i v e  substance in  seminal plasma was soluble in 
organic solvents and there fore  appeared to  be a l i p i d  o r  l i p i d ­
l i k e  substance. von E u le r  (1936) repor ted  t h a t  s i m i l a r  
substances were found in sheep seminal vesicles and proposed tha t  
the  a c t i v e  substance had the proper t ies of a f a t t y  acid. I t  was 
Von Eu ler  who named these substances p ro s ta g la n d in s  as he 
i n i t i a l l y  though tha t  they or ig inated in the prostate gland. The 
act ive p r in c ip le  was l a t e r  found to  be in  the f ra c t io n  of seminal 
f l u i d  containing unsaturated hydroxy acids (Bergstrbm, 1967).
The methodological advances o f  gas- l iqu id  chromatography and mass 
spectrometry in  the 1960's were to  allow fu r th e r  character isa t ion 
of the prostaglandins. I t  became apparent t h a t  p ro s ta g la n d in s  
conta ined 20 carbon atoms and a 5 membered r ing .  The hypothesis 
t h a t  they might be derived from a C20 polyunsaturated f a t t y  acid 
was te s te d  by van Dorp et_al_., (1964) and Bergstrbm, Danielsson 
and Samuel sson (1964) us ing  t r i t i u m  labe l led  arachidonic acid.
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Th is  was incubated with sheep seminal vesicles and prostaglandin 
E2 was id e n t i f i e d  as the end product. Thus, i t  became known that 
essent ial  f a t t y  acids were the precursors of prostaglandins.
A d iscove ry  o f  major  s i g n i f i c a n c e  was the  demonstrat ion that 
asp i r in  inh ib i te d  prostaglandin synthesis (Vane, 1971; Smith and 
W i l l i s ,  1971). This allowed much information to  be gained on the 
ro le  of prostaglandins in physiology, and st imulated i n t e r e s t  in  
the regula t ion of prostaglandin production. Since i t  was already 
known th a t  asp i r in  inh ib i ted  p la te le t  aggregation (Weiss, Aledort 
and Kochwa, 1968), p ros tag land ins  produced by p la te le ts  became 
implicated in haemostasis.
In experiments to study the e f fec ts  of anaphylaxis on guinea pig 
lung. Piper and Vane (1969) noted tha t  an unstable substance was 
produced which had the a b i l i t y  to  st imulate  contract ion of rabbi t  
a o r ta .  I t  became c le a r  t h a t  t h i s  was not a c l a s s i c a l  
p ro s ta g la n d in ,  al though a s p i r i n  had the a b i l i t y  to  i n h ib i t  i t s  
production. V a r g a f t i g  and Z i r i n u s  (1973) a lso repor ted  t h a t  
a d d i t i o n  of arachidonic acid to  p la te le ts  induced an aggregatory 
response and r e s u l te d  in  fo rm a t io n  o f  t h i s  same r a b b i t  ao r ta  
contract ing substance.
This  substance was l a t e r  d iscovered to  be thromboxane A2 , a 
de r iva t ive  o f  prostaglandin endoperoxides (Hamberg, Svensson and 
Samuelsson, 1975), and the  major  product o f  arachidonic  acid 
metabol ism in  p l a t e l e t s ,  which i t s e l f  can s t im u la te  vaso­
c o n s t r i c t i o n  and p l a t e l e t  aggrega t ion  (Hamberg ^  aj_., 1975; 
Hamberg et a l . ,  1974).
21
Reasoning t h a t  p l a t e l e t s  and blood vesse ls  had fu n c t i o n a l  
s i m i l a r i t i e s ,  Moncada, Vane and colleagues star ted to  study blood 
vessel homogenates, to  a s c e r ta in  whether they, l i k e  p la te le ts ,  
produced thromboxane A£. A fe a tu re  which might e x p la in  the 
vasoconst r ic t ion which immedia te ly  fo l l o w s  c u t t i n g  o f  a small 
ve sse l .  Unexpectedly they  d iscovered t h a t  blood vessel 
homogenates produced a h i th e r to  unknown prostaglandin, which they 
c a l l e d  p ro s ta g la n d in  X. This substance had p la te le t  i n h ib i t o r y  
and v a s o d i1a to ry  p ro p e r t i e s  (Moncada et 1976; Bunting et
al . ,  1976); p ro p e r t ie s  d i r e c t l y  opposed to  those of thromboxane 
A2 . At about the same t im e ,  Ku lka rn i  e^ aj_., (1976)
independen t ly  found t h a t  i n t a c t  blood vessel p repa ra t ions  
converted a ra ch id o n ic  ac id  i n t o  an uns tab le  va so d i1a to ry  
substance.
The chemical s t r u c t u r e  o f  p ro s ta g la n d in  X was soon defined as 
9-deoxy-6 ,9  a -e p o x y -d e l ta -p ro s ta g l  andin (Johnson et a l . ,
1976) and r a p i d l y  renamed prostacyc l in .  Prostacycl in  was found 
to  be the main product of arachidonic acid metabolism in  vascular 
t i s s u e  (Salmon et , 1978). The main h yd ro ly t ic  product of 
p r o s t a c y c l i n  was found to  be 6- k e t o - p r o s t a g i andi n Fx^, a 
substance which had been described several years p re v io u s ly  by 
Pace-Asciak and Wolfe (1971) as a product of arachidonic acid 
metabolism in ra t  stomach.
Thus, from a chance observation over 50 years ago, our knowledge 
of prostaglandins has developed through numerous c o n t r i b u t i o n s  
from va r io u s  d i s c i p l i n e s ,  i n t o  what appears to  be an important
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re g u la to r y  system both in  physiology and pathology. The rapid 
p ro l i f e ra t io n  of knowledge on prostacycl in  and thromboxane, which 
has occurred in  the  l a s t  10 yea rs ,  has a lso h ig h l i g h te d  the  
importance of these two substances both in  the  phys io logy  and 
pathology of haemostasis, thrombosis and vascular disease.
1.2 NOMENCLATURE, STRUCTURE, SYNTHESIS AND METABOLISM OF 
PROSTAGLANDINS, AND IN PARTICULAR PROSTACYCLIN AND THROMBOXANE
1.2.1 Nomenclature and Structure
Prostag land ins  and thromboxanes are derived from essent ial  f a t t y  
acids. Essential f a t t y  acids cannot be synthesised by the  body 
and th e r e fo r e  must be derived in  s u f f i c i e n t  quan t i t ies  from the 
d ie t  (Crawford, 1983). Prostaglandins con ta in  20 carbon atoms 
made up in to  a cyclopentane r ing  with 2 side chains. Prostacyc l in  
d i f f e r s  from th i s  as i t  has a b ic y c l i c  s tructu re  ( f ig u re  1 . 1 ) and 
thromboxanes contain a completely d i f fe re n t  r ing s t ruc tu re  which 
is  e ssen t ia l ly  an oxane. Due to  the absence of the pentane r i n g  
thromboxanes are not considered to  be prostaglandins.
P ros tag land ins  and thromboxanes can be synthes ised from 3 
d i f f e re n t  essent ial  f a t t y  acid precursors; dihomo-gamma-1ino len ic  
ac id  which con ta ins  3 double bonds, a rach idon ic  a c id ,  which 
con ta ins  4 double bonds and eicosapentaenoic acid which contains 
5 double bonds (Crawford, 1983). Prostaglandins and thromboxanes 
derived from these essent ial  f a t t y  acids are given the subscripts 
1, 2 and 3, r e s p e c t i v e l y  ( e . g . ,  PGE%, PGI2 ) ,  ind ica t ing  t h e i r  
f a t t y  ac id  p re c u rs o r .  W i th in  each se r ies  the compounds are 







































Swedish In v e s t i g a to r s  s u c c e s s fu l l y  i s o la te d  two pure 
prostaglandins from seminal f l u i d .  The f i r s t  they termed PGE (as 
i t  was so lu b le  in  e the r ) ,  and the second PGF (as i t  was soluble 
in  phosphate b u f f e r  phosphate being sp e l le d  w i th  an "F" in  
Swedish).  Since then a large number of prostaglandins have been 
id e n t i f i e d  and f o r  c l a r i t y  have been given l e t t e r s  s t a r t i n g  at 
th e  beginn ing o f  the  alphabet. Thus, the most recent addit ion, 
p r o s t a c y c l i n  i s  termed PGI2 . An addit ional subscript a or 3 is 
given to  "F" series prostaglandins to  ind ica te  the stereoisomeric 
p o s i t i o n  o f  the  hydroxyl group at the carbon pos it ion  number 9, 
f o r  example PGF^^.
The p ro s ta g la n d in s  and thromboxanes o f  the  "two" se r ies  are 
cu r ren t ly  considered to be the most important in man, Arachidonic 
ac id  can be obta ined from two sources, e i t h e r  d i r e c t l y  from the 
d ie t  or by formation from i t s  precursor l i n o l e i c  ac id. Li no le i  c 
ac id  i s  f i r s t  converted to  Y - l in o len ic  acid, then by elongation 
of the carbon chain to dihomo-gamma-1 ino len ic  acid (the precursor 
o f  th e  "one" se r ie s  p ro s ta g la n d in s )  and then by f u r t h e r  
d e s a tu ra t io n  to  a ra ch id o n ic  ac id  (Ramwell e t , 1980). The 
bu lk  o f  arachidonic acid does not remain in  the c i r c u la t io n ,  but 
is  incorporated in to  ce l l  membrane phospholipids (Ramwell et a l . ,  
1980). Since prostaglandin  formation requires free  arachidonic 
acid i t  must f i r s t  be l ibe ra ted  before serving as substrate.
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1.2.2 Release of Arachidonic Acid
Pros tag land ins  are not s to red  but are re leased as soon as 
arachidonic acid is  freed from i t s  e s t e r i f i e d  form in  the c e l l  
membrane and t h i s  is  the r a te  l i m i t i n g  step in  prostaglandin 
p roduc t ion  (Ramwell e^ aj_., 1980). The breakdown of membrane 
phospho l ip ids  to  produce free  arachidonic acid is  brought about 
by the act ion o f  various phosphol ipases, which are t r i g g e r e d  as 
soon as the i n t e g r i t y  of the ce l l  membrane phospholipid b i layer  
i s  d i s t u r b e d .  The main enzyme invo lved  i s  though t  to  be 
phosphol ipase A2 but the  combined action of phospolipase C and 
d ig l y c e r id e  l ip a s e  can a lso  re lease  a ra ch id o n ic  ac id .  
Phospholipase A2 requires the presence of calcium ions (Ca2+) f o r  
opt imal  a c t i v i t y  (B lackw e l l  and Flower, 1983), and u n l i k e  
phosphol ipase C, phosphol ipase A2 i s  p resent w i t h i n  the ce l l  
membrane and can be act ivated when cer ta in  receptors on the  c e l l  
su r face  are occupied (B lackwe l l  and Flower, 1983). Once 
arachidonic acid is ava i lab le  i t  serves as s u b s t ra te  f o r  e i t h e r  
the l ipoxygenase pathway or the  cyc lo-oxygenase pathway. The 
l ipoxygenase enzyme system forms leucotr ienes which are invo lved  
in  the  in f lamm atory  response and are the const i tuents of the so 
cal led slow react ing substance of anaphylaxis (P iper,  1983). The 
cyc lo-oxygenase enzyme system forms p ro s ta g la n d in s  and 
thromboxanes.
1.2.3 The Cyclo-oxygenase Pathway
Cyclo-oxygenase is  present in a l l  t issues except red blood c e l l s .  
I t  is  a substrate act ivated enzyme which t rans fo rms a rach id o n ic  
acid i n t o  PGG2 by oxygenat ion .  I t  a lso has a perox idase 
component which converts PGG2 to PGH2 (Bakhle, 1983). Since the
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endoperoxides PGG2 and PGH2 are synthesised in  a l l  prostaglandin 
and thromboxane producing c e l l s ,  th e re  i s  no apparent 
h e te rog e n e i ty  in  the  cycl o-oxygenase enzyme, regardless of ce l l  
type.
The endoperoxides are unstable in aqueous so lu t ion and isomerise 
spontaneously or  e n z y m a t ic a l l y  t o  the  s ta b le  p ro s ta g la n d in s ,  
namely PGD2 , PGE2 and PGF2a ( f ig u re  1.1). For prostacyc l in  and 
thromboxane A2 production there are two well recognised enzymes, 
p r o s ta c y c l i n  synthe tase  and thromboxane synthetase (Bakh le , 
1983).
The substances formed v ia  the cyclo-oxygenase pathway have widely 
d i f f e r i n g  b io log ica l  proper t ies .  The actual product formed shows 
marked s p e c i f i c i t y  f o r  c e l l ,  t i ssue  and species. The c learest  
example of th i s  is  the a b i l i t y  o f  vascu la r  endothel ium to  form 
prostacyc l in ,  and of p la te le ts  to  form thromboxane A2 . These two 
substances have d ia m e t r ica l ly  opposing b io log ica l  p ro p e r t ie s  ye t  
are produced from the same substrate.
P ros tag land ins  and thromboxanes are not s to re d ,  but are 
synthesised and released on demand, production being t r iggered by 
release of arachidonic a c id .  An except ion  to  t h i s  i s  pr imate  
seminal v e s ic le s  where p ro s ta g la n d in s  are "stored" in seminal 
f l u i d .
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1.2.4 Catabolism of Prostacyc l in  and Thromboxane A?
P ro s ta c y c l in  i s  an uns tab le  molecule  w i th  a h a l f  l i f e  o f  3 
minutes at 37°C and physioloigcal pH (Dust ing, Moncada and Vane, 
1978). I t  i s  r a p id l y  hydro lysed to  the i n a c t i v e  d e r i v a t i v e  
6 -ke to-PGFig .  S t a b i l i t y  o f  p r o s ta c y c l i n  can be maintained by 
s tor ing i t  at a lka l ine  pH (>9) and in  a cold environment.
Both p ros tacyc l in  and 6-keto-PGF%a may be enzymatically degraded 
by prostaglandin  dehydrogenase and subsequently  by d e l t a - 1 3 -  
reduc tase .  The m e ta b o l i te s  so formed are then sub jec ted  to  
b e ta - o x id a t i  on (removal of 2 carbon units  from the posit ion) 
and omega-oxidat ion (removal o f  2 carbon u n i t s  from the  C20 
posit ion)  (Ramwell et , 1980). The rate l im i t i n g  step is  tha t  
of prostaglandin dehydrogenase (Bakhle, 1983).
Most t issues possess these cytoplasmic enzymes, however, t h e i r  
i n t r a c e l l u l a r  s i t u a t i o n  means tha t  the e x t ra c e l lu la r  substrate 
has to  pass through the c e l l  membrane be fo re  i n a c t i v a t i o n  can 
proceed. Un l ike  o th e r  p ros tag land ins ,  such as PGE% and PGF2a, 
p r o s ta c y c l i n  i s  not c lea red  by the lungs (Bakh le ,  1983) as 
prostacyc l in  is  not a good substrate f o r  the ce l l  membrane uptake 
process. However, th i s  s e le c t i v i t y  o f  prostaglandin ina c t iva t io n  
i s  not shared by the  l i v e r  where a l l  p ro s ta g la n d in s  are 
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FIGURE 1.2 
Metabolism of Prostacyc l in  (PGIg)
PGIg is  rap id ly  hydrolysed to 6-keto-PGF-j^ or enzymatical ly converted 
to 15-keto-PG%2 by prostaglandin dehydrogenase (PGDH). 6-keto-PGF^^ 
can be d i r e c t l y  oxidised and excreted in the ur ine, or fu r th e r  
metabolised p r io r  to excret ion.
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There are many u r in a r y  m e ta b o l i te s  o f  p r o s t a c y c l i n ,  the most 
im por tan t  being 2 ,3 ,d in o r -6 -k e to -P G F ia  and 6 ,1 5 ,d i k e t o -  
14-15 , d i h y d r o , 2 - 3 ,d i n o r  PGF}* (Rosenkranz et , 1980). The 
catabolism of prostacyc l in  is  shown in f ig u re  1 . 2 .
Thromboxane A2 (TxA£) i s  a lso  an unstable molecule with a ha l f  
l i f e  o f  30 seconds under p h ys io lo ig ica l  condit ions (Hamberg et 
a l . ,  1975). I t  is  rap id ly  hydrolysed to  i t s  inac t ive  der iva t ive  
thromboxane 82 (TXB2 ) ,  which can subsequently only undergo one 
enzymatic s te p ,  t h a t  of beta-ox idat ion, to form 2 ,3 , -d ino r  TxB2 
the  major  u r i n a r y  product o f  thromboxane A2 ( Roberts et a l . ,
1977).
1.3 TISSUE DISTRIBUTION OF PROSTACYCLIN AND THROMBOXANE 
PRODUCTION
P ro s ta c y c l in  is  the major product o f arachidonic acid metabolism 
in  va scu la r  t i s s u e  (Salmon 1978). I n i t i a l  studies on
p r o s t a c y c l i n  syn thes is  were performed e i t h e r  w i th  a r t e r i a l  
microsomal p repa ra t ions  (Bunting et aj_., 1976) or with rings or 
s t r i p s  o f  a r t e r i a l  o r  venous t i s s u e .  In 1977 Moncada et a l . ,  
examined the  d i f f e r e n t i a l  formation of p rostacyc l in  by layers of 
rabbi t  aorta , and found tha t  prostacyc l in  production was highest, 
in  the i n t im a i  l a y e r  and p ro g re s s iv e ly  decreased to  the 
a d v e n t i t i a l  s u r fa ce .  Weksler,  Marcus and J a f f e  (1977) 
demonstrated t h a t  human endothel ial  c e l l s  produced prostacyc l in  
and M c In ty re ,  Pearson and Gordon (1978) showed t h a t  porc ine  
endothel ial  and smooth muscle ce l ls  produce prostacyc l in .  I t  has
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a lso  been shown t h a t  f o l l o w i n g  removal of the endothelium from 
rabbit  aorta, production of prostacycl in  at the luminal  sur face  
ceased (Eldor et , 1981).
Feta l  t i s s u e  appears t o  be more a c t i v e  than a d u l t  t i s s u e  in  
producing prostacycl in  (Terragno, McGiff and Smigel, 1978). The 
human p lacen ta  a lso  shows a high ca p a c i ty  f o r  s yn th e s is in g  
prostacycl in  (Myatt and Elder, 1977). A r t e r i a l  t i s s u e  seems to  
produce g re a te r  amounts of prostacycl in  than venous t issue on a 
weight f o r  weight basis (Johnson et aj_., 1980).
Non-vascular  c e l l s  such as f ib ro b la s ts  (Baenziger, Becherer and 
Majerus, 1980), gas t r ic  mucosa ce l l s  (Whi t t le ,  Moncada and Vane, 
1978) and w h i te  c e l l s  (Deckmyn, Proesmans and Vermylen, 1983; 
B lackwel l  et al_., 1978) produce prostacyc l in ,  however, p la te le ts  
do not.
Thromboxane A2 i s  produced from the endoperoxides PGG2 and PGH2 
by the act ion of thromboxane synthetase. I t  is  the major product 
o f  a ra ch id o n ic  ac id  metabol ism in p la te le ts  and is  synthesised 
and released when p la te le ts  aggregate (Hamberg et , 1975).
Other c e l l s  are capable of synthesising thromboxane A2 including 
polymorphnuclear leukocytes, and human lung f i b r o b l a s t s .  Some 
v a scu la r  t i s s u e s  have been shown to  be capable o f  producing 
thromboxane A2 , i n c l u d in g  human u m b i l i c a l  a r t e r y  and r a b b i t  
pulmonary a r te ry  (Bunting, Moncada and Vane, 1983), although th is  
is  u n l ike ly  to be phys io log ica l ly  relevant.  However, i t  has been 
shown that kidneys rendered hydronephro t ic  by l i g a t i o n  o f  the
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ureters w i l l  begin to  synthesise thromboxane A2 (Morrison et
1981) suggest ing t h a t  t issue damage may reorien ta te  arachidonic 
acid metabolism and t h i s  may be im por tan t  in  the  pa th o lo g ica l  
s i tu a t io n .
1.4 BIOLOGICAL EFFECTS OF PROSTACYCLIN AND THROMBOXANE 
Prostacycl in and thromboxane A2 have opposing b io log ica l  actions. 
P ro s ta c y c l in  is  a potent  a n t i - p l a t e l e t  agent ,  v a s o d i l a t o r ,  
bronchodi la tor and cy to -p ro tec t ive  agent, whi le thromboxane A2 is 
a potent p la te le t  aggregating agent,  v a s o c o n s t r i c t o r  and cy to -  
destruct ive agent. The ma jo r i ty  of these propert ies are mediated 
through a l t e r a t i o n s  in  i n t r a c e l l u l a r  c y c l i c  adenosine 
monophosphate (cAMP) l e v e l s .  C y c l i c  AMP in tu rn  controls the 
f re e  Ca2+ co n c e n t ra t io n  which i s  re sp on s ib le  f o r  c e l l u l a r  
response. Cyclic AMP is  formed from adenosine tr iphosphate (ATP) 
by the a c t io n  o f  adeny la te  cyc lase ,  and i s  broken down to  5' 
adenosine monophosphate by the act ion of phosphodiesterase. The 
a c t i v i t y  o f these two enzymes there fo re  contro ls  i n t r a c e l l u la r  
cAMP l e v e l s .  P ros tacyc l in  and thromboxane A2 oppose each other 
th rough r e g u la t i o n  o f  adeny la te  cyc lase  a c t i v i t y  (Tateson, 
Moncada and Vane, 1977).
P ro s ta c y c l in  i s  the most po ten t  endogenous s t im u lus  to  cAMP 
p roduc t ion  in  man, a c t in g  by d i r e c t l y  s t im u la t i n g  adenyla te  
cyc lase  (Gorman, Bunting and M i l l e r ,  1977). There are spec i f ic  
receptors f o r  prostacycl in  on the c e l l  membranes o f  p l a t e l e t s ,  
va scu la r  c e l l s  and o th e r  mammalian t issues and these receptors 
are coupled to  adeny la te  cyc lase  (Shepherd ^  aj_., 1983; 
MacDermot et a l . ,  1981; Siegl et a l . ,  1979).
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S t im u la t io n  of cAMP production by prostacyc l in  has been shown to  
occur in  severa l types o f  c e l l  i n c lu d in g  p la te le ts  (Gorman et 
a l . ,  1977), and endothel ial  ce l ls  (Hopkins and Gorman, 1981). A 
d i r e c t  s t im u la t o r y  e f f e c t  on cAMP le v e ls  in  i n t a c t  a r t e r i a l  
t issue has a lso  been documented and the  inc rease  in  cAMP was 
shown to  precede va scu la r  smooth muscle r e l a x a t i o n  (Weksler,
1982). This increase in cAMP and smooth muscle re laxat ion  can be 
p o te n t ia te d  by phosphodiesterase i n h ib i t o r s  (Moncada and Korbut,
1978). However, p r o s ta c y c l i n  has no i n h i b i t o r y  e f f e c t  on 
phosphodiesterase (Hopkins and Gorman, 1981) and i t s  b io log ica l  
e f f e c t s  can be prevented by i n h i b i t o r s  o f  adeny la te  cyc lase 
(Weksler ,  1982), c o n f i rm in g  i t s  d i r e c t  s t im u la t o r y  e f fe c t  on 
adenylate cyclase.
The mechanism by which the prostacyc l in -s t imula ted elevat ion in 
cAMP a f fe c ts  c e l l u l a r  response i s  perhaps best documented in  
p la te le ts  where mobi l isa t ion of Ca2+ is required f o r  shape change 
(Hathaway, Eaton and Adel s te in ,  1980), phospholipase a c t i v i t y  and 
subsequent thromboxane production (Blackwell and Flower, 1983) 
and the re lease re a c t io n  (Feinman and D i t w i l e r ,  1974). When 
leve ls  of cAMP are high Ca2+ is  sequestered in  the p la te le t  dense 
tubu la r  system thereby lowering Ca2+ a v a i l a b i l i t y ,  and i n h ib i t in g  
p l a t e l e t  f u n c t i o n .  When le v e l s  o f  cAMP are low the re  i s  
increased Ca2+ a v a i l a b i l i t y  and p la te le t  ac t iva t ion  is  free to  
occur. Since p ros tacyc l in  is  a po ten t  s t i m u la t o r  o f  adeny la te  
cyc lase ,  cAMP le v e ls  w i l l  r i s e  and Ca2+ yvill be sequestered in 
in t ra -ce l  l u l a r  storage s i te s ,  thereby i n h i b i t i n g  a l l  stages o f  
p la te le t  ac t iva t ion .
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In c o n t r a s t ,  thromboxane A2 i n h i b i t s  adenyla te  cyc lase  and 
therefore reduces cAMP leve ls ,  but th i s  only occurs when cAMP has 
a l ready  been increased by a s t imu la tor  of adenylate cyclase such 
as prostacyc l in  (W h i t t le  and Moncada, 1983). Thromboxane A2 does 
not lower basal leve ls  o f cAMP, so that although th is  is  the s i te  
o f  an important in te rac t ion  between prostacyc l in  and thromboxane 
Ag, i t  does not account f o r  a l l  the e f fec ts  of thromboxane A2 on 
p la te le ts  and vascular t i s su e .  This can be supported by evidence 
showing that an adenylate cyclase i n h ib i t o r  which lowers p la te le t  
cAMP le v e ls  does not on i t s  own induce p l a t e l e t  aggregat ion  
(Salzman ^  al_., 1978).
P ro s ta c y c l in  a f f e c t s  many aspects of p la te le t  func t ion ,  and is  
the most potent endogenous i n h i b i t o r  o f  p l a t e l e t  a c t i v a t i o n  in  
man. I t  i n h ib i t s  shape change and p la te le t  procoagulant a c t i v i t y  
(Ehrman and Ja f fe ,  1980), a v a i l a b i l i t y  o f  f i b r in o g e n  recep to rs  
which are important f o r  p la te le t  aggregation (Hawiger, Parkinson 
and Timmons, 1980), and p la te le t  aggregation (Higgs _et _al. , 1978; 
Ubatuba, Moncada and Vane, 1979). In a d d i t i o n ,  systemic 
prostacyc l in  in fus ion can i n h i b i t  e l e c t r i c a l l y  induced thrombus 
fo rm a t ion  in  the  c a r o t i d  a r t e r y  o f  r a b b i t s  (Ubatuba et a l . ,
1979). P ro s ta c y c l in  may a lso  cause disaggregation of p la te le t  
aggregates. I n h i b i t i o n  o f  p l a t e l e t  adhesion, however, on ly  
occurs at very high concentrat ions (Higgs et j ^ . , 1978) which are 
u n l i k e l y  to  be achieved j_n v i v o . P ro s ta c y c l in  i n h i b i t s  
thromboxane A2 p roduc t ion  from p l a t e l e t s  by reducing Ca2+ 
a v a i l a b i l i t y ,  which i n h i b i t s  the a c t io n  o f  phosphol ipase and 
prevents the release of substrate fo r  thromboxane A2 product ion.
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Thromboxane A2 i s  a po ten t  s t im u la to r  o f  p la te le t  aggregation, 
act ing not on ly  by i n h i b i t i n g  adeny la te  cyc lase ,  but a lso by 
d i r e c t l y  promoting Ca2+ release from i n t r a - c e l l u l a r  storage s i tes 
(Gerrard, But le r  and White, 1977). I t  also promotes the p la te le t  
re lease  re a c t io n  which in  t u r n  promotes f u r t h e r  aggregation, 
ampl ifying the aggregatory response. I t  is  c lear  th e re fo re  th a t  
the balance between prostacyc l in  and thromboxane may be important 
in the control  of p la te le t  func t ion ,  haemostasis and thrombosis.
P ro s ta c y c l in  is  a potent v a s o d i la to r ,  re lax ing vascular smooth 
muscle, by reduc ing Ca2+ a v a i l a b i l i t y  secondary to  increased 
leve ls  of cAMP. I t  a f f e c t s  both la rg e  and small vesse ls ,  and 
a lso  acts on both the systemic  and pulmonary c i r c u l a t i o n s  
(Weksler, 1982). As i t  is  not cleared by the lungs, prostacycl in  
i s  e q u a l ly  e f f e c t i v e  f o l l o w i n g  e i t h e r  in t ra -ve n o u s  or in t ra -  
a r t e r i a l  a d m in i s t r a t i o n  (Armstrong et_ aj_., 1978). I t  is also 
a c t i v e  in  the  m i c r o c i r c u l a t i o n  and may be invo lved  in  the 
modulation of local blood f low (W h i t t le  and Moncada, 1983). The 
c o n t r i b u t i o n  o f  p r o s ta c y c l i n  t o  maintenance of normal vascular 
tone, however, is  unknown but c i r c u la t in g  l e v e ls  are lower than 
the  concen t ra t io n s  needed to  a f f e c t  va scu la r  tone.  Whi le 
prostacyc l in  cannot funct ion as a c i r c u la t i n g  v a s o d i l a to r  i t  is  
s t i l l  l i k e l y  t o  be im por tan t  in  the lo c a l  control of vascular 
tone, and maintenance of vascular i n t e g r i t y  in the  presence of 
p la te le t  ac t iva t ion  (Whi t t le  and Moncada, 1983). The presence of 
spec i f ic  prostacyc l in  receptors on vascular t issue also supports 
a r o le  f o r  p r o s ta c y c l i n  in  co n t ro l  o f  vascular tone and local 
blood f low (MacDermot et a l . ,  1981).
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Thromboxane A2 is  a potent vasoconst r ic tor act ing on a l l  vascular 
beds including umbil ical a r te ry ,  coronary a r te ry ,  cerebral a rtery  
and mesenter ic  a r t e r y  (Whi t t le  and Moncada, 1983). Although i t  
is  un l ike ly  to be invo lved in  the  p h y s io lo g i c a l  r e g u la t io n  o f  
vascu la r  tone and blood f low ,  i t  may be an important mediator of 
vasospasm in condit ions associated with p l a t e l e t  a c t i v a t i o n  and 
vasocontr ict ion.
P ro s ta c y c l in  and thromboxane have opposing a c t io ns  on renal 
vesse ls ,  however, p r o s ta c y c l i n  a lso  promotes ren in  re lease 
independent ly  o f  b e ta -ad re n e rg ic  s t i m u la t i o n  or haemodynamic 
changes and th i s  may r e f l e c t  a lo c a l  r o le  f o r  p r o s ta c y c l i n  in  
regulat ing juxta-g lomerular  funct ion (Patrono et ^ . , 1982).
In the  bronchopulmonary system, prostacyc l in  and thromboxane A2 
again have opposing a c t i o n s .  P r o s ta c y c l in  causes pulmonary 
v a s o d i l a t io n  and b ro n c h o d i la t  ion w h i le  thromboxane A2 causes 
pulmonary vasoconstr ict ion and bronchoconstri  c t i  on ( W h i t t l e  and 
Moncada, 1983).
In the stomach prostacycl in  reduces acid production and increases 
blood f l o w .  I t  a lso  seems to  have a g a s t r i c  c y to p r o te c t i v e  
a c t io n  which i s  separate from i t s  e f f e c t s  on ac id  output and 
blood f l o w .  Thromboxane A2 on the o the r  hand promotes gas tr ic  
u lcerat ion and reduces mucosal blood f low ( W h i t t l e  and Moncada,
1983).
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The cy to -d e s t ru c t ive  proper t ies of thromboxane A2 can usual ly be 
exp la ined by i t s  v a s o c o n s t r i c to r  and p l a t e l e t  aggregato ry  
f u n c t i o n s ,  which cause t issue  ischaemia. I t  may also, however, 
have a d i rec t  c y to d e s t ru c t i  ve e f f e c t ,  p o s s ib ly  due to  a l y t i c  
e f fe c t  on ce l l  membranes leading to release of t issue destruc t ive  
lysosomal enzymes. These enzymes enhance the t i s s u e  damage 
caused by loca l  ischaemia (W h i t t l e  and Moncada, 1983). In 
c o n t r a s t ,  p r o s ta c y c l i n  has been shown to  have some cy to -  
p r o te c t i v e  e f f e c t s  as i t  can reduce i n fa r c t  s ize, oxygen demand 
and enzyme re lease in  experimenta l  models o f  myocardia l  
i n f a r c t i o n  independen t ly  o f  i t s  i n h i b i t o r y  e f fec t  on p la te le t  
aggregation and coronary vasodi lat ion (Ogletree et ^ . , 1979). I t  
has a lso  been shown to  have c y to p r o te c t i v e  e f f e c t s  in  o the r  
s i t u a t i o n s  such as endo tox ic  shock and hypoxic l i v e r  damage 
(Whi t t le  and Moncada, 1983). These cy to-pro tect ive  q u a l i t i e s  may 
also occur in  the c l i n i c a l  s i tu a t io n  as a symptomatic improvement 
in  per iphera l  vascular disease and Raynaud's phenomenon has been 
documented up to  several months a f te r  terminat ion of prostacyc l in  
in f u s io n s  (Bel ch e^ , 1983a; Bel ch et _a]_., 1983b). Clearly 
t h i s  b e n e f i t  cannot be a t t r ib u te d  to  the short l ived  vasodi lator  
and a n t i - p l a t e l e t  e f f e c t s  o f  p r o s ta c y c l i n  i n f u s i o n ,  which 
d isappear  a few minutes a f t e r  s topp ing  the i n f u s i o n .  This 
cy top ro tec t ive  e f f e c t  o f  p r o s ta c y c l i n  th e r e fo r e  does seem to  
occur both in the experimental and c l i n i c a l  s i tua t ions  but as yet 
is  poorly understood.
P ro s ta c y c l in  was i n i t i a l l y  thought to funct ion as a c i r c u la t in g  
hormone in  man (Moncada _et aj_., 1978). This concept was 
supported by repor ted  l e v e l s  f o r  i t s  s tab le  hydrat ion product
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6-keto-PGFia o f  70-100 pg/ml, measured both by radioimmunoassay 
(M i tche l l ,  1978) and by gas-chromatography mass-spect rometry  
(Hensby et , 1979). In 1982, however, i t  was reported that 
the  abso lu te  value f o r  6-keto-PGFig in  peripheral venous plasma 
was below 5 pg/ml using the technique o f  nega t ive  ion chemical 
i o n i s a t i o n  gas chromatography - mass spectrometry (B1a i r  et a l . ,
1982). This  was compat ib le  w i th  the re su l ts  of other workers 
using gas chromatography with elect ron capture detect ion (Chr is t -  
Hazelhof and Nugteren, 1981) and radioimmunoassay (Siess and 
Dray, 1982) who reported s im i l a r l y  low leve ls .  These le v e ls  are 
probably  not compat ible with the concept tha t  prostacyc l in  is a 
c i r c u la t in g  hormone in  man. However, t h i s  does not prec lude a 
r o le  f o r  p r o s ta c y c l i n  f u n c t i o n in g  as a lo ca l  hormone in  the 
regulat ion of p la te le t  - vessel w a l l  i n t e r a c t i o n  and in  loca l  
c o n t ro l  o f  va scu la r  tone and blood f lo w  (Patrono, Preston and 
Vermylen, 1984). There is  also considerable evidence t o  support 
a f u n c t i o n a l  r o le  f o r  prostacyc l in  in v iv o . There are spec i f ic  
prostacyc l in  receptors coupled to  adenylate cyclase in  p la te le ts ,  
va scu la r  c e l l s  and o th e r  mammalian t i s s u e s  ( Shepherd et a l . ,  
1983; MacDermot et a l . ,  1981; Siegl et ^ . , 1979). Furthermore, 
i t  has been shown th a t  m i ld  s t im u l i  can s t imulate  prostacyc l in  
production from human blood vessels (R i t t e r  et j i l_. , 1983). I t  is 
thought  t h a t  f o l l o w in g  va scu la r  i n j u r y  the extent of thrombus 
fo rm a t ion  i s  l im i t e d  and vascu la r  patency main ta ined by 
p r o s t a c y c l i n .  F a i lu re  of t h i s  mechanism might therefore resu l t  
in  excessive p la te le t  consumption and in t ravascu l  ar  th rombos is .  
P r o s ta c y c l in  d e f i c ie n c y  has been documented in diseases such as 
pregnancy induced hyper tens ion  (Goodman et ^ . , 1982; Downing, 
Shepherd and Lewis,  1980; Remuzzi et , 1980) and haemolytic
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uraemic syndrome (Remuzzi 1981) which are characterised
by p l a t e l e t  consumption and i n t r a v a s c u l a r  thrombosis  in  the 
m i c r o c i r c u la t i o n ,  and t h i s  would support the concept o f  
prostacycl in  acting as a vasoprotective hormone.
1.5 THE REGULATION OF PROSTACYCLIN SYNTHESIS AND THE EFFECT OF 
DRUGS ON PROSTACYCLIN PRODUCTION
P ro s ta c y c l in  syn thes is  i s  modulated by a wide v a r i e t y  o f  
na tu ra l ly  occurring b io log ica l  substances and by drugs. Thrombin 
induces p ro s ta c y c l i n  p ro du c t io n  in human endothel ial  ce l l s  and 
th is  may be a physiological mechanism to  prevent the  u n l im i te d  
growth o f  thrombi at s i tes  of vascular i n ju r y  (Weksler, Ley and 
Ja f fe ,  1978). Trypsin, bradykin in, histamine and ang io tens in  I I  
can also stimulate p rostacyc l in  production (Weksler, 1982).
High density l ipoprote ins  can increase p r o s ta c y c l i n  p roduc t ion  
whi le low density l ipopro te ins  can i n h i b i t  i t  (Weksler, 1982) and 
th i s  may b e im p o r ta n t  in  the  a s s o c ia t io n  between low d e n s i ty  
l ipoprote ins  and atherosc lerosis .
L ip id  peroxidat ion induced by free radical formation may a lso  be 
im por tan t  in  the r e g u la t i o n  o f  prostacycl in  production. Lip id  
peroxides i n h i b i t  p r o s ta c y c l i n  p roduc t ion  by i n a c t i v a t i n g  
p r o s ta c y c l i n  syn thetase and a lso  cyc lo-oxygenase (Warso and 
Lands, 1983). Atherosc lerot ic  plaques have long been known to  
have increased levels of l i p i d  peroxides which may predispose to 
fu r th e r  vascu la r  damage and thrombus fo rm a t ion  by i n h i b i t i n g  
prostacyc l in  production (Warso and Lands, 1983).
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Serum i s  known to  possess prostacycl in  s t imu la t ing  a c t i v i t y  and 
the fa c to r  responsible may be p l a t e l e t  de r ived  growth f a c t o r ,  
which has been shown to  s t im u la te  p r o s t a c y c l i n  p roduct ion  
independently o f  i t s  m i togen ic  e f f e c t  on smooth muscle c e l l s  
(Bunting, Moncada and Vane, 1983).
Control o f  prostacycl in  production there fo re  i s  possibly due to  a 
v a r i e t y  o f  substances, however, the precise mechanisms are yet 
unknown.
Asp i r in  is the most studied i n h ib i t o r  of p rostacyc l in  production, 
i t  i r r e v e r s i b l y  a ce ty la te s  cyc lo-oxygenase and th e re fo re  
permanently i n a c t i v a te s  the enzyme. I t  was i n i t i a l l y  thought 
tha t  vascular cycl o-oxygenase was less  s e n s i t i v e  than p l a t e l e t  
cyc l  o-oxygenase, suggesting tha t  low dose asp i r in  might funct ion 
as a s e le c t i v e  i n h ib i t o r  of thromboxane A2 (Burch et , 1978). 
I t  was subsequently  shown th a t  va scu la r  cyc lo-oxygenase was 
equal ly sens it ive  to  asp ir in  (Ja ffe  and Weksler, 1979). However, 
u n l i k e  p l a t e l e t s ,  e n d o th e l ia l  c e l l s  have the  ca p ac i ty  to  
regenerate cyclo-oxygenase and w i l l  recover s i g n i f i c a n t l y  w i t h i n  
4 - 6  hours o f  a s in g le  dose o f  asp i r in  and recover completely 
w ith in  24 - 36 hours (Jaffe  and Weksler, 1979).
More recent studies have shown tha t  d a i l y  ingest ion of asp i r in  at 
doses as low as 20 or 40 mg w i l l  resu l t  in  cumulative i n h i b i t i o n  
o f  both p r o s ta c y c l i n  and thromboxane A2 p roduc t ion  (Preston, 
Greaves and Jackson, 1981; F i t z g e r a ld  ^  al_., 1983), although 
th e re  may be a r e l a t i v e  spar ing o f  p r o s ta c y c l i n  p roduc t ion  
(Weksler et , 1983). The use of in f requent ly  administered low
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dose a s p i r i n  may t h e r e fo r e  permi t  a d isc r im ina t ion  to  be made 
between in h ib i t i o n  of p ros tacyc l in  and thromboxane p ro d u c t io n .  
In  support o f  t h i s  hypo thes is ,  a recent study has shown tha t  a 
d a i l y  dose o f  9 mg o f  a s p i r i n  can s i g n i f i c a n t l y  reduce 
thromboxane A2 w h i le  sparing prostacycl in  production (Toivanen, 
Y l ikorka la  and V i in ikka ,  1984).
N on -s te ro ida l  a n t i - i n f l a m m a to ry  agents a lso  i n h i b i t  c y c lo -  
oxygenase but do so r e v e r s l b l y  and are much less  po ten t  than 
a s p i r i n  (Weksler,  1982). Cor t icos tero ids  i n h i b i t  prostacyc l in  
p roduc t ion  by i n h i b i t i n g  phospholipase A2 and thereby reducing 
substrate a v a i l a b i l i t y  (Blackwell and Flower, 1983).
S e le c t i v e  i n h i b i t i o n  of thromboxane synthetase by drugs such as 
dazoxiben, a lso  represents  a poss ib le  method o f  enhancing 
p ro s ta c y c l i n  production. Vascular endothelium has been shown to  
have the a b i l i t y  to  use p la te le t  der ived  endoperoxides to  form 
p r o s ta c y c l i n  (Marcus et , 1980). In h ib i t i o n  of thromboxane 
syn the tase  may th e re fo re  d iv e r t  endoperoxides from p la te le ts  to  
vascular t issue and thereby  increase p r o s ta c y c l i n  p ro d u c t io n .  
Dazoxiben has been shown to  e f f e c t i v e l y  b lock thromboxane 
synthetase in human p la te le ts ,  although i t  i s  not c l e a r  whether 
vascu la r  p r o s ta c y c l i n  production is enhanced (Ty le r ,  Saxton and 
Parry, 1981; Randall et , 1981).
N i t r o g l y c e r in  has been shown to  increase prostacyc l in  production 
from human e n d o th e l ia l  c e l l s  (Lev in  et aj_., 1981), and
d ip y r id am o le ,  a phosphodiesterase i n h i b i t o r ,  may enhance the 
e f f e c t  o f  p r o s ta c y c l i n  by reducing breakdown of cAMP.
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Dipyridamole was i n i t i a l l y  thought also to  st imulate  prostacycl in 
production (Vermylen, Chamone and Verstraete, 1979), but th is  has 
s ince been shown not t o  occur (Deckmyn et aj_., 1984).
D ipyr idamole  does, however, delay exhaust ion o f  prostacycl in  
p roduc t ion  from i r r i t a t e d  vesse ls (Deckmyn et a j ^ ,  1984) by 
reducing peroxides which would o the rw ise  i n a c t i v a t e  vascular 
cyclo-oxygenase (Deckmyn et a^ . ,  1984).
I t  i s  c le a r  t h a t  th e re  are several p o s s ib i l i t i e s  to protect or 
enhance p r o s ta c y c l i n  p ro d u c t io n ,  or t o  r e - o r i e n t a t e  the 
p r o s ta c y c l i n  - thromboxane balance, however, the most e f fec t ive  
technique in  the c l i n i c a l  s i tu a t io n  remains to be established.
Regulation of thromboxane A2 production and p la te le t  funct ion are 
discussed in chapter 2.
1.6 PROSTACYCLIN AND THROMBOXANE IN DISEASE
Several c o n d i t io n s  assoc ia ted  w i th  e n d o th e l ia l  damage and 
p la te le t  ac t iva t ion  have been associa ted w i th  a d is tu rbance  o f  
p r o s ta c y c l i n  and thromboxane metabol ism, a l though no d i r e c t  
causal re la t ionsh ip  has yet been documented.
A t h e r o s c le r o t i c  t i s s u e  is  known to have a decreased capacity to  
produce prostacyc l in  (Sinzinger,  Fe ig l  and S i lb e rb a u e r ,  1979). 
This may be due to  increased levels of l i p i d  peroxides, which can 
inac t iva te  the enzymes responsible f o r  p r o s ta c y c l i n  p roduc t ion  
(Warso and Lands, 1983). Low d e n s i t y  l ipopro te ins  can reduce 
prostacyc l in  production p o s s ib l y  again through an increase in  
l i p i d  peroxide formation (Weksler, 1982) and th is  may be involved
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in  the associat ion between hyperl ipidaemia and a r te r io s c le ro s is .  
Diabetes m e l l i tus  is  well known to  be associated w i th  premature 
vascular disease and increased thromboxane A2 product ion enhanced 
p la te le t  aggregation and reduced vascular p ros tacyc l in  production 
have a l l  been documented in th is  condit ion (Halushka, Dol lery and 
MacDermot, 1983).
Thromboxane A2 has a lso  been impl icated in the pathogenesis of 
myocard ia l  i n f a r c t i o n  (Coker e ^ ^ . ,  1981), arrhythmias (Coker 
and P a r r a t t ,  1983), vasospast ic  angina (Lewy et , 1979; 
Robertson e^ aj_., 1981) and angina in  pa t ien ts  with ischaemic 
h e a r t  d isease (H irsh  et a j [ . , 1981). Haemolyt ic  -  uraemic 
syndrome, th ro m b o t ic  thrombocytopaenic  purpura and pregnancy 
induced hypertension, are also diseases associated w i th  reduced 
p r o s t a c y c l i n  p roduc t ion  (Remuzzi et , 1981; Goodman et a l . ,  
1982; Bussolino et , 1980; Downing, Shepherd and Lewis, 1980). 
In c o n c lu s io n ,  a l t e ra t io n s  in the synthesis o f both thromboxane 
and pros tacyc l in  appear to  be involved in  the pathophysiology o f  
severa l  card iovascular diseases, however, t h e i r  precise roles in 
the aet io logy of these condit ions remains to  be def ined.
1.7 THERAPEUTIC APPLICATIONS OF PROSTACYCLIN
In view o f  p r o s ta c y c l i n ' s  potent a n t i - p l a te l e t  and vasodi la to ry 
p r o p e r t i e s ,  i n f u s io n  o f  p r o s ta c y c l i n  may be o f  b e n e f i t  in  
s i t u a t i o n s  assoc ia ted  w i th  p l a t e l e t  consumption and vaso­
c o n s t r i c t io n .  As i t  is  not metabol ised by the  lungs i t  can be 
given e f fe c t i v e l y  by intra-venous in fus ion .  I t  i n i t i a l l y  found a 
r o le  in  e x t ra co rpo re a l  c i r c u l a t i o n s ,  such as charcoal 
haemoperf us io n ,  haemodi a lys is  and cardiopulmonary bypass, where
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i t  reduced both p l a t e l e t  loss  and a c t i v a t i o n  (Weksler, 1982). 
However, because of i t s  therapeut ic potent ial  i t s  use was rap id ly  
exp lo red  in  o th e r  s i t u a t io n s .  I t  has been used successful ly in 
both severe peripheral vascular disease and Raynaud's phenomenon 
(Belch et aj_., 1983a; Belch e^ a / [ . , 1983b) and i t s  benef ic ial  
e f f e c t s  in  these s i t u a t i o n s  were s t i l l  apparent up to  several 
months a f t e r  te rm in a t io n  o f  the i n f u s io n ,  d e sp i te  the shor t  
h a l f - l i f e  of p rostacyc l in .  This prolonged benef i t  may be due to 
the poorly understood cy to -p ro tec t ive  e f fe c t  which p r o s ta c y c l i n  
seems to  possess. I t s  use i s  also being explored in ischaemic 
heart disease where i t  may l i m i t  u n fa r c t  s ize  and reduce the  
f requency o f  anginal a t ta cks  (Henr iksson,  Edhag and Wennmalm, 
1985; Szczekl ik  et , 1985).
P ro s ta c y c l in  in f u s io n  has a lso  been used in haemolytic uraemic 
syndrome (Beatt ie  et ^ . , 1981) where i t  may help reduce p la te le t  
consumption. I t  has more recent ly  been used in pregnancy induced 
hypertension where i t  was of some va lue both as an hypotensive 
and a n t i - p la te le t  agent (Belch et £]_., 1985).
However, p r o s ta c y c l i n  i s  a d i f f i c u l t  drug to  use. I t  i s  
unstable, requires to be given by continuous intravenous infusion 
and the  dose related side e f fec ts  o f  headache, f lush ing ,  nausea, 
and hypotens ion l i m i t  the  dose range and mean th a t  p a t ie n t  
supervision is  required. Despite these l im i ta t io n s  the potent ial  
b e n e f i t s  o f  p r o s ta c y c l i n  i n f u s io n  are enormous and f u r t h e r  
s tu d ies  are requ i red  to  e s ta b l i s h  which diseases might benef i t  
f rom i t s  use. The a p p l i c a t i o n  o f  p r o s ta c y c l i n  therapy t o
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c l i n i c a l  s i tua t ions  may be f a c i l i t a t e d  by the development of more 
stable and o ra l l y  act ive analogues, which would overcome some o f  






The c i r c u l a t i n g  p l a t e l e t  i s  an anucleate cytoplasmic fragment, 
o r ig ina t ing  from megakoryocytes. They are biconvex d iscs w i th  a 
mean diameter of 3.6 ± 0.7 (SD) um, 0.9 ± 0.3 um th ick  and 7.06 ± 
4.85 f l  in  volume (Fro jmov ic  and Panjwani,  1976) and are the 
sm a l les t  formed elements of the blood. When studied by scanning 
electron microscopy t h e i r  surface appears fuzzy and contains many 
in d e n ta t i o n s ,  which are the  openings o f  an e labo ra te  tubular 
system which extends th roughou t  the i n t e r i o r  o f  the p l a t e l e t ,  
forming the so cal led open canal icu lar  system (White and Gerrard, 
1976). Transmission e le c t ro n  microscopy has al lowed more 
d e ta i l e d  s tudy o f  the p l a t e l e t  anatomy and the recognit ion of 
several d i s t i n c t  regions (White, Clawson and Gerra rd ,  1981), a 
pe r ip h e ra l  zone, a s o l -g e l  zone, and an organelle zone ( f igu re  
2.1).
2.1.1 The Peripheral Zone
The p e r ip h e ra l  zone forms the p l a t e l e t  wa l l  w i th  the  many 
invaginat ions of the open cana l icu la r  system connecting the c e l l  
su r face  w i th  the  i n t e r i o r .  I t  plays a major ro le  in p la te le t  
funct ion, maintaining ce l l  i n t e g r i t y ,  p ro v id in g  re c e p to r  s i t e s  
f o r  s t im u la t in g  or in h ib i t i n g  agents, mediates p ia te le t - p la te le t  
and pi atel et-sur face  i n t e r a c t i o n s  and p rov ides  a phospho l ip id  
su r face  to  accelerate blood coagulation. The peripheral zone is 
made up o f  3 morpho log ica l  p a r t s ,  the  e x te rna l  coat or 
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The ex te rna l  coat i s  r i c h  in  g ly c o p ro te in s ,  some of which are 
unique to  p la te le ts ,  and several p la te le t  membrane g lycop ro te ins  
have been character ised (GP I ,  I I ,  I I I ,  e tc . )  (Co l le r ,  1984). The 
ro le  of these substances in  p la te le t  adhesion and aggregation has 
been e lu c id a te d  by s tu d ie s  on i n d i v i d u a l s  w i th  congen i ta l  
disorders of p la te le t  func t ion ,  in  whom there is  a d e f i c ie n c y  of 
c e r t a i n  o f  these g ly c o p r o te in s .  GP I f o r  example is  necessary 
fo r  normal p la te le t  adhesion whi le GP I I  and I I I  are required fo r  
p l a t e l e t  aggregat ion ( P h i l l i p s ,  1980). The sur face  g lyco ­
p ro te in s  have te rm ina l  s i a l i c  ac id  carboxy l groups which 
c o n t r i b u te  to  a negat ive surface charge on the p la te le t ,  and i t  
is  l i k e l y  that th is  e le c t r o s ta t i c  re p u ls io n  plays an impor tant 
r o le  in  p reven t ing  spontaneous aggregation, since reducing the 
charge has been shown to  increase aggregation (Greenberg et a l . ,  
1975).
The u n i t  membrane is  a p h ospho l ip id  b i l a y e r  which plays an 
important ro le  in  accelerat ing coagulat ion, and contains enzymes 
invo lved  in  membrane t r a n s p o r t  and c y c l i c  AMP metabolism. In 
addit ion i t  is  r ich in arachidonic ac id, the l i p i d  p recursor  o f  
prostaglandins and thromboxane (Marcus, 1976).
The submembrane region is the space between the un it  membrane and 
the c i  rcu m fe re n t ia l  band of microtubules. I t  contains a system 
of f i laments which are involved in  maintaining p la te le t  shape and 
in pseudopod formation and c lo t  re t ra c t io n .
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2.1.2 The Sol-Gel Zone
The sol-gel zone is  a viscous matr ix ins ide the p la te le t  composed 
o f  the c o n t r a c t i l e  p r o te in s ,  a c t i n  and myosin, and the non- 
c o n t r a c t i l e  p r o te in ,  t u b u l i n  (C o l le r ,  1984), which make up the 
p la te le t  cytoskeleton. The cytoskeleton is  respons ib le  f o r  the 
p l a t e l e t s  normal d i s c - l i k e  shape and a lso  fo r  the rapid shape 
change which can occur.  When p l a t e l e t s  are a c t i v a t e d ,  they 
t ra n s fo rm  i n t o  small  i r r e g u l a r  spheres w i th  f i l o p o d i a  and 
pseudopodia ( f igu re  2 .2 ) .  This is  a c o n t ra c t i le  response o f  the 
cy toske l  eton, due to  Ca2+ dependent phosphorylation of myosin by 
the enzyme myosin kinase which i s  t r i g g e r e d  by an increase in  
f r e e  cy top lasm ic  Ca2+ a c t in g  in  concer t  w i th  ca lmodul in  
(Nachmias, Kava le r  and Jacubow i tz ,  1985; Hathaway, Eaton and 
Adel s t e i n ,  1980). The phosphorylated myosin in tu rn  in teracts  
with ac t in  and contract ion ensues. A f u r t h e r  c o n t ro l  mechanism 
also ex is ts  as the kinase can be inh ib i ted  by increased levels of 
i n t r a c e l l u l a r  cyc l ic  AMP.
2.1.3 Organelle Zone
W i th in  the  p l a t e l e t  are a la rg e  number o f  granules which have 
been subd iv ided i n t o  a -g ra n u le s ,  dense bodies (due to  t h e i r  
e le c t ro n m ic ro sco p ic  appearance) and lysosomes. They have a 
random d i s t r i b u t i o n  but become c e n t r a l i s e d  when p l a t e l e t  
a c t i v a t i o n  occurs. They act as s to res  f o r  a la rg e  number of 
pharmacologically act ive substances (tab le  2 .1) .  The a-granu les  
are the most numerous o f  these structures and contain proteins 
such as 3- thromboglobulin,  p la te le t  fa c to r  4 and p l a t e l e t  basic 
p r o t e in ,  which have p ro -c o a g u la n t ,  chemotact ic  and heparin 
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In  a d d i t io n ,  « -g ranu les  a lso  conta in  p la t e le t  derived growth 
fa c to rs  which have m itogen ic a c t iv i t y  fo r  several c e l l  l in e s  
in c lu d in g  smooth muscle c e l ls  and f ib ro b la s ts  (N iewiarowski, 
1981). These substances are released when p la te le ts  adhere to  
th e  subendothelium o f  damaged blood vesse ls , and w hile  these 
factors may be part o f the normal repair process, they have been 
im p l ic a te d  in  the  i n i t i a t io n  o f atherosclerosis by stim u la ting  
p ro l i fe ra t io n  of smooth muscle c e l l s  w ith in  the  media o f blood 
vesse ls  (Ross and Glomset, 1976), The «-granules also contain 
several glyco-proteins such as fib rinogen, von Willebrand fa c to r  
and f ib r o n e c t in .  Lysosomes are membrane bound o rgan e lles  
con ta in in g  h y d ro ly tic  enzymes which may be invo lved  in  the  
inflammatory response by a lte rin g  vascular perm eability.
Dense bodies contain high concentrations o f ADP, ATP, calcium and 
s e ro to n in .  Since ADP and calcium  are im portant in  p la te le t  
aggregation, release o f the contents o f dense bodies acts as a 
p o s it ive  feedback mechanism fo r  promoting aggregation. Serotonin 
on i t s  own has only weak p la te le t aggregating a c t iv i t y ,  however 
i t  enhances the aggregatory response to  other inducers and causes 
vasoconstriction.
Other p la te le t organelles include the dense tubular system (White 
et a l . ,  1981) a membranous system which sequesters Ca2+ analogous 
to  th e  sarcoplasmic re ticu lu m  o f ske le ta l muscle, several 
m itochondria  (White e t 1981), and the  occasional Golgi
apparatus (White and Gerrard, 1976).
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2.2 PLATELET FUNCTION
2.2.1 P la te le t adhesion
P l a t e l e t s  normally in te ract  only with red c e l l s ,  white ce l l s  and 
vascular endothelium. Al l  other surfaces are fore ign to  them and 
they w i l l  adhere to  any such fo r e ig n  sur face  which they 
encounter .  Much o f  the a v a i l a b le  in fo rm a t io n  on p l a t e l e t  
adhesion comes from the work of Baumgartner (1973). Baumgartner 
exposed de-endothel ialised a o r t i c  s t r ip s  to  f l o w in g  b lood ,  then 
examined the a o r t i c  s t r i p s  m ic ro s c o p ic a l l y  fo l lowing f i x a t i o n  
with glutaraldehyde. Using th i s  technique, many o f  the f a c to r s  
i n f l u e n c in g  p l a t e l e t  adhesion were s tu d ie d .  Both p l a t e l e t  
adhesion and mural thrombus formation are inf luenced by the ra te  
o f  blood f low  over the subendothel ia l  surface. The higher the 
f low  ra te  the g rea te r  the number o f  p l a t e l e t s  depos i ted 
(Baumgartner,  1973; T u r i t to  and Baumgartner, 1979). The number 
o f  p l a t e l e t s  in  the blood and the haemotaocr i t  are a lso 
important,  as red ce l ls  phys ica l ly  enhance p la te le t  deposition by 
increasing the number of p ia te le t-vessel wall i n te rac t io n s  which 
occur (T u r i t to  and Baumgartner, 1975).
Further information on adhesion came from s tud ies  o f  p a t ie n ts  
w i th  von W i l le b ra n d 's  d isease. In von W i l le b ra n d 's  disease 
fa c to r  V l l l - vo n  Willebrand fac to r  is  reduced or abnormal and i t  
has long been known th a t  p l a t e l e t  adhesion is  impaired in th i s  
c o n d i t i o n  (Salzman, 1963), and can be co r rec ted  by adding 
f a c t o r  V l l l - v o n  Wil lebrand's fa c to r  from normal plasma (Weiss et 
al . ,  1978). Factor VI11-von W i l le b ra n d 's  fac to r  seems to  be 
espec ia l ly  important at high f low rates (Baumgartner, Tschopp and 
Meyer, 1980).
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In Bernard-Soul ier  syndrome p la te le t  count is  low, the p la te le ts  
are very la rg e  and b io ch e m ica l l y  abnormal,  as they lack 
g ly c o p ro te in  Ib on the ce l l  surface (Nurden and Caen, 1979), and 
they have reduced adhesion to  subendothelium. F u r th e r  evidence 
fo r  the role of glycoprotein Ib in adhesion came from the work of 
Tobelem et ^ . , (1976) who showed t h a t  an an t ibody to
g ly c o p ro te in  Ib i n h i b i t e d  the  adhesion o f  normal p la te le ts  to 
damaged vascular t issue.
P la t e le t s  a lso  adhere more r e a d i l y  to  s t r u c tu re s  l y i n g  deep 
w ith in  the vessel w a l l ,  such as co l la g e n ,  than the s t r u c tu re s  
immedia te ly  below the vascular endothelium (Crowley and Pierce, 
1981).
2.2.2 P la te le t  Aggregation
The understanding o f  p l a t e l e t  r e a c t i v i t y  owes much to  the 
development o f  the photometric aggregometer (Born, 1962; Born and 
Cross, 1963; O 'B r ie n ,  1962) which has proved invaluable in the 
study of p la te le t  aggregation. P la te le t  aggregation i s  a se r ies  
o f  morpholog ica l  and f u n c t i o n a l  changes, s t a r t i n g  with shape 
change and going on to  aggregation ( f igure  2.3) and re lease o f  a 
v a r i e t y  o f substances such as Ca2+, ADP, thromboxane A2 and 
serotonin, which ampli fy the aggregation response.
FIGURE 2.3
Scanning electron micrograph showing a p la te le t  aggregate, fo l low ing  
s t imu la t ion  by thrombin in whole blood, note the red ce l l s  on the 
l e f t  of the micrograph (magnif icat ion x 5,000) Courtesy of 
A.R. Saniabadi.
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Aggregat ion can be induced by a va r ie ty  of agonists such as ADP, 
collagen, thrombin, adrenal in,  r i s to c e t in ,  a rach idon ic  ac id  and 
p l a t e l e t  ac t iva t ing  fac to r  (PAF). The primary stimulus involves 
in te rac t ion  of the agonist with a receptor s i t e ,  which i s  o f te n  
sp e c i f ic ,  on the p la te le t  membrane.
While shape change usual ly precedes aggregat ion, t h i s  i s  not an 
abso lu te  p r e r e q u is i t e  as a d re n a l in  induced aggregation is  not 
preceded by shape change (Co l le r ,  1984). The phys io log ica l  r o le  
o f  shape change is  not e n t i r e l y  clear  but is  thought to  expose 
the open cana l icu la r  system where spec i f ic  f ibr inogen and f a c t o r  
VI11-von W i l leb rand  f a c t o r  recep to rs  may be located. I t  also 
allows a greater surface area f o r  contact with other p la te le ts  or 
fo re ign surfaces.
There are th re e  pathways of aggregation which w i l l  be described 
(Vargaf t ig ,  Chignard and Benveniste, 1981).
The F i r s t  Pathway of Aggregation
Adenosine d iphosphate is  a spec i f ic  p la te le t  s t imulat ing agent, 
which causes a typ ica l  b ip h a s ic  aggregat ion response which i s  
dependent on both f ib r inogen  (Cross, 1964) and d iva lent cations 
(Han and A rd l ie ,  1974).
The pr imary  or re v e rs ib le  phase is  produced by an agent such as 
ADP which exposes f ib r inogen receptors on the p l a t e l e t  membrane 
a l lo w in g  aggregat ion  to  occur (Bennet t  and Vi 1 ai re, 1979), by 
means o f  f i b r in o g e n  molecules occupying t h e i r  receptors  and 
forming ce l l  bridges with other p la te le ts .
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The second or i r r e v e r s i b l e  phase is  mediated by genera t ion  of 
p ro s ta g la n d in s ,  thromboxane A2 , and the  subsequent release of 
substances such as ADP, serotonin, and f ib r inogen .  In h ib i to rs  of 
cyclo-oxygenase such as asp ir in  w i l l  i n h i b i t  the second phase of 
ADP induced aggregat ion (V a rga f t ig  e;t , 1981) by preventing 
p ro s ta g la n d in  and thromboxane A2 formation. Whether the second 
phase of aggregation w i l l  occur depends on the  dose o f  ADP. I f  
i n s u f f i c i e n t  ADP is  present to  induce secondary aggregation then 
disaggregation w i l l  occur and the p l a t e l e t s  w i l l  resume t h e i r  
non-adhesive d is c - l i k e  shape.
The Second Pathway of Aggregation
The second pathway of aggregation is  arachidonic acid dependent, 
and i s  t r i g g e re d  by agon is ts  such as c o l la g e n  and th rombin 
(V a r g a f t i g  et aj_., 1981). The agonist binds to  a receptor and 
s t im u la te s  phospholipase A2 , possibly by increasing Ca2+ as th is  
enzyme is  Ca2+ dependent. Phosphol ipase A2 breaks down 
phosphatidyl-ethanolamine, a membrane p h o s p h o l ip id ,  to  produce 
f r e e  a rach idon ic  ac id ,  which is  converted by cyclo-oxygenase to  
endoperoxides, and then by thromboxane synthetase to  thromboxane 
A2 . Thromboxane A2 st imulates aggregation both d i r e c t l y ,  as i t  
i s  a potent inducer  o f  aggregat ion (Hamberg et , 1975), and 
i n d i r e c t l y  by re lease o f  the contents of the p la te le t  granules 
(Hamberg et , 1974; Hamberg et , 1975) which w i l l  cause 
fu r th e r  aggregation. This forms a pos i t ive  feedback loop.
Phûsphatidyl imiosttol
2+Ca
Phosphol lipase C 





(PQ&2' "  " " 2 '
Thromboxane SjTRthetase
Vasoconstric tion
P la te le t
FIGURE
The second or arachidonic acid dependent pathway o f aggregation. 
Collagen and thron*in  w i l l  stim ulate th is  pathway by a c tiva tin g  
the phospholipases. Exogenous arachidonic acid w i l l  bypass the 
phospholipase step, and induces aggregation by generation o f
thromboxane Ag.
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Arach idon ic  ac id can a lso be l i b e r a te d  by the  a c t io n  o f  
phosphol ipase C and d ig l y c e ro l  l i p a s e ,  which are a lso  Ca2+ 
dependent, on phosphatidyl inos i to l  in the ce l l  membrane.
Exogenous arach idon ic  acid i s  not a d i r e c t  s t i m u la t o r  o f  
aggregat ion  but acts through production of thromboxane ^2•  This 
pathway is  i l l u s t r a te d  in  f igu re  2.4.
The Third Pathway of Aggregation
The ex is tence of a possible t h i r d  pathway of aggregation came to 
l i g h t  when i t  was discovered that p la te le t  aggregation induced by 
Ca2+ ionophore or high concentrat ions of thrombin or collagen, 
was not abol ished by b lock ing  both ADP and a rach id o n ic  ac id  
pathways s im u l taneous ly ,  and PAF, a p h osp h o l ip id ,  may be 
respons ib le  f o r  t h i s  (V a rg a f t i g  et , 1981). PAF induces 
aggregat ion  and release of both a-granules and dense bodies and 
is  independent of arachidonic acid and ADP. The mode o f  re lease  
o f  PAF i s  unknown but Ca2+, and high dose collagen and thrombin 
w i l l  cause release of s u f f i c ie n t  PAF from the p la te le ts  t o  cause 
aggregation (Vargaft ig et ^ . , 1981).
2.3 PLATELET PRODUCTION, KINETICS AND SIZE
P la te le ts  are produced from the fragmentation of the cytoplasm of 
megakaryocytes. Megakaryocytes are derived from m u l t i  p o te n t i a l  
c e l l s  in  the bone marrow and are unique as they can reproduce 
t h e i r  d eoxy r ibonuc le ic  ac id  (DMA) w i tho u t  undergoing c e l l  
d i v i s i o n ,  a process termed endomitosis. They s ta r t  as d ip lo id  
stem ce l ls  and t h e i r  DMA content doubles several times u n t i l  they 
are p o ly p lo id  w i th  somewhere between 2 and 32 t imes the  DNA
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con ten t  o f a s in g le  c e l l .  The cytoplasm then enlarges and 
granules are formed as the ce l l  matures. The whole matu ra t ion  
process takes between 4 and 5 days. The cytoplasm then fragments 
and p la te le ts  are released into the c i rcu la t io n  (C o l le r ,  1984).
Recently  i t  has been suggested that the whole megakaryocyte is  
released from the marrow and fragments a f te r  being trapped in the 
pulmonary c i rcu la t ion  (Trowbridge, Martin and S la te r ,  1982).
P l a t e l e t  p roduct ion  is  thought to  be under the  co n t ro l  o f  a 
th ro m b op o ie t ic  hormone (C o l l e r ,  1984; F i r k i n ,  1984) which 
increases when p la te le t  count f a l l s  and vice-versa.
The normal c i r c u l a t i n g  p l a t e l e t  count in  man i s  150 - 350 x 
10^/1i t r e  in whole blood (Sloan, 1951), and the p la te le t  l i fespan 
in normal humans is  around 8 - 1 0  days as determined by r a d io ­
iso tope  (Gardner, 1972) and asp i r in  la b e l l in g  (Rakoczi et ^ . , 
1979; Wallenburg and van Kessel, 1978) techniques.
P la te le ts  are heterogeneous in terms of size and dens i ty .  Large 
heavy p l a t e l e t s  are thought to  be young c e l l s ,  and progress to 
smaller l i g h te r  p la te le ts  with age. The la rg e  young p l a t e l e t s  
are thought to be metabol ica l ly and fu n c t io n a l ly  more act ive than 
the small older ones (Karpatkin and Charmatz, 1969; K a rp a tk in ,  
1969; Karpatkin, 1978).
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2.4 PLATELETS AND COAGULATION
P l a t e l e t s  play a centra l  ro le  in haemostasis. Following damage 
to  the vessel wall a p la te le t  plug forms to  a r res t bleeding. This 
i s  dependent on p l a t e l e t  adhesion to  co l lagen  in  the damaged 
vessel wa l l ,  and subsequent p la te le t  aggregation. The importance 
o f  t h i s  i s  seen in  von W i l le b ran d 's  disease where adhesion is  
defect ive (Salzman, 1963) and as a r e s u l t  the  b leed ing  t ime  i s  
prolonged. ’
The p la te le t  plug is  i n s u f f i c ie n t  on i t s  own to  provide long-term 
haemostasis and a c t iva te d  p la t e l e t s  are invo lved  in  the  
a c t i v a t i o n  o f  the coagu la t ion  cascade. This culminates in the 
fo rm a t io n  o f  a f i b r i n  mesh at the s i t e  o f  b leed ing  which 
maintains haemostasis and promotes wound heal ing.
The coagula t ion cascade i s  a chain o f  enzymatic re a c t ion s  in  
which proenzymes are converted to  act ive enzymes which in turn 
ac t iva te  fu r th e r  enzymes (Davie and Ratnoff , 1964). This f i n a l l y  
r e s u l t s  in  thrombin formation which in turn cleaves f i b r i n  from 
f i b r i n o g e n .  The i n t e r a c t i o n  o f  these c l o t t i n g  f a c to r s  i s  
acce le ra ted  by t h e i r  being absorbed and concentra ted onto a 
su i tab le  phospholipid surface thereby a m p l i f y in g  the response. 
P l a t e l e t s  prov ide such a su r face ,  and in  a d d i t i o n  a c t i v a t e  
fac to rs  XI and XII d i r e c t l y  (Walsh, 1972a; Walsh, 1972b).
Ac t iva t ion  of fac tor  X by activated fac to r  IX, and of prothrombin 
by a c t i v a te d  f a c t o r  X, occur on a n e g a t iv e ly  charged l i p i d  
s u r fa c e .  P la te le t s  have an assymetr ic  d i s t r i b u t i o n  o f  
phospholipids in the two layers o f  the c e l l  membrane, w i th  the
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The Coagulation Cascade 
Coagulation is i n i t i a t e d  by e i ther  the i n t r i n s i c  pathway, act ivated 
by surface contact,  or the e x t r in s ic  pathway, act ivated by t issue 
thromboplastins. In the i n t r i n s i c  pathway, phospholipid is provided 
by p la te le ts  and in the e x t r in s ic  pathway by the phospholipid 
component of t issue thromboplastins. After ac t iva t ion  of fa c to r  X 
both pathways converge. This diagram is s im p l i f ied  as in h ib i t o r s  
of the steps and in teract ions between the two pathways have been 
omitted.
(FXTT = fa c to r  IT T ; FXTTa = Activated F m  e tc . )
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most n e g a t iv e ly  charged phospholipids on the ins ide. Following 
a c t iva t ion  by thrombin or collagen a transmembrane " f l i p - f l o p "  of 
phospho l ip ids  occurs and the most n e g a t iv e ly  charged 
phospholipids move to the o u ts ide ,  thus p ro v id in g  a c a t a l y t i c  
su r fa ce  f o r  f a c t o r  X and prothrombin act iva t ion  (Bangham, 1961; 
Schick, 1979). This capacity of activated p l a t e l e t s  t o  enhance 
prothrombin act ivat ion has been termed p la te le t  fac to r  3 (Col ler ,  
1984).
P l a t e l e t s  a lso re lease f a c t o r  V from a granules and bind 
f a c t o r  V. When a c t i v a te d ,  f a c t o r  V acts as an a d d i t i o n a l  
re c e p to r  f o r  a c t iva te d  f a c t o r  X on the p l a t e l e t  membrane 
promoting thrombin formation (Majerus, Mi le t ich  and Kane, 1980). 
The f a c t o r  V I I I  re la ted  ant igen bound by the p la te le t  may also 
act as a b ind ing  s i t e  f o r  the f a c t o r  V I I I  coagulant mo ie ty ,  
th e reby  increasing the concentration of fac to r  V I I I  coagulant on 
the p la te le t  surface where i t  may act as a r e g u la to ry  p r o te in  
enhancing a c t i v a t i o n  o f  f a c t o r  X (S a i to ,  1984). F in a l l y ,  the 
f i b r i n  becomes int imate ly  involved in the p la te le t  mass ( C o l l e r ,  
1984). A s i m p l i f i e d  scheme of the coagulation cascade is  given 
in  f ig u re  2.5.
2.5 PLATELETS AND THROMBOSIS AND ARTERIOSCLEROSIS 
From the foregoing descript ion of p la te le t  funct ion and p la te le ts  
in coagulat ion, i t  is  apparent tha t  p la te le ts  may play a r o le  in  
the  pathogenesis o f  th rombot ic  vascular occlusion and a r te r io ­
sc le ros is .
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P l a t e l e t s  probably c o n t r i b u te  to  a r te r iosc le ros is  in two ways. 
F i r s t l y ,  p la te le ts  form thrombi at the s i te  of endothel ial  i n ju ry  
and these become organised and incorporated in to  the vessel wall 
causing a r t e r i o s c l e r o t i c  narrowing (Jorgensen ^  a l . , 1972; 
F u s te r ,  1981). Secondly, when p la te le ts  are act ivated fo l low ing  
adhesion to  the subendothel ium, they re lease a v a r i e t y  o f  
vasoac t ive  substances in c lu d in g  thromboxane which increases 
vascular permeabi l i ty and causes v a s o c o n s t r i c t i o n .  A m i togen ic  
fa c to r ,  p la te le t  derived growth fac to r ,  is also released and th is  
causes p ro l i f e ra t i v e  changes in the vessel wal l  which have been 
im p l i c a te d  in  the pathogenesis o f  a r t e r i o s c l e r o s i s  (Ross and 
Glomset, 1976). Additional evidence fo r  the ro le  o f  p la te le ts  in  
a r t e r i o s c l e r o s i s  comes from animal models. Animals rendered 
thrombocytopaenic, are protected from a r te r iosc le ros is  induced by 
repeated e n d o th e l ia l  i n j u r i e s  (F r i  edman et aj_., 1977) w h i le  
animals rendered thrombocythaemic develop increased a r te r io ­
s c le ro t ic  lesions i f  they are also fed on a high cholesterol  d ie t  
(Cohen and McCombs, 1967).
In the  c l i n i c a l  s i t u a t i o n  p a t ie n ts  w i th  vascular disease have 
been shown to  have increased p la te le t  turnover rates (Zahavi and 
Zahavi, 1985; Murphy and Mustard, 1962; Steele et ^ . ,  1973), and 
abnormal p l a t e l e t  funct ion  has been reported in pat ients  with a 
wide var ie ty  of vascular disease (Zahavi and Zahavi, 1985; Steele 
et 1973; Mehta, Mehta and Pepine, 1978; Walsh, Pareti  and
C o rb e t t ,  1977). In addit ion decreased s e n s i t i v i t y  o f p la te le ts  
from pat ients with ischaemic heart  disease to  p r o s ta c y c l i n  has 
been reported (Mehta and Mehta, 1980). Thromboxane A2 , the major 
a ra ch id o n ic  acid metabol i te in p la te le ts  (Hamberg et a l . , 1975),
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which is  a potent p la te le t  aggregating agent and vasoconstr ic to r ,  
has been impl icated in thrombotic and a r t e r io s c le ro t i c  s i tua t ions  
such as ischaemic heart disease (Hirsh et al_., 1981; Mehta, 1983) 
and peripheral vascular disease (Zahavi and Zahavi, 1985).
2.6 CONTROL OF PLATELET FUNCTION
Control o f  p la te le t  funct ion  centres on the concentrat ion o f  free 
i n t r a c e l l u l a r  Ca2+, which i s  the intermediary l in k in g  receptor 
occupancy with c e l l u l a r  response. S t im u l i  t r i g g e r i n g  p l a t e l e t  
a c t i v a t i o n  such as c o l l a g e n ,  th rombin  or ADP act by promoting 
Ca2+ release from i t s  storage s i tes  in  the dense tubu la r  system.
In c re a s in g  Ca%+ re lease  promotes p l a t e l e t  shape change by 
a c t i v a t i n g  the Ca2+ dependent phosphorylat ion of myosin, and the 
subsequent myosin-act in in te ra c t io n  responsib le  f o r  c o n t r a c t i o n  
(Hathaway et a l . ,  1980).
Free i n t r a c e l l u l a r  Ca^+ a lso  promotes the  re le a se  r e a c t io n  
(Feinman and D i t w i l e r ,  1974) by causing the p la te le t  granules to  
fuse with the ce l l  membrane thereby discharging t h e i r  contents.
In a d d i t i o n  Ca2+ s t im u la te s  p ro du c t io n  o f  endoperoxides and 
thromboxane by a c t iva t in g  Ca2+ dependent phospholipases which 
act on membrane p h o sp h o l ip id s  to  re lease  a ra ch id o n ic  a c id .  
A rach idon ic  ac id  i s  then conver ted v ia  cyc lo-oxygenase and 
thromboxane synthetase to  thromboxane A2 .
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The f ree  i n t r a p la t e l e t  Ca2+ concentrat ion is  con tro l led  by c y c l ic  
adenosine monophosphate (cAMP) c o n c e n t ra t io n s .  When l e v e l s  o f  
cAMP are high Ca2+ is  taken up by the dense tu b u la r  system. When 
cAMP leve ls  are low Ca2+ concentrat ions can increase and p la te le t  
a c t i v a t io n  occurs (Kaser-Glanzmann, Gerber and Luscher, 1979).
Cycl ic  AMP is  regulated by 2 enzymes, adeny la te  cyc lase which 
forms cAMP from adenosine t r i p h o s p h a te  (ATP), and phospho­
diesterase which breaks down cAMP t o  5' adenosine monophophate 
(S'  AMP). The a c t i v i t y  o f  these enzymes is  also regulated by 
Ca2+ concentra t ion. Adenylate cyclase is  in h ib i te d  by Ca2+ whi le 
phosphod ies te rase  is  s t im u la t e d .  Consequently when f r e e  
i n t r a p l a t e l e t  Ca2+ i s  high i t  i n h ib i t s  formation,  and promotes 
breakdown o f  cAMP, the re by  main ta in ing high leve ls  o f  Ca%+ and 
promoting p la te le t  a c t i v a t io n .
Thromboxane A2 and p r o s t a c y c l i n  oppose each o th e r  th rough 
r e g u l a t i o n  o f  adeny la te  cyc lase  (Tateson, Moncada and Vane, 
1977). The p roagg rega to ry  substances thromboxane A2 and 
p ro s ta g la n d in s  G2 and H2 i n h i b i t  adenylate cyclase a l lowing free  
i n t r a p l a t e l e t  Ca%+ to  r i s e .  They a lso  have a d i r e c t  e f f e c t ,  
promoting Ca%+ release from i n t r a c e l l u l a r  storage s i tes  (Gerrard, 
Bu t le r  and White, 1977).
On th e  o th e r  hand, p l a t e l e t  i n h i b i t o r y  prostaglandins such as 
PG%2 s t im u la t e  adeny la te  cyc lase ,  increasing cAMP and reducing 
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E f fec t  of Ca and cAMP on p la t e le t  arachidonic acid metabolism.
(— ►  = s t im u la to ry  e f fe c t :  --------------- 11 = i n h i b i t o r y  e f fe c t )
2 +cAMP exerts i t s  e f fe c t  by lowering Ca concentra t ion. Thromboxane Ag 
also d i r e c t l y  s t imulates Ca^^ release.
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The e f f e c t s  o f  Ca^+ and cAMP on p l a t e l e t  a ra c h id o n ic  ac id  
metabolism are i l l u s t r a t e d  in  f ig u re  2.6.
2.7 PROSTACYCLIN AND THROMBOXANE IN THE PLATELET-ENDOTHELIUM 
INTERACTION
P l a t e l e t s  do not no rma l ly  adhere to  va scu la r  
endothelium ( f i g u r e  2 . 7 ) .  The reasons f o r  t h i s  are u n c le a r ,  
however, th e re  are severa l  p o s s i b i l i t i e s .  F i r s t l y ,  both 
p la te le ts  and endothelium have a negat ive surface charge, making 
them n a t u r a l l y  repel each o th e r .  This,  however, cannot be the 
so le  e x p la n a t io n ,  as p l a t e l e t s  adhere r e a d i l y  t o  the  sub­
endothelium which has a s im i l a r  negative charge.
A second p o s s i b i l i t y  is  a continuous release o f  p r o s t a c y c l i n  by 
the  endothe l ium i t s e l f .  P r o s ta c y c l in  i n  the major product o f  
arachidonic acid metabolism in  vascular t i s s u e .  The a b i l i t y  o f  
th e  v a s c u la r  w a l l  t o  generate  p r o s ta c y c l i n  is  greatest on the 
e n d o th e l ia l  s u r fa c e ,  and decreases p r o g r e s s i v e l y  to  th e  
a d ve n t i t ia l  surface (Moncada ^  aj_., 1977).
Prostacyc l in  is  a potent i n h i b i t o r  o f  p la te le t  a c t i va t io n ,  act ing 
by s t im u la t ing  p la te le t  adenylate cyclase to  increase cAMP, which 
in  t u r n  reduces Ca^+ a v a i l a b i l i t y  and m a in ta ins  p l a t e l e t  
s t a b i l i t y .  Maintenance o f  the  normal d is c  l i k e  shape i s  a lso  
p h y s i c a l l y  u n s u i ta b le  f o r  c e l l - c e l l  contact.  Prostacyc l in  also 
reduces f ib r inogen  receptor exposure on the p la te le t  and th i s  may 
a lso  help m a in ta in  p l a t e l e t  s t a b i l i t y  (Hawiger, Parkinson and 
Timmons, 1980). I t  is  there fore  thought tha t  p rostacyc l in  plays 
a major  r o le  in  p re v e n t in g  p l a t e l e t s  from adher ing  to  
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q u a n t i t y  t o  funct ion as a c i r c u la t in g  a n t i - p l a t e l e t  agent (B la i r  
e^ aj_ ., 1982), a l though i t  i s  s t i l l  thought to  be important in 
th e  l o c a l  p ia te le t -vesse l  wall in te rac t io n  (Patrono, Preston and 
Vermylen, 1984). In add i t ion ,  the concentrat ion o f  p r o s ta c y c l i n  
re q u i re d  t o  i n h i b i t  adhesion is  much greater  than tha t  required 
to  i n h i b i t  aggregat ion (Higgs _et aj_., 1978), and is  un l ike ly  to  
be achieved even on the  e n d o th e l ia l  s u r fa c e .  Consequently,  
p ros tacyc l in  cannot alone by responsible f o r  i n h i b i t i n g  p l a t e l e t  
adhesion t o  the vessel w a l l .  I t  may, however, be important in 
l im i t i n g  p la te le t  aggregation and thrombus fo rm a t io n  in  damaged 
v e s s e ls .  Fol lowing damage to  the endothelium, p la te le ts  qu ick ly  
adhere to  the subendothelium ( f i g u r e  2 .8 )  and the  surround ing  
traumatised vascular t i ssue  releases r e la t i v e l y  large amounts of 
p ros ta cyc l in  which l i m i t  subsequent p l a t e l e t  aggrega t ion  and 
thrombus formation.  In add i t ion ,  the act iva ted p la te le ts  release 
endoperoxides (Hamberg et al_., 1974) which can be u t i l i s e d  by the 
su r round ing  vessel wal l to  produce pros tacyc l in  (Bunting et a l . ,  
1976; Marcus, Weksler and J a f fe ,  1978; Marcus _et , 1980). This 
in  t u r n  may l i m i t  f u r th e r  p la te le t  aggregat ion. These phenomena 
may be par t  o f  a nega t ive  feedback loop to  p reven t  excess ive 
p l a t e l e t  a c t i v a t i o n  and thrombus fo rm a t io n  at the s i t e  o f  
endothel ia l  i n ju r y .  However, the a b i l i t y  o f p la te le ts  to provide 
endoperoxides f o r  v a s c u la r  convers ion  t o  p rostacyc l in  has not 
been conf irmed by o th e r  workers (H o rn s t ra ,  Haddeman and Don, 
1979), thus b r in g in g  the  e x is te nce  o f  t h i s  possible mechanism 
in to  quest ion. A fu r th e r  poss ib le  mechanism l i m i t i n g  p l a t e l e t  
agg rega t ion  and thrombus fo rm a t io n  i s  t h a t  thrombin, which is  
generated by ac t iva t ion  o f  the coagulation system, can s t im u la t e
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p r o s t a c y c l i n  p ro d u c t io n  (Weksler,  Ley and J a f f e ,  1978) which 
could maintain vascular patency by l im i t i n g  p la te le t  aggrega t ion  
and producing local vasod i la t ion .
Other  p o s s ib le  mechanisms f o r  reducing p l a t e l e t  adhesion, 
aggregation and thrombus formation include the presence of ADPase 
and a c t i v a t o r s  o f  f i b r i n o l y s i s  (Ash fo rd ,  1969; Heyns et a l . .  
1974) in  th e  endothe l ium. However, i t  i s  l i k e l y  t h a t  many 
f a c t o r s  c o n t r i b u t e  to  the " th rom bores is tance "  o f  vascu la r  
endothelium.
2.8 EFFECT OF DRUGS ON PLATELET FUNCTION
From the  foregoing discussions i t  is  c lear  th a t  p la te le ts  play a 
major ro le  in  the pathophysiology of vascular disease and a great 
deal o f  work has cen t red  on drugs which i n h i b i t  p l a t e l e t  
a c t i v a t io n .  There have been innumerable studies on a n t i - p l a te l e t  
agents, which a f fe c t  p la te le t  funct ion in a va r ie ty  o f  ways. The 
most w idely  studied groups are drugs which a f f e c t  a ra ch id o n ic  
acid metabolism, cAMP and Ca^+ a v a i l a b i l i t y .
2.8.1 Drugs A f fec t ing  Arachidonic Acid Metabolism 
In h ib i to r s  o f  Phospholipase
Phosphi1pases break down p l a t e l e t  membrane p h o sp h o l ip id s  to  
produce free  arachidonic ac id, the substrate f o r  thromboxane A£»
Cort icos tero ids  i n h i b i t  the act ion o f  phosphol ipases (Hong and 
Lev ine ,  1976), and also block vascular p ros tacyc l in  product ion, 
and may thus contr ibu te  to  the thrombotic problems o c c a s io n a l l y  
seen with s te ro id  admin is tra t ion (Blajchman et a l . ,  1979).
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The a n t i m a l a r i a l  d rug, mepacrine, also blocks arachidonic acid 
release (Winocour, Kinlough-Rathbone and Mustard, 1979). Local 
an ae s th e t ic s  reduce phospholipase a c t i v i t y  possibly by acting on 
calmodulin (Wong and Cheung, 1979), an i n t r a c e l l u l a r  Ca?+ binding 
pro te in  involved in  in t ra -ce l  1u la r  Ca2+ t ra n sp o r t .  None of these 
drugs, however, have been tested in c l i n i c a l  s i tu a t ion s .
Adrenocepto r  a n ta g on is ts  i n h i b i t  p l a t e l e t  aggregat ion  and
thromboxane A2 p ro du c t io n  (Weks ler ,  G i l  l i c k  and Pink, 1977; 
Campbell et^ , 1981), p o s s ib l y  by reduc ing  phosphol ipase 
a c t i v i t y  (Vanderhoek and F e in s t e in ,  1979). Some adrenoceptor 
antagonists have also been shown to  improve prognosis in pat ients 
f o l l o w i n g  myocard ia l  i n f a r c t i o n  (Norwegian M u l t i  centre Study 
Group, 1981; Hj al marson et aj_., 1981), and a possible mechanism 
may be i n h i b i t i o n  o f  p la te le t  func t ion .  A f u l l e r  discussion of 
the a n t i - p l a t e l e t  propert ies of adrenoceptor antagonists fo l l o w s  
in  subsequent chapters.
Cyclo-oxygenase In h ib i to rs
Cyclo-oxygenase occupies a p i v o t a l  r o le  in  a ra ch id o n ic  ac id  
metabolism, convert ing arachidonic ac id  t o  endoperoxides which 
are then converted by thromboxane synthetase in  the p la te le t  to  
thromboxane A£. In the vessel wal l the endoperoxides formed from 
arachidonic acid are converted to  p ros tacyc l in .  Cyclo-oxygenase 
i s  i n h i b i t e d  by numerous non-s tero ida l  ant i- in f lammatory drugs 
such as a s p i r i n  (Smith and W i l l i s ,  1971; Vane, 1971),
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i ndomethacin (Roth, S tan fo rd  and Majerus, 1975), and the newer 
non-stero idal ant i- in f lammatory agents such as ibuprofen (Mustard 
and Packham, 1978).
A s p i r i n  i r r e v e r s i b l y  ace ty l  ates cyclo-xoygenase. Indomethacin 
blocks cyclo-oxygenase a c t i v i t y  but the mechanism is  u nc lea r  and 
may be r e la t e d  to  reduced Ca2+ a v a i l a b i l i t y  (Northovpr, 1978). 
Ibup ro fen  causes r e v e r s i b l e  i n h i b i t i o n  o f  cyc lo-oxygenase 
p robab ly  competing f o r  the same s i t e  as a sp i r in  (Parks, Hoak and 
Czervionke, 1981).
Sul phi npyrazone i s  a u r i c o s u r i c  agent which is  claimed to  have 
a n t i t h r o m b o t i c  p r o p e r t i e s ,  i t  a lso  r e v e r s i b l y  b locks  cyc lo -  
oxygenase (A l i  and McDonald, 1978).
Asp i r in  and sul phi npyrazone have been the most e x te n s iv e l y  used 
cyc lo -oxygenase  i n h i b i t o r s  in  c l i n i c a l  s tud ies , and have been 
evaluated in  the secondary p revent ion  o f  myocard ia l  i n f a r c t i o n  
( A s p i r i n  Myocard ia l  I n fo rm a t io n  Study Research Group, 1980; 
Coronary Drug Pro ject  Research Group, 1980; Elwood and Sweetnam, 
1980; Anturane R e in fa rc t io n  T r ia l  Research Group, 1980; Anturan 
Rein fa rc t ion  I t a l i a n  Study Group, 1982). The r e s u l t s  o f  these 
s tu d ie s  have not been e n t i r e l y  c o n s i s t e n t ,  however, they have 
shown at leas t  a trend towards reduc ing  the  inc id e nce  o f  non- 
fa ta l  myocardial r e - in fa r c t io n  and to ta l  m o r ta l i t y .
More recent ly  a combination of dipyridamole and a s p i r in  has been 
shown to  be e f fe c t i v e  in  reducing non-fatal  myocardial i n fa rc t io n  
and cardiac deaths, espec ia l ly  when combined with an adrenoceptor
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a n ta g o n is t  (P e rsa n t in e -A sp 1 r i n R e in fa r c t i o n  Study I I  Research 
Group, 1985). A lthough the  combinat ion o f  a s p i r i n  and 
d ip y r id a m o le  has not been shown to  be s t a t i s t i c a l l y  any be t te r  
than a s p i r in  alone i n  the  secondary p re ve n t io n  o f  myocard ia l  
r e - i n f a r c t i o n  (P e rsa n t i  ne-As pi r i  n R e in fa rc t io n  Study Research 
Group, 1980).
A s p i r i n  has a lso  been shown to  be e f f e c t i v e  in  the  secondary 
prevent ion of cerebrovascular disease, whi le sulphinpyrazone had 
no e f f e c t  on i t s  own and a combinat ion o f  both was not 
s i g n i f i c a n t l y  be t te r  than a s p i r in  a lone (Canadian C o-o p e ra t ive  
Study Group, 1978). Strangely the benef i ts  of asp i r in  therapy in 
t h i s  study were confined to  mal es I
A s p i r i n  and d ip y r id a m o le  have a lso  been shown to  be o f  
p r o p h y la c t i c  va lue in  pregnancies at high r isk  of i n t r a -u t e r i  ne 
growth re ta rda t ion  and pregnancy induced hyper tens ion  (B e a u f i l s  
et a l . ,  1985).
There i s ,  however, an asp i r in  dilemma as the benef ic ia l  e f fec ts  
o f  a s p i r i n  on p l a t e l e t  f u n c t i o n  may be o f f s e t  by a s i m i l a r  
i n h ib i t o r y  e f fe c t  on vascular prostacyc l in  production (Preston et 
al . ,  1981). C learly  t h i s  is  undesirable. To avoid t h i s  problem 
lower  doses o f  a s p i r i n  have been used in  an a ttempt  to  
s e l e c t i v e l y  b lock p l a t e l e t  aggrega t ion  and thromboxane A2 
f o rm a t io n .  P la te le t  thromboxane A2 production has been shown to  
be completely in h ib i te d  by 20 mg o f  a s p i r i n  a day ( P a t r i g n a n i ,
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F i la b o z z i  and Patrono,  1982), w h i le  p r o s t a c y c l i n  m e ta b o l i t e  
excre t ion was unaffected, implying tha t  t h i s  dose of a s p i r i n  had 
no e f fe c t  on vascular p rostacyc l in  product ion.
However, even complete p reven t ion  of thromboxane A2 production 
does not n e c e s s a r i l y  reduce p l a t e l e t  aggrega t ion  as has been 
shown w i th  s e le c t i v e  thromboxane synthetase in h ib i t o r s  (Bertele 
et a l . ,  1981).
A f u r t h e r  method o f  a vo id ing  the e f fe c t  o f asp i r in  on vascular 
p r o s t a c y c l i n  p ro du c t io n  i s  t o  a d m in is te r  the drug less  
f r e q u e n t l y .  The p l a t e l e t  cyc l  o-oxygenase i s  permanently
acety lated and as the p la te le t  is  anucleate i t  cannot syn thes ise  
any f u r t h e r  enzyme. In con tras t ,  vascular endothel ial  c e l l s  can 
synthesise p ro te in  and t h e r e f o r e  can rep lace  the  i n a c t i v a t e d  
enzyme ( J a f f e  and Weksler ,  1979) , and m a in ta in  p r o s t a c y c l i n  
p ro d u c t i o n .  Since a s p i r i n  b locks  p l a t e l e t  aggrega t ion  and 
thromboxane A2 production f o r  at least 24 hours (Preston et a l . ,  
1981; Patrignani et , 1982), there is  no need to  give the drug 
more than once a day.
Oral a d m in i s t r a t i o n  o f  low dose a s p i r i n  might a lso  produce 
pharmacologically act ive  drug concentrat ions on ly  in  the  p o r ta l  
c i r c u l a t i o n  and not in  the  systemic c i r c u l a t i o n  as a sp i r in  is  
metabol ised in  the l i v e r .  Since p l a t e l e t  cyc lo-oxygenase i s  
i r r e v e r s i b l y  i n h i b i t e d  by a s p i r i n ,  e f f e c t i v e  i n h i b i t i o n  o f  
p la te le t  funct ion would occur f o l l o w i n g  exposure to  a s p i r i n  as 
the  p l a t e l e t  passes th rough the p o r ta l  c i r c u l a t i o n ,  w h i le  
systemic vascular pros tacyc l in  production would remain unaffected
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due t o  the lower  a s p i r i n  c o n c e n t ra t io n  in  the  sys temic  
c i r c u la t i o n .  A recent study (Rosenkranz and F r o l i c h ,  1985) has 
shown such e f f e c t s  t o  occur a f t e r  a s i n g le  dose o f  100 mg of 
asp i r i  n.
Thromboxane Synthetase In h ib i to r s
The use o f  thromboxane synthetase i n h ib i t o r s  is  t h e o re t i c a l l y  a 
very a t t r a c t i v e  method f o r  i n h i b i t i n g  p l a t e l e t  f u n c t i o n .  They 
s e l e c t i v e l y  b lock conversion o f  endoperoxides to  thromboxane A2 
in  p la te le ts .  Furthermore the endoperoxides may also be d iver ted 
t o  th e  endothelium and be converted to  p ros tacyc l in ,  as vascular 
t i s sue  has been shown to  be ab le  to  u t i l i s e  p l a t e l e t  d e r ived  
endoperoxides to  form pros tacyc l in  (Marcus et aj_., 1980). Both 
these features would be des irab le  in  i n h ib i t i n g  thrombosis.
Im idazo le  and i t s  d e r i v a t i v e s  s e l e c t i v e l y  b lock  thromboxane 
syn the tase  (Needleman e t  , 1977). One such compound is  
dazox iben,  and i t  has been shown t o  e f f e c t i v e l y  i n h i b i t  
thromboxane synthetase in  human p l a t e l e t s ,  a l though i t  i s  not 
c l e a r  whether  va s c u la r  p r o s t a c y c l i n  p ro d u c t io n  i s  enhanced 
( T y l e r ,  Saxton and Parry,  1981; Randall et  al^., 1981). Despite 
b lo c k in g  thromboxane fo rm a t io n  these drugs do not a b o l i s h  
aggrega t ion  ( Vermyl en £ t  ^ . , 1981; B e r te le  _et al_., 1981) and 
t h i s  suggests tha t  endoperoxides may themselves be able to  induce 
aggregation without conversion to  thromboxane A2 .
2 .8 .2  Drugs which Increase P l a t e l e t  C y c l i c  Adenosine 
Monophosphate
C y c l i c  AMP i s  formed from ATP by adenylate cyclase, and broken
down to  5' AMP by phosphodiesterase. Increased leve ls  o f CAMP 
low er  i n t r a p l a t e l e t  f r e e  Ca2+ and the reby  i n h i b i t  p l a t e l e t  
fu n c t io n .  Drugs can there fo re  in f lu e n c e  cAMP by promoting i t s  
f o rm a t io n  by s t im u la t i n g  adeny la te  cyc lase ,  or i n h ib i t i n g  i t s  
breakdown, by act ing on phosphodiesterase.
Drugs St imulat ing Adenylate Cyclase
P ro s ta g la n d in s  D% and E%, and p r o s t a c y c l i n  increase adenylate 
cyclase a c t i v i t y  and thereby reduce Ca%+ a v a i l a b i l i t y  and i n h i b i t  
aggregation (Gorman, Bunt ing and M i l l e r ,  1977).  The o rder  o f  
potency o f  these p r o s ta g la n d in s  to  i n h i b i t  aggrega t ion  are 
p r o s t a c y c l i n ,  the most p o te n t ,  then p ro s ta g la n d in  D2 then 
prostaglandin E2 .
P r o s ta c y c l i n  in fusions have been used successfu l ly  in  peripheral 
v a s c u la r  d isease (Belch ejt aj_., 1983a), Raynaud's phenomenon 
(Belch et aj_., 1983b) and severe pregnancy induced hypertension 
(Be lch , 1985), where both i t s  v a s o d i l a t o r  and a n t i ­
p la te le t  e f fec ts  have been o f  value.
Phosphodiesterase In h ib i to rs
I n h i b i t i o n  o f  phosphodieste rase prevents  degrada t ion  of cAMP 
r e s u l t i n g  in  cAMP accum u la t ion .  D ipy r idamo le  and the 
t h e o p h y l l i n e s  are i n h i b i t o r s  o f  phosphodiesterase (Moncada and 
Korbu t ,  1978). D ipyr idamo le  on i t s  own has l i t t l e  e f f e c t  on 
p l a t e l e t  aggregation in v i t r o  (Cucuianu, Nishizawa, and Mustard, 
1971), but when combined w i th  a s p i r i n  i n h i b i t s  adhesion to  
co l la g e n  (Cazenave ^  aj_ . ,  1978) and damaged endothel ium 
(Kinlough-Rathbone et a1_., 1978).
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Dipyr idam o le  in  combina t ion  has been assessed in the secondary 
p re ve n t io n  o f  myocard ia l  i n f a r c t i o n  ( P e r s a n t i ne A s p i r i n  
R e in f a r c t i o n  Study Research Group, 1980; P e r s a n t i ne A s p i r i n  
Rein fa rc t ion  Study I I  Research Group, 1985),  and has a lso  been 
shown to  be o f  va lue in  m a in ta in in g  g r a f t  patency f o l l o w i n g  
coronary a r te ry  bypass g ra f ts  (Chesebro et al_., 1982).
D ipy r idamo le  was a lso  i n i t i a l l y  thought  to  st imula te  vascular 
p ros tacyc l in  production (Vermylen, Charnone and Verstraete,  1979).
This has been recent ly  shown not to  occur (Deckmyn et , 1984), 
however d ipy r idam o le  does de lay  exhaus t ion  o f  p r o s t a c y c l i n  
p ro d u c t io n  by i r r i t a t e d  vesse ls  (Deckmyn e;t aj_., 1984).
Exhaust ion of t issue cyclo-oxygenase fo l low ing  trauma may be due 
to  an accumulation o f  peroxides which ina c t iva te  cyclo-oxygenase. 
D ipy r idamo le  i s  an a n t i - o x i d a n t  and ac ts  as a c o - f a c t o r  f o r  
peroxidase which keeps peroxide leve ls  low and the reby  p ro te c ts  
cyclo-oxygenase al lowing p ros tacyc l in  synthesis to  continue f o r  a 
longer period (Deckmyn et a%., 1984).
2.8.3 Drugs Blocking Calcium A v a i l a b i l i t y
Ca2+ channel b lo c k in g  agents can reduce p l a t e l e t  Ca2+ 
a v a i l a b i l i t y  and drugs such as verapamil  and n i f e d i p i n e  have 
i n h i b i t o r y  e f f e c t s  on p la t e le t  aggregation ( Ikeda _et , 1981;
Han, Boatwr ight and A rd l ie ,  1983). They have also been shown to  
have a s y n e r g i s t i c  a c t i o n  w i t h  p r o s t a c y c l i n  in  i n h i b i t i n g  
p l a t e l e t  f u n c t i o n  ( Ikeda  et , 1981). A fu r th e r  and f u l l e r  
d is c u s s io n  o f  ca lc ium channel b lo ck in g  agents i s  g iven i n  
chapter 9.
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2.9 Dietary L ip ids and P la te le t  Function
Eicosapentaenoic acid is  the major f a t t y  acid in  s a l t  water f i s h ,  
which i s  th e  s ta p le  d i e t  o f  the  Eskimo peop le .  Greenland 
Eskimos have a very low incidence of card iovascular  disease and 
pregnancy induced hypertension. I t  has been suggested t h a t  t h i s  
may be due to  a d i e t  r i c h  i n  e icosapentaeno ic  ac id  which may 
re su l t  in  a benef ic ia l  e f fe c t  on p la te le t  funct ion (Dyerberg and 
Bang, 1979).
When arachidonic acid is  replaced by eicosapentaenoic acid in the 
d ie t  i t  also replaces arachidonic acid in  the p la te le t  membrane. 
Eicosapentaenoic  acid is  metabol ised to  thromboxane A3 which has 
l i t t l e  p ro -a g g re ga to ry  e f f e c t .  In the vessel wal l  
e icosapentaenoic  acid is  converted to  prostaglandin I 3 which has 
s im i la r  e f fe c ts  to  p ros tacyc l in ,  being a potent v a s o d i l a t o r  and 
i n h i b i t o r  o f  p l a t e l e t  a g g rega t ion  (Dyerberg ^  , 1978).
Volunteer studies have confirmed th a t  such a d ie ta ry  modif ica t ion 
w i l l  reduce p l a t e l e t  aggrega t ion  and thromboxane A2 production 
(Si ess e t  , 1980; Thorngren and Gusta fson, 1981). These 
s tu d ie s  suggest tha t  d ie ta ry  m od i f ica t ion  may be an exc i t ing  new 
therapy in  the prevention o f  vascular disease.
CHAPTER 3
PREGNANCY INDUCED HYPERTENSION
3.1 CARDIOVASCULAR CHANGES DURING NORMAL PREGNANCY 
Normal pregnancy i s  assoc ia ted  with a number of a l te ra t io n s  in 
the  c a rd io v a s c u la r  system which s t a r t  to  occur e a r l y  in  
pregnancy. Cardiac ou tpu t  increases by around 40% during the 
f i r s t  t r im e s te r  and t h i s  increase is  maintained during the  t h i r d  
t r i m e s t e r  (Lees ^  aj_. , 1967).  However, i f  cardiac output is  
measured in  the supine pos i t ion  a f a l l  in  output i s  noted in the 
t h i r d  t r im es te r  (Uel and et a]_., 1969) as the venous re tu rn  to  the 
heart  is  obstructed by the gravid uterus.
Blood pressure s ta r ts  to  f a l l  in  the f i r s t  t r i m e s t e r ,  reaches a 
n a d i r  i n  m id-pregnancy,  then s low ly  r i s e s  d u r in g  the  t h i r d  
t r im e s te r  to  leve ls  com pat ib le  w i th  those in  the  non-pregnant 
s ta te  (MacGil l i v r a y  et , 1969).
As b lood p ressure  i s  dete rmined by c a rd ia c  ou tpu t  and t o t a l  
per ipheral res is tance, the decrease in blood pressure must be due 
t o  a f a l l  i n  the  l a t t e r .  Since these changes occur ear ly  in 
pregnancy, they  must r e f l e c t  a change in  systemic va scu la r  
r e s i s t a n c e ,  as th e  u te r o - p la c e n t a l  c i r c u l a t i o n  i s  not 
s u f f i c i e n t l y  large to  account f o r  such a reduct ion in p e r ip h e ra l  
resis tance at t h i s  stage of pregnancy.
The f a l l  i n  p e r ip h e ra l  re s is ta n c e  in  normal pregnancy i s  
assoc ia ted  w i t h  a r e la t i v e  i n s e n s i t i v i t y  to  the pressor e f fec ts  
o f  exogenous a n g io te n s in  I I  (Gant ^  aj_., 1973), which is  
d e te c ta b le  as e a r ly  as 8 weeks gestation and reaches a peak in 
mid-pregnancy. The mechanism underlying t h i s  i n s e n s i t i v i t y  may 
be p ro s ta g la n d in  dependent .  The vasodepressor prostaglandin.
p ro s ta g la n d in  E2 , enhances the  i n s e n s i t i v i t y  to  angiotensin I I  
(B ro u g h to n -P ip k i  n ^  al_., 1982), whi le prostaglandin synthetase 
i n h i b i t o r s  such as indomethacin , have th e  o ppos i te  e f f e c t  
(Everett  jet j l _ . , 1978a). In add i t ion ,  i t  has recent ly  been shown 
th a t  exogenous prostacyc l in  infusions w i l l  reduce the s e n s i t i v i t y  
t o  a n g io te n s in  I I  in  normal pregnancy (Broughton-Pipkin et a l . ,  
1984) .  Thus, the  p ressor  e f f e c t s  o f  a n g io te n s in  I I  may be 
balanced in  normal pregnancy by prostaglandin E2 and prostacyc l in  
which have vasodepressor e f fe c ts .  However, i t  i s  p o s s ib le  th a t  
th e  p roges te rone  m e ta b o l i t e ,  5a-d i  hydroprogesterone, which is  
known t o  enhance the i n s e n s i t i v i t y  to  angiotensin I I  (Everett  et 
a l . ,  1978b) may also be involved.
3.2 DEFINITIONS OF HYPERTENSION IN PREGNANCY 
There are th r e e  p o ss ib le  v a r i e t i e s  o f  hyper tens ion  which can 
occur in  pregnancy.  F i r s t l y ,  th e re  are women who were 
h y p e r te n s iv e  p r i o r  t o  pregnancy, remain h y p e r ten s ive  du r ing  
pregnancy and are s t i l l  h y p e r ten s ive  a f t e r  pregnancy. These 
women have " c h ro n i c  hypertension" and usual ly  t h i s  i s  so cal led 
"essent ia l  hypertens ion" ,  which i s  o f te n  i n h e r i t e d  and has no 
d e f in e d  underlying pathology - although some women with chronic 
h yper tens ion  may have an u n d e r l y in g  problem such as renal 
d ise a se .  Secondly , there are women who were normotensive p r io r  
to  pregnancy, develop hyper tens ion  du r ing  pregnancy and then 
become normotensive again w i th in  a few weeks of d e l i v e ry .  These 
women have pregnancy induced hypertension (PIH). T h i r d l y ,  th e re  
are women who become hyper tens ive  due to  a new medical problem 
such as phaeochromocytoma. Conn's syndrome, or Cushing's
syndrome, which a r is e s  c o i n c i d e n t a l l y  du r ing  a pregnancy, 
however, t h i s  is  very rare. This chapter is  concerned on ly  w i th  
pregnancy induced hypertension.
The te rm in o lo g y  o f  hypertension induced by pregnancy has become 
somewhat c o n fu s in g .  Pre-ec lampsia  i s  a term which i s  o f te n  
lo o s e ly  app l ied  to  p a t i e n t s  w i th  hyper tens ion  induced by 
pregnancy, but pre-eclampsia means d i f f e r e n t  th ings to  d i f f e r e n t  
people and t h e r e f o r e  can lead t o  f u r t h e r  co n fu s io n .  I t  is  a 
useful  term in  tha t  i t  h ig h l ig h ts  the end-po int o f  th e  d isease ,  
namely eclampsia, however, t r a d i t i o n a l l y  i t  is  associated with 3 
c lass ica l  featu res, hypertension, prote inura  and oedema. Since 
p r o t e i n u r i a  i s  r e a l l y  a measure o f  d isease s e v e r i t y  
(M acG i l l iv ray , 1961) and oedema is  re gu la r ly  a feature o f  normal 
pregnancy (Thomson, Hy t ten  and B i l l e w i c z ,  1967),  many 
obs te t r ic ians  now use the term "pregnancy induced h yper tens ion"  
(PIH) the reby  a vo id in g  th e  a s s o c ia t i o n  w i th  p r o t e i n u r i a  and 
oedema which is  impl ied by pre-eclampsia.
Blood pressure in  pregnancy i s  d is t r ib u te d  cont inuously in the 
populat ion, and the d iv id in g  l i n e  between normal and abnormal i s  
somewhat a r b i t r a r y  and a r t i f i c i a l .  Most a u th o r i t i e s ,  however, 
w i l l  use a threshold of 140/90 mm of mercury or a r i s e  in  blood 
pressure  o f  g re a te r  than 20 mm of mercury over the measurement 
taken at 8 - 10 weeks g e s ta t i o n  as the d i v i d i n g  l i n e  between 
"normotens ion"  and "hypertension".  There is  some j u s t i f i c a t i o n  
f o r  t h i s  as the  p e r in a ta l  m o r t a l i t y  r a te  has been shown to  
inc re a se  when maternal d ia s t o l i c  blood pressure exceeds 90 mm of 
mercury (Bu t le r  and Alberman, 1969; Page and Christ ianson, 1976).
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Recording o f  blood pressure i s  also a problem as i t  is  subject to  
observer e r r o r .  In a d d i t i o n ,  blood pressure  i n  pregnancy i s  
h ig h l y  v a r i a b l e  both during waking and sleeping (Redman et a l . ,  
1976a), consequent ly  the  average o f  several measurements taken 
under standard condit ions should be used to  accurately assess the 
p a t i e n t .  I t  i s  a lso  important to  use phase IV, m u f f l ing  of the 
Koro tko f f  sounds to  assess d ia s t o l i c  blood p ressure ,  as phase V 
(d isappearance o f  K o r o t k o f f  sounds) o f t e n  does not e x i s t  in  
pregnancy. Pregnancy creates a hyperdynamic c i r c u la t i o n  and the  
K o r o t k o f f  sounds may t h e r e f o r e  con t inue  down to  "ze ro "  c u f f  
pressure.
P r o t e i n u r i a  i s  a lso  im p o r ta n t  in  de f in ing  PIH, but essen t ia l ly  
re f le c ts  a more severe form of the disease (MacG i l l i v ray ,  1961). 
I t  has been shown t h a t  i f  p ro te inur ia  and hypertension are both 
present then the per inata l  m o r ta l i t y  ra te ,  and the  inc idence  o f  
i n t r a - u t e r i  ne growth r e t a r d a t i o n  are increased (MacGil l i v r a y ,  
1981).
P r o t e i n u r i a  is  easier  to  quant i ta te  than hypertension; providing 
tha t  a u r ina ry  t r a c t  in fe c t io n  has been excluded, the presence of 
g r e a t e r  than 0.3 grams o f  p r o te in  per 24 hours i s  considered 
s i g n i f i c a n t .
3.3 AETIOLOGY OF PREGNANCY INDUCED HYPERTENSION 
Over the past 100 years innumerable hypotheses have been advanced 
to  explain the aet io logy of PIH, and i t  has long been termed the 
"d isease  o f  t h e o r i e s "  ( M a c G i l l i v r a y ,  1981). Th is  s ta tement
remains t r u e  today as the primary cause of PIH remains obscure. 
I t  i s  c lea r ,  however, t h a t  the  t r i g g e r  f o r  the  c o n d i t i o n  l i e s  
w i t h i n  the  u te ru s ,  as d e l i v e r y  i s  r a p id l y  fo l lo w e d  by 
disappearance o f  the signs and symptoms o f  the  d isease ,  and by 
the re tu rn  to  normal o f  the biochemical markers of the disease.
A number o f  r i s k  f a c t o r s  have emerged from th e  s tudy o f  t h i s  
c o n d i t i o n .  PIH i s  much more common in  p r i m i g r a v i dae and a 
previous pregnancy, or  even an abort ion, o f f e r s  some p r o te c t i o n  
a g a in s t  the  d isease (MacGi11i v r a y , 1958). The r i s k  increases 
s l i g h t l y  with age, but is  not a f fe c te d  by so c ia l  c lass  ( B a i r d ,
1977). There i s  a lso  a f a m i l i a l  tendency, suggest ing  some 
g e ne t ic  s u s c e p t i b i l i t y  (Chesley et 1968). Women w i th
c h ro n ic  h yp e r ten s io n  are more l i k e l y  to  develop "superimposed" 
PIH than  are normal pregnant women (Chesl ey _et a1_., 1947), and 
women w i t h  u n d e r l y in g  rena l  d isease are e s p e c ia l l y  a t  r i s k  
(Pel ding, 1969).
C o n d i t ion s  assoc ia ted  w i th  la rg e  p la ce n ta s ,  such as m u l t ip le  
pregnancy, diabetes and hydat id i fo rm mole also put the pa t ien t  at 
r i s k  o f  PIH (MacGi11i v r a y ,  1981), and th e re  are r a c ia l  and 
geographical va r ia t io n s ,  with PIH being more common in  the Far 
East (Davies, 1971).
A v a r i e t y  o f  b i o l o g i c a l  "cascades" are a c t i v a te d  in  PIH, 
i n c l u d in g  the  c o a g u la t io n  system, the r e n in - a n g io t e n s in -  
a ldos te ro n e  system, the  k i n i n s ,  the p ro s ta g la n d in s ,  and the  
complement cascade. However, these seem to  be secondary 
phenomena, t r i g g e r e d  by a s t im u lus  which remains unknown
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(MacGi11i v r a y , 1981). A c u r re n t  th e o ry  i s  t h a t  some
immunological fa c to r  i n i t i a t e s  the  a c t i v a t i o n  o f  these systems 
but how t h i s  occurs remains obscure.
3.4 EPIDEMIOLOGY OF PIH
Owing t o  d i f f e r i n g  d ia g n o s t i c  c r i t e r i a ,  i t  i s  d i f f i c u l t  t o  
provide accurate f igures f o r  the true  incidence o f  PIH. However, 
PIH i s  a r e la t i v e l y  common disease of pregnancy, and may be seen
in  as many as 15% o f  pregnancies (Chamberla in ^  a 2 . , 1978;
B u t l e r  and Bonham, 1963). C om p l ica t ions  assoc ia ted  w i th  
hypertension were the la rges t  s ing le  cause o f  maternal deaths i n  
England and Wales in  th e  years  1973 - 1975 (Report on
Confident ial  Enquiries in to  Maternal Deaths in England and Wales 
1973 - 1975 (1 9 7 9 ) ) ,  and PIH i s  a ssoc ia ted  w i th  one in seven 
p e r in a t a l  deaths (M c l lw a ine  ejt , 1984). The e f f e c t  o f  
h yp e r te n s io n  a lone on th e  f e t u s  has been th e  su b je c t  o f  
c o n f l i c t i n g  reports .  The 1970 B r i t i s h  B i r ths  Survey (Chamberlain 
e t  al . ,  1978) suggested t h a t  pregnancies complica ted  by
hype r ten s io n  alone had a per inata l  m o r ta l i t y  rate which was not 
s i g n i f i c a n t l y  d i f f e re n t  from th a t  o f  normal pregnancy, and was in  
f a c t  n u m e r ic a l l y  low er !  Whi le  Page and C h r i s t ia n s o n  (1976) 
showed an increased fe ta l  r i s k  with even the mildest e levat ion of 
b lood p ressure .  There i s  no doubt ,  however, t h a t  when 
h yp e r ten s io n  and p r o t e i n u r i a  c o - e x i s t  both the  p e r in a ta l  
m o r t a l i t y  r a te  and the  inc idence  o f  i n t r a u t e r i n e  growth 
re ta rda t ion  are s i g n i f i c a n t l y  increased ( MacGi11i v r a y ,  1981). 
Prematuri ty also contr ibutes to  the increased perinata l  morbid i ty
seen in  PIH (Lin et aj_., 1982).
3.5 CLINICAL FEATURES OF PIH
PIH i s  a h yp e r ten s ive  d is o rd e r  of the second h a l f  of  pregnancy 
which, once establ ished,  w i l l  progress s t e a d i l y  u n t i l  d e l i v e r y .  
I t  i s  v i r t u a l l y  always asymptomatic,  w i t h  hyper tens ion  or 
p ro te in u r ia  being picked up by antenatal s c re e n in g .  Sometimes, 
however, i t  may develop and r a p id l y  become severe and in  t h i s  
r a p i d l y  p ro g re ss ive  form the p a t i e n t  u s u a l l y  f e e l s  u n w e l l .  
Headache, i r r i t a b i l i t y ,  b lu r r e d  v i s i o n ,  re s t le s s n e s s  and 
e p ig a s t r i c  discomfort are serious symptoms t h a t  u s u a l l y  he ra ld  
the onset of seizures.
Oedema i s  found in  85% of women with  p ro te in u r ic  PIH (Thomson et 
a l . ,  1967) and may be severe. The oedema f l u i d  i s  an u l t r a ­
f i l t r a t e  o f  plasma and is  associated with reduced plasma, albumen 
and oncot ic pressure, and with re ten t ion  of sodium and potassium. 
However, i t  has l i t t l e  va lue as a s p e c i f i c  d iagnost ic  sign as 
oedema occurs f r e q u e n t l y  in  normal pregnancy (Thomson et a l . ,  
1967; Robertson, 1971). In add i t ion ,  in  a prospective study of 
oedema in  pregnancy, pat ients  with oedema had an incidence of PIH 
which was s im i la r  to  pat ients  without oedema (Robertson, 1971).
3.6 PATHOPHYSIOLOGY OF PIH
3.6.1 The Cardiovascular System in  PIH
Hyper tens ion  i s  an e a r l y  fe a tu re  of PIH and is  caused by vaso­
c o n s t r i c t i o n  associated with a reduced plasma volume (Gal lery  et 
al . ,  1979; Chesley, 1972) and a normal or reduced cardiac output 
(Sm i th ,  1970).  Vascu la r  r e a c t i v i t y  i s  inc reased  so th a t  the 
normal i n s e n s i t i v i t y  to  exogenous angiotensin I I  is l o s t  and th i s  
may be detectable p r io r  to  the onset of the hypertension (Gant _et
a l . ,  1973). This loss of vascular re s is i  stance may be associated 
w i t h  a d e f i c ie n c y  o f  vasodepressor p ro s ta g la n d in s ,  such as 
p r o s t a c y c l i n  which has a lso  been documented in  PIH (Goodman et 
al_., 1982; Downi ng ^  al_., 1980; Remuzzi et al^., 1980).
Severe hyper tens ion  causes a r t e r i a l  damage and t h i s  has been 
demonstrated both in animals (Goldby and B e i l i n ,  1972) and in the 
c l i n i c a l  s i t u a t i o n  (Johansson et al_., 1974). Th is  a r t e r i a l  
damage exp la ins the convulsions seen in  untreated severe PIH and 
is  also the cause of cerebral  haemorrhage, which is  the commonest 
cause o f  death in  PIH (Report on C o n f id e n t i a l  Enquir ies in to  
Maternal Deaths 1973 - 1975 (1979), 1976 - 1978 (1982).
3.6.2 The Kidney in  PIH
P r o t e i n u r i a  in  PIH i s  assoc ia ted  w i th  d isease s e v e r i t y  
(MacG i l l iv ray ,  1961). The p ro te inur ia  i s  moderately se lec t ive  in  
terms o f  s ize  o f  the  f i l t e r e d  proteins (Maclean et al_., 1972), 
but can be heavy with more than 5 grams of prote in  per day being 
l o s t .  I t  i s  due to  a g lom eru la r  p ro te in  le a k ,  s i g n i f y i n g  
g lo m e ru la r  invo lvement  i n  the  d isease process.  Renal biopsy 
shows a non-i n f l  ammatory glomeru lar l e s i o n .  There i s  s w e l l i n g  
and vacuolat ion of the glomerular endothel ia l  c e l l s  which occlude 
the  g lo m e ru la r  lumen and t h i s  has been termed "g lo m e ru la r  
endothel  i osi  s " . The e p i th e l ia l  c e l l s  are also swollen although 
t h e i r  foo t  processes remain i n t a c t  (P o l ia k  and N e t t l e s ,  1960). 
F i b r i n  deposits  w i th in  and under the endothel ia l  c e l l s  have also 
been noted (Vassal i et , 1963). Complete reso lu t ion  o f  these 
changes can be seen as ear ly as four  weeks pos t-partum.
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Other aspects o f  renal  f u n c t i o n  are a lso  im p a i re d .  There is  
reduced u r ic  acid clearance implying tubu la r  dysfunct ion (Chesley 
and W i l l i a m s ,  1945), le a d in g  to  increased plasma u r i c  ac id  
concentra t ions. Increased plasma u r ic  acid i s  an e a r l y  s ign  o f  
PIH and precedes the development of p ro te inu r ia  and any increase 
in  urea and c rea t in ine  (Redman et , 1976b). I t  is  also useful 
in  d i f f e r e n t i a t i n g  between PIH and chronic hypertension, as in 
th e  l a t t e r  th e r e  i s  no change in  on u r ic  acid leve ls  (Redman et 
a l . ,  1976b).
Oedema is  a feature of normal pregnancy but can be more marked in 
PIH due to  c a p i l l a r y  leakage ,  and reduced plasma albumen 
c o n c e n t ra t io n  which resu l ts  in  a lower osmotic pressure. Renal 
r e t e n t i o n  o f  sodium a lso  occurs (Chesley et a l . , 1958) and 
contr ibu tes  to  the oedema. Complications of renal impairment and 
f l u i d  r e t e n t i o n  i n c lu d e  a s c i t e s ,  pulmonary oedema (Strauss et 
a l . ,  1980) and acute renal f a i l u r e  with tubu la r  and even c o r t i c a l  
necrosis (Smith et a l . ,  1968). In view o f  these complicat ions i t  
i s  important to  c a re fu l l y  monitor renal funct ion in  PIH.
3.6.3 The PIacenta in  PIH
In PIH the  te rm in a l  segments o f  the u te r i n e  s p i r a l  a r t e r i e s  
w i th in  the p lacen ta  become o b s t ru c te d  by f i b r i n  and p l a t e l e t  
aggregates (Zeek and A ssa l i ,  1950) and t h i s  explains the reduced 
u tero-p l  acenta l  blood f l o w ,  p la ce n ta l  i n f a r c t s  and p la c e n ta l  
d y s fu n c t i o n .  I t  i s  though t  l i k e l y  t h a t  many o f  th e  maternal 
changes seen in  PIH are secondary to  p la ce n ta l  ischaemia,  as 
animal models o f  the  d isease  depend on procedures which cause 
p la c e n ta l  ischaemia (Cavanagh e t  ^ . , 1977). The t r i g g e r  f o r
t h i s  p la c e n ta l  damage is  unknown but the les ions do not seem to  
be due to  hypertensive in ju r y  and an immune a e t i o l o g y  has been 
suggested (Redman, 1980).
3.6.4 The L ive r  in PIH
L i v e r  d y s fu n c t io n  can be seen in PIH and can be detected by an 
e le v a t i o n  o f  c i r c u l a t i n g  hepat ic enzymesi (Shukla et , 1978). 
Th is  may progress t o  c l i n i c a l  ja u n d ice  and h e p a t ic  f a i l u r e  
(Ki 11 am ^  a / [ . , 1975; Davies et 1980). H i s t o l o g i c a l l y
p e r i p o r t a l  haemorrhage and necrosis i s  seen (Sheehan and Lynch, 
1973), and is  associated with microvascular thrombosis.
3.6.5 Coagulat ion, F ib r in o ly s is  and P la te le ts  in  PIH
There is  now considerable evidence suggesting th a t  some degree of 
d issem inated  i n t r a v a s c u l a r  c o a g u la t io n  (DIG) occurs in  PIH. 
While t h i s  is  u n l i k e ly  to  be the primary cause of the disease, i t  
does e x p la in  many o f  the  fe a tu re s  o f  PIH, such as the 
m ic ro v a s c u la r  obstruct ion seen in the placenta, kidney and l i v e r  
(Howie, 1977).
D e p o s i t io n  o f  f i b r i n  in  p a t i e n t s  w i th  eclampsia has long been 
known t o  occur (Schmorl, 1893; McKay ^  , 1953; Govan, 1954).
More r e c e n t l y ,  p a th o lo g ic a l  examination of biopsy material has 
shown f i b r i n  deposit ion and f i b r i n o i d  necrosis in  l i v e r ,  placenta 
and k idney  in  p a t ie n ts  with PIH (Howie, 1977). The c i r c u la t in g  
p la te le t  count is  known to be reduced in  PIH (T ru d in g e r ,  1976; 
Redman, Bonnar and B e i l i n ,  1978) and t h i s  is  due to  a reduced 
p l a t e l e t  l i f e - s p a n  (Rakoczi a j [ . , 1979) . An inve rse
r e l a t i o n s h i p  between p l a t e l e t  count and f i b r i n o g e n  - f i b r i n
degrada t ion  products (FDP's) has been noted, suggesting tha t  the 
f a l l  in  p l a t e l e t  count i s  due to  the  increased p l a t e l e t  
consumption seen in DIG (Howie, Prentice and McNicol, 1971). The 
p la te le t  s p e c i f i c  p r o te in  b e ta - th ro m b o g lo b u l i  n has a lso  been 
found to  be increased in  PIH ( Redman _et ^ . , 1977a; Douglas et 
al . ,  1982; Socol e;t _al_., 1985) and t h i s  is  a marker of p la te le t  
a c t i v a t i o n .  Furthermore, beta-thromboglobulin has been shown to  
c o r r e l a t e  w i th  p r o t e i n u r i a  and serum c rea t in ine  (Socol et a l . ,  
1985), l i n k i n g  p l a t e l e t  a c t i v a t i o n  w i th  renal  m ic rova scu la r  
damage in PIH.
The p l a t e l e t  con ten t  o f  5 -h y d ro x y t r y p ta m ine is  reduced in PIH 
(Whigham et , 1978). This is  a vasoact ive amine released when 
p l a t e l e t s  aggregate, and i t s  loss indicates p la te le t  aggregation 
and s t i m u la t i o n  o f  the  p l a t e l e t  release react ion in  v iv o . Low 
p l a t e l e t  5 -h yd ro xy t  ryptami ne l e v e l s  have also been associated 
w i th  loss  o f  p l a t e l e t  responsiveness to  v a r io u s  aggregat ing  
agents (Whigham et aj_., 1978). The e x p la n a t io n  suggested fo r  
these f i n d in g s  i s  t h a t  p l a t e l e t s  are a c t i v a te d  in  the micro­
c i r c u la t io n  of the p la ce n ta ,  k idney and l i v e r ,  re lease  t h e i r  
products such as beta-thromboglobulin and 5-hydroxytryptamine and 
then re -en ter  the c i r c u la t i o n  in an "exhausted" s ta te ,  unable to  
respond normally to  aggregating agents and having lower levels of
5 - h y d ro x y t r y p ta m ine (Howie, 1977). In suppor t  o f t h i s  
h y p o th e s is ,  i t  had p re v io u s ly  been noted t h a t  placentas from 
pat ients  with PIH had high leve ls  of 5-hydroxytryptamine (Sen io r  
_et aj_., 1963), possibly of p la te le t  o r ig in .
A r e l a t i v e  macrothrombocytosi  s is  also seen in  PIH and th i s  is  
due to  an increased e n t r y  o f  l a r g e ,  young p l a t e l e t s  i n t o  the  
c i r c u l a t i o n  (Gi les and I n g l i s ,  1981) and t h i s  is  in  keeping with 
accelerated p la te le t  consumption.
P l a t e l e t s  have also been shown to  be less  s e n s i t i v e  to  the  
ant i -aggregatory e f fec ts  o f prostacyc l in  in  PIH ( B r i e l ,  Kieback 
and L i p p e r t ,  1984), and t h i s  may c o n t r i b u t e  to  the  p l a t e l e t  
consumption seen in t h i s  d isease ,  e s p e c i a l l y  as d e f i c ie n c y  o f  
p r o s t a c y c l i n  p roduc t ion  may c o e x is t  (Downing ejt ^ . ,  1980; 
Goodman _et _al_., 1982; Remuzzi et , 1980).
Increased p l a t e l e t  thromboxane A2 p roduct ion  ex vivo has also 
been shown to  occur in  PIH complicated by i n t r a - u t e r i  ne growth 
re ta rda t ion  (Wallenburg and Rotmans, 1982). Since thromboxane A2 
i s  a po ten t  v a s o c o n s t r i c t o r  and p l a t e l e t  aggrega t ing  agent 
(Hamberg et aj_., 1975), i t  may a lso  c o n t r i b u t e  to  the
pathogenesis  o f  PIH. The r o le  o f  p l a t e l e t s  in  the  
p a thophys io logy  o f  PIH may a lso  be emphasised by the recent  
success o f  a n t i - p l a te le t  therapy in  the treatment o f pregnancies 
at high r isk  of PIH (Beauf i ls  et , 1985).
An increased r a t io  of fa c to r  V I I I  re la ted antigen to  fa c to r  V I I I  
coagulant a c t i v i t y  has been shown to  be c h a r a c t e r i s t i c  o f  PIH 
(Redman jet ^ . , 1977b) and a lso  to  c o r r e l a t e  w i th  d isease 
s e v e r i t y  (Redman et a]^., 1977b). This i s  probably due to  fa c to r  
V I I I  consumption and i t  is  thought th a t  t h i s  r e f le c ts  low grade 
DIG (Bonnar and Shepherd, 1981).
So lub le  f i b r i n  complexes are also known to  be increased in PIH 
(Howie et a l . ,  1971; McKillop et l l_ . ,  1976; Edgar et D_.,  1977) 
and again  t h i s  supports the concept o f low grade DIG occuring in 
PIH. In normal pregnancy f i b r i n o l y t i c  a c t i v i t y  has been shown to  
d e c l i n e  s te a d i l y  and to  increase fo l low ing  d e l ive ry  ( S t i r l i n g  et 
al . ,  1984; Bonnar, McNicol and Douglas, 1970). This decl ine in  
f i b r i n o l y t i c  a c t i v i t y  i s  accompanied by an increase in  f ib r inogen 
- f i b r i n  degrada t ion  products  (FDP's) from mid-pregnancy 
(St i  r l  ing et H _ . , 1984).
In PIH, serum FDP's are known to  be increased compared to  normal 
pregnancy (Bonnar, McNicol and Douglas, 1971; Howie e t  a l . ,  
1971) . Ur inary FDP's, which are not usual ly  found during normal 
pregnancy,  are increased in  PIH (Howie _et 1971) and r is e  
f u r t h e r  a f t e r  d e l i v e r y  (Howie _et _al_., 1971; Gondie and Ogston, 
1976) .  F i b r i n o l y t i c  a c t i v i t y  may be f u r t h e r  reduced in  PIH 
compared t o  normal pregnancy (Bonnar e t  al_., 1971). While 
f i b r i n o l y t i c  a c t i v i t y  may be impa i red  in  PIH, i t  cannot be 
t o t a l l y  abol ished in view of the presence o f FDP' s . In ad d ition , 
plasminogen leve ls  have been shown to  be reduced in  PIH (Howie e t 
a l . ,  1971) and t h i s  would suggest consumption o f plasminogen in  
keeping with  some degree o f  f i b r i n o l y t i c  a c t iv i ty .  These studies 
suggest th a t  there is  excessive deposition o f f i b r in  in  PIH which 
i s  on ly  p a r t i a l l y  c lea red  due t o  impaired f ib r in o ly s is .  A fte r  
de l ive ry  the  f i b r i n o l y t i c  a c t i v i t y  re tu rn s  to  normal and the  
f i b r i n  i s  then broken down and excreted in  th e  u r in e , explaining 
the higher leve ls  o f  FDP's seen in  the u rine  fo llow ing  d e liv e ry .
Al l  these changes in  the coagulat ion system and p la te le t  funct ion 
in PIH, support the concept that DIG occurs in  t h i s  condi t ion . A 
" c o a g u la t io n  index"  o f  serum FDP's, p l a t e l e t  count and plasma 
fa c to r  V I I I  has been shown to  co r re la te  with  a " c l i n i c a l  index"  
o f  d isease sever i ty  (Howie et ^ . ,  1976) and t h i s  h igh l igh ts  the 
associa t ion of DIG with PIH.
3.7 PROSTAGYGLIN AND THROMBOXANE Ap IN PREGNANCY AND PIH 
P r o s ta c y c l i n  i s  a p o te n t ,  v a s o d i l a t o r ,  i n h i b i t o r  o f  p la te le t  
aggrega t ion  (Moncada jet aj_., 1976) and a s t im u la to r  o f  ren in  
s e c re t i o n  (Patrono e t  , 1982). The pa tho log ica l fea tures o f 
PIH are v i r t u a l l y  a m i r r o r  image of these, as i t  is  associated 
w i th  v a s o c o n s t r i c i t i o n ,  p l a t e l e t  consumption and low  re n in  
s e c r e t i o n  (Brown et 1965). Furthermore, women w ith PIH are 
very s e n s i t i v e  to  exogenous a n g io te n s in  I I  in fu s io n s  when 
compared t o  normal pregnant women (C he s le y , 1966; la l le d o ,  
Chesley and Zuspan, 1968; Gant et al^., 1973). This in s e n s it iv ity  
t o  a n g io te n s in  I I  seen in  normal pregnancy can be abolished i f  
women are t r e a te d  w i th  a cyclo-oxygenase i n h ib i t o r  such as 
indomethacin (Everett  et  a]_., 1978), and enhanced by prostacyclin  
i n f u s i o n  (Broughton-P i  pki  n elt a l_ ., 1984) o r PGEg in fu s io n  
( Broughton-Pi pki n et _a]_., 1982). These experiments suggest th a t  
i n  normal pregnancy angiotensin I I  may be balanced by the  act ion 
o f  vasodepressor p ro s ta g la n d in s  such as p ro s ta c y c lin . A 
d e f i c i e n c y  o f  p r o s t a c y c l i n  m igh t th e re fo re  r e s u lt  i n  th e  
s e n s i t i v i t y  to  angiotensin I I  seen in  PIH and many i n v e s t i g a t o r s  
have now studied p ros tacyc l in  in  th is  c o n d itio n .
Reduced p rostacyc l in  production from both placental  and umbil ical  
a r t e r y  t i s s u e  has been documented in  PIH by a v a r i e t y  o f  
te c h n iq u e s ,  i n c l u d in g  b ioassay f o r  p ros tacyc l  in-1 ike a c t i v i t y  
(Remuzzi e t , 1980), t h i n  l a y e r  chromatography and gas 
chromatography-mass spec trometry  (Downi ng et aj_., 1980) and 
radioimmunoassay (Carreras  et , 1981) fo r  6-keto-PGFio, the 
s t a b le  h y d ra t io n  product  o f  p r o s t a c y c l i n . Th is  has been 
confirmed in  a more recent s tudy which showed a re d u c tio n  i n  
p r o s t a c y c l i n  p roduc t ion  from p la c e n ta l  t is s u e  in  PIH compared 
with normal pregnancy (Walsh, Behr and A l le n ,  1985). M a k ila , 
V i i n i k k a  and Y l i k o r k a l a  (1984) have proposed tha t p ro s tacyc lin  
de f ic iency  in pregnancy i s  s p e c i f i c  to  PIH as they documented 
reduced p r o s t a c y c l i n  p ro d u c t io n  from u m b il ic a l a r te ry  in  
pregnancies complica ted  by PIH, but not in  pregnancies 
com p l ica ted  by c h ro n ic  h yp e r ten s io n  o r in t r a - u t e r ine growth 
re ta rd a t io n .  This,  however, i s  a t  v a r ia n ce  w i th  o th e r s tu d ie s  
which have shown d e f i c ie n t  p ros tacyc l in  production from placenta l 
c e l l s  (Jogee, Myatt and Elder,  1983) and um bilical a rte ry  (S tuart 
c t  aj_., 1981) t o  occur in  i  n t r a - u t e r i  ne growth re ta rd a t io n . 
Maternal vascular p ros tacyc l in  product ion has also been shown to  
be reduced in  PIH (Bussolino e t _al_., 1980).
The u m b i l i c a l  a r te ry  la c k s  any type  o f  in n e rv a tio n , i t  is
the re fo re  l i k e l y  tha t blood flow  is  c o n tro lle d  by huaora l means 
(Tuvemo, 1980) .  P rostacyc l in  and PGEi re la x  um bilical a rte ry  
v /h i le  thromboxane Ag con s tric ts  i t  (Tuvemo, 1980|- Prostacycl in  
i s  the major prostaglandin produced by u m b ilic a l a r t e r y  ( (R it te r  
et a l . .  1982; Tuvemo, 1980) and u m b ilic a l a r t e r y  produces 
s i g n i f i c a n t l y  more prostacyc lin  than vessels o f comparable size
and weigh t  taken from h e a l th y  a d u l ts  (Remuzzi et 1979). 
M ak i la  ^  ^  (1983) have r e c e n t ly  shown tha t  umbi l ica l  a r te ry  
b lood f lo w  measured u l t r a s o n i c a l  l y  j_n v ivo  c o r r e la te d  
s i g n i f i c a n t l y  w i th  the vessels'  a b i l i t y  to  produce prostacyc l in  
in  v i t r o  and confirmed th a t  prostacyc l in  production was lower in  
pregnancies complica ted  by PIH. These f i n d in g s  would be in  
keeping with prostacycl in  being invo lve d  i n  the  maintenance of 
the  low pressure - high f l o w  f e t o - p l a c e n t a l  c i r c u l a t i o n  and 
p r o s t a c y c l i n  d e f i c ie n c y  might r e s u l t  in  reduced f lo w  and 
subsequent in t ra u te r in e  growth re ta rda t ion .
The prostacyc l in  content o f amniotic f l u i d  in  la te  pregnancy has 
a lso  been s tu d ie d .  In the  normal s i t u a t i o n  a m n io t i c  f l u i d  
6-keto-PGFict corre la tes  w ith  gestat iona l age (Y l iko rka la ,  Makila 
and V i in ikka ,  1981a) in the t h i r d  t r im e s te r  and increases dur ing  
la b o u r  f o l l o w i n g  the  onset o f  u te r ine  contract ions (Makarainen 
and Y l i k o r k a l a ,  1984; M i t c h e l l  e t  aj_., 1979a) suggest ing a 
possible ro le  f o r  p ros tacyc l in  in p a r t u r i t i o n .
In PIH, the  p r o s t a c y c l i n - l i k e  a c t i v i t y  o f  am n io t ic  f l u i d  i s  
reduced (Bodzenta, Thomson and P o l le r ,  1980) and Y l iko rka la  et al 
(1981a) have documented reduced amniotic f l u i d  G-keto-PGFi# in  
pregnancies complicated by severe PIH but not in those w i th  m i ld  
d isease .  Dur ing la b o u r  am n io t ic  f l u i d  6-keto-PGF]c^ i s  
s i g n i f i c a n t l y  lower in  PIH as compared with normal pregnancy and 
the  maximal r i se  in  6-keto-PGFia is  also less in  PIH (Makarainen 
and Y l iko rka la ,  1984).
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Maternal p r o s t a c y c l i n  status has also been studied in PIH. The 
f i r s t  re p o r t  of reduced maternal plasma 6-keto-PGFi% in  PIH came 
from Lewis _et aj_., in  1981. They showed tha t  the level of th is  
pros tacyc l in  metabol i te f e l l  as the disease progressed in a women 
with severe PIH, however, the pat ient had been started on asp i r in  
as an a n t i - p l a t e l e t  agent immediately before the levels  star ted 
to  f a l l  and i t  is  there fore  d i f f i c u l t  to  know whether t h i s  was an 
e f f e c t  o f  the d isease or an e f f e c t  o f  the t re a tm e n t .  More 
r e c e n t l y ,  s i g n i f i c a n t l y  lower plasma leve ls  of 6-keto-PGFia have 
been recorded in  women with ec lampsia, or impending ec lampsia, 
than in  normal pregnant women (Moodley, Norman and Reddi, 1984), 
and th is  was associated with lower l e v e l s  o f  PGE and PGF a ls o .  
S i g n i f i c a n t l y  lower  6-keto-PGFia leve ls  have also been recorded 
in  maternal and u m b i l i c a l  venous plasma in  pregnancies 
comp l ica ted  by severe PIH as compared w i th  normotensive 
pregnancies (Yamaguchi and M o r i ,  1985) and t h i s  d i f f e r e n c e  
d isappeared fo l low ing  d e l i v e ry .  Urinary p rostacyc l in  metabol i te 
excret ion has also been shown to  be reduced in  women w i th  PIH 
(Goodman ^  , 1982).
Reports on maternal p ros tacyc l in  status in PIH have not a l l  been 
cons is tent .  Y l iko rka la ,  Kirk inen and V i in ik k a  (1981b) found no 
d i f f e r e n c e  in  plasma G-keto-PGFig^ l e v e l s  in  PIH compared to  
normal pregnancy and p r o s t a c y c l i n  m e ta b o l i te s  have a lso  been 
found t o  be increased in PIH (Str ick land jet aj_., 1984; Koullapis 
et a l . ,  1982).
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Remuzzi e t  a l  (1981b) have s tud ied  th e  a b i l i t y  o f  plasma to  
s t im u la t e  p r o s t a c y c l i n  p roduc t ion  from vascular t i s s u e .  They 
found th a t  plasma from women with PIH had a much g rea te r  a b i l i t y  
t o  s t im u la t e  p r o s t a c y c l i n  product ion than plasma from women in 
the t h i r d  t r im e s te r  o f normal pregnancy and th e y  concluded t h a t  
t h i s  was c o n s is te n t  w i th  d e f i c i e n t  p ro s ta c y c l in  product ion in  
PIH.
These va r io u s  s tu d ie s  suggest ,  both from i n d i r e c t  and d ire c t 
evidence, th a t  p ro s ta c y c l in  d e f i c ie n c y  may be In v o lv e d  in  the  
pa thophys io logy  o f  PIH a l though the  ev idence Is  no t e n t ire ly  
cons is ten t .  Further s tu d ie s  are t h e r e f o r e  re q u ire d  to  d e fin e  
changes in  l e v e l s  o f  p r o s ta c y c l i n  in  PIH. I t  is  u n lik e ly  th a t 
p ros tacyc l in  de f ic iency  is  the primary cause of PIH -  i t  is  more 
l i k e l y  to  be a secondary phenomenon -  as p ro s ta cyc lin  in fus ions  
used th e ra p e u t ica l l y  do not "cure" the disease, although they do 
de lay  d isease p rogress ion ,  reduce p la te le t  consumption and help 
t o  lower  b lood p ressure  ( F id le r  ^  _al_., 1981; Belch e t a l . ,  
1985) .  However, i n  view o f  p ro s ta c y c lin 's  po ten t 
actions i t s  de f ic iency  may be o f major importance in  the  
physiology o f  PIH and replacement o f  prostacyc lin  may be a useful 
t h e r a p e u t i c  o p t io n .  The use o f o th e r drugs w hich can cause 
v a s o d i l a t a t i o n  and reduce p la te le t  consumption might a lso  be o f 
value in  preventing the consequences o f p ro s ta cyc lin  de f ic iency .
D esp i te  these  observa tions in  the  abnormal s itu a tio n  there  i s  
l i t t l e  in formation on maternal plasma p ro s ta cyc lin  m etabolites in  
normal pregnancy. In  1980 Lewis e t a l[ - ,  p u b lish e d  a c ross  
s e c t i o n a l  s tudy  on 22 pregnancies showing increased leve ls  o f
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6-keto-PGF%a in  the t h i r d  t r i m e s t e r  as compared w i th  normal 
non-pregnant and e a r ly  pregnancy values. Bolton et (1982) 
i n  th e  on ly  p ro sp e c t ive  l o n g i t u d in a l  study o f  p r o s t a c y c l i n  
metabol i tes in pregnancy found a peak at 18 - 22 weeks gesta t ion, 
although they did not sample in the f i r s t  t r im e s te r .  Other cross 
s e c t i o n a l  s tu d ies  have shown no d i f f e r e n c e  in  p r o s t a c y c l i n  
th ro u gh o u t  pregnancy ( M i t c h e l l ,  1981; Y l iko rka la  and V i in ik ka ,  
1981). Goodman ^  aj_., (1982) s tu d ied  u r ina ry  metabol i tes of 
p r o s t a c y c l i n  in  the  second and t h i r d  t r i m e s t e r s  o f  normal 
pregnancy and found a f i v e - f o l d  increase in  u r i n a r y  m e ta b o lite s  
of p ros tacyc l in  in  comparison to  non-pregnant women.
The va lues given by these studies f o r  plasma 6-keto-PGFig, using 
radio immunoassays, were between 100 and 500 pg/ml and were 
com pat ib le  w ith  values f o r  normal non-pregnant subjects obtained 
by radioimmunoassay (M i tc h e l l ,  1978) and by gas chrom atography 
-mass spectrometry (Hensby e t ^ . ,  1979). These find ings were in  
keeping w i t h  the  b e l i e f  t h a t  p ro s ta c y c lin  was a c i r c u la t in g  
hormone i n  man (Moncada et a [ . , 1978). In 1982, however, B la ir  
_et aj_., pub l ished  work us ing nega t ive  ion  gas chromnatography 
-mass spec t rom et ry  which showed t h a t  the  abso lu te  va lue f o r  
6-keto-PGFic j  was below 5 pg/ml-, and they concluded th a t  the  
l e v e l s  were too  low t o  a llo w  p ro s ta c y c lin  to  fu n c tio n  as a 
c i r c u la t i n g  hormone in  man as previously thought. T h is , however, 
does not p rec lude  a r o l e  f o r  p ro s ta c y c lin  as a lo c a l hormone 
which i s  im p o r ta n t  In  th e  re g u la t io n  o f p la te le t  -  vessel wall 
i n te ra c t io n  (Patrono et a i . ,  1984).
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In  view o f  these f i n d i n g s ,  however, th e re  was a need to  re ­
examine the ro le  of p r o s ta c y c l i n  both in  normal pregnancy and 
PIN.
Thromboxane A2 i s  a po ten t  p l a t e l e t  aggrega t ing  agent and 
vasoconst r ic to r .  An excess of such a substance might c o n tr ib u te  
t o  the  p l a t e l e t  consumption and v a s o c o n s t r i c t io n  seen in  PIH, 
however, th e re  i s  l i t t l e  i n f o r m a t io n  on thromboxane A2 i n  
pregnancy. Y l i k o r k a l a  and V i in i k k a  (1980) measured 1x82 -  the 
s t a b le  h y d ra t io n  p ro du c t io n  o f  thromboxane Â2 -  in  normal 
pregnancy and found increased l e v e l s  o f  both plasma and serum 
TxB2 compared to  non-pregnant control  subjects but could show no 
r e l a t i o n s h i p  t o  g e s ta t io n  w h i l e  M i tche l l  (1978) showed
increased leve ls  at term as compared to  “ l a t e  pregnancy" (28 -  36 
weeks ges ta t ion ) .
There i s  no demonstrable  change in  TxB2 in  am n io tic  f lu id  o f 
pregnancies comp l ica ted  by PIH (Y lik o rk a la  e t  , 1981a; 
Makarainen and Y l i k o r k a l a ,  1984) and Yamaguchi and Mori (1985) 
demonstrated no s i g n i f i c a n t  increase in  plasma ÏXB2 in  
pregnancies compl ica ted  by PIH. Makila e t al_-, (1983) studied 
u m b i l i c a l  a r t e r y  thromboxane A2  production in  pregnancy. They 
found t h a t  u m b i l i c a l  arte ry  produced very l i t t l e  thromboxane A2 
r e la t i v e  to  prostacyclin  and there was no increase in  thromboxane 
A2 production in  umbi l ica l  arte ry  from pregnancies complicated by 
PIH. Furthermore, thromboxane A2  production, u n like  prostacyclin  
p r o d u c t i o n ,  was un re la ted  to  u m b il ic a l a r te ry  blood f lo w  as 
dete rmined u lt r a s o n ic a l 1y p r io r  to  d e l iv e r y -  More receii 
(Walsh, 1985) placentas taken from pregnancies complicated S
have been shown to  produce more TxÂ2 and less PGIg than placentas 
from normal pregnancies. Wallenburg and Rotmans (1982) have 
shown th a t  ex vivo p la te le t  thromboxane A2 production is  elevated 
in  PIH complicated by in tra u te rine  growth re ta rd a tion , thus both 
p la c e n ta l  and p l a t e l e t  derived thromboxane A2  may contribu te  to  
the disease process.
The use o f  drugs which can reduce thromboxane A2 production and 
p la te le t  aggregation may therefore be o f bene f i t  in  the treatment 
o f  PIH and studies are required to  explore f u r t h e r  the ro le , o f 
thromboxane A2 i n  PIH and the  possible benefits  o f drugs which 
would i n h i b i t  i t s  formation.
3.8 TREATMENT OF PIH
PIH i s  a ma jo r  cause o f  both maternal and f e t a l  « o r t a l l t y  
m orb id i ty .  The fe tus  i s  at r i s k  o f  growth re ta rda t lo i tu ,  
and prematur i ty  from untimely de l ive ry  ÇChamberlain e t  a l . ,
Page and Chr ist ianson, 1976; Lin e t  a l . ,  1982)- The mother Is  a t  
r i s k  o f  v a s c u la r ,  r e n a l ,  h e p a t ic  and nemtrologlcal damage as 
discussed above.
PIH i s  e s s e n t i a l l y  a cu ra b le  fo rm o f  hypertemslem as d e l i ve ry  
w i l l  remove the disease. The alms o f  treatment th e re fo re  a re  t o  
c o n t r o l  b lood pressure , pro long  th e  pregimarmry s e f f l c l e m t l y  t® 
avoid the complicat ions o f p re m a tu r i t y ,  prewemtt progress lom ®f 
th e  disease and avo id  h yp e r te n s ive  ((and h ypo tens ive )  c r i s e s ,  
especia lly  during labour.
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3.8.1 Bed Rest
T r a d i t i o n a l l y ,  o b s t e t r i c i a n s  have advocated bed re s t  f o r  the 
treatment of PIH. T h e o r e t i c a l l y  i t  i s  used t o  t r y  and reduce 
blood pressure, increase cardiac output ( E u l a n d ^ ^ . ,  1969) and 
in c re a se  sodium e xc re t ion  (Redd et aj[ . ,  1968). However, i t  may 
a lso  be assoc ia ted  w i t h  reduced c a rd ia c  ou tpu t  due t o  the  
p ressure  o f  the gravid uterus on the great vessels (Lees et a l . ,  
1967), and lower utero-p lacenta l  blood f low  (Ab i tbo l ,  1977) which 
would be detrimental  to  the pa t ien t .
Only two con t ro l led  studies of bedrest have been performed. The 
f i r s t  showed no b e n e f i t  f rom bedres t  In  n o n -p ro te in u r ic 
hyper tens ion  (Mathews, 1977) and the second showed some bene fit 
in  severe p r o t e i n u r i c  h yp e r ten s io n  w i t h  i n t r a - u t e r i  ne growth 
r e t a r d a t i o n  (Mathews et al_., 1982). Overal l the re fo re ,  the use 
o f  bedres t  in  the treatment o f  PIH remains unproven, at leas t i n  
the less severe forms of the disease.
3.8.2 Sedation
S eda t ion ,  l i k e  bed r e s t ,  has formed a t r a d i t i o n a l  par t  o f  the 
management o f PIH. The use o f  ant iconvulsants i n  th e  t re a tm e n t  
o f  impending eclampsia i s  obviously l o g i c a l ,  however, there  has 
been no proven bene f i t  from chronic sedation i n  the management o f 
PIH (Mathews, 1977).
3.8 .3  Ant i-hypertensive Drugs
The use o f  drugs to  c o n tro l blood pressure  i n  pregnancy i s  
gradua l ly  increasing, due to  the increasing knowledge about  th e  
drugs and th e ir  safe ty  i n  pregnancy.
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Methyl dopa was assessed in  hypertension o ccu r r in g  in  pregnancy, 
as long ago as 1968 (Leather _et _a]_., 1968) and has become one o f  
th e  most w id e ly  used ant i -hypertens ive agents in  PIH. The most 
comprehensive s tudy o f  i t s  use in  pregnancy was performed by 
Redman e;t , (1976c). They concluded th a t  i t  v/as safe f o r  use 
in  pregnancy and t h a t  i t  appeared t o  reduce f e t a l  l o s s ,  
espec ia l ly  from m id - t r im e s te r  a b o r t io n s .  The c h i l d r e n  o f  the  
women who took p a r t  i n  t h i s  study were fol lowed up a f te r  seven 
years, and there was no obvious d i f fe rence  between the  c h i l d r e n  
from the  t re a tm e n t  group, and those from the control  group in  
terms o f  phys ica l  and mental  hand icaps, b e ha v io u r ,  v i s i o n ,  
hear ing  and i n t e l l e c t u a l  a b i l i t y  (Cockburn _et , 1982), thus 
emphasising the  d ru g 's  s a f e t y .  Methyl dopa, however, i s  
assoc ia ted  w i th  some adverse e f f e c t s  such as l a s s i t u d e ,  
depress ion  and po s tu ra l  h ypo tens ion .  These side e f fec ts  were 
troublesome enough to  cause 15% o f  the women assessed by Redman 
et ^ . , (1976c) to  be withdrawn from the study (Redman, B e i l i n  
and Bonnar, 1977b).
Adrenoceptor  a n ta g on is ts  are i n c r e a s i n g l y  be ing used in  th e  
t re a tm e n t  o f  PIH. I n i t i a l l y  t h e i r  use i n  pregnancy was 
assoc ia ted  with some degree o f  h e s i ta t io n ,  as they have possible 
depressant e f fec ts  on the f e ta l  c i r c u la t i o n  and u te r ine  tone. In 
a d d i t i o n ,  i n i t i a l  s tu d ie s  had suggested th a t they  might be 
associated with adverse e f fe c ts  such as neonatal  hypoglycaemia, 
i n t r a - u t e r i  ne growth re ta rda t ion  and increased fe ta l loss . Most 
o f  these studies,  however, have been anecdotal and have not been 
conf i rmed in  p ro s p e c t iv e  s tu d ie s  (Rubin , 1981). Adrenoceptor
94
a n ta g o n is ts  have now been studied f a i r l y  extensive ly  in  PIH, and 
they have been shown to  be both safe and e f fe c t i v e  in c o n t ro l l i n g  
blood pressure (G a l le r y  et aj_., 1979b; Lubbe and Hodge, 1981; 
Symonds et , 1982; Walker e t a ^ . , 1982; W alker, Greer and 
Calder, 1983; Rubin et al_., 1983; Gal le ry,  Ross and Gyory, 1985). 
They are a lso  r e l a t i v e l y  f r e e  o f  s ide  e f f e c t s ,  making them 
acceptable to  p a t i e n t s .  There are a v a r i e t y  o f  adrenoceptor  
antagonists ava i lab le  which have varying receptor s p e c i f i c i t y  and 
varying degrees of i n t r i n s i c  sympathomimetic a c t i v i t y  and most of 
these have been assessed to  some extent in  pregnancy. Oxprenolol , 
a n o n - s e le c t i v e  6 - r e c e p to r  a n ta g on is t  w i t h  i n t r i n s i c  
sympathomimetic a c t i v i t y ,  has been compared with  methyl dopa In 
the treatment of hypertension in  pregnancy. The pat ients  studied 
were mos t ly  c h ro n ic  h y p e r te n s iv e s .  Both drugs had s i m i l a r  
e f fec ts  on blood pressure c o n t ro l ,  but the oxprenolol  group had a 
be t te r  outcome in  terms o f  f e ta l  and placental  weight (Gal le ry  et 
a l . ,  1979b).
More r e c e n t l y  G a l le r y  e t  aJL., (1985) have publ ished the f i n a l  
r e s u l t s  o f  t h i s  s tu d y ,  where 183 pat ients  with  hypertension in  
pregnancy were randomly a l located to  receive e i t h e r  oxprenolol  o r  
methyl dopa. Contro l  o f  blood pressure  was equivalent in  both 
groups, but fe ta l  grov/th was increased in  th e  oxpreno lo l group. 
However, w i th  i n c re a s in g  d u ra t io n  of treatment the d i f fe rences 
between the groups diminished, so tha t  a f t e r  ten weeks t re a tm e n t  
no d i f f e r e n c e  in  f e t a l  growth was found. The authors have 
suggested tha t  the ea r ly  e f fe c t  i s  due t o  o xp ren o lo l  producing
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p e r ip h e ra l  v a s o d i l a t a t i o n ,  and they suggest tha t  over t ime the 
same e f fe c t  on fe ta l  growth can be achieved by long term c o n t ro l  
o f  blood pressure as seen with  the methyl dopa group.
The l a r g e s t  s tudy o f  an adrenoceptor  a n ta g o n is t  in  PIH was 
performed w i th  a t e n o lo l ,  a s e le c t i v e  g ^ - re c e p to r  a n ta g o n is t  
(Rubin jet ^ . ,  1983). This v/as a double b l ind  placebo con tro l led  
s tudy  in  120 women w i th  PIH. A te n o lo l  e f f e c t i v e l y  con tro l led  
b lood pressure  and reduced the  subsequent development o f 
p r o t e i n u r i a ,  suggest ing a p o s s ib le  b e n e f i c i a l  e f f e c t  on the 
disease process. There was no d i f fe rence  in  f e t a l  and neonatal 
c o m p l ica t ion s  such as i n t r a - u t e r i  ne growth re ta rda tion , neonatal 
hypoglycaemia o r  h y p e rb i1i ru b in a e m ia  between the  two groups. 
Respiratory d is t ress was seen only in  the control  group, however, 
neonatal  b ra dyca rd ia  was more common i n  the a te n o lo l  group, 
a l though  th e re  was no e f f e c t  on blood pressure. The ch ild ren 
f rom t h i s  s tudy have a l l  been fo l lo w e d  up f o r  one year and 
a te n o lo l  has not been shown to  have any adverse e f fe c ts  on t h e i r  
development (Reynolds et , 1984).
L a b e ta lo l  i s  a unique adrenoceptor a n tag on is t as i t  has both 
n o n - s e le c t i v e  g -adrenocep to r  an tag on is t and s e le c t iv e  a j  
ad renoceptor  a n ta g o n is t  p r o p e r t i e s .  Th is  means th a t i t  can 
d i r e c t l y  cause p e r ip h e ra l  v a s o d ila tio n  and t h i s  may help to  
reduce blood pressure and maintain renal and u te rine  blood f l o w .  
I t  has been shown to  be e f fe c t i v e  in  c o n t ro l l i n g  blood pressure 
(Symonds et ^ . ,  1982; Redman, 1982; Walker e t a l . ,  1983; Walker 
e t  a l . ,  1982) and may have a b e n e fic ia l e f fe c t  on p la te le t  
consumption (Walker  e t , 1982). Labe ta lo l has a lso  been
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compared with  atenolol  in  PIH (Lardoux et , 1983). Both drugs 
c o n t r o l l e d  b lood pressure  but b i r t h  weights were s i g n i f i c a n t l y  
higher in  the labe ta lo l  group, possibly due t o  inc reased  u te ro ­
placental  blood f low.
I t  would seem from these s tud ies  tha t  adrenoceptor antagonists 
are both safe and e f fe c t iv e  in  the treatment o f PIH, and may have 
some b e n e f i c i a l  e f f e c t s  on the d isease p rocess .  Whether any 
p a r t i c u la r  adrenoceptor a n ta g o n is t  i s  more e f f e c t i v e  than the  
o the rs  i s  not yet known and fu r th e r  studies are required in th i s  
f i  e ld .
H yd ra la z in e  i s  a v a s o d i l a t o r  which can be used both o ra l l y  or 
p a re n te ra l  l y  in  PIH and i s  o f te n  used in  the  t rea tm en t  o f  
h yp e r te n s ive  c r i s e s  (Lubbe, 1984). I t  has s ide  e f f e c t s  o f  
headache and tachycardia which can be avoided by concomitant use 
o f  an adrenoceptor antagonis t.  At higher doses, however, i t  can 
cause a lu p u s - l ike  syndrome (Lubbe, 1984). H yd ra laz ine  i s  a lso  
f requen t ly  used as a "second l in e "  drug to  augment the e f fec ts  of 
adrenoceptor antagonists and methyl dopa when sa t i s fa c to ry  control 
i s  not achieved with a s ing le  agent.
Diazoxide, a potent v a s o d i l a t o r ,  and l a b e t a l o l  have a lso  been 
used e f f e c t i v e l y  in  th e  acute h y p e r ten s ive  s i t u a t i o n  where 
parenteral therapy is  required (Lubbe, 1984). Both agents are 
po te n t  but severe hypotens ion can occur e s p e c i a l l y  w i th  
diazoxide.
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Magnesium su lpha te  remains a popular drug in  North America fo r  
c o n t ro l  o f  impending ec lamps ia .  I t  i s  e f f e c t i v e ,  but has 
depressant e f fec ts  on both the maternal and fe ta l  cardiovascular 
and resp i ra to ry  systems. I t  causes peripheral vasod i la ta t ion  and 
a lso  has e f f e c t s  on the  c e n t r a l  and peripheral nervous systems 
(Lubbe, 1984).
Recently calcium channel b locking drugs have become ava i lab le  and 
have proven usefu l  in  the  management o f  hyper tens ion  in  non­
pregnant subjects. One such agent, n i fed ip ine ,  has recent ly  been 
assessed in PIH (Walters and Redman, 1982) and was found to  be an 
e f f e c t i v e  a n t i - h y p e r te n s iv e  agent with no notable side e f fe c ts .  
Further studies are required to  dete rmine the  place o f  ca lc ium 
channel blocking agents in  PIH.
An i n t e r e s t i n g  development in  the  t rea tm en t  of severe PIH has 
been th e  use o f  p r o s t a c y c l i n  i n f u s io n s  (Belch e t  ^ . , 1985; 
F i d l e r  ^  i l * »  1981). Th is  i s  a l o g i c a l  step as PIH i s  
assoc ia ted  with vasoconstr ic t ion  and p la te le t  consumption, whi le 
prostacyc l in  is  a potent vasod i la to r  and a n t i - p l a te l e t  agent. I t  
has a lso  been shown tha t  p ros tacyc l in  production may be impaired 
in  PIH (Remuzzi et , 1980, Downing _et , 1980; Goodman et 
a l . ,  1982). Thus f a r  i t  has on ly  been used in  pa t ien ts  with 
severe disease but i t  has been successful both in lowering blood 
pressure and reducing p la te le t  consumption. I t  i s  d i f f i c u l t  to  
use as i t  is  unstable, requires to  be given pa ren te ra l ly ,  and i t s  
dose i s  l im i te d  by vasod i la to r  s ide  e f f e c t s .  However, r e s u l t s  
from the  s tu d ies  c i t e d  are s u f f i c i e n t l y  encouraging to  warrant 
f u r th e r  inves t iga t ion .
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3.8 .4  A n t i - p la te le t  Drugs in  PIH
Another  recent development in  the treatment o f PIH is  the use of 
a n t i - p l a t e l e t  drugs. In view o f  the  r o l e  o f  p l a t e l e t s  in  the  
pathogenesis  o f  PIH t h i s  i s  an a t t r a c t i v e  therapeut ic  opt ion, 
espec ia l ly  when a n t i - p l a t e l e t  agents have been used w i th  some 
success in  a r t e r i o s c l e r o t i c  va s c u la r  disease (see chapter 2 ) .  
B e a u f i l s  jet , (1985) have recent ly  published the resu l ts  of a 
s tudy lo o k in g  at the e f f e c t s  o f  an a s p i r i n  - d ip y r id am o le  
combination in  102 pregnancies a t  h igh  r i s k  o f  PIH and growth 
re ta rda t ion .
They found t h a t  the  in c id e n ce  o f  PIH, f e t a l  death and i n t r a ­
u t e r i n e  growth r e t a r d a t i o n  were lower  i n  th e  t r e a te d  group 
compared w i th  the  c o n t r o l  group who received no treatment.  In 
add i t ion ,  the p la te le t  count was protected in  the treatment group 
and no adverse e f fec ts  were noted.
C lea r ly ,  f u r th e r  studies of a n t i - p l a t e l e t  drugs are requ ired  in  
PIH, but t h i s  study at leas t  o f fe rs  a great deal o f encouragement 
to  pursue t h i s  p o te n t ia l l y  very e x c i t i n g  l i n e  o f  research. I t  
may be t h a t  a comb ina t ion  o f  an a n t i - p l a t e l e t  agent and an 






4.1 MEASUREMENT OF PROSTACYCLIN AND THROMBOXANE
4 .1 .1  General C ons idera t ions  in  the  Measurements of PGI? and 
TxA? Metabol i tes
The normal physio logical concentrat ions of PGI2 and TxA2 are very 
low ,  consequent ly  h ig h l y  s e n s i t i v e  and s p e c i f i c  assays are 
re q u i re d  to  measure these substances in  b i o l o g i c a l  samples. 
Radioimmunoassay (RIA) and gas-chromatography-mass-spectrometry 
the re fo re  provide the only techniques sens i t ive  enough to  measure 
these substances. Measurement o f PGI2 metabol i tes in  plasma has 
been, and remains, a subject o f great controversy. I n i t i a l  work 
on 6 -ke to-PGFio  by radioimmunoassay (RIA) suggested that leve ls  
in normal subjects were of the o rd e r  70 - 100 pg/ml ( M i t c h e l l ,
1978) ,  and t h i s  was supported by gas-chromatography mass- 
spectrometry (GCMS) work which suggested s i m i l a r  l e v e l s  (Hensby 
e t  , 1979).  In 1982, however, B la i r  et published work
using negat ive ion GCMS which showed tha t  the absolute values fo r
6-keto-PGFioj in  peripheral plasma were below 5 pg/ml, confirming 
the e a r l i e r  work of Christ-Hazelhof and Nugteren (1981) using the 
te ch n iq u e  o f  gas chromatography with e lect ron capture detect ion. 
I t  was concluded tha t  PGI2 could not be a c i r c u la t i n g  hormone in 
man as previously thought.  This ,  however, does not prec lude a 
ro le  f o r  PGI2 funct ion ing as a local hormone in  the regulat ion of 
p ia te le t -vesse l  wall in te rac t io n  (Patrono, Preston and Vermylen, 
1984). Changes in levels  of i t s  stable metabol i tes must r e f l e c t  
changes in  product ion, i t  is  s t i l l  therefore valuable to  measure 
these m e ta b o l i te s  in  an a t tempt  to  e lu c i d a t e  the  r o le  o f  
p r o s t a c y c l i n  in  d isease .  RIA has a lso  been d i s c r e d i t e d  by 
v a r y in g  'no rm a l '  va lues obta ined by RIA. Such d i f ferences are
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due t o  v a r i a t i o n s  in  methodology and an t ibody  s e n s i t i v i t y  
(V in n ik k a  and Y l i k o r k a l a ,  1982). While R IA 's  cannot g ive  
a b so lu te  va lues f o r  PGI2 m e ta b o l i te s ,  they can s t i l l  produce 
accurate comparative values.
Much improved RIA 's  have been developed re c e n t l y  w i th  
s e n s i t i v i t i e s  and normal leve ls  much c loser  to  those ob ta ined  by 
GCMS (McLaren et al_., 1985). RIAs there fo re  can s t i l l  y ie ld  much 
va lu a b le  and accurate data provided proper contro ls  are included 
and v a l i d a t i o n  performed (Salmon, 1983). They have many 
advantages over GCMS, as they are r e la t i v e l y  sens i t ive ,  sp e c i f ic  
and can cope with  large number of samples. For these reasons RIA 
is  probably the method of choice from rout ine measurements (Belch 
et a]_., 1983; Salmon, 1983).
Measurement o f  plasma TxB2 also has methodological problems, as 
p l a t e l e t  a c t i v a t i o n  a t  the  t ime o f  venepuncture can e a s i l y  
produce a r t i f a c tu a l  re su l ts .  In add i t ion ,  RIA of TxB2 , l i k e  th a t  
o f  PGI2 m e ta b o l i t e s ,  can on ly  g ive  comparat ive  r a th e r  than 
absolute values f o r  TxB2 .
4.1.2 Problems with Extract ion in RIA
E x t r a c t i o n  of plasma and serum samples is  a debatable subject in 
the  f i e l d  o f  RIA, as many o f  the  procedures invo lved  can 
themselves be a source of e r ro r .  The main reason f o r  ex t rac t ion  
is  to  remove unwanted substances which might i n t e r f e r e  w i th  the  
assay. However, the  oppos i te  may hold t r u e .  In unextracted 
plasma the i n te r fe r in g  substances may remain bound to  albumen and 
are thus harmless, w h i le  e x t r a c t i o n  would s t r i p  the  albumen
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molecu les o f  many substances which could d is tu rb  the subsequent 
ant igen/ant ibody binding (Kindahl and Granstrom, 1980). Free 
f a t t y  ac ids e s p e c ia l l y  w i l l  remain in high concentrat ions a f te r  
e x t ra c t io n ,  and unless extensive p u r i f i c a t i o n  i s  performed w i l l  
i n t e r f e r e  w i th  the assay (Gold and Edgar, 1978) .  These 
e x t r a c t i o n  evapora t ion  and p u r i f i c a t i o n  steps can a lso  add 
f u r t h e r  i m p u r i t i e s  (Greaves and P res ton ,  1982;. Kindahl and 
Granstrom, 1980), which can cause marked and unacceptable  
non-speci f ic  in ter ference with  the assay.
In view o f  these problems, the  assays desc r ibed  below were 
developed on unex t rac ted  plasma and have been shown to  be 
accurate, sens i t ive  and reproducible.
4.1 .3  PGIpM Assay Method
Venous blood was taken w i t h o u t  s t a s i s  i n t o  an a n t ic o a g u la n t  
mixture cons is t ing  of 3.8% w/v t r isod ium c i t r a t e  c o n ta in in g  3 x 
lO 'S  mola r  indomethacin and 10"^ molar adenosine (9 volumes of 
blood to  1 volume ant icoagulant) ,  and then centr i fuged at 4°C f o r  
20 minutes at 2500 g. Plasma was stored at -70°C u n t i l  the assay 
was perfo rmed. Plasma immunoreactive 6-keto-PGFig (PGI2M), was 
measured on unextracted plasma by radioimmunoassay as p re v io u s ly  
d esc r ibed  (McLaren ejt ^ . , 1985; Belch ^  A l *  » 1983). The 
antibody used was a polyclonal antibody raised in  rabbi ts  by Dr. 
F.E. Preston of the Department o f Haematology, Royal Ha l lamsh i re  
H o s p i t a l ,  She f f ie ld .  The cross re a c t i v i t e s  f o r  t h i s  antibody are 
shown in  tab le  4.1. The bu f fe r  used was O.IM phosphate b u f f e r  pH 
7.0 conta ining 0.1% bovine serum albumen (The pro te in  being added 
to  prevent adso rp t io n  losses  onto w a l l s  o f  tubes and p ip e t t e
TABLE 4.1
Cross r e a c t i v i t i e s  of PGI^M antibody with  
ava i lab le  prostaglandins and metabol i tes








13,14-dihydro-6 ,15-d iketo-P6Fi^ 0.075
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FIGURE 4.2
Standard curve f o r  6-keto-PGF^^ compared to
standard curve f o r  hydrol ised PGIg.
TABLE 4.2
PGIg Metabol i te  Concentrations During Infusions of PGI^ 
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103
t i p s ) .  Separa t ion  was performed using acid washed charcoal in 
assay bu f fe r .  A l l  measurements were performed in  d u p l i c a t e  and 
the mean value recorded.
The lower l i m i t  of  s e n s i t i v i t y  of the assay was 5 pg/ml, recovery 
of added 6-keto-PGFia was 95 ± 9 (SD)%; the in t ra -assay va r ia t io n  
was 4% and interassay va r ia t ion  4.9%.
The standard curves over 10 assays are shown in  f ig u re  4.1.
The assay was fu r th e r  val idated by hydrolys ing known q u a n t i t i e s  
o f  PGI2 in  b u f f e r ,  and comparing t h i s  w ith  the same quan t i t ies  
of 6-keto-PGFia measured by the same assay (McLaren et , 1985; 
Belch e t  aj_., 1983), t h i s  produced a p a r a l l e l  standard curve 
which i s  shown in  f i g u r e  4 .2 . Va l ida t ion  was also performed in  
v ivo  by measuring PGI2M in a normal volunteer infused with PGI2 
(McLaren et , 1985) where measured plasma PGI2M correlated 
we l l  w i th  th e  ra te  o f  th e  i n f u s io n  ( t a b l e  4 .2 ) .  Furthermore, 
su b je c ts  given n o n -s te ro id a l  a n t i - i n f l a m m a t o r y  agents had 
undetectable PGI2M levels  a f t e r  treatment.
4 .1 .4  TxB? Assay Method
Venous blood was prepared as fo r  the PGI2M assay described above. 
TxB2 was measured by RIA on unextracted plasma. Antibody was 
obtained from Upjohn Diagnost ics L im i te d ,  Kalamazoo, M ich igan,  
U.S.A.,  and t h i s  was a polyclonal antibody raised in  rabb i ts .  The 
cross r e a c t i v i t i e s  fo r  t h i s  antibody are shown in  tab le  4.3. The 
method used was tha t  of Granstrom and Kindahl (1978). The assay 
bu f fe r  was again O.IM phosphate b u f f e r  pH 7.0  w i t h  0.1% bovine
TABLE 4.3
Cross r e a c t i v i t i e s  f o r  TxB2 antibody with  ava i lab le  
prostaglandins and metabol ites
% C ross - reac t iv i t y  
(50% B/Bq Replacement)





















6 ,15 -d i -ke to  PGFi* .001
PGBi .001
13.14-diH-15-keto PGF2a < .001
15 keto PGFia < .001
15-Epi PGE2 < .001
13.14-diH-15-keto PGFi^ < .001
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FIGURE 4.3
TxBg Assay: standard curve over 10 assays using H t race r
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serum albumen to  prevent adsorp t ion  lo s s e s .  Separa t ion  was 
performed w i th  ac id  washed charcoal in  assay b u f f e r .  A l l  
measurements were performed in  d u p l i c a t e  and th e  mean va lue 
recorded .  The lower  l i m i t  o f  s e n s i t i v i t y  was 10 pg /m l ;  the 
i n t r a -a s s a y  v a r i a t i o n  was 4% and inter-assay va r ia t io n  was 10%. 
Recovery of added TxB2 v/as 91.2 ± 5.5 (SD)%. The standard curves 
over 10 assays are shown in  f ig u re  4.3.
4.2 PLATELET AGGREGATION STUDIES IN PLATELET RICH PLASMA
4.2.1 P la te le t  Aggregation in  P la te le t  Rich Plasma 
The most commonly used method f o r  studying p la te le t  shape change 
and aggrega t ion  i n  p l a t e l e t  r i c h  plasma (plasma c o n ta in in g  
p l a t e l e t s  but not e r y t h r o c y t e s ) ,  i s  the  photometric technique 
descr ibed  by Born in  1962. Th is  measures changes in  l i g h t  
t r a n s m is s io n  th rough s t i r r e d  p l a t e l e t  r i c h  plasma (PRP). 
I n i t i a l l y ,  the d isc shaped p la te le ts  cause o s c i l l a t i o n s  in  l i g h t  
t ra n s m is s io n  through the p l a t e l e t  suspension. Fol lowing the 
a d d i t i o n  o f  an aggrega t ing  agent such as c o l la g e n  these 
o s c i l l a t i o n s  decrease in  ampli tude and l i g h t  transmission f a l l s  
s l i g h t l y .  Dur ing t h i s  t im e  the  p l a t e l e t s  have been shown to  
change from a d isc  t o  a more rounded form w i th  pseudopodia 
(O'Brien and Heywood, 1966; Born, 1970). This shape change which 
i s  due to  ca lc ium dependent myosin p h o s p h o ry la t io n  in  the  
p la te le t  cytoskeleton (Nachmias, Kavaler and Jacubow i tz ,  1985), 
i s  fo l lo w e d  by a g g re g a t ion .  As the  p l a t e l e t s  aggregate  the  
opt ica l  density o f the plasma decreases, and l i g h t  t ra n s m is s io n  
increases. The increase in  l i g h t  transmission is  proport ional  to  
the  aggregat ion  response and a lso  v a r ie s  w i th  the  i n i t i a l  
p l a t e l e t  count (Born and Cross, 1963). P la te le t  contents must
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there fore  be standardised in  the various samples of PRP, and th is  
can be achieved by d i l u t i o n  with autologous p la te le t  poor plasma. 
Most workers standardise the p la te le t  count to  200 or 300 x 10^/1 
p ia te le ts .
4.2.2 Conditions In f luencing P la te le t  Aggregation Tests 
The an t icoagu lan t  used in the study is  important,  as heparin can 
i t s e l f  induce aggregat ion (Zucker ,  1970; E ika ,  1972) and EDTA 
w i l l  i n h i b i t  aggregation (Zucker and B o r r e l l i ,  1962). Trisodium 
c i t r a t e  i s  t h e r e fo r e  the  a n t i c o a g u la n t  o f  ch o ice .  Al though 
d i f f e r e n c e s  in  c i t r a t e  c o n c e n t ra t io n  can a f f e c t  ADP induced 
aggrega t ion  (T s 'a o ,  Lo and Raymond, 1976), c o l la g e n  induced 
aggrega t ion  has been shown to  be the  l e a s t  a f f e c t e d  by t h i s  
(Rossi and Louis, 1977). The pH o f  the  suspending plasma a lso  
in f lu e n c e s  aggrega t ion .  Only shape change occurs below a pH of
6.4 or above 10, and maximal aggregat ion occurs between pH 7.4 
and 8.0 (Packharn, Kinlough-Rathbone and Mustard, 1976). The rate 
of s t i r r i n g  inf luences p l a t e l e t  aggrega t ion  as i t  a f f e c t s  the  
number o f  c o l l i s i o n s  between p l a t e l e t s ,  and the  p l a t e l e t  
suspension is  usual ly  s t i r r e d  at 1000 rpm by a magnetic s t i r  bar 
(Born, 1962; Born and Cross, 1963). Temperature and time of 
storage are also important.  There is  l i t t l e  change in  p l a t e l e t  
funct ion  during the f i r s t  2 hours of storage at room temperature, 
whi le there  is  a progressive loss o f  f u n c t i o n  i f  s to rage  i s  at 
37°C (Han and A r d l i e ,  1974). I t  i s  conven t iona l  to  study 
aggregation at 37°C (Packham ^  al_., 1976).
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4 .2 .3  Measurement o f  P l a t e l e t  Aggregat ion  in  P l a t e l e t  Rich 
PIasma
Var ious  parameters have been used to  measure the  degree o f  
aggregat ion. The maximal change in  l i g h t  t ra n s m is s io n  and the 
maximal r a te  o f  aggrega t ion  (maximal rate o f  change in  opt ica l  
d e n s i t y )  being those most commonly adopted (Packham et a l . ,  
1976) .  The l a t t e r  has been shown to  be r e l i a b l e  and to  have 
greater re p ro d u c ib i l i t y  f o r  collagen induced aggrega t ion  (Rossi 
and L o u is ,  1977). I t  i s  t h e r e f o r e  the  method adopted f o r  
measuring aggregation in the fo l low ing  s tudies.
4.2 .4  Preparation of P la te le t  Rich Plasma
Venous blood was c o l l e c t e d  w i t h o u t  s t a s i s  from h e a l th y  
vo lunteers, using a 21 gauge b u t t e r f l y  cannula and ant icoagulated 
w i th  3.2% t r i  sodium c i t r a t e  (9:1 volume: volume). No volunteer 
had taken drugs of any k ind  f o r  a minimum o f  2 weeks p r i o r  t o  
ve n e se c t io n .  P l a t e l e t  r i c h  plasma (PRP) was obta ined by 
c e n t r i fu ga t io n  at 150 g f o r  15 minutes at room tem pera tu re ,  and 
p l a t e l e t  poor plasma (PPP) by fu r th e r  cen t r i fu ga t io n  at 1500 g 
f o r  10 minutes. The PRP p la t e le t  count  was determined us ing a 
C o u l te r  th rombocounter  ( C o u l t e r  E lect ronics L td . ,  England) and 
s tanda rd ised  to  300 x 10^/1 by d i l u t i o n  with autologous PPP i f  
r e q u i r e d .  A l l  exper iments were completed w i t h i n  2 hours o f  
venepuncture.
4.2.5  E f fec t  of Drugs on P la te le t  Aggregation
Vary ing  c o n cen t ra t io n s  o f  drug or vehic le , the l a t t e r  act ing as 
contro l  were added to  200 ul a l iquo ts  o f PRP. The volume of drug 
o r  v e h ic le  s o lu t i o n  added was kept constant at 100 ul g iv ing a
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t o t a l  volume o f  300 ul in  the aggregometer cuvette, and a f i n a l  
p la te le t  concentrat ion of 200 x lO ^ / l .  Treated PRP v/as incubated 
at 37°C fo r  5 minutes. P la te le t  aggregation was performed a f t e r  
the  method o f  Born (1962) us ing a Malins photometric 2 channel 
p la te le t  aggregometer (Malins Electronics L td . ,  U.K.) coupled to 
a pen re c o rd e r .  The PRP was s t i r r e d  at a cons tan t  1000 rpm. 
C a l ib ra t ion  was performed using s t i r r e d  PRP w i th  v e h i c l e  as 0% 
l i g h t  t r a n s m is s io n ,  and PPP w i th  v e h ic l e  as 100% l i g h t  
t ransmiss ion. Col lagen was used as the  aggrega t ing  agent at 
f i n a l  c o n c e n t ra t io n s  o f  1 ug/ml and 2 ug/ml.  Maximum rate of 
aggregation was determined by measuring the maximum g ra d ie n t  o f  
the  aggrega t ion  curve (change in  o p t i c a l  d e n s i t y / t i m e )  and 
expressed as a percentage of the control  (PRP with v e h ic le )  r a te  
o f  a g g re g a t io n .  A l l  drugs were d is s o lv e d  in  0.1 M phosphate 
bu f fe r  pH 7.0 (pH 7.0 was required to  f a c i l i t a t e  d i l u t i o n  of some 
o f  the drugs assessed).
4.3 THROMBOXANE GENERATION FROM PLATELET RICH PLASMA
4.3.1 Thromboxane A? Generation
The main p roduct  o f  the cyclo-oxygenase pathway in p la te le ts  is  
TxB2 which i s  a potent  vasoconstr ic to r  and p la te le t  aggregating 
agent (Hamberg et 1975). I t  i s  re leased when p la te le ts
aggregate and the  q u a n t i t y  produced is  dependent on p la te le t  
concentrat ion and the type and dose of the aggregating agent used 
(S ie s s ,  Roth and Weber 1981).  The aim o f  the  f o l l o w i n g  
methodology was to  provide a re l i a b le  method f o r  dete rmin ing the 
e f fe c t  of drugs on p la te le t  TxB2 product ion.
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4 .3 .2  E f f e c t  o f  D i f f e r e n t  Aggregat ing Agents and T h e i r  
Concentrations on Thromboxane B? Production from PRP 
P l a t e l e t  r i c h  plasma (PRP) was prepared and s tanda rd ised  as 
above, from healthy donors none of whom had taken any drugs fo r  a 
minimum of two weeks p r io r  to  venesection. The PRP was incubated 
with the vehicle which was to  be used in the l a t e r  studies ( 0.1 M 
phosphate b u f f e r  pH 7.0) f o r  10 minutes at 37°C. The volume of 
vehic le  was kept constant with  100 ul o f  v e h ic le  being added to  
each 200 ul a l iquo t  o f PRP. The f i n a l  p la te le t  concentrat ion was 
t h e r e fo r e  200 x l O ^ / l .  Vary ing  doses o f  c o l la g e n ,  ADP and 
arachidonic acid were used to  induce aggregation.
Exact ly 4 minutes a f t e r  adding the aggregating agent the react ion 
was halted by adding 100 ul o f  abso lu te  a l c o h o l .  The samples 
were then frozen in  dry ice ,  and stored at -70°C. Thromboxane A2 
was measured by radioimmunoassay o f  i t s  s table  hydrat ion product  
thromboxane 82 (TXB2 ) as descr ibed above. P r io r  to  radio-imm­
unoassay the samples were thawed, c e n t r i f u g e d  at 1500 g f o r  10 
minutes at 4°C to  remove c e l l  d e b r i s ,  and d i lu ted  1:300 using 
assay b u f fe r  (0 .1  M phosphate b u f f e r  pH 7.0 w i th  0.1% bovine 
albumen) f o r  col lagen and ADP induced aggregation, and 1:400 f o r  
a ra ch id o n ic  ac id  induced a g g re g a t ion .  Resu l ts  f o r  TxB2 
generation are expressed as ng/ml/lO? p la te le ts  to  compensate fo r  
minor v a r i a t i o n s  in  the  f i n a l  p l a t e l e t  coun t .  Rate o f  
aggrega t ion  was a lso  determined f o r  these exper iments and 
expressed as change in op t ica l  densi ty / t ime (a rb i t r a r y  u n i t s ) .
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4.3 .3  E f fec t  of Indomethadn on Thromboxane A? Generation 
To c o n f i rm  t h a t  the  method could measure i n h i b i t i o n  o f  TxB2 
product ion, indomethacin an i n h ib i t o r  o f p la te le t  cyclo-oxygenase 
was studied in  t h i s  model.
P la te le t  r ich  plasma was prepared and standardised as before, and 
Incubated with  e i th e r  vehicle (0.1 M phosphate b u f f e r  pH 7.0 or 
indomethacin  in  f i n a l  drug concentrat ions of 0.1  and 1.0  ug/ml, 
f o r  10 minutes at 37°C. The volume o f  d r u g / v e h i c l e  was kept 
co n s ta n t  w i th  100 ul being added to  each 200 ul o f  PRP. 
Aggrega t ion  was induced w i th  e i t h e r  4 ug/ml c o l la g e n  ( f i n a l  
concentrat ion) or 0.5 niM arachidonic acid ( f i n a l  concentra t ions) .  
These c o n c e n t ra t io n s  were used as they  p rov ided maximal 
agg rega t ion  and TxB2 p ro d u c t io n .  ADP was not assessed as i t  
Induced r e l a t i v e l y  l i t t l e  TxB2 g e n e ra t io n  compared to  
arachidonic acid and collagen (see f i g u r e  5 . 1 ) ,  c o n f i rm in g  the 
f i n d i n g s  o f  p rev ious  s tu d ie s  (Si ess et , 1977; Koh et a l . ,  
1980).
Exact ly 4 minutes a f te r  adding the aggregating agent the react ion 
was halted by adding 100 ul o f  ab so lu te  a l c o h o l .  The samples 
were then frozen in  dry ice, and stored at -70°C. Thromboxane A2 
was measured by radioimmunoassay of i t s  stab le  hydrat ion product 
thromboxane 82 (TxBg;) as described above. P r io r  to  radioimmu­
noassay the samples were thawed, c e n t r i f u g e d  at 1500 g f o r  10 
minutes at 4°C to  remove c e l l  d e b r i s ,  and d i lu te d  1:300 using 
assay b u f f e r  f o r  collagen induced aggregation and 1:400 f o r  TxB2
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g e ne ra t io n  was expressed as ng/m l / lO? p l a t e l e t s .  Rate of 
aggrega t ion  was a lso  determined and expressed as change in  
op t ica l  dens i ty / t ime (a rb i t r a r y  u n i t s ) .
4 .3 .4  E f f e c t  o f  Var ious A n t ih y p e r te n s iv e  Agents on TxA? 
Generation
PRP was prepared as be fo re  from h e a l th y  donors, and incubated 
w i th  drug or  v e h ic le  at 37°C f o r  10 m inu tes .  The volume o f  
d r u g / v e h i c l e  was again kept constant with 100 ul being added to 
each 200 ul o f  PRP. Aggregation was then performed using 4 ug/ml 
co l la g e n  ( f i n a l  c o n c e n t ra t io n )  as the agg rega t ing  s t im u lu s .  
Exact ly 4 minutes a f te r  adding col lagen the r e a c t i o n  was ha l ted  
by adding 200 ul o f  ab so lu te  a l c o h o l .  The samples were then 
f rozen  in  d ry  i c e ,  and s to re d  at -70°C. Thromboxane A2 was 
measured by radioimmunoassay o f  i t s  stable hydrat ion product TxB2 
as described above (Chapter 4 . 1 . 4 ) .  P r i o r  t o  radioimmunoassay 
the  samples were thawed, centr i fuged at 1500 g f o r  10 minutes at 
4°C to  remove ce l l  debr is ,  and d i lu te d  1:300 using assay b u f f e r .
The dose of collagen was chosen to  provide maximal aggregation so 
tha t  there was no d i f fe rence  in  the rate o f  aggrega t ion  between 
drug t r e a te d  or  c o n t ro l  PRP. This  was done to  exc lude any 
d i f f e r e n c e  in  ra te  o f  agg rega t ion  be ing re s p o n s ib le  f o r  any 
change in  TxB2 g e n e ra t io n .  Drugs found to  have an i n h ib i t o r y  
e f f e c t  on TxB2 g ene ra t ion  were assessed fu r th e r  to  determine 
whether t h i s  i n h i b i t o r y  e f f e c t  could be overcome by us ing 
exogenous a ra c h id o n ic  ac id  as the aggrega t ing  s t im u lus .  The 
experiment was repeated as before w i th  0.5  mM a ra c h id o n ic  ac id  
r e p la c in g  co l la g e n  as the aggrega t ing  agent .  F o l lo w in g
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a ra c h id o n ic  acid aggregation, TxB2 was assayed as before except 
tha t  a d i l u t i o n  of 1:400 with assay bu f fe r  was performed. Results 
f o r  TxB2 g ene ra t ion  are expressed as ng /m l / lO? p la te le ts  to  
compensate f o r  minor var ia t ions in  the f i n a l  p la te le t  count. Rate 
o f aggregation was also determined fo r  a l l  these experiments, and 
expressed as percentage of co n t ro l .  None o f  the  drugs assessed 
had any demonstrable cross r e a c t i v i t y  with  the assay. Exogenous 
arachidonic acid also had no demonstrable cross r e a c t i v i t y .
4 .4  SYNERGISM OF PROSTACYCLIN WITH ADRENOCEPTOR ANTAGONISTS IN 
INHIBITING PLATELET AGGREGATION IN PLATELET RICH PLASMA 
PGI2 i s  a po ten t  i n h i b i t o r  o f  p la te le t  aggregation (Moncada et 
a l . ,  1976). Some o f  the foregoing studies have shown tha t  some 
adrenoceptor  antagonists have a n t i - p l a t e l e t  e f fe c ts .  The aim of 
the  f o l l o w i n g  exper iments was t o  determ ine  whether  PGI2 was 
syne rg is t ic  with adrenoceptor antagonis ts,  in  i n h ib i t i n g  p la te le t  
aggregation in  PRP.
4.4.1 E f fec t  o f Prostacyc l in  on P la te le t  Aggregation 
I n i t i a l l y  dose response curves f o r  th e  e f f e c t  o f  PGI2 on 
col lagen induced aggregation were constructed t o  determine what 
dose to  use in  the  exper iments .  P l a t e l e t  r i c h  plasma was 
prepared and standardised as before. 100 ul o f  0.1 M phosphate 
b u f f e r  was added t o  each 200 ul a l i q u o t  o f  PRP. The f i n a l  
p l a t e l e t  c o n c e n t ra t io n  was 200 x 10^/1. Varying doses of PGI2 
(Wellcome, U.K.) or i t s  vehic le  (g lycine bu f fe r  pH 10.5, Wellcome 
U .K.)  were added 2 minutes p r io r  to  aggregation being performed 
and incuba ted  at 37°C. The volume of PGI2 or bu f fe r  added was 
kept constant at 10 u l . Aggregat ion was induced using 1 ug/ml
112
and 2 ug/ml co l la g e n  ( f i n a l  c o n c e n t r a t io n s ) .  The volume o f  
aggregating agent was also kept constant at 3 ul . Maximal ra te  
o f  aggregat ion  was measured and expressed as a percentage of the 
contro l  aggregation.
4 .4 .2  E f f e c t  o f  Adrenocepto r  A n tagon is ts  and Prostacyc l in  on 
P la te le t  Aggregation
200 ul a l i q u o t s  o f  p la te le t  r ich  plasma were prepared as before 
and incuba ted  w i th  100 ul o f  e i t h e r  drug,  in  f i n a l  
co n cen t ra t io n s  o f  1 ug/ml or 12.5 ug/ml, or vehic le  alone (0.1 M 
phosphate bu f fe r  pH 7 .0 ) .  A f te r  8 minutes i n c u b a t io n  a t  37°C, 
PGI2 a t  a f i n a l  c o n c e n t ra t io n  o f  100 pg/ml or  i t s  v e h ic le  
( g l y c in e  b u f f e r  pH 10.5) was added (10 u l )  and in c u b a t io n  
con t inued  f o r  a f u r th e r  2 minutes. Aggregation was then induced 
by collagen in a f i n a l  concentrat ion of 2 ug/ml. Maximal rate of 
a gg rega t ion  was measured and expressed as a percentage of the 
control  value.
4 .4 .3  S y n e r g i s t i c  A c t io n  o f  P G I? - l i k e  A c t i v i t y  from Human 
U m b i l i c a l  A r t e r y  w i th  Adrenocepto r  A n ta g o n is ts  in  In h ib i t i n g  
P la te le t  Aggregation
PGI2 is  the major prostanoid produced by umbil ica l  a r te ry  ( R i t t e r  
^  aj_., 1982). The a b i l i t y  o f  the PGl2- l i k e  a c t i v i t y  o f  human 
u m b i l i c a l  a r t e r y  to  act s y n e r g i s t i c a l l y  w i th  adrenoceptor  
antagonists was examined us ing  t h i s  method. Fresh u m b i l i c a l  
cords were ob ta ined  from normal pregnancies at te rm .  The 
umbil ica l  a r te r ie s  were f lushed with p h ys io lo g ica l  s a l i n e ,  then 
d is s e c te d  out and cut in to  r ings 2 mm wide. The r ings were then 
washed in  Ringer's lac ta te  b u f fe r ,  which had been gassed w i th  a
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mixture of 95% a i r : 5% CO2 , f o r  approximately 3 hours at 37°C. Two 
r ings were then placed in  each t i s s u e  bath c o n ta in in g  2 ml o f  
R in g e r 's  l a c t a t e  b u f f e r  at 37°C. Drugs were dissolved in 0.1 M 
phosphate bu f fe r  pH 7.0. PRP was prepared as before.
50 ul o f  drug s o lu t i o n  or v e h ic le  ( b u f f e r  alone) was added to  
each 200 ul a l iquo t  o f PRP, and incubated at 37°C f o r  8 m inutes. 
50 ul of  supernatant from the umbil ica l  a r te ry  r ings ,  or 50 ul of 
R in g e r 's  l a c t a t e  b u f f e r  a lone was then added and in c u b a t io n  
con t inued  f o r  a f u r t h e r  2 m inu tes .  Aggrega t ion  was then 
performed as before using col lagen in  a f i n a l  concent ra t ion  o f  2 
ug/ml. Maximal rate of aggregation was measured and expressed as 
a percentage o f  the  c o n t r o l  ( c o n t ro l  = 200 ul PRP, 50 ul 
phosphate bu f fe r  and 50 ul Ringer 's  lac ta te  b u f fe r ) .
4 .5  EFFECT OF DRUGS ON PGI9 PRODUCTION FROM HUMAN UMBILICAL 
ARTERY
PGI2 i s  the  main p roduct  o f  the a ra c h id o n ic  ac id  cascade in  
v a s c u la r  t i s s u e  (Moncada et al_., 1977) and has been shown to  be 
th e  majo r  prostaglandin produced from umbil ica l  a r te r ie s  ( R i t t e r  
e t al . ,  1982). The o b je c t  o f  the f o l l o w i n g  method was to  
de term ine  whether  any o f  the  drugs assessed had any e f fe c t  on 
PGI2 production from human umbil ica l  a r te ry .
Fresh umbil ical  cords were obtained from normal pregnancies at 
te rm .  The u m b i l i c a l  a r t e r i e s  were f lu sh ed  with physiological 
sa l ine ,  then dissected out and cut i n t o  r i n g s  2 mm wide. The 
a r t e r y  r ing s  were then washed in  Ringer's lac ta te  bu f fe r ,  which 
had been gassed with a mixture of 95% a i r : 5% CO2 , f o r  3 hours at
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37°C t o  exaust them o f  spontaneous endogenous PGI2 product ion. 
Two r ings (wet weight approximately 25 mg) were then placed i n t o  
each tube c o n ta in in g  1 ml of pooled plasma, and e i t h e r  the drug 
or i t s  veh ic le  to  act as con t ro l ,  or 100 ug/ml a s p i r i n .  A s p i r i n  
was used to  con f i rm  tha t  i n h ib i t i o n  of PGI2 production from the 
a r te ry  r ings  was p o s s ib le .  Pooled plasma was prepared from 6 
h e a l th y  donors using 3.2% t r i s o d iu m  c i t r a t e  (9 :1  v :v )  as the 
a n t i c o a g u la n t .  A f t e r  15 minutes in c u b a t io n  at 37°C 750 ul 
a l i q u o t s  were removed and PGI2M measured by RIA as described 
above. The amount o f  PGI2M was corrected f o r  t issue  weight, i f  
required, and is  expressed as pg/ml/25 mg t issue .
4.6 PLATELET AGGREGATION IN WHOLE BLOOD
4 .6 .1  L i m i t a t i o n s  o f  P l a t e l e t  Aggregation Studies in  P la te le t  
Rich Plasma and Advantages of Studying Aggregation in  Whole Blood 
The most commonly used method f o r  studying p la te le t  aggregation 
i n v i t r o  i s  the photometric technique of Born (1962) and O'Brien 
(1962) which measures aggrega t ion  in  s t i r r e d  p l a t e l e t  r i c h  
plasma. Whi le t h i s  method has proved i n v a lu a b le  in  the  
assessment o f  p l a t e l e t  f u n c t i o n ,  i t  has severa l  i n h e re n t  
l im i t a t i o n s .  F i r s t l y ,  the  whole blood must be c e n t r i f u g e d  to  
produce PRP, separating p la te le ts  from red c e l l s  and white c e l l s .  
Red c e l l s  are known to  inf luence aggrega t ion  by re lease  o f  ADP 
(H a r r i s o n  and M i t c h e l l ,  1966; Born and Wehmeier, 1979; Fox et 
al . ,  1982; Saniabadi et , 1984a) and a lso  by a mechanical 
a c t i o n  on the  p l a t e l e t s  which f a c i l i t a t e s  p i a t e l e t - p l a t e l et 
c o l l i s i o n s  (Goldsmith, 1971; Tur i to  and Baumgartner, 1975). White 
c e l l s ,  converse ly ,  may reduce p la te le t  aggregation by generating 
PGI2 (Blackwel l  et a l . ,  1978; Deckmyn et a l . , 1983).
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Furthermore, p la te le ts  are heterogenous with  regard to  age, size, 
dens i ty  and metabol ic a c t i v i t i e s  (Karpatkin and Charmatz, 1969; 
Karpatkin, 1969; Karpatkin, 1978; Nannucci and Sharp, 1967), with 
l a r g e r  and denser p l a t e l e t s  being m e t a b o l i c a l l y  more a c t i v e  
(K a rp a tk in  and Charmatz, 1969), than smal ler  and l i g h t e r  ones. 
Consequently, ce r ta in  sub-populations may be spun down and l o s t  
on c e n t r i f u g a t i o n  and studies in  p la te le t  r i ch  plasma may not be 
representat ive o f  p la te le t  func t ion  in  whole blood.
In a d d i t i o n  the photometric technique using p la te le t  r ich  plasma 
is  only semi-quant i ta t ive .  I t  has been shown by microscopy th a t  
a f t e r  a d d i t i o n  o f  an a g g re g a to r /  s t im u lu s  f ree p la te le ts  form 
small  aggregates p r i o r  to  any change in  l i g h t  t ra n s m is s io n  
o c c u r r i n g  (Born and Hume, 1967). The f i r s t  v i s i b l e  change in 
l i g h t  transmission in  p la te le t  r ich  plasma treated with  low dose 
ADP has been shown to  occur at the  moment a l l  f r e e  p la te le ts  
d isappear  (N ich o ls  and Bosmann, 1979) and the  presence o f  a 
second wave o f  aggregation, induced by ADP is  not re la ted to  any 
change in  p la te le t  number (Gear and Lambrecht, 1981) but possibly 
to  formation of la rge r  aggregates or changes in density  (Born and 
Hume, 1967).
In view o f  these l i m i t a t i o n s  i t  i s  o f  value to  study p la te le t  
aggregation in whole blood, leaving the whole p la te le t  population 
i n  t h e i r  natural  mi l ieu surrounded by red c e l l s  and white c e l l s .  
I t  has recent ly  become possible to  measure p l a t e l e t  aggrega t ion  
i n  whole blood using the Clay Adams U l t r a  Flo 100 whole blood 
p la te le t  counter (Lumley and Humphrey, 1981), thus a vo id ing  the
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problems associated with preparation of p la te le t  r i ch  plasma. The 
U l t ra  Flo 100 can count accurately the number of s ing le  p la te le ts  
in  whole blood (Day, Young and H e l f r i c h ,  1979) . I t  i s  
e s s e n t ia l l y  an impedence type  e l e c t r o n i c  c e l l  co u n te r ,  which 
counts both p l a t e l e t s  and red c e l l s  in  a d i l u t e d  specimen of 
whole blood d i f f e r e n t i a t i n g  them accord ing  to  s i z e .  The U l t r a  
Flo 100 was used in the fo l low ing  studies on p la te le t  aggregation 
in  whole blood.
4.6.2 Studies on P la te le t  Aggregation in  Whole Blood 
Venous blood was ob ta ined w i tho u t  s tas is  from healthy male and 
female v o lu n te e rs  us ing a 21 gauge b u t t e r f l y  cannu la ,  and 
a n t ico a g u l  ated w i th  3.2% tr isod ium c i t r a t e  (9:1 v : v ) .  No donor 
had taken  any drugs f o r  a minimum o f  2 weeks p r i o r  t o  
venepuncture .  The blood was d iv id e d  i n t o  0.9 ml a l iquots  and 
varying concentrat ions of drug or vehic le  were added, the  l a t t e r  
a c t i n g  as co n t ro l .  The volume of drug or vehic le  added was kept 
constant at 100 ul g iv ing a f i n a l  volume of 1 ml. Red ce l l  count 
was determined on one o f  the a l iquo ts  f o r  each donor using the 
Clay-Adams Haematology Analyser (HA-5) ,  the  va lue ob ta ined  was 
then d ia le d  i n t o  the  Clay Adams U l t r a  F lo  100 whole blood 
p la te le t  counter p r io r  to  any p l a t e l e t  count being performed. 
Each sample was incubated  f o r  30 minutes at 37°C. A 10 ul 
a l iq u o t  was then withdrawn from the  sample and r in s e d  i n t o  a 
p r e f i l l e d  d i l u e n t  r e s e r v o i r  (Clay Adams) and p l a t e l e t  count 
dete rm ined us ing the  U l t r a  Flo 100. The va lue  ob ta ined  was 
recorded as the b a se l in e  ( t ime  0) p l a t e l e t  count .  The 
aggregat ing agent was then added and each sample placed in  a 
shaking water bath (Gallenkamp; 200 shakes/min; excursion of tube
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h o ld e r  approximately 5 cm). Further 10 ul a l iquo ts  were removed 
at 1,2,3 and 5 minutes f o l l o w i n g  a d d i t i o n  o f  the  aggrega t ing  
agen ts ,  and p la te le t  count determined as before. At a l l  times 2 
p l a t e l e t  counts were taken and the  mean value recorded and 
expressed as a percentage of the basel ine (time 0) value. Three 
aggregating agents were used, co l lagen  (Hormone Chemie) in  a 
f i n a l  c o n c e n t ra t io n  o f  0.5 ug/ml , ;  ADP (Sigma) in  a f i n a l  
concentrat ion of 10 uM and arach idon ic  ac id  (Sigma) in  a f i n a l  
concentrat ion of 0.5 mM; the volume of a l l  aggregating agents m s  
kept constant at 10 u l .
Th is  techn ique  o f  p la t e l e t  aggregation in  whole blood using the 
Clay-Adams U l t ra  Flo 100 has previously been f u l l y  eva luated by 
Saniabadi et aj_., (1983a; 1983b; 1984a; 1984b) in  our labora tory, 
and has been shown to  be a sens i t ive  and r e l ia b le  method.
4 .6 .3  E f fec t  of PGI? on P la te le t  Aggregation in  Whole Blood 
Blood was prepared as before and incubated f o r  2 minutes at 37°C 
w i t h  v a ry in g  c o n c e n t ra t io n s  o f  PGI2 (Wellcome U.K.)  or i t s  
v e h ic l e  ( g l y c i n e  b u f fe r  pH 10.5).  The volume of PGI2 or bu f fe r  
which was added was kept cons tan t  a t  10 u l . Aggregat ion  was 
per formed as above using 0.5 ug/ml col lagen. A concentrat ion of 
PGI2 which had minimal e f fe c t  on aggregation to  collagen in a l l  
s u b je c ts  was thus determined (125 pg/ml PGI2 ) .  Th is  
c o n c e n t ra t io n  was used in assessing whether PGI2 was synerg is t ic  
with adrenoceptor a n ta g o n is ts  and a ca lc ium  channel b lo ck in g  
agent (n ica rd ip ine )  in i n h ib i t i n g  p la te le t  aggregation.
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4 .6 .4  S y n e r g i s t i c  E f f e c t s  o f  Adrenocepto r  A n ta g o n is ts  and 
Nicardipine with PGI? in  I n h ib i t i n g  P la te le t  Aggregation in  Whole 
Blood
A l iq u o ts  o f  whole blood were prepared as before and incubated 
w i th  e i t h e r  l a b e t a l o l ,  p in d o lo l  o r  p ro p ra n o lo l  a t  a f i n a l  
c o n c e n t ra t io n  o f  1 ug /m l ,  or  t h e i r  veh ic les . A f t e r  28 minutes 
incubat ion at 37°C, PGI2 in  a f i n a l  concentrat ion o f  125 pg/ml or 
i t s  vehic le  was added, and incubat ion cont inued f o r  a f u r t h e r  2 
minutes. Aggregation studies were then performed as before using 
0.5 ug/ml col lagen as the aggregating agent.
The p o s s ib le  s y n e r g i s t i c  e f fe c t  o f  the calcium channel blocking 
agent n i c a r d i p i n e  was s i m i l a r l y  assessed w i th  the  f i n a l  
concentrat ion o f  n icard ip ine  being 10 ug/ml.
The volume o f  drug or vehic le  added was kept constant a t 100 u l ,  
in  a l l  experiments.
4 .6 .5  S y n e r g i s t i c  A c t io n  o f  A s p i r i n  w i th  an Adrenocepto r  
An ta g o n is t  o r  Calcium Channel B lock ing  Agent in  I n h i b i t i n g  
P la te le t  Aggregation in  Whole Blood
Blood from h e a l th y  donors, none of whom had taken any drugs fo r  
at least  2 weeks before venesect ion, was ant icoagulated with 3.2% 
t r i s o d iu m  c i t r a t e  (9 :1  v : v ) .  Samples were then incubated with 
l a b e t a l o l ,  n i c a r d i p i n e ,  or  t h e i r  v e h ic le s  ( c o n t r o l s )  f o r  25 
minutes at 37°C. A s p i r i n  or i t s  v e h ic le  was then added and 
incubat ion continued f o r  a fu r th e r  5 minutes. The concentrat ions 
o f  a l l  t h re e  drugs were known from p r i o r  assessment t o  have 
l i t t l e  e f f e c t  on a g g re g a t ion  when used a lone i n  a l l  su b je c ts .
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s tu d ie d .  Whole blood aggrega t ion  was performed with the Clay 
Adams U l t ra  Flo 100 whole blood p la te le t  counter, p la te le t  counts 
being measured 1, 2, 3 and 5 minutes a f t e r  a d d i t i o n  o f  the 
aggrega t ing  agent (0 .5  ug/ml co l la g e n )  and expressed as a 
percentage of the count at t ime zero.
A l l  aggregation studies in whole b lood were completed w i t h i n  2 
hours of venesection.
4.7 GENERATION OF TxBp AND PGIpM FROM WHOLE BLOOD 
I t  is  known tha t  whole blood i f  allowed to  c lo t  w i l l  produce TxA2 
due to  endogenous thrombin induced a c t iva t ion  o f  p la te le ts .  This 
has been shown to  be a simple and reproducible capacity re la ted 
index o f  p l a t e l e t  TxA2 p ro d u c t io n  ( Al essandri  ni et , 1985; 
Patrono et , 1980). Whole blood is  also known to  produce PGI2 
(Blackwel l et , 1978; Deckmyn et ^ . ,  1983) from white c e l l s .
The e f f e c t  o f  va r io u s  drugs on product ion of TxA2 and PGI2 from 
whole blood was determined using the fo l low ing  methodology. Fresh 
venous blood was ob ta ined  w i th o u t  s t a s i s  us ing  a 21 gauge 
b u t t e r f l y  cannula, from heal thy male and female v o lu n te e r s .  No 
donor had taken any medication f o r  a minimum of 2 weeks p r io r  to  
venepunture. No ant icoagulant was used and 0.9 ml a l i q u o t s  were 
immediately placed in to  glass tubes containing e i th e r  the drug or 
i t s  veh ic le ,  the l a t t e r  act ing as con t ro l .  The volume of drug or 
v e h ic l e  was kept cons tan t  at 100 u l . The samples were then 
a l lowed t o  c l o t  spontaneously  at 37°C f o r  30 m inu tes .  The 
r e a c t i o n  was halted by cen t r i fuga t ion  at 3000 rpm fo r  15 minutes 
at 4°C. The serum was then assayed f o r  immunoreact ive
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6 -ke to -PGFia  (PGI2M) and TxB2 using radioimmunoassays which have 
been desc r ib e d  above. P r i o r  to  TxB2 measurement the  serum 
required to  be d i lu ted  1:300 with assay b u f fe r .
To c o n f i rm  th a t  i n h ib i t i o n  of PGI2M and TxB2 product ion could be 
measured using th i s  technique, the experiment was f i r s t  performed 
w i th  v a ry in g  concentrat ions of indomethacin or i t s  vehic le  (0.9% 
sodium c h lo r id e ) .
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P l a t e l e t s  have a wel l  e s ta b l i s h e d  r o le  in  the pathogenesis of 
vascular disease, and p la te le t  r e a c t i v i t y  has been shown to  be 
inc reased  in  p a t i e n t s  w i th  a r t e r i o s c le r o t i c  disease (Steele et 
al . ,  1973; Murphy and Mustard, 1962; Marker and S l i c h te r ,  1972; 
Mehta ^  aj_., 1978). P la te le ts  contr ibu te  to  the disease process 
both by o b s t r u c t i n g  the  m ic ro c i r c u la t io n  when aggregates form, 
and by re lease  o f  va so ac t ive  substances such as thromboxane A2 
(TXA2 ) which i s  the  major  a ra ch id o n ic  ac id m e ta b o l i te  in  
p la te le t s .  I t  i s  re leased when p l a t e l e t s  aggregate and i s  a 
potent p la te le t  aggregating agent and vasoconstr ic to r  (Hamberg et 
al  . ,  1975) which has been impl icated in  experimental myocardial 
i n f a r c t i o n  (Coker _ e t ^ . ,  1981), vasospast ic angina (Lewy et a l . ,  
1979; Robertson et ^ . , 1981), and ischaemic heart disease (Hirsh 
et a l . ,  1981).
3-ad renocep to r  antagonists are used extensively  in the treatment 
o f hypertension and ischaemic heart disease. Propranolol has been 
shown t o  reduce p l a t e l e t  aggregation responses in  pat ients  with 
coronary  a r te ry  disease (Frishman et a_][., 1974) and hypertension 
(Campbell et  aj_., 1981a). Th is  has provoked i n t e r e s t  in the 
e f f e c t  o f  3-a d renocep to r  a n ta g o n is ts  on p la te le t  funct ion and 
p l a t e l e t  aggrega t ion  i s  known to  be a f fe c te d  by these drugs 
(Weksl er et _a]_., 1977; Fri  shman et ^ . , 1978; Small et aj^., 1982; 
Campbell et  , 1981b; Rubegni, Provvedi and B e l l i n i ,  1974). 
A lthough the  mechanism is  not e n t i r e l y  c lea r ,  i t  is  independent 
o f  3-a d re n o ce p to r  antagonism ( Weksl er ^  aj_., 1977) and may be 
due to  the membrane s ta b i l i s i n g  a c t i v i t y  (MSA) of these compounds 
(Weksl e r  e t a l . , 1977; Dachany-Prigent .et _al., 1979; Heinroth &t
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a l . ,  1983) . More recen t ly  studies have described an in h ib i t o r y  
e f f e c t  on TxA2 p ro du c t io n  (Campbell et a]_., 1981a; Campbell et 
al . ,  1981b; H e i n r o t h ^ ^ . ,  1983; Mehta and Mehta, 1982; Mehta, 
Mehta and O s t row sk i ,  1983). The m a j o r i t y  o f  s tu d ie s  have 
concentrated on propranolol  desp i te  the  la rg e  numbers o f  a and 
3 -ad renocep to r  a n ta g o n is ts  a va i la b le .  Furthermore, adrenergic 
blocking agents d i f f e r  w id e ly  in  t h e i r  r e c e p to r  s e l e c t i v i t y ,  
possession of MSA, and i n t r i n s i c  sympathomimetic a c t i v i t y  ( ISA), 
and l i p o p h i 1i c i t y .  The aim o f  t h i s  s tudy was to  compare the 
e f f e c t s  o f  a wide range of adrenoceptor antagonists with varying 
ISA, MSA, l i p o p h i l i c i t y  and receptor s p e c i f i c i t y  ( t a b l e  5 .1 )  on 
p la te le t  aggregation and TxA2 generation.
5.2 MATERIALS AND METHODS
The m a te r ia l s  and methods f o r  the  f o l l o w i n g  j_n v i t r o  studies 
us ing p l a t e l e t  r i c h  plasma (PRP) are f u l l y  described in  Chapter 
4. Venous blood from normal vo lu n te e rs  was ob ta ined and PRP 
prepared as described in  Chapter 4 .2 .4 .
The e f fe c t  of adrenoceptor an tagon is ts  on p l a t e l e t  aggrega t ion  
was studied using the method described in Chapter 4 .2 .5 .  Collagen 
was used as the aggregating agent at a f i n a l  c o n c e n t ra t io n  o f  1 
ug /m l .  Drugs showing an i n h i b i t o r y  e f fe c t  on 1 ug/ml col lagen 
induced aggregation, were also assessed with  2 ug/ml col lagen.
The e f f e c t s  of adrenoceptor antagonists on TxB2 production from 
PRP were s tu d ied  us ing the  methodology descr ibed  in  Chapter 
4 .3 .4 .  P r io r  to  any studies using the drugs, the methodology was 
v a l i d a t e d  by c o n s t r u c t i n g  dose response curves f o r  TxB2
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p ro d u c t io n  and p l a t e l e t  aggrega t ion  in  response to  collagen, 
arachidonic acid and adenosine diphosphate (ADP) as descr ibed in  
Chapter  4 .3 .2  and the  minimal concentrat ion of each aggregating 
agent which produced maximal TxB2 gene ra t io n  and p l a t e l e t  
aggregation was thus determined.
To c o n f i rm  t h a t  t h i s  method cou ld  measure i n h i b i t i o n  of TxB2 
p r o d u c t i o n ,  indomethacin , an i n h i b i t o r  o f  p l a t e l e t  c y c lo -  
oxygenase, was s tud ied  in  t h i s  system as described in  Chapter 
4 .3 .3 .
S t a t i s t i c a l  analysis was by the Wilcoxon rank sum te s t  f o r  paired 
data and a l l  resu lts  are expressed as mean ± SEM. C o r r e la t i o n  
was assessed using the Spearman rank t e s t .
5.3 RESULTS
5 .3 .1  Dose Response Curves f o r  TxB? P roduc t ion  and P la te le t  
Aggregation in  Response to  Arachidonic Acid, Collagen and ADP.
The dose response curves f o r  TxB2 p ro d u c t io n  and p l a t e l e t  
aggregation in response to  arachidonic ac id , col lagen and ADP are 
i l l u s t r a t e d  in  f igu re  5.1 . As can be seen, a l l  three aggregating 
agents s t im u la te d  TxB2 product ion and p la te le t  aggregation in a 
dose dependent manner. However, ADP induced r e l a t i v e l y  l i t t l e  
TxB2 p ro d u c t io n  compared to  a ra c h id o n ic  acid or collagen, and 
there fo re  was not used in any o f  th e  subsequent exper iments to  
































Dose response curves f o r  TxB2 generation and p la t e l e t  
aggregation in  response to  arachidonic ac id, collagen and ADP 
(Each po in t represent the mean ± SEM o f  6 experiments)
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Maximal aggrega t ion  and TxB2 p ro du c t io n  were ob ta ined  at a 
concentrat ion of 4 ug/ml collagen and 0.5  mM a ra c h id o n ic  a c id .  
In c re a s in g  th e  dose o f  each aggrega t ing  agent above these 
concentrat ions did not produce any s i g n i f i c a n t  e f f e c t  on e i t h e r  
p la te le t  aggregation or TxB2 production. These concentrat ions of 
col lagen and arachidonic acid were there fo re  used t o  assess the 
e f fe c t  o f  drugs on TxB2 product ion in the fo l low ing  experiments.
Under maximal s t im u la t ion ,  arachidonic acid st imulated more TxB2 
product ion than e i th e r  of the other  aggregating agents.
The dose o f  arachidonic acid used corre la ted p o s i t i v e l y  with the 
ra te  o f  aggrega t ion  ( r  = 0 .7 4 ;  p <0 .001) ,  and w i th  TxB2 
production ( r  = 0.97; p <0.001). Rate of aggregation in  response 
to  a rach idon ic  acid corre la ted  with TxB2 product ion ( r  = 0.72; p 
<0 .001).
The dose o f  collagen used corre la ted  with the rate of aggregation 
( r  = 0 .7 5 ;  p <0.001) and TxB2 production ( r  = 0.75; p <0.001). 
Rate o f  aggregation in  response to  collagen corre la ted with TxB2 
production ( r  = 0.72; p <0.001).
The dose of ADP used corre la ted with the rate of aggregation ( r  = 
0 .83 ;  p <0.001) and TxB2 production ( r  = 0.89; p <0.001). Rate 
of aggregation in  response to  ADP corre la ted with TxB2 production 
( r  = 0.74; p <0.001).
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5.3.2 E f fec t  o f  Indomethacin on TxB? Production
The e f f e c t s  o f  indomethacin  on TxB£ p ro d u c t io n  and p l a t e l e t  
agg rega t ion  induced by 0.5 mM/arachidonic ac id  and 4 ug/ml 
col lagen are i l l u s t r a t e d  in  f ig u re  5.2.
Indomethacin s i g n i f i c a n t l y  i n h ib i t e d  both aggregation and TxB2 
production in response to  0.5 mM a ra ch id o n ic  ac id  a t  a dose o f  
0.1 ug /m l ,  and v i r t u a l l y  abo l ished  both aggrega t ion  and TxB2 
product ion at a dose of 1.0 ug/ml. However, both aggregation and 
TxB2 p roduct ion  induced by col lagen were unaffected by 0.1 ug/ml 
indomethacin, but were s i g n i f i c a n t l y  in h ib i ted  by the higher dose 
o f indomethacin (1.0 ug/ml).
5.3.3 Ef fec t  of Adrenoceptor Antagonists on P la te le t  Aggregation 
and Thromboxane Generation
L a b e t a l o l ,  p in d o lo l  and p ro p ra n o lo l  had s i g n i f i c a n t  a n t i ­
aggregatory act ions on both 1 ug/ml and 2 ug/ml col lagen induced 
aggrega t ion  and these are i l l u s t r a t e d  in  the form o f  dose 
response curves ( f i g u r e  5 . 3 ) .  The dose response curves were 
" s h i f t e d "  to  the r i g l i t  when the la rge r  dose of collagen was used 
( f i g u r e  5 . 3 ) .  None o f  these agents had any e f f e c t  on the  
p l a t e l e t  shape change react ion which occurred fo l low ing  addi t ion  
o f  co l la g en  as measured by the change in  wave form o f  the  
aggrega t ion  t r a c e .  A t e n o lo l ,  me top ro lo l  and t i m o l o l  had no 
demonstrable  e f f e c t  on co l la g e n  induced aggrega t ion  a t  drug 
c o n c e n t ra t io n s  up to  100 ug/ml ( tab le  5.2) and prazosin had no 
e f fe c t  at concentrat ions up to  4 ug/ml ( ta b le  5 . 2 ) .  L a b e t a lo l ,  
p in d o lo l  and p ro p ra n o lo l  a lso  s i g n i f i c a n t l y  i n h i b i t e d  TxB2 
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FIGURE 5.2
E f fe c t  o f  indomethacin on p la te le t  aggregation and TxB2 
generation in  response to  0.5 mM arachidonic acid and 4 ug/ml 
co l lagen. Each bar represents the mean ± SEM of 6 experiments 
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FIGURE 5.3
Ef fec t  o f  la b e ta lo l ,  p indolo l  and propranolol  on p la t e l e t  
aggregation to  col lagen. Each poin t represents the mean (± SEM) 
o f  5 separate experiments.
TABLE 5.2
E f fe c t  o f  adrenoceptor antagonists on p la t e le t  aggregation to  
1 ug/ml col lagen ( a l l  resu l ts  expressed as mean ± SEM).
Drug Concentration n Rate o f  Aggregc
1 ug/ml (% con t ro l )
Metoprolol 25 8 90 ± 8.6
50 8 95 ± 12.5
100 8 92 ± 6.5
Atenolol 25 8 109 ± 15.7
50 8 126 ± 17.5
100 8 128 ± 16.0
Timolol 25 7 103 ± 2.3
50 7 116 ± 7.0
100 7 110 ± 7.6
Prazosi n* 0.5 6 105 ± 6.5
1 6 104 ± 9.4
4 6 92 ± 9.8
*low drug s o l u b i l i t y  prevented assessment 
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FIGURE 5.4
E f fe c t  o f  l a b e ta lo l ,  pindolol  and propranolol  on p la t e l e t  
aggregation and TxBg generation from PRP st imulated w i th  4 
ug/ml col lagen. (Mean ± SEM of 8 separate experiments)
*  p <0.05
* *  p <0.02
TABLE 5.3
E f fe c t  o f  adrenoceptor antagonists on 1x82 generation 
( a l l  re s u l t s  expressed as mean ± SEM of  8 separate experiments)
Drug Concentration Rate o f  Aggregation TxB?
(ug/ml) ' {% con t ro l ) (ng/ml/lOZ pla te! ets)
Metoprolol control 100 ± 0 17.7 ± 1.00
1 99 ± 6.4 17.1 ± 0.75
12.5 101 + 6.8 18.0 ± 1.01
25 99 ± 2.1 17.5 ± 0.86
Atenolol control 100 ± 0 15.8 ± 1.35
1 114 ± 9.5 17.3 ± 0.95
12.5 114 ± 13.6 17.5 ± 0.86
25 119 ± 18.9 15.7 ± 0.92
Timolol control 100 ± 0 18.6 ± 1.11
1 111 ± 13.0 17.7 ± 0.62
12.5 112 ± 12.2 19.8 ± 1.27
25 111 ± 10.3 19.0 ± 1.63
Prazosin contro l 100 + 0 18.1 + 0.92
0.05 107 ± 11.3 18.7 ± 0.74
0.5 113 ± 8.0 17.4 ± 0.94
1 105 ± 10.6 19.0 ± 0.85
TABLE 5.4
E f fec t  o f  l a b e ta lo l ,  pindolol  and propranolol  on p la te le t  aggregation and 
TxB2 generat ion with  0.5^mM/l arachidonic acid. A l l  re su l ts  expressed as 
mean ± SEM o f  8 separate experiments.
Drug Concentration 
(ug/ml)
Rate of Aggregation 
(% contro l)
TxB2
(ng/ml/ lO^ p la te le ts )
Labetalol contro l 100 + 0 50 ± 2.1
1 136 + 17.6 53 ± 1.5
12.5 119 ± 14.8 54 ± 1.7
25 105 ± 14.1 52 ± 2.6
Pindolol contro l 100 ± 0 47 ± 2.6
1 103 + 15.4 43 ± 2.8
12.5 99 ± 16.1 47 ± 2.7
25 97 ± 12.5 43 ± 2.7
Propranolol contro l 100 ± 0 48 ± 0.8
1 98 ± 7.4 49 ± 0.6
12.5 96 ± 3.1 49 ± 0.6
25 114 ± 6.1 48 ± 0.8
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d e s p i te  the re  being no in h ib i t o r y  e f fe c t  on p la te le t  aggregation 
in  these experiments ( f igu re  5 .4 ) .  Labetalol  and p in d o lo l  were 
e q u a l ly  p o te n t ,  i n h i b i t i n g  TxB2 g e n e ra t io n  at a l l  3 
concentrat ions assessed - 1 ug/ml, 12.5 ug/ml and 25 ug/ml, whi le 
p ro p ra n o lo l  on ly  had a s i g n i f i c a n t  e f f e c t  at 25 ug/ml ( f igu re  
5 .4 ) .  A teno lo l ,  metoprolol ,  t imo lo l  and prazos in  had no e f f e c t  
on TxB2 p ro du c t io n  ( tab le  5.3) to  4 ug/ml col lagen. Labeta lo l ,  
p in d o lo l  and p rop ra n o lo l  f a i l e d  t o  i n h i b i t  e i t h e r  p l a t e l e t  
ag g re g a t ion  or TxB2 generation in  response to  0.5 mM arachidonic 
acid ( tab le  5 .4 ) .
5.4 DISCUSSION
5 .4 .1 .  Va l ida t ion  of TxB? Generation Method
The dose response curves f o r  TxB2 g e ne ra t io n  and p l a t e l e t  
aggregation in  response t o  a ra c h id o n ic  a c id ,  co l la g e n  and ADP 
show t h a t  both the type  and th e  dose o f  the aggregating agent 
used w i l l  in f luence these responses.
Fol lowing ADP induced aggregation only small amounts of TxB2 were 
produced despite maximal p la te le t  aggregation occurr ing. This is  
in  keeping with previous studies (Siess et al_., 1981; Koh et a l . ,  
1980), and suggests t h a t  ADP induced aggrega t ion  i s  l a r g e l y  
independent o f  TxA2 production, although a small amount of TxA2 
may be required to  produce i r r e v e rs ib le  aggregat ion  in  response 
to  ADP (see chapter 2 .2 .2 ) .
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As expected,  a rach idon ic  acid was the most potent s t imu la to r  of 
TxBg p roduc t ion .  I t  induces p la te le t  aggregation so le ly  by TxA2 
f o r m a t io n ,  as i t  i s  the  su b s t ra te  f o r  th e  p l a t e l e t  c y c lo -  
oxygenase pathway, the end product of which is  TxA2 .
Col lagen induced aggrega t ion  a lso  produced r e l a t i v e l y  la rg e  
amounts o f  TxB2 . Col lagen induces ag g re g a t ion  by ac t iva t ing  
phosphol i pase A2 in  the p la te le t  membrane which in  tu rn  releases 
arachidonic acid from the ce l l  membrane p h o s p h o l ip id s ,  and t h i s  
i s  subsequently  transformed to  TxA# (see chapter 2 .2 .2) although 
high doses of collagen can induce aggrega t ion  indep e nd e n t ly  o f 
TxA2 (Vargaf t ig  et a]_., 1981).
As aggrega t ion  i n  response to  collagen and arachidonic acid was 
maximal p r io r  to  TxB2 production reaching i t s  peak, the p la te le ts  
b io s y n t h e t i c  capacity f o r  TxA2 production is  much higher than is  
necessary to  produce aggregation and t h i s  seems to  be e s p e c ia l l y  
t rue  f o r  col 1agen.
The exper iments  w i th  indom ethac in , an i n h i b i t o r  o f  c y c lo -  
oxygenase, confirmed tha t  t h i s  method can measure i n h i b i t i o n  o f  
TxB2 product ion st imulated by arachidonic acid and col lagen.
5.4.2 E f fec t  o f Adrenoceptor Antagonists on P la te le t  Aggregation 
and TxA? Generation
These studies have shown th a t  l a b e ta lo l ,  pindolo l  and propranolol  
have s i g n i f i c a n t  ant i-aggregatory e f fec ts ,  and conf irm t h a t  t h i s  
e f f e c t  i s  not due to  a or e b lockade, as t i m o l o l  ( 3 i ,  32)»
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a te n o lo l  ( 3 i ) ,  m e top ro lo l  ( 3 i ) ,  and p razos in  («%) had no 
in h ib i t o r y  e f fe c t  on e i th e r  p la te le t  aggregat ion to  co l lagen  o r  
on TxA2 g e n e ra t io n .  Th is  i s  in  agreement w i th  s tud ies  on 
p ro p ra n o lo l  (Campbell e t  , 1981a; Weksl er et , 1977) which 
showed t h a t  both d( + ) and l ( - )  isomers o f  p rop rano lo l  had 
i n h ib i t o r y  e f fec ts  on p la te le t  aggregation whi le  the d(+) isomer 
had on ly  1% o f  the  3 r e c e p to r  b lo c k in g  a c t i v i t y  o f  l ( - )  
p r o p r a n o lo l .  Since both isomers possess MSA, Weksler et a l . ,  
(1977) suggested t h a t  MSA was re s p o n s ib le  f o r  t h i s  a n t i ­
aggregatory  e f f e c t .  The r e s u l t s  o f  th e  presen t  study a lso 
suggest t h a t  MSA and 1 i pophi 1 i c i t y , which are c lose ly  re la ted, 
may be responsible, as a l l  3 drugs which were found to  possess 
a n t i -a g g re g a to ry  q u a l i t i e s  had t h i s  feature in  common. Although 
MSA and 1ipoph i1i c i t y  do not e n t i r e l y  explain t h i s  as metoprolol ,  
which has MSA and i s  more l i p i d  s o lu b le  than p indo lo l ,  had no 
e f fe c t .
Th is  study has a lso  demonstrated t h a t  l a b e ta lo l ,  pindolol and 
p ro p ra n o lo l  have an i n h i b i t o r y  e f fe c t  on TxA^ production in PRP 
st imulated with co l lagen .  Th is  e f f e c t  was independent o f  any 
i n h i b i t o r y  e f f e c t  on p l a t e l e t  a g g re g a t io n ,  as th e re  was no 
d i f fe rence in the rate of aggregat ion between drug t re a te d  PRP 
and con t ro ls .  In h ib i t i o n  of TxA2 product ion by these drugs could 
be overcome by using exogenous a ra c h id o n ic  acid as the 
aggrega t ing  s t im u lu s .  Normal ly  when p l a t e l e t s  aggregate in  
response to  c o l la g e n ,  phosphol ipase A2 (PLA2 ) is  act ivated and 
t h i s  in  tu r n  acts  on p l a t e l e t  membrane p h o s p h o l ip id ,  in  the
presence o f  Ca2+^ to  produce f r e e  a ra c h id o n ic  ac id  which is  
conver ted  by cycl  o-oxygenase to  PGH2 , and then by thromboxane
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syn the tase  to  TxA2 (Bakh le ,  1983). Thus, i t  appears th a t  
l a b e t a l o l ,  p i n d o l o l ,  and propranolol  may i n h i b i t  TxA# by acting 
at the phospholipase A2 step. There are 3 possible mechanisms by 
which t h i s  enzyme can be in h ib i te d  (Blackwel l and Flower, 1983), 
f i r s t l y  by b in d ing  to  the enzyme, secondly  by b in d ing  to  
s u b s t r a t e ,  and t h i r d l y  by i n t e r f e r i n g  w i th  Ca2+ a v a i l a b i l i t y  
which i s  e s s e n t ia l  f o r  PLA2 a c t i v i t y .  Weksl er et , (1977) 
demonstra ted t h a t  propranolol  in te r fe re d  with Ca2+ a v a i l a b i l i t y  
probably by in te r fe r in g  w i th  i n t e r n a l  s h i f t s  at i n t r a c e l l u l a r  
s i t e s .  This in ter fe rence with Ca2+ a v a i l a b i l i t y  may therefore be 
the  u n d e r ly in g  mechanism f o r  the  e f f e c t  o f  these drugs on 
p l a t e l e t s .  N e i th e r  l a b e ta lo l ,  p indolo l  nor propranolol  had any 
e f fe c t  on p la te le t  shape change in  response to  co l lagen. This is  
in  agreement w i th  the r e s u l t s  o f  Weksl e r  _et _a2., (1977) who 
showed t h a t  p roprano lo l  did not i n h i b i t  shape change induced by 
ADP, epinephrine, thrombin or c o l l a g e n .  However, shape change 
has r e c e n t l y  been shown to  be due to  Ca2+ dependent myosin 
p h o s p h o ry la t io n  (Nachmias ^  , 1985).  I t  i s  t h e r e fo r e
s u r p r i s i n g  t h a t  shape change was not a f fec ted  by these drugs, 
unless th e re  are o th e r  mechanisms whereby shape change can 
proceed independen t ly  o f  Ca2+. The f a i l u r e  to  i n h i b i t  shape 
change does not therefore support the hypothesis tha t  these drugs 
i n h i b i t  p l a t e l e t  fu n c t io n  by in te r fe r in g  with Ca2+ a v a i l a b i l i t y  
as proposed by Weksl e r ^ ^ . ,  (1977).
Campbell £ t  aj_., (1981a) have shown tha t  hypertensive pat ients  
t r e a te d  w i t h  p roprano lo l  had reduced TxA2 generation from t h e i r  
PRP ex v i v o . I t  has been suggested tha t  t h i s  is  not due to  MSA, 
but t h a t  reduced aggrega t ion  was secondary to  reduced TxA2
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p ro d u c t io n  (Campbell et , 1981b). These studies (Campbell et 
al  1981a; Campbell ^  , 1981b) showed tha t  i n h i b i t i o n  of
a g g rega t ion  and TxA2 product ion occurred hand in hand, there fo re  
th e y  cou ld  not exclude th e  p o s s i b i l i t y  t h a t  the  reduced TxA2 
product ion may have been secondary to  reduced aggregation, ra ther 
than v i c e  ve rsa .  The exper iments in  the  present  s tudy were 
designed to  exclude i n h ib i t i o n  o f  TxA2 production being secondary 
t o  reduced p l a t e l e t  a g g re g a t io n ,  by using a high dose o f  
c o l l a g e n ,  and low concentrat ions o f  the drugs so th a t  the drugs 
had no i n h i b i t o r y  a c t i o n  on aggrega t ion  per se. Th is  s tudy 
demonstra ted t h a t  d e s p i te  the  same degree o f  agg rega t ion  
o c c u r r i n g  in  both drug t r e a t e d  and c o n t ro l  PRP, l a b e t a l o l ,  
p in d o lo l  and p roprano lo l  s i g n i f i c a n t l y  reduced TxA2 generat ion. 
Thus, i n h i b i t i o n  o f  TxA2 by these drugs was independent of any 
e f f e c t  on p l a t e l e t  a g g rega t ion  a t  the drug c o n c e n t ra t io n s  
assessed.
I t  has been suggested t h a t  the  a n t i - a g g re g a to r y  e f f e c t s  o f  
3-adrenoceptor antagonists are not present in  v i v o , as MSA occurs 
o n ly  a t c o n c e n t ra t io n s  much h igher than those obtained in vivo 
(Weksler  et , 1977). There a re ,  however, several studies 
documenting an e f f e c t  on p la te le t  aggregation ex vivo (Mehta et 
al . ,  1978; Frishman et al_., 1974; Campbell ^  a l - ,  1981a; Small 
^  l l *  » 1982; Mehta and Mehta, 1982) and propranolol  has been 
shown to  reduce c i r c u la t i n g  aggregates in vivo (Green, Rossi and 
Haring, 1982). P la te le ts  there fore  may be more sens i t ive  in vivo 
than in  v i t r o  to  the e f fec ts  of these agents. This may be due to  
accumula t ion  o f  these drugs w i th in  the p la t e le t ,  which has been 
shown to  occur w i th  p ro p ra n o lo l  (Weksler et al_., 1977). These
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present  ^  v i t r o  s tu d ie s  demonstrated t h a t  the IC50 
co n c e n t ra t io n s  f o r  l a b e t a l o l ,  p in d o lo l  and p r o p r a n o lo l ,  f o r  
aggregation induced by col lagen, were above the therapeut ic  range 
o f  plasma concentrat ions ( tab le  5 .1 ) .  I t  is d i f f i c u l t ,  however, 
t o  r e l a t e  aggrega t ion  induced by 1 or 2 ug/ml collagen in v i t r o  
t o  the  i n  v ivo  s i t u a t i o n  where the  aggregatory  cha l lenge  i s  
l i k e l y  t o  be much lower. As the dose response curves f o r  these 
drugs is  "sh i f ted "  to  the l e f t  when sm a l le r  c o n c e n t ra t io n s  o f  
c o l la g e n  are used they may we l l  possess th i s  ant i -aggregatory 
e f f e c t  j_n v i v o . These studies have also shown tha t  labe ta lo l  at 
a c o n c e n t ra t io n  o f  1 ug/ml has an i n h i b i t o r y  e f f e c t  on TxA£ 
ge ne ra t io n  J j i  v i t r o . Th is  drug concen t ra t ion  is  only 1.5 - 2 
t imes th e  mean c o n c e n t ra t io n s  o f  l a b e t a l o l  which have been 
observed in  p a t i e n t s  w i th  pregnancy induced hyper tens ion  
(unpub l ished  o b s e r v a t i o n s ) ,  so these drugs may we l l  have an 
e f fe c t  J_n v iv o .
T im o lo l  and metop ro lo l  have been shown to  improve prognosis in 
p a t i e n t s  f o l l o w i n g  myocard ia l  i n f a r c t i o n  (Hja lmarson et a l . ,  
1981; Norwegian M u l t i c e n t r e  Study Group, 1981). The mechanism 
behind t h i s  is  unclear. An a t t r a c t i v e  hypothesis is  reduct ion of 
TxAg p ro d u c t io n  by these 3-adrenoceptor  antagonists espec ia l ly  
with the growing volume of evidence imp l ica t ing  TxA£ in  ischaemic 
heart disease. The present resu l ts  suggest tha t  n e i the r  t i m o lo l  
nor m e top ro lo l  were e f f e c t i v e  in  i n h ib i t i n g  TxA£ generation in  
response t o  c o l la g e n ,  and th e r e fo r e  do not suppor t  t h i s  
hypothesis,  and suggest tha t  the card iopro tec t ive  e f fe c t  on these 
agents is  mediated by some other mechanism.
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In co n c lu s ion  these s tu d ie s  suggest t h a t  some adrenoceptor  
antagonists are ab le  to  i n h i b i t  both p l a t e l e t  aggrega t ion  t o  
co l lagen, and TxA2 generat ion. The l a t t e r  e f fe c t  was shown to  be 
independent of i n h ib i t i o n  of aggregation. The mechanism of these 
e f f e c t s  may be due to  i n h i b i t i o n  o f  p l a t e l e t  PLA2 , and may be 
re lated to  the MSA and l i p o p h i l i c i t y  o f  these agen ts .  Whether 
these i n h i b i t o r y  e f f e c t s  on p l a t e l e t  a g g rega t ion  and TxA2 
g e ne ra t io n  are c l i n i c a l l y  r e le v a n t  w i l l  depend on long term 
prospect ive studies.  However, there are good theo re t ica l  reasons 
to  use drugs which possess these p r o p e r t i e s  in  p a t i e n t s  w i th  
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P r o s t a c y c l i n  (PGI2 ) is  the  major p ro s ta g la n d in  produced by 
v a s c u la r  t i s s u e  (Moncada et a [ . ,  1977; R i t t e r  et 1982). I t  
i s  a po ten t  v a s o d i l a t o r  and i n h i b i t o r  o f  p la te le t  aggregation 
(Moncada et a j^ . , 1976) which i s  thought to  func t ion  as a local 
hormone in  the regula t ion o f  the p ia t e l e t - vessel wal l in te rac t ion  
(Pa trono  e t  , 1984). I t  may also be important in  the local 
c o n t r o l  o f  va scu la r  tone and blood f lo w  as there are spec i f ic  
PGI2 re ce p to rs  in  va scu la r  t i s s u e  (MacDermot _et aj_., 1981). 
Thromboxane A2 (TXA2 ) is  the major product of arachidonic acid in  
p l a t e l e t s ,  and has actions d i r e c t l y  opposed to  those of PGI2 , as 
i t  is a potent v a s o c o n s t r i c to r  and p l a t e l e t  aggrega t ing  agent 
(Hamberg e t  , 1975). PGI2 and TxA2 oppose each other through 
r e g u l a t i o n  o f  p l a t e l e t  adeny la te  cyc lase  a c t i v i t y  (Tateson et 
a l . ,  1977) and i t  has been proposed th a t  a balance ex is ts  between 
these two substances (Bunting et al  ^ 1977). Consequently, an 
imbalance between these two substances might con tr ibu te  to  the 
pathophysiology of diseases associated with vasocons t r ic t ion  and 
p l a t e l e t  aggrega t ion  and subsequent th ro m b o t ic  va scu la r  
occlusion.
V ascu la r  PGI2 p roduc t ion  can be read i ly  st imulated by a va r ie ty  
o f  m i ld  s t im u l i  to the vessel wall ( R i t t e r  et ^ . ,  1983). I t  is 
th o u g h t  t h a t  f o l l o w i n g  va s c u la r  i n j u r y  the extent of p la te le t  
a c t i v a t i o n  and thrombus fo rm a t io n  i s  l i m i t e d  and va scu la r  
i n t e g r i t y  ma in ta ined by PGI2 p ro d u c t io n .  F a i l u r e  o f  t h i s  
mechanism might t h e r e f o r e  r e s u l t  i n  excess ive  p l a t e l e t  
consumption, in t ravascu la r  thrombosis and vasocont r ic t ion .
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Pregnancy induced hypertension (PIN) is  a disease associated with 
p l a t e l e t  consumption (Redman et , 1978) and vasocontr ic t ion . 
Since reduced PGI2 p roduc t ion  both from fe ta l  (Remuzzi et a l . ,  
1980; Downing ^  aj_., 1980; Walsh jet , 1985) and maternal 
(B u s s o l in o  ^  , 1980) vascular t issue  has been documented in
t h i s  d ise a se ,  PGI2 d e f i c i e n c y  may c o n t r i b u t e  to  the  disease 
process (see chapter 3 .7 ) .
Adrenoceptor antagonists such as labe ta lo l  are being increasing ly  
used in  the  t re a tm e n t  o f  PIN (Lubbe, 1984).  The s tu d ies  
d e sc r ibed  in  chapte r  5 have shown t h a t  some adrenoceptor  
antagonists can i n h i b i t  p la te le t  aggregation and TxA2 product ion, 
and suggest th a t  the l a t t e r  e f f e c t  may be accomplished through 
i n h i b i t i o n  o f  phosphol ipase A2 the  enzyme which prov ides 
a ra c h id o n ic  acid substrate f o r  both PGI2 and TxA2 formation (see 
chapter 1 .2 ) .  Consequently, these drugs may i n h i b i t  vascu la r  
PGI2 p roduc t ion  as well as p la te le t  TxA2 production, and th is  is 
p o te n t i a l l y  harmful e s p e c ia l l y  in  a d isease such as PIN where 
PGI2 production may already be compromised.
The aims o f  t h i s  study were t w o - f o l d ,  f i r s t l y  t o  determine 
whether adrenoceptor antagonists had any e f fe c t  on vascular PGI2 
product ion and secondly to  determine whether these drugs might 
ac t  synerg i  s t i c a l  l y  w i th  PGI2 to  i n h i b i t  p la te le t  aggregation. 
The l a t t e r  e f fe c t  would be assessed both with  pure PGI2 and also 
with  the PGI2 d i r e c t l y  produced from vascular t i ssue .
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6.2 MATERIALS AND METHODS
The m a te r ia ls  and methods used in the fo l low ing  experiments have 
been f u l l y  described in chapter 4.
The e f f e c t s  o f  the  adrenoceptor antagonists l a b e ta lo l ,  pindolol 
and p ro p ra n o lo l  on u m b i l i c a l  a r t e r y  PGI2 p ro du c t io n  were 
determined using the method described in  chapte r  4 .5 .  Vascu la r  
PGI2 p ro d u c t io n  was measured as the  s ta b le  PGI2 m e ta b o l i t e  
6 -ke to-PGFia  (PGI2M) us ing the  radioimmunoassay described in 
chapter 4 .1 .3 .
In o rd e r  to  dete rmine whether adrenoceptor  an ta g on is ts  were 
s y n e r g i s t i c  w i th  PGI2 i n  i n h i b i t i n g  p la te le t  aggregation, dose 
response curves f o r  the  e f f e c t  o f  PGI2 on co l la g e n  induced 
aggrega t ion  in  p l a t e l e t  r i c h  plasma were f i r s t  c o n s t ru c te d .  
P l a t e l e t  r i ch  plasma was prepared as described in  chapter 4 .2 .4 ,  
and the  e f f e c t  o f  PGI2 on aggregat ion induced by 1 ug/ml and 2 
ug/ml col lagen was assessed as described in  chapte r  4 . 4 . 2 .  The 
dose response curves obtained allowed the concentrat ion of PGI2 
f o r  use in the subsequent experiments to  be determined.
The p o s s ib le  s y n e r g i s t i c  e f f e c t s  o f  PGI2 and adrenoceptor  
antagonists on p la te le t  aggregation were studied using the method 
described in chapter 4 .4 .3 .
The possible synerg is t ic  e f fec ts  of PGl2~ l ike  a c t i v i t y  from human 
umbil ical  a r te ry  and adrenoceptor  a n ta g on is ts  were determined 
using the method described in  chapter 4 .4 .4 .
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The doses o f  adrenocepto r  an tagon is ts  used were known from 
previous s tu d ie s  (see chap te r  5, f i g u r e  5 .3 )  t o  have minimal 
e f f e c t s  on p l a t e l e t  aggrega t ion  to  2 ug/ml collagen when used 
alone.
S t a t i s t i c a l  analysis was by the Wilcoxon rank sum te s t  f o r  paired 
data.
6.3 RESULTS
6 .3 .1  E f f e c t  o f  Adrenoceptor  A n ta g o n is ts  on Umbil ical A r te ry  
PGI?M Production
The r e s u l t s  f o r  the  e f f e c t s  o f  p i n d o l o l ,  p ro p ra n o lo l  and 
l a b e t a l o l  on PGI2M p ro d u c t io n  from human umbil ica l  a r te ry  are 
shown in  ta b le  6.1. Asp i r in  (100 ug/ml) was used to  confirm tha t  
PGI2M p ro d u c t io n  cou ld  be i n h i b i t e d  and s i g n i f i c a n t l y  reduced 
PGI2M product ion in a l l  experiments compared to  the con t ro ls .
Each of the 3 adrenoceptor a n ta g o n is ts  was assessed at 2 drug 
concentrat ions, 1 ug/ml and 100 ug/ml. None of the drugs had any 
e f f e c t  on PGI2M product ion at the lower concentrat ion. Pindolol  
s i g n i f i c a n t l y  i n h i b i t e d  PGI2M production at the higher dose and 
was as e f f e c t i v e  as a s p i r i n  (100 ug/ml)  in  reduc ing  PGI2M 
product ion. Neither labe ta lo l  or  p roprano lo l ,  however, had any 
s i g n i f i c a n t  e f f e c t  on PGI2M p ro d u c t io n ,  a t  the h ig h e r  
concentra t ion, although there was a trend towards lower leve ls  of 
PGI2M with 100 ug/ml l a b e ta lo l .
TABLE 6.1
E f fe c t  o f Adrenoceptor Antagonists on PGIgM Product ion 
from Umbi l ical  A r te ry .  A l l  values are mean ±SEM pg/ml PGIgM
Labetalol ! P indo lo l Propranolol
Control 790.0 ! 762.8 ! 771.4 1
±28.1 ±44.9 ±37.4
1 ug/ml drug 762.8 ! 634.3 1 792.8 !
±17.2 ±51.9 ±52.3
100 ug/ml drug 721.4 ! 571.4* ! 750.0 !
±59.9 ±48.3 ±41.3
Asp i r in  100 ug/ml 621.4* I 585.7* 1 614.3* 1
±36.5 I ±41.1 j ±43.5 I
^p<0.05 compared to  contro l  n = 7 in a l l  experiments 
(Pool plasma PGIgM concentra t ion was 6 pg/ml p r io r  
to  incubat ion with  the a r te ry  r in g s . )
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6 .3 .2  Dose Response Curves f o r  the E f fec t  o f  PGI? on Collagen 
Induced P la te le t  Aggregation
The dose response curves f o r  the  e f f e c t  o f  PGI2 on p l a t e l e t  
a g g rega t ion  are shown in  f i g u r e  6.1 and a re p re s e n ta t i v e  
ag g re g a t ion  t r a c e  i s  shown in  f i g u r e  6 .2 .  As can be seen, 
aggregation induced by 2 ug/ml co l la g en  was v i r t u a l l y  t o t a l l y  
i n h i b i t e d  by 400 pg/ml PGI2 , and aggregation induced by 1 ug/ml 
c o l la g e n  was abol ished by 200 pg/ml PGI2 . The concentrat ion of 
PGI2 caus ing 50% i n h i b i t i o n  of aggregation was approximately 50 
pg/ml f o r  1 ug/ml col lagen, and 200 pg/ml f o r  2 ug/ml co l la g en  
( f i g u re  6 .1 ) .
6 .3 .3  S y n e r g i s t i c  E f fec ts  of Adrenoceptor Antagonists and PGI? 
on P la te le t  Aggregation
The r e s u l t s  f o r  these experiments are shown in  f ig u re  6.3 and a 
r e p r e s e n t a t i v e  aggrega t ion  t r a c i n g  i s  shown in  f i g u r e  6 .4 .  
P r o p r a n o lo l ,  p in d o lo l  and labeta lo l  were a l l  assessed at 2 drug 
concentra t ions, 1 ug/ml and 12.5 ug /m l .  These c o n c e n t ra t io n s  
were known from prev ious  s tu d ies  to  have minimal e f f e c t s  on 
p la te le t  aggregation induced by 2 ug/ml collagen when used alone 
(see Chapter 5, f i g u r e  5 . 3 ) .  PGI2 was used in  a f i n a l  
concentrat ion of 100 pg/ml which was known from the above studies 
to  cause around 20% in h ib i t i o n  of aggregation to  2 ug/ml collagen 
when used alone (see f i g u r e  6 . 1 ) .  As can be seen at these 
c o n c e n t ra t io n s  o f  drug and PGI2 which on t h e i r  own produced no 
s i g n i f i c a n t  e f fe c t  on p la te le t  aggregation a combination o f  both 
produced an a d d i t i v e  or s y n e r g i s t i c  e f f e c t ,  s i g n i f i c a n t l y  
i n h i b i t i n g  aggregation at both drug concentrat ions assessed. A l l  
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FIGURE 6.1
Dose response curves f o r  the e f fe c t  o f  PG%2 on p la t e le t  
aggregation induced by col lagen. A l l  points represent the mean ± 




















Representative aggregation t rac ing  o f  the e f fe c t  o f  PGI2 on 









Synerg is t ic  e f fe c t  o f adrenoceptor antagonists and PGI2 on 
p la te le t  aggregat ion. A l l  values are mean ± SEM o f  7 separate 
experiments. The dose of PGI2 used v/as 100 pg/ml f o r  a l l  
experiments.








Representat ive aggregation t rac ing  showing the i n h i b i t o r y  e f fec ts  
o f  P6 I 2 and labe ta lo l  on p la te le t  aggregation.
Control  = labe ta lo l  vehic le plus PGIg veh ic le .
L = labe ta lo l  12.5 ug/ml plus PGI2 veh ic le .
PG%2 = labe ta lo l  vehicle plus PGI2 100 pg/ml.
PG%2 + L = labe ta lo l  12.5 ug/ml plus PGI2 100 pg/ml
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6 .3 .4  S y n e r g i s t i c  A c t io n  o f  PGI?-1ike A c t i v i t y  from Human 
U m b i l i c a l  A r t e r y  w i th  Adrenoceptor  A n ta g o n is ts  in  I n h ib i t i n g  
P la te le t  Aggregation
The r e s u l t s  from th is  part  o f  the study are shown in  f ig u re  6.5 . 
P i n d o l o l ,  p ro p ra n o lo l  and l a b e t a l o l  were a l l  assessed at a 
c o n c e n t ra t io n  o f  12.5 ug /m l ,  which when used alone had minimal 
e f fec ts  on p la te le t  aggregation induced by 2 ug/ml co l lagen. The 
superna tan t  from umbil ical  a r te ry  also had no s i g n i f i c a n t  e f fe c t  
on p l a t e l e t  aggrega t ion  when used a lo n e .  However, when a 
comb ina t ion  o f  um b i l ica l  a r te ry  supernatant and an adrenoceptor 
a n ta g o n is t  was used aggrega t ion  t o  2 ug/ml co l la g e n  was 
s i g n i f i c a n t l y  i n h i b i t e d  compared to  the  c o n t r o l , adrenoceptor 
antagonist alone and umbil ica l  a r te ry  supernatant alone.
6.4 DISCUSSION
These s tu d ie s  have shown t h a t  adrenoceptor antagonists have no 
s i g n i f i c a n t  e f f e c t  on va s c u la r  PGI2 product ion in  v i t r o  at low 
doses, but may i n h i b i t  vascular PGI2 product ion i f  high doses o f  
the drugs are used, as seen w i th  p in d o lo l  (100 u g /m l ) .  Th is  
p o t e n t i a l  i n h i b i t o r y  e f f e c t  i s  u n l i k e l y  the re fo re  to  occur in  
v iv o  as mean plasma l e v e l s  f o r  a l l  o f  these agents when used 
t h e r a p e u t i c a l  l y  are considerably below 1 ug/ml (see tab le  5 .1 ) .  
Th is  f i n d i n g  is  compatible with tha t  o f  Campbell et , (1981b) 
who showed th a t  propranolol  had no e f fe c t  on PGI2 product ion from 
v a s c u la r  e n d o th e l ia l  c e l l s  in  v i t r o . However, propranolol  has 













Synerg is t ic  act ion o f  PGl2- l i k e  a c t i v i t y  from'human umbil ica l  
a r te r y  with adrenoceptor antagonists in  i n h ib i t i n g  p la te le t  
aggregat ion. A l l  values are mean ± SEM o f  7 experiments.
UA = umbil ical  a r te ry  supernatant.
La = labeta lo l  12.5 ug/ml 
Pi = pindolol  12.5 ug/ml 
Pr = propranolol  12.5 ug/ml 
*  p <0.05 compared to  co n t ro l ,  umbi l ical  a r te ry  supernatant alone
and drug alone.
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p re p a ra t io n  (Fors te r ,  1980) which does not agree with e i t h e r  the 
r e s u l t s  o f  the  present  study or  those o f  Campbell e t  a l . ,  
(1981b).
I t  has a lso  been proposed t h a t  adrenoceptor antagonists exert  
t h e i r  a n t i - h y p e r t e n s i v e  e f f e c t  by s t i m u la t i n g  vasodepressor 
p ro s ta g la n d in  product ion  (Durao et , 1977),| as in h ib i t o r s  of 
p ro s ta g la n d in  syn thes is  such as indomethacin have been shown to  
reduce the ant i -hypertens ive e f fe c t  o f propranolol  (Durao et a l . ,  
1977) . I f  the  a n t i - h y p e r t e n s i v e  e f f e c t s  o f  these drugs are 
mediated through increased prostaglandin p ro d u c t io n ,  in  view of 
th e  r e s u l t  o f  the present study, i t  i s  u n l i ke ly  to  be due to  any 
d i re c t  s t imula tory  e f fe c t  on vascular PGI2 production.
Umbil ical  vessels lack any form o f  innervat ion (Tuvemo, 1980) and 
consequent ly  the  c o n t r o l  o f  b lood f l o w  must be re gu la ted  by 
humeral means (Tuvemo, 1980). PGI2 is  the major prostaglandin 
produced by umbil ical  a r te ry  ( R i t t e r  et 1982), and umbil ical  
a r t e r y  produces s i g n i f i c a n t l y  more PGI2 than adul t  vessels o f  
comparable s ize  and weigh t  (Remuzzi ^  £]_., 1979). PGI2 may 
t h e r e f o r e  be im po r tan t  in  the  r e g u l a t i o n  o f  u m b i l i c a l  a r te ry  
b lood f l o w .  Mak i la  e t , (1983) have shown t h a t  umbi l ical  
a r te ry  blood f low in vivo corre la tes  with the vessels'  a b i l i t y  to  
produce PGI2 , and they have also shown both to  be reduced in  PIN. 
Since reduced u m b i l i c a l  a r t e r y  b lood f l o w  may lead t o  f e t a l  
compromise and in t r a - u t e r i  ne growth re ta rda t ion ,  i t  is  important 
to  know whether ant i -hypertens ive agents used in  the treatment of 
PIH have any d e t r im e n ta l  e f f e c t s  on PGI2 p ro d u c t io n .  The 
adrenoceptor antagonists assessed in  t h i s  s tudy are u n l i k e l y  t o
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produce any s ig n i f i c a n t  e f fe c t  on PGI2 product ion at therapeut ic 
doses, but i t  would be w o r th w h i le  measuring u m b i l i c a l  a r te r y  
b lood f lo w  j_n v ivo  be fo re  and a f t e r  t re a tm e n t  w i th  an 
ad renocepto r  a n ta g o n is t  in  PIH. I t  i s  a lso  conceivable tha t  
these drugs might even enhance u m b i l i c a l  a r t e r y  blood f lo w  
th rough o th e r  mechanisms, as labe ta lo l  f o r  example has a d i re c t  
v a s o d i l a t o r  e f f e c t  mediated by i t.s a \ adrenoceptor antagonist 
ac t ion .
In th e  s tu d ie s  descr ibed in  chapter 5, l a b e ta lo l ,  pindolol  and 
propranolol  were shown to  have an i n h i b i t o r y  e f f e c t  on p l a t e l e t  
agg rega t ion  and p l a t e l e t  TxA2 p r o d u c t i o n ,  the l a t t e r  e f f e c t  
p o s s ib l y  being due to  i n h i b i t i o n  o f  phosphol ipase A2 a c t i v i t y .  
This occurred at drug concentra t ions as low as 1 ug /m l .  Since 
these drugs did not reduce vascular PGI2 product ion at th i s  same 
drug concentrat ion p la te le ts  must be more s e n s i t i v e  than blood 
vessels to  the i n h ib i t o r y  e f fec ts  o f these drugs on prostaglandin 
p ro d u c t i o n .  Th is  f e a tu r e  may prove use fu l  in  v iv o  as TxA2 
p ro d u c t io n  may be suppressed w h i le  v a s c u la r  PGI2 p roduc t ion  
remains unaffected.
Th is  s tudy has a lso  shown t h a t  l a b e t a l o l ,  p in d o lo l  and 
p ro p ra n o lo l  are s y n e r g i s t i c  w i th  PGI2 , inc lud ing the PGl2~ l ike  
a c t i v i t y  produced by u m b i l i c a l  a r t e r y ,  in  i n h i b i t i n g  p l a t e l e t  
aggregation.
Some in  v i t r o  s tu d ies  have suggested t h a t  the  a n t i - p l a t e l e t  
e f f e c t s  o f  adrenoceptor  an tagon is ts  are only present at supra- 
pharmacological drug concentrations and there fo re  could not occur
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in  v i v o . However, severa l  s tud ies  have shown a s i g n i f i c a n t  
a n t i  pi a te l  e t  e f f e c t  o f these drugs ex vivo (Mehta ^  al_., 1978; 
Campbell et  , 1981a) and c i r c u la t in g  p la te le t  aggregates have 
been shown to  be reduced in  v ivo  by propranolol  (Green et a l . ,  
1982) .  Th is  d isc repancy  between in  v iv o  and in  v i t r o  studies 
suggests t h a t  p l a t e l e t s  in  v ivo  may be more s e n s i t i v e  to  the 
e f f e c t s  o f  adrenoceptor antagonists.  This might be explained by 
the  synergy between these drugs and PGI2 in i n h i b i t i n g  p la te le t  
aggregation which might occur in the in  vivo s i t u a t i o n .
These s y n e r g i s t i c  e f f e c t s  might a lso  be b e n e f i c i a l  in  the  
t re a tm e n t  o f  d iseases assoc ia ted  with reduced PGI2 production, 
such as PIH, where the combination of the drug and the remain ing 
endogenous PGI2 m ight have s u f f i c i e n t  a n t i - p l a te l e t  e f fec ts  to  
compensate f o r  the r e la t i v e  PGI2 de f ic iency .
In c o n c lu s io n ,  these s tu d ies  have shown t h a t  ad renoceptor  
a n ta g o n is t s ,  d e s p i te  having an i n h i b i t o r y  e f f e c t  on p la te le t  
prostaglandin product ion, have no i n h i b i t o r y  e f f e c t  on va scu la r  
PGI2 production at leas t  at low drug concentrat ions. Furthermore, 
these drugs act s y n e rg is t i c a l l y  with PGI2 to  i n h i b i t  aggregation. 
This e f fe c t  may be use fu l  i n  the  t re a tm e n t  o f  d is o rd e rs  where 
PGI2 production is  reduced such as in  PIH.
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CHAPTER
INHIBITION OF PLATELET AGGREGATION IN WHOLE BLOOD BY 
ADRENOCEPTOR ANTAGONISTS AND SYNERGISM WITH 
PROSTACYCLIN AND ASPIRIN
7.1 INTRODUCTION
P l a t e l e t  r e a c t i v i t y  has been shown to  be increased in  pat ients 
w i th  a r t e r i  oscl  e r o t i c  va s c u la r  d isease (S tee l  e ejt , 1973; 
Murphy and Mustard, 1962; Marker and S l i c h te r ,  1972; Mehta, Mehta 
and Pepine, 1978), and p la te le t  consumption i s  a well recognised 
f e a t u r e  o f  pregnancy induced hypertension (Redman et _a]_., 1978; 
Trudinger,  1976; Rakoczi ^  jal_., 1979).
Adrenoceptor  a n ta g on is ts  are w id e ly  used in  th e  treatment of 
a th e r o s c le ro t i c  va scu la r  d isease ,  and t h e i r  use i n  pregnancy 
induced hypertension is  rap id ly  becoming establ ished (Gal lery et 
al . ,  1979b; Lubbe and Hodge, 1981; Symonds et ^ . ,  1982; Walker 
et ^ . , 1982; Walker, Greer and Calder, 1983; Rubin _et aj_., 1983; 
Lardoux e^ ^ . ,  1983; G a l l e r y  et aj_., 1985). These drugs are 
known to  have an i n h i b i t o r y  e f f e c t  on p l a t e l e t  aggrega t ion  
(Fr ishman et , 1974; Campbell et , 1981a; Campbell et a l . ,  
1981b; Weksl e r  ^  al_., 1977; Mehta et al_., 1983) and have been 
shown to  reduce c i r c u la t i n g  aggregates in  pat ien ts  with  coronary 
a r t e r y  d isease (Green i t  ^ . , 1982). I t  is  possible there fo re  
t h a t  some o f  the  b e n e f i c i a l  e f f e c t s  o f  these drugs may be 
mediated through an i n h ib i t o r y  e f fe c t  on p la te le t  func t ion .
A s p i r i n  has long been known to  i n h i b i t  p l a t e l e t  aggrega t ion  
(O'Br ien, 1968) and has been used as an a n t i p l a te l e t  agent in the 
secondary prevention of myocardial i n f a r c t i o n  (Asp i r in  Myocardial 
In fa r c t io n  Study Research Group 1980; El wood and Sweetnam, 1980 ; 
Anturan R e i n f a r c t i o n  T r i a l  Research Group 1980; Pe rsa n t in  
-A sp i r in  Re in fa rc t ion  Study I I  Research Group 1985; Pe rsan t ine  
A sp i r in  Re in fa rc t ion  Study Research Group, 1980) and threatened
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stroke (Canadian Co-operat ive Study Group 1978). More recent ly  a 
combination o f  a s p i r i n  and d ipy r idam o le  has been shown to  be 
b e n e f i c i a l  i n  pregnancies a t  high r i s k  o f  pregnancy induced 
h yper tens ion  and i n t r a - u t e r i ne growth re ta rdat ion  (Beauf i ls  et 
al_., 1985).
Most p rev ious  s tu d ies  on the e f fe c t  o f  adrenoceptor antagonists 
on p la te le ts  have concentrated on p ro p ra n o lo l  d e s p i te  the  wide 
range of adrenoceptor antagonists ava i lab le ,  and a l l  studies have 
been performed in  p l a t e l e t  r i c h  plasma (PRP), by t r a d i t i o n a l  
t u r b i d o m e t r i c  techn iques  (Born, 1962). I t  has recent ly  become 
possible to  study p la te le t  aggregation in  whole b lood us ing  the  
Clay-Adams U l t ra  Flo 100 whole blood p la te le t  counter.  This may 
be a more physio logical method than tu rb idom e t r i  c techn iques  as 
i t  leaves p l a t e l e t s  in  t h e i r  natural  m i l ieu ,  surrounded by red 
and white c e l l s  which can themselves inf luence p la te le t  behaviour 
by re lease  o f  ADP (Saniabadi ^ t  aj_., 1984a) and p ros tacyc l in  
(PGI2 ) (Deckmyn _et _al_., 1983; B lackwe l l  and F lower ,  1978), 
respec t ive ly .  In add i t ion ,  a d i re c t  counting technique of s ing le  
p la te le ts  i s  employed ra ther  than the i n d i r e c t  method o f  change 
in  opt ical  dens ity used with  PRP (see chapter 4 .6 .1 ) .
The aim o f  t h i s  s tudy was to  determine the  e f f e c t s  o f  
adrenoceptor  antagonists on p la te le t  aggregation in  whole blood. 
As these drugs vary not only in  t h e i r  re c e p to r  s p e c i f i c i t y  but 
a lso  in  t h e i r  l i p i d  s o l u b i l i t y ,  possession o f  membrane 
s ta b i l i s i n g  a c t i v i t y  (MSA), and possession of i n t r i n s i c  sympatho­
mimet ic  a c t i v i t y  ( IS A ) ,  a v a r i e t y  o f  drugs which d i f fe re d  in
TABLE 7.1 
Propert ies o f  Adrenoceptor Antagonists
Drug S p e c i f i c i t y * ISA* MSA*
L ip id  so lu b i l  
(D is t r ib u t io n  
len t  f o r  octai 
pH 7.4 and 37'
Atenolo l h - - 0.015
Labeta lo l - + 11.5
Pindolo l 6 ,B2 + + / - 0.82
Propranolol - + 20.2
*See Feely, de Vane and MacLean, 1983.
See Woods and Robinson, 1981.
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these respects  were s tu d ied  ( t a b le  7 . 1 ) .  L a b e ta lo l  was also 
assessed in  combination w i t h  a s p i r i n  to  determ ine  whether  the 
drugs might act s y n e rg is t i c a l l y  to  i n h i b i t  p la te le t  aggregation.
7.2 MATERIALS AND METHODS
7.2.1 Whole Blood Aggregation Studies
Venous blood was ob ta ined w i tho u t  s tas is  from healthy male and 
female volunteers using a 21 gauge b u t t e r f l y  cannula. The blood 
was prepared and p la te le t  aggregation studies performed in whole 
blood as described in chapter 4 . 6 . 2 .  The f o l l o w i n g  drugs were 
assessed: a teno lo l ,  labe ta lo l  and propranolol (using 0.9% sodium
d i l o r i d e  as vehic le) and pindolol  (using 0.1 M phosphate b u f f e r  
pH 7.0  as v e h i c l e ) .  The v e h ic le  alone was used in  c o n t ro l  
experiments. Collagen (0.5 ug/ml f i n a l  c o n c e n t ra t i o n ) ,  ADP (10 
uM f i n a l  c o n c e n t ra t io n )  and a ra c h id o n ic  ac id  (0 .5  mM f i n a l  
concentrat ion)  were used as the aggregating agents.
7.2.2 Ef fec t  o f  PGI? on P la te le t  Aggregation in  Whole Blood
A dose response curve f o r  the  e f f e c t  o f  PGI2 on whole blood 
p la te le t  aggregation induced by col lagen (0.5 ug/ml) was obtained 
using the methods described in  chapter 4 .6 .3 .  A concentrat ion of 
PGI2 which had minimal e f fe c t  on aggregation to  col lagen in  a l l  
s u b je c ts  was thus determined (125 pg/ml PGI2 ) .  Th is  
concentrat ion was used in  assessing whether PGI2 and adrenoceptor 
antagonists were synerg is t ic  in  i n h ib i t i n g  p l a t e l e t  aggrega t ion  
in  whole blood.
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7.2 .3  Synerg is t ic  E f fec t  of Adrenoceptor Antagonists and PGI? in 
I n h ib i t i n g  P la te le t  Aggregation in Whole Blood
These exper iments were performed as described in  chapter 4 .6 .4 .  
Col lagen (0 .5  ug/ml f i n a l  c o n c e n t ra t io n )  was used as the  
a g g rega t ing  agent .  L a b e t a lo l ,  p in d o lo l  and proprano lo l  at a 
f i n a l  concentrat ion of 1 ug/ml were assessed with PGI2 in  a f i n a l  
concentrat ion of 125 pg/ml. The vehicle f o r  each drug was used 
alone in  the control  experiments.
7 .2 .4  Syne rg is t ic  Action of Asp i r in  and Labetalol  in In h ib i t i n g  
P la te le t  Aggregation in Whole Blood
Th is  exper iment was performed as desc r ibed  in  chapter  4 .6 .5 .  
Collagen (0.5 ug/ml) was used as the aggregating agent. Labetalol  
was used in  a f i n a l  co n ce n t ra t io n  of 1 ug/ml, and a sp i r in  in a 
f i n a l  concentrat ion o f  5 ug /m l .  The drug v e h ic le s  a lone were 
used i n  the  c o n t ro l  exper im ents .  The c o n c e n t ra t io n s  o f  both 
drugs used were known from p r io r  study to  have minimal e f fec ts  on 
aggregation when used alone.
7.2.5 S t a t i s t i c a l  Analysis
S t a t i s t i c a l  analysis was by the Wilcoxon paired rank sum te s t  f o r  
a l l  experiments.
7.3 RESULTS
L a b e t a l o l ,  p in d o lo l  and p rop ra n o lo l  i n h i b i t e d  p l a t e l e t  
aggregation in whole blood stimulated with 0.5 ug/ml co l la g e n  in  
a dose dependent manner ( f ig u re  7 .1 ) .
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L a b e t a l o l ,  p in d o lo l  and p roprano lo l  a lso  i n h i b i t e d  0.5  mM 
arachidonic acid induced aggregation in a dose dependent manner 
( f i g u re  7.2) but much higher concentrat ions of drug were required 
to  produce a s i g n i f i c a n t  e f f e c t  as compared t o  aggrega t ion  
induced by col lagen.
These th re e  drugs a lso  produced a dose dependent reversal of 
10 uM ADP induced aggregation ( f ig u re  7 .3 ) .  This dose of ADP was 
s u f f i c i e n t  t o  cause i r r e v e r s i b l e  aggrega t ion  in  the  c o n t ro l  
experiments of a l l  subjects studied. However, only labe ta lo l  and 
propranolo l ,  at high concentrat ion, had any e f fe c t  on aggregation 
to  10 uM ADP.
A te n o lo l  had no s i g n i f i c a n t  e f f e c t  on aggrega t ion  induced by 
co l lagen, arachidonic acid or ADP, at drug c o n c e n t ra t io n s  up to  
1000 ug/ml ( f ig u re  7 .4 ) .
A dose response graph f o r  the  e f f e c t  o f  PGI2 on 0.5 ug/ml
c o l la g e n  induced aggrega t ion  was obta ined ( f i g u r e  7 . 5 ) .  A
c o n c e n t ra t io n  o f  125 pg/ml PGI2 had no s i g n i f i c a n t  e f fe c t  on
aggregation whi le 1000 pg/ml caused v i r t u a l l y  complete i n h ib i t i o n  
of aggregation.
Labeta lo l ,  pindolol  and propranolol  were syne rg is t ic  with PGI2 in  
i n h i b i t i n g  aggrega t ion  induced by 0.5 ug/ml c o l la g e n  ( f i g u r e  
7 . 6 ) ,  a t  c o n c e n t ra t io n s  o f  the drugs which on t h e i r  own had 
































E f fe c t  o f  l a b e ta lo l ,  p indo lo l  and propranolol  on p la t e l e t  
aggregation in  whole blood st imulated with 0,5 ug/ml 
co l lagen. A l l  po in ts  represent mean ± SEM (n = 8 f o r  
l a b e ta lo l ,  n = 7 f o r  propranolol  and p indo lo l )
* p  <0.05 )
) compared to  contro l



































E f fe c t  o f  l a b e ta lo l ,  p indo lo l  and propranolol  on p la t e l e t  aggregation 
in whole blood st imulated w ith  0.5 mM arachidonic ac id . A l l  po in ts  
represent the mean ±SEM of  5 experiments.





























E f fe c t  o f  l a b e ta lo l ,  pindolol  and propranolol  on p la t e l e t  
aggregation in  whole blood st imulated with  10 uM ADP. A l l  
points represent the mean ± SEM o f  5 experiments.
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FIGURE 7.4
E f fe c t  o f atenolol  on p la te le t  aggregation in  whole blood 
stimulated by 0.5 ug/ml col lagen, 10 uM ADP and 0.5 mM
arachidonic acid.
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FIGURE 7.5
E f fe c t  o f  PGI2 on p la te le t  aggregation in  whole blood 
st imulated with 0.5 ug/ml co l lagen.
A l l  points  represent the mean ± SEM of  6 experiments. 



































Synerg is t ic  e f fe c t  o f adrenoceptor antagonists and PGI2 in  
i n h i b i t i n g  p la te le t  aggregation in  whole blood st imulated by 0.5 
ug/ml co l lagen. (PGI2 concentrat ion = 125 pg/ml; l a b e ta lo l ,  
p indolo l  and propranolol  concentrat ion = 1 ug/ml).
A l l  po in ts  represent mean ± SEM of 6 experiments.
*  p <0.05 compared to  control
p <0.05  compared to adrenoceptor antagonist alone, and PGI2 alone.








E f fe c t  o f  labe ta lo l  and a sp i r in  on whole blood p la te le t  
aggregation (Mean ± SEM o f  7 experiments)
a = contro l  b = 5 ug/ml asp i r in
c = 1 ug/ml labe ta lo l  d = 5 ug/ml a sp i r in  and 1 ug/ml lab e ta lo l
*  p <0.05 compared with  contro l  (a)
* *  p <0.02 compared with  a, b and c.
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L a b e ta lo l  was a lso  found to  be s y n e r g i s t i c  w i th  a s p i r i n  in  
i n h i b i t i n g  p la te le t  aggregation ( f igu re  7 .7 ) .  As can be seen, at 
c o n c e n t ra t io n s  o f  l a b e t a l o l  and a s p i r i n  which on t h e i r  own 
produced minimal e f fec ts  on p la te le t  aggregat ion, a combinat ion 
o f  both the drugs resulted in  a s i g n i f i c a n t l y  greater  i n h ib i t i o n  
of p la te le t  aggregation.
7.4 DISCUSSION
The resu l ts  o f  t h i s  study show th a t  some adrenoceptor antagonists 
have a dose dependent i n h ib i t o r y  e f fe c t  on p l a t e l e t  aggrega t ion  
in  whole b lood .  Previous studies using PRP have shown th a t  t h i s  
e f fe c t  is  independent o f  3-receptor blockade (see Chapter 5),  and 
suggested t h a t  t h i s  may be due to  MSA (Weks ler e^ aj_., 1977; 
H e in ro th  ^  aj_., 1983) which i s  c l o s e l y  r e la t e d  to  l i p i d  
s o l u b i l i t y .  Th is  s tudy i s  in  agreement with these f ind ings  as 
a t e n o l o l ,  which has no MSA and i s  very  p o o r ly  l i p i d  s o lu b le  
( tab le  7 .1 ) ,  had no e f fe c t  on aggregation.
As col lagen induced aggrega t ion  was i n h i b i t e d  and ADP induced 
aggrega t ion  was reversed, we would suggest tha t  these drugs may 
i n h i b i t  thromboxane Ag (TxAg) p ro d u c t io n ,  as TxA2 is  a major 
mediator of collagen induced aggregation, and the second phase of 
ADP induced aggrega t ion  ( V a rg a f t ig  et aj_., 1981). These drugs 
on ly  i n h i b i t  a ra ch id o n ic  ac id  induced aggrega t ion  at high 
concentrat ions, suggesting th a t  a ra ch id o n ic  ac id  may bypass at 
l e a s t  in  par t  the block to  aggregation. This would lo c a l i s e  the 
i n h i b i t o r y  a c t io n  to  the  phosphol ipase A2 step which releases 
membrane bound arachidonic acid fo l low ing  s t i m u la t i o n  by agents 
such as col lagen.
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This  s tudy has a lso  shown t h a t  adrenoceptor  a n ta g o n is ts  act 
s y n e r g i s t i c a l l y  w i th  PGI2 t o  i n h i b i t  p l a t e l e t  aggregat ion in 
whole blood s t im u la te d  w i th  0.5 ug/ml co l lagen. Some in  v i t r o  
s tu d ie s  have suggested t h a t  the c o n c e n t ra t io n  o f  these drugs 
required to  i n h i b i t  aggrega t ion  are supra-pharmacol ogi cal  and 
there fore  could not occur in  v i v o . However, several studies have 
shown a s i g n i f i c a n t  e f f e c t  ex v i v o , and c i r c u la t i n g  aggregates 
have been shown to  be reduced in vivo by propranolol  (Green et 
a l . ,  1982). This discrepancy suggests th a t  p ia te le ts  in  vivo may 
be more s e n s i t i v e  than p l a t e l e t s  in  v i t r o  to  the a n t i - p l a te l e t  
e f f e c t  o f  adrenoceptor  antagonists.  This might be explained by 
the  synergy between PGI2 and these drugs in  i n h i b i t i n g  
a g g re g a t io n ,  which may occur in  the  in  v i v o  s i t u a t i o n .  The 
lowest  c o n c e n t ra t io n  o f  l a b e t a l o l  which on i t s  own had a 
s ig n i f i c a n t  e f fe c t  was 1 ug /m l ;  t h i s  i s  a p p ro x im a te ly  1 . 5 - 2  
times greater  than mean plasma levels  which have been recorded in 
women w i th  pregnancy induced hyper tens ion  g iven l a b e t a l o l  
(unpublished observations) so t h i s  e f fe c t  could possib ly occur in  
v i v o .
Th is  study has shown t h a t  l a b e t a l o l  and a s p i r i n  act 
synerg i  s t i  cal l y  to  i n h i b i t  p la te le t  aggregation in  v i t r o . This 
may be due to  sequen t ia l  i n h i b i t i o n  of the enzymes involved in 
TxA2 p ro d u c t io n  as adrenoceptor  a n ta g o n is ts  may i n h i b i t  
phosphol ipase A2 (see chap te r  5 ) ,  w h i le  a s p i r i n  i r r e v e r s i b l y  
i n h ib i t s  cyclo-oxygenase (Vane, 1971; Smith and W i l l i s ,  1971). 
Such a drug combina t ion  may wel l  prove useful  in  vivo as both 
adrenoceptor  a n ta g o n is ts  and a s p i r i n  have been shown to  be of
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some b e n e f i t  when used alone in  the secondary p re v e n t io n  o f  
myocard ia l  i n f a r c t i o n  (Hjalmarson ^  , 1981; Norwegian
M u l t i c e n t r e  Study Group 1981; DeGaetano et a_l_., 1982). Recently 
th e  r e s u l t s  o f  the Pe rsa n t in  - A s p i r i n  R e i n f a r c t i o n  Study I I  
Research Group (1985) have become ava i lab le .  These showed that a 
combina t ion  of the a n t i - p l a te l e t  agents a sp i r in  and dipyr idamole 
improved prognosis fo l low ing  myocardial i n f a r c t i o n ,  and th a t  t h i s  
e f f e c t  was f u r t h e r  enhanced i f  the  p a t i e n t  was a lso  on a 
b e ta -ad renocep to r  a n ta g o n is t .  The mechanism behind t h i s  
p r o t e c t i v e  e f f e c t  may be the  syne rg is t ic  act ion of asp i r in  and 
adrenoceptor a n ta g on is ts  on p l a t e l e t  f u n c t i o n  which has been 
documented in  v i t r o  in  t h i s  present study.
In i t s  r o le  as an a n t i - p l a t e l e t  agent, asp i r in  has been given in  
low doses to  t r y  t o  avo id  suppress ing v a scu la r  p r o s t a c y c l i n  
p ro d u c t io n  which i s  p o t e n t i a l l y  harmful (de Gaetano et a l . ,  
1982). Use of an aspir in /adrenoceptor antagonist combination may 
al low even lower doses o f  a s p i r i n  to  be used which m igh t ,  in  
combination with the adrenoceptor antagonis t,  e f f e c t i v e l y  i n h i b i t  
p l a t e l e t  aggregation and TxA2 production, whi le  sparing vascular 
PGI2 production. However, fu r th e r  studies are required to  ensure 
t h a t  t h i s  combinat ion does not a lso  ac t  s y n e r g i s t i c a l  l y  t o  
i n h i b i t  vascular PGI2 production in  v i v o .
Such a combinat ion o f  an a n t i - h y p e r te n s i v e  agent w i th  a n t i ­
p la te le t  propert ies and low dose asp i r in  may a lso  be o f  b e n e f i t  
in  the  t re a tm e n t  o f  pregnancy induced h y p e r te n s io n ,  s ince  
p la te le t  aggregation may play a major ro le  in the pathophysiology 
o f  t h i s  disease. This requires urgent c l i n i c a l  i n ve s t ig a t io n .
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In c o n c lu s io n ,  t h i s  s tudy has shown t h a t  some adrenoceptor  
a n ta g o n is ts  can i n h i b i t  p la te le t  aggregation in  whole blood and 
can ac t  s y n e r g i s t i c a l l y  w i t h  PGIg and a s p i r i n .  Whether these 
propert ies w i l l  prove useful in  the c l i n i c a l  s i tu a t io n  remains to  
be estab l ished but there are at leas t  good theo re t ica l  reasons to  
use an adrenoceptor antagonist with a n t i - p l a te l e t  proper t ies .
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CHAPTER 8
INHIBITION OF THROMBOXANE AND PROSTACYCLIN PRODUCTION 
IN WHOLE BLOOD BY ADRENOCEPTOR ANTAGONISTS
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8.1 INTRODUCTION
Thromboxane Ag (TXA2 ) i s  the  major product o f arachidonic acid 
metabol ism in  p l a t e l e t s  and i s  a po ten t  v a s o c o n s t r i c t o r  and 
p l a t e l e t  aggregat ing  agent (Hamberg et _al_., 1975). I t  has been 
impl icated in the pathogenesis o f myocardial i n f a r c t i o n  (Coker et 
al . ,  1981), arrhythmias (Coker and P a r ra t t ,  1983), vasospastic 
angina (Lewy et , 1979; Robertson et aj_., 1981) and in  angina 
i n  p a t i e n t s  w i th  ischaemic hear t  disease (Hirsh ^  _a]_., 1981). 
Increased ex vivo production of TxA2 has also been documented in  
pregnancy induced hypertension (PIH) complicated by i n t r a - u t e r i  ne 
growth re tardat ion (Wallenburg and Rotmans, 1982). Since PIH i s  
assoc ia ted  w i th  vasocons t r ic t ion  and p la te le t  consumption, TxA2 
may well play a ro le  in  i t s  pathophysiology.
P r o s ta c y c l i n  is  the major product of arachidonic acid metabolism 
in  v a s c u la r  t i s s u e  (Moncada e t  , 1977), but can a lso  be 
produced by w h i te  c e l l s  in  the  blood (Blackwel l  ^  Jj.*» 1978; 
Deckmyn _et l i . ,  1983).  I t  has actions d i r e c t l y  opposed to  TxA2 
as i t  i s  a po ten t  v a s o d i l a t o r  and i n h i b i t o r  o f  p l a t e l e t  
aggregation (Moncada et , 1976). I t  is  thought th a t  a balance 
e x i s t s  between these two substances to  m a in ta in  va scu la r  
i n t e g r i t y  (Bunti ng et al_., 1983).
Beta-adrenoceptor antagonists are widely used in the treatment of 
hypertension and ischaemic heart disease, and they are also being 
i n c r e a s i n g l y  used in  the  trea tment  o f  PIH (see chapter 3 .8 .3 ) .  
They have a lso  been shown to  improve prognos is  f o l l o w i n g  
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M u l t i c e n t r e  Study Group 1981), and may reduce p l a t e l e t  
consumption and disease progression in PIH (Walker et , 1982). 
The mechanism behind these benef ic ia l  e f fe c ts  is  unclear but an 
a t t r a c t i v e  hypothesis would be i n h ib i t i o n  o f  p la te le t  thromboxane 
p ro d u c t io n .  There have been severa l  s tu d ie s  showing th a t  
beta-adrenoceptor antagonists can reduce p la te le t  aggregation and 
TxA2 p roduct ion from p la te le t  r ich  plasma st imulated by thrombin 
and a ra c h id o n ic  ac id (Campbell et aj_., 1981a; Campbell et a l . ,  
1981b; H e in ro th  ^  , 1983; Brandt et aj_., 1984; Mehta, Mehta
and Ostrowsk i ,  1983) both in  v i t r o  and in  v i v o , although most of 
these s tu d ies  have concentrated on proprano lo l .  There has been 
l i t t l e  work, however, on the  e f fe c t  o f  these drugs on TxB2 and 
PGI2 production from whole blood, which may be more physiological 
as i t  avoids the separation of p la te le ts  from red and white ce l ls  
which can themselves inf luence p la te le t  behaviour by release of 
ADP (Saniabadi eit aj_., 1984a) and PGI2 , respec t ive ly .
The aim o f  t h i s  s tudy was to  determine what e f fe c t  a va r ie ty  of 
ad renocepto r  a n ta g on is ts  had on TxA2 and PGI2 production from 
whole blood in  v i t r o . As adrenoceptor antagonists vary not only 
in t h e i r  receptor s p e c i f i c i t y  but also in  t h e i r  l i p i d  s o l u b i l i t y ,  
possession of membrane s ta b i l i s i n g  a c t i v i t y  (MSA) and i n t r i n s i c  
sympathomimetic a c t i v i t y  ( ISA), a va r ie ty  o f drugs which d i f fe re d  
in  these respects ( tab le  8.1) were studied.
8.2 MATERIALS AND METHODS
Venous blood was obtained without s tas is  from healthy volunteers 
using a 19 gauge b u t t e r f l y  cannula and the  e f f e c t s  o f  several  
adrenoceptor  a n ta g o n is ts  on TxA2 and PGI2 p ro d u c t io n  from
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spontaneous whole blood c l o t t i n g  in v i t r o  was determined using 
th e  method descr ibed  in  chap te r  4 .7 .  Serum TxB2 , the stable 
h y d ra t io n  product o f  TxA2 , was determined by radioimmunoassay as 
descr ibed  in  chap te r  4 . 1 . 4 .  Serum immunoreactive 6-keto-PGFig 
(PGI2M) the  s ta b le  p roduct  o f  PGI2 was a lso  measured by 
radioimmunoassay as described in chapter 4 .1 .3 .
To con f i rm  th a t  i n h ib i t i o n  of PGI2M and TxB2 production could be 
measured using t h i s  technique, the experiment was f i r s t  performed 
w i th  va ry ing  concentrat ions of indomethacin or i t s  vehic le  (0.9% 
sodium c h l o r i d e ) .  The f o l l o w i n g  drugs were then assessed; 
a t e n o l o l ,  l a b e t a l o l ,  propranolol  (using 0.9% sodium ch lo r ide  as 
veh ic le ) ,  and p indolo l  (us ing  O.IM phosphate b u f f e r  pH 7.0  as 
v e h i c l e ) .  A l l  f o u r  drugs were assessed at f i n a l  drug 
concentrat ions of 1, 10 and 100 ug/m l ,  compared w i th  c o n t r o l s  
(veh ic le  a lone).  None o f  the drugs assessed had any demonstrable 
cross r e a c t i v i t y  with e i th e r  assay.
S ta t i s t i c a l  analysis was performed using the Wilcoxon paired rank 
sum te s t ,  and co r re la t io n  was assessed us ing the  Spearman rank 
t e s t .
8.3 RESULTS
Indomethacin t r e a te d  blood showed a dose dependent reduct ion in 
serum PGI2M and TxB2 (Figure 8 .1 ) ,  confirming tha t  i n h ib i t i o n  of 
production of these substances in  whole blood could  be measured 

































































































Effect of la b e ta lo l, pindolol and propranolol on TxB2 and P6 I 2M 
production from whole blood. Mean ± SEM of 8 experiments fo r  
labetalo l and propranolol. Mean ± SEM of 7 experiments fo r  
pindolol (*p <0.05, **p < 0 .02 , * * *  p <0.001).
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E f fe c t  o f  atenolol  on TxB2 and PGI2M production from whole 
blood c l o t t i n g .  Mean ± SEM of  8 experiments.
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L a b e t a l o l ,  p in d o lo l  and propranolol  a l l  showed a dose dependent 
re d u c t io n  in  both PGI2M and TxB2 . Labetalol  was the most potent 
as i t  s i g n i f i c a n t l y  i n h i b i t e d  the production of both PGI2M and 
TxB2 a t  a f i n a l  drug concentrat ion of 1 ug/ml, whi le propranolol  
and p indolo l  had s ig n i f i c a n t  e f fec ts  at 10 ug/ml ( f ig u re  8 .2 ) .
A t e n o lo l ,  however, had no s i g n i f i c a n t  e f fe c t  on e i th e r  TxB2 or 
PGI2M p ro du c t io n  from whole blood at concentrat ions up to  100 
ug/ml o f  the drug ( f ig u re  8 .3 ) .
The i n h i b i t i o n  of TXB2 product ion co rre la ted p o s i t i v e ly  with the 
i n h i b i t i o n  of PGI2M product ion f o r  labe ta lo l  (p <0.002), pindolol  
(p <0.001), propranolol  (p <0.001) and indomethacin (p <0 .001) .  
There was no c o r r e l a t i o n  between TxB2 and PGI2M in the atenolol  
experiments.
8.4 DISCUSSION
This  s tudy has shown t h a t  ad renoceptor  a n ta g on is ts  d i f f e r  in  
t h e i r  a b i l i t y  to  reduce TxB2 and PGI2M p ro du c t io n  from whole 
blood in  v i t r o . The in h ib i t i o n  o f  TxB2 production in the present 
s tudy i s  com pat ib le  w i th  s tu d ie s  us ing  p l a t e l e t  r i c h  plasma 
(Campbell et , 1981a; Campbell e t _ ^ . ,  1981b; Hei nroth _et a l . ,
1983; Mehta and Mehta, 1984; Mehta et 1983) both in  v i t r o  
and ex v i v o . However, the  r e s u l t s  o f  t h i s  and o the r  studies 
(Campbell et , 1981a; Campbell et aj_., 1981b; Mehta and Mehta,
1984; Mehta et , 1983) disagree with those of Brandt et 
(1984 ) ,  who showed t h a t  p rop ra n o lo l  had no e f f e c t  on TxB2 
p ro d u c t io n  ex v i v o , whi le atenolol  s i g n i f i c a n t l y  in h ib i ted  TxB2 
product ion.
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Since i n h i b i t i o n  o f  PGI2M and TxB2 production occurred hand in  
hand t h i s  i n h ib i t o r y  e f f e c t  may be due t o  a b lock  at a common 
p o in t  i n  th e  pathways f o r  TxA2 and PGI2 f o r m a t io n .  These 
substances are syn thes ised from a ra c h id o n ic  ac id  which i s  
re leased  from the  c e l l  membrane by the act ion of phospholipases 
which are a c t i v a te d  dur ing  p l a t e l e t  a c t i v a t i o n  and blood 
c l o t t i n g .  The f re e  a ra ch id o n ic  acid i s  then converted to  PGH2 
by the act ion of cyclo-oxygenase, the  pathway then d iv id e s  and 
PGH2 is  converted to TxA2 , PGI2 or other prostaglandins depending 
on the  c e l l  t y p e .  T h e re fo re ,  the  i n h i b i t o r y  e f f e c t s  o f  
ad renocepto r  an ta g on is ts  may be at e i t h e r  the phosphol ipase or 
cyc lo-oxygenase s teps .  Weksl er aj_., (1977) have shown that 
propranolol  can i n te r fe re  with i n t r a c e l l u l a r  Ca2+ a v a i l a b i l i t y  in 
th e  p l a t e l e t .  Since Ca2+ is  essent ial  f o r  phospholipase a c t i v i t y  
(Blackwel l  and Flower, 1983), t h i s  i s  a p o s s ib le  mechanism o f  
a c t i o n .  However, Hei n ro th  et (1983) showed th a t  pindolol
but not p ro p ra n o lo l  i n h i b i t e d  cyclo-oxygenase a c t i v i t y  in  ram 
seminal v e s ic le s  so t h a t  a b lock  at e i t h e r  o f  these steps i s  
poss ib le.
The r e s u l t s  o f t h i s  study also suggest th a t  membrane s ta b i l i s i n g  
a c t i v i t y  or l i p i d  s o l u b i l i t y  o f adrenoceptor a n ta g o n is ts  is  the 
p ro p e r ty  which is  requ i red  f o r  i n h i b i t i o n  o f  TxBg; and PGI2M 
product ion. Labeta lo l ,  pindolol  and propranolol  a l l  possess MSA, 
are l i p i d  soluble and in h ib i ted  PGI2 and TxB2 product ion, whi le 
atenolol  which is  very poorly l i p i d  solub le had no e f f e c t .  This 
i s  in  agreement w i th  o th e r  stud ies which also suggest that MSA
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and l i p i d  s o l u b i l i t y ,  which are c lose ly  re la ted ,  are responsible 
f o r  th e  e f f e c t s  o f  these drugs on p la te le t  aggregation and TxB2 
product ion (Heinroth et , 1983; Weksl er et , 1977).
The i n h i b i t i o n  o f  TxA2 p ro du c t io n  by these drugs may be 
c l i n i c a l l y  benef ic ia l  in view o f  the growing evidence impl ica t ing  
TxA2 i n  va scu la r  d isease ,  w h i le  the  i n h i b i t i o n  o f  PGI2 
p ro d u c t io n  i s  p o t e n t i a l l y  harmful i n  view o f  PGI2 ' s 
vasoprotect ive e f fe c t .  However, the  e f f e c t  o f  these drugs on 
v a s c u la r  PGI2 p ro d u c t io n  may be more im p o r ta n t  than PGI2 
product ion from whole blood. I t  has been shown th a t  p ro p ra n o lo l  
has no e f f e c t  on PGI2 p ro du c t io n  from c u l t u r e d  va scu la r  
e n d o th e l ia l  c e l l s  (Campbell ^  aj_., 1981b), so th a t  vessel wall 
PGI2 p ro d u c t io n  may be less sens i t ive  to  the i n h ib i t o r y  e f fec ts  
of these drugs. This would suggest tha t  the net e f fe c t  o f  these 
drugs might be a re d u c t io n  in  TxA2 p roduc t ion  with  sparing of 
v a s c u la r  PGI2 • The e f f e c t s  o f  l a b e t a l o l ,  p in d o lo l  and 
p ro p ra n o lo l  on u m b i l i ca l  a r te ry  PGI2 product ion were studied in 
chap te r  6 o f  t h i s  t h e s i s  and a l l  3 drugs were shown to  have 
minimal e f f e c t s  on th e  amount o f  PGI2 produced. Th is  i s  in  
keeping w i th  the  hypo thes is  t h a t  v a s c u la r  PGI2 production is  
less  s e n s i t i v e  than p l a t e l e t  TxA2 production to  the e f fec ts  of 
these drugs.
I t  has been suggested tha t  the i n h ib i t o r y  act ions of adrenoceptor 
a n ta g o n is ts  on p la te le ts  and TxA2 product ion only occurs at drug 
c o n c e n t ra t io n s  h ig h e r  than those ob ta i  ned in  vivo  (Weksler et 
al . ,  1977) .  However, th e re  are several studies documenting an 
e f f e c t  ex v ivo  (Campbell ^  i l » ,  1981a; Mehta and Mehta, 1984;
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Small 1982; F r i shman et al_., 1974), and propranolol  has
been shown to  reduce c i r c u la t i n g  p la te le t  aggregates in vivo at 
therapeut ic  doses in  pat ients  with coronary a r te ry  disease (Green 
et al_., 1982). In the present study labe ta lo l  had a s ig n i f i c a n t  
e f f e c t  at a f i n a l  concentrat ion of 1 ug/ml which is  only 1.5 -  2 
times greater  than the mean plasma concentrat ions which have been 
recorded fo l low ing  oral admin is t ra t ion in  pregnancy (unpublished 
observat ion) ,  therefore these drugs may we l l  have an im por tan t  
therapeut ic  e f fe c t  in v i v o .
In c o n c lu s io n ,  t h i s  s tudy suggests t h a t  some adrenoceptor  
a n ta g o n is ts  i n h i b i t  TxA2 and PGI2 product ion from whole blood. 
Whether t h i s  is  c l i n i c a l l y  useful  remains to  be e s ta b l i s h e d ,  by 
in  vivo s tud ies. However, there  are good theo re t ica l  reasons f o r  
using adrenoceptor antagonists which can i n h i b i t  TxA2 production, 
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P la te le ts  are in t im a te ly  involved in the pathogenesis of vascular 
disease. They act by o b s t r u c t i n g  the  m i c r o c i r c u l a t i o n  and by 
re le a se  o f  vasoac t ive  substances which can a l t e r  v a scu la r  
permeabi l i ty ,  and cause p r o l i f e r a t i v e  changes in  the vessel wa l l  
(Ross e t  a1_., 1974). Thromboxane A2 (TXA2 ) i s  the major product 
o f  the  a ra c h id o n ic  ac id  cascade i n  p l a t e l e t s  (Hamberg et a l . ,
1975). I t  i s  re leased when p la te le t s  aggregate and in  tu rn  i t  
promotes v a s o c o n s t r i c t i o n  and f u r t h e r  p l a t e l e t  aggrega t ion  
(Hamberg e t  a]_., 1975), possibly by increasing Ca2+ a v a i l a b i l i t y  
(Gorman, 1979).  There i s  growing evidence im p l ica t ing  TxA# in 
ischaemic hear t  d isease and va so spa s t ic  angina (Hirsh et a l . ,  
1981; Coker et , 1981; Robertson et ^ . , 1981).
Pregnancy induced hypertension (PIH) is  associated with  p la te le t  
a c t i va t io n  and consumption (Trudinger,  1976; Redman et al_., 1978; 
Socol et , 1985) and p la te le t  aggregates may con t r ibu te  to  the 
m ic ro v a s c u la r  o b s t r u c t i o n  and t i s s u e  ischaemia seen in organs 
such as the placenta and kidney in  PIH. Release o f  vasoac t ive  
substances from the  p l a t e l e t s ,  such as 5 - h y d r o x y t r y p ta m ine 
(Whigham et _al_., 1978) and thromboxane A2 , may also con tr ibu te  to  
th e  d isease process and Wallenburg and Rotmans (1982) have 
recent ly  documented increased p la te le t  TxA2 product ion ex vivo in  
PIH complicated by i n t r a - u t e r i  ne growth re ta rda t ion .
Calcium channel blocking agents (CCB) are of proven value in  the  
t re a tm e n t  o f  vasospast ic  angina, e f f o r t  angina and hypertension 
(Braunwald, 1982) and have recent ly  been used w i th  some success 
in  the  t re a tm e n t  o f  PIH (W a l te rs  and Redman, 1982). Although
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they do not yet have an establ ished ro le  in  the treatment o f t h i s  
disease, they may be of value not only because they lower  blood 
p ressure  but also because they produce peripheral vasod i la ta t ion  
which may improve u te ro -piacental  blood f low.
CCB's are known to  have an i n h i b i t o r y  a c t io n  on p l a t e l e t  
agg rega t ion  to  a v a r ie t y  o f s t im u l i  in  v i t r o  (Onoda, Sloane and 
Honn, 1984; L ipp ton  e t _ ^ . ,  1984; Mehta et , 1983; Addonizio 
e t  al . ,  1982; Han ^  aj_., 1983) and an e f f e c t  has a lso  been 
documented ex v ivo  (Da le ,  Landmark and Myhre, 1983). They are 
tho u g h t  to  act by b locking Ca2+ a v a i l a b i l i t y ,  prevent ing i n f lu x  
o f  e x t r a c e l l u l a r  Ca2+ or  m o b i l i s a t i o n  o f  i n t r a c e l l u l a r  Ca2+ 
s to re s  (Han ^  , 1983) .  Free c y t o s o l i c  Ca2+ i s  the
b iochemica l  in te rm e d ia ry  l in k in g  st imulus to  c e l l u l a r  response, 
and Ca2+ i s  re q u i re d  f o r  i r r e v e r s i b l e  p l a t e l e t  aggrega t ion  
( F e i n s t e in ,  1978; Rink, Smith and Tsien, 1981; Le Breton et a l . ,
1976).
Prostacyc l in  (PGI2 ) ,  the major prostaglandin produced by vascular 
endothelium, is  a potent vasod i la to r  and p la te le t  i n h i b i t o r  which 
may act by increasing Ca2+ sequestrat ion w i th in  the p la te le t  (see 
chapter 1 .4 ) .  Consequently, CCBs and PGI2 may have a synerg is t ic  
act ion on in h ib i t i o n  of p la te le t  aggregat ion.
A l l  p rev ious  s tu d ies  w i th  CCBs have been performed on p la te le t  
r ich  plasma (PRP) by t r a d i t i o n a l  tu rb idometr ic  techniques (Born, 
1962) .  i t  has r e c e n t l y  become p o s s ib le  to  measure p l a t e l e t  
aggregation in  whole blood using a whole blood p la te le t  co u n te r ,  
which can count s in g le  p l a t e l e t s  without separation from other
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blood c e l l  t y p e s .  Th is  may be s u p e r io r  t o  t u r b id o m e t r i c  
techniques, as p la te le ts  are l e f t  i n  t h e i r  n a tu ra l  m i l i e u  w i th  
both red and w h i te  c e l l s  present which can themselves inf luence 
aggrega t ion  by release of ADP and PGI2 respect ive ly  (see chapter
4 .6 .1 ) .
The aims o f  t h i s  study were to  determine what e f fe c t  a CCB had
on p l a t e l e t  aggregat ion  and TxA2 and PGI2 product ion from whole
blood j_n v i t r o  and a lso  determine whether i t  had any e f fe c t  on 
PGI2 p ro d u c t io n  from th e  vessel w a l l .  As a r e p re s e n ta t i v e  
example we used n icard ip ine  (suppl ied by Syntex Research) a drug 
chemical ly and pharmacologically s im i la r  to  n i fe d ip in e .
9.2 MATERIALS AND METHODS
The m a te r ia l s  and methods used in  the fo l low ing  in  v i t r o  studies 
w i th  n ic a r d ip in e  are f u l l y  described in  chapter 4 (Methodology). 
The e f fe c t  o f n icard ip ine  on p la te le t  aggregation in  whole blood 
was dete rmined using th e  method descr ibed  in  chap te r  4 . 6 . 2 .  
Vary ing  c o n c e n t ra t io n s  o f  n i c a r d ip i n e  or  i t s  v e h ic le  
( p h y s io lo g i c a l  s a l i n e  and h y d r o c h lo r i c  ac id  pH 3 .6 )  were
assessed, the l a t t e r  act ing as co n t ro l .  S y n e rg i s t i c  e f f e c t s  o f  
n i c a r d i p i n e  and PGI2 o r  a s p i r i n  in  i n h i b i t i n g  p l a t e l e t
aggregation in  whole blood were determined us ing  the  methods 
described in  chapter 4 .6 .4  and 4 .6 .5 ,  respect ive ly .
The e f f e c t  o f  n i c a r d i p i n e  on p r o s t a c y c l i n  and thromboxane A2 
generation from whole blood was assessed using the  methodology 
desc r ibed  i n  chapte r  4.7 and the  e f f e c t  o f  n i c a r d i p i n e  on 
pros tacyc l in  product ion from u m b i l i c a l  a r t e r y  was assessed as
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desc r ibed  in  chapter 4 .5 . TxA2 was measured by radioimmunoassay 
o f  i t s  s ta b le  h y d ra t io n  product  TxB2 , and p r o s t a c y c l i n  was 
measured by radioimmunoassay f o r  immunoreact ive  6-keto-PGFia 
(PGI2M). These assays are described in  chapter 4.1 .4  and 4 .1 .3 ,  
respec t ive ly .
S t a t i s t i c  Methods
S ta t i s t i c a l  analysis was by the Wilcoxon paired rank sum te s t  f o r  
a l l  experiments.
9.3 RESULTS
R esu l ts  f o r  the e f fe c t  o f n icard ip ine  on p la te le t  aggregation in 
whole blood are shown in  f i g u r e s  9.1 -  9 .5 .  As can be seen, 
n i c a r d i p i n e  produced a dose dependent i n h i b i t i o n  o f  0.5 ug/ml 
collagen induced aggregat ion, and produced a s i g n i f i c a n t  e f f e c t  
at concentrat ions as low as 1-10 ug/ml ( f ig u re  9 .1 ) .  N icard ip ine, 
however, had no e f fe c t  on aggregat ion to  10 uM ADP, but caused 
s i g n i f i c a n t  reversal o f aggregation at 200 ug/ml ( f ig u re  9 .2 ) .  I t  
also produced a dose dependent i n h ib i t i o n  o f  agg rega t ion  t o  0.5 
mM a ra c h id o n ic  a c id ,  but was on ly  s i g n i f i c a n t  a t high 
concentrat ions ( f i g u re  9 .3 ) .
N ic a rd ip in e  was s y n e r g i s t i c  w i th  both a s p i r i n  and PGI2 a t  
c o n c e n t ra t io n s  o f  the  drugs which on t h e i r  own had minimal 
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E f fe c t  of Nicard ip ine on 1x82 and PGI9M Product ion from 
Whole Blood C lo t t in g
A l l values gi ven as mean ± SEM (n = 7)
Control Nicard ip ine
1 ug/ml 10 ug/ml 100 ug/ml
PGIgM 562.9 607.1 605.7 757.1*
(pg/ml) ±55.8 ±29.7 ±37.9 ±27.7
TxBg 138.3 116.0 116.6 121.7
(ng/ml) ±11.5 ±11.4 ±10.6 ± 7.9
*
p <0.05 compared w ith  a l l  other groups
TABLE 9.2
E f fe c t  o f Nicard ip ine and Asp i r in  on PGI^M Product ion 
frpm Umbil ica l  A r te ry  Rings 
A l l  values given as mean ± SEM o f  5 experiments
Control  Asp i r in  N icard ip ine 
(100 ug/ml) (100 ug/ml) 
PGIgM 788.0 540.0* 660.0
(pg/ml) ±59.5 ±40.0 ±40.0
*
p <0.05 compared w ith  contro l
(Pool plasma PGI2M concentra t ion was 6 pg/ml p r io r  to  
incubat ion w ith  the a r te ry  r ings)
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N ic a r d ip in e  had no s i g n i f i c a n t  e f f e c t  on TxB2 product ion from 
whole blood but s i g n i f i c a n t l y  increased PGI2M at 100 ug/ml ( tab le
9 . 1 ) .  I t  had no e f f e c t  on PGI2M p ro d u c t io n  from u m b i l i c a l  
a r t e r y ,  w h i le  100 ug/ml a s p i r i n  s i g n i f i c a n t l y  i n h i b i t e d  the 
production of PGI2M ( tab le  9 .2 ) .
9.4 DISCUSSION
These r e s u l t s  show t h a t  n i c a r d i p i n e  can i n h i b i t  p l a t e l e t  
aggregation in  whole blood. Furthermore, a s i g n i f i c a n t  e f f e c t  
was noted at lower drug concentrat ions than prev ious ly  described 
in  p la te le t  r i ch  plasma experiments although i t  i s  d i f f i c u l t  to  
compare s t u d i es due t o  d i f f e r e n c e s  in  methodology and in  the 
aggregating agents used. This i n h ib i t o r y  e f f e c t  may be re la te d  
t o  the  a b i l i t y  of CCBs to  reduce the r i s e  in  free  cy toso l ic  Ca2+ 
which is  required fo r  p la te le t  aggregation (Rink et , 1981; Le 
Breton et ^ . ,  1976).
We have a lso  shown th a t  PGI2 is  synerg is t ic  with  n icard ip ine in  
i n h i b i t i n g  aggrega t ion  i n  whole b lood .  This  supports  the  
f i n d in g s  o f  Onoda ^  aj_. , (1984) and Ikeda et al_., (1981 ) who 
showed tha t  such synergy existed with other CCBs in  p la te le t  r ich  
plasma. A l l  the  j_n v i t r o  s tu d ie s  have shown t h a t  CCBs can 
i n h i b i t  aggrega t ion  only at suprapharmacological concentrat ions 
which cannot be obta ined j_n v i v o , yet CCBs have been shown to  
have a n t i - p l a t e l e t  e f f e c t s  in  v i v o . Dale_et a]_., (1983) have 
shown t h a t  n i f e d i p in e  can pro long b le e d in g  t im e  and reduce 
collagen and ADP induced aggregat ion in  p a t i e n t s  w i th  coronary  
a r te ry  disease. This discrepancy suggests th a t  p la te le ts  in vivo 
may.be more sens it ive  than p la te le ts  in  v i t r o  to  CCBs. This might
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be exp la ined  by the synergy of CCBs with  PGI2 which may occur in 
the  j_n v iv o  s i t u a t i o n .  I t  i s  a lso  d i f f i c u l t  t o  r e l a t e  the  
c o n c e n t ra t io n  o f  the  aggrega t ing  agent used in  v i t r o  to  the  
co n c e n t ra t io n  which may occur in  vivo which is  l i k e l y  to  be much 
1ower.
A s p i r i n  i s  we l l  known to i n h i b i t  p la te le t  aggregation (O'Brien, 
1968; Evans et a1_., 1968) and TxB2 generation (Preston et a l . ,  
1981; Smith and W i l l i s ,  1971), and has been invest igated in the 
secondary prevention of myocardial i n f a r c t i o n  and in  th rea tened  
s t ro k e  as previously described (see Chapter 2 ) .  More recent ly  a 
combina t ion  o f  a s p i r i n  and d ip y r id a m o le  have been used w i th  
success in  pregnancies at high r i s k  o f  PIH and i n t r a - u t e r i  ne 
growth re ta rdat ion  (Beaufi l  s et aj_., 1985).
Low dose a s p i r i n  has been used to  t r y  t o  avoid  suppress ing
p r o s t a c y c l i n  p ro du c t io n  from va s c u la r  t i s s u e  which may be 
p o t e n t i a l l y  harmful (De Gaetano, C e r l e t t i  and B e r te le ,  1982; 
Toivanen ejt aj_., 1984). Th is  s tudy has shown t h a t  a low
c o n c e n t ra t io n  of asp i r in  is  syne rg is t ic  w ith  a low concentrat ion
of n icard ip ine  in  i n h ib i t i n g  aggregation. Furthermore th i s  study 
has shown tha t  even at a high drug concentrat ion n icard ip ine had 
no e f f e c t  on the  PGI2 p ro d u c t io n  by vascu la r  t issue  in  v i t r o . 
Th is  synergy may be o f  va lue in  the  p ro p h y la x is  o f  va scu la r  
disease, where CCBs are already used in the t re a tm e n t  o f  angina 
and hypertension (Braunwald, 1982).
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Use of n icard ip ine concurrent ly  with a sp i r in  may al low even lower 
doses o f  a sp i r in  to  be used which could s t i l l  e f f e c t i v e l y  reduce 
p l a t e l e t  aggregation and TxA^ production, whi le sparing vascular 
PGI2 p ro d u c t io n .  Reduced a s p i r i n  dosage would a lso  reduce 
gas tro - i  n tes t i  nal si d e -e f fe c ts .
Such a combination o f  a vasod i la to r  ant i -hyper tens ive agent with 
a n t i - p l a t e l e t  p ro p e r t i e s  and low dose a s p i r i n  might a lso  be 
use fu l  in  PIH s ince i t  i s  a d isease c h a r a c t e r i  sed by 
vasoconstr ic t ion and p la te le t  a c t i va t io n  and consumption.
N ic a rd ip in e  had no e f f e c t  on TxB2 p roduc t ion  from whole blood 
c l o t t i n g ,  although there was a trend towards lower l e v e l s .  Th is  
i s  at va r iance  w i th  o th e r  s t u d ie s .  Han _et (1983) showed 
t h a t  both verapamil  and n i fe d ip in e  in h ib i te d  TxA2 product ion in  
p l a t e l e t  r i c h  plasma and Dahl et a1_., (1984) have shown tha t  
verapamil i n h ib i t s  TxB2 production from whole blood. However, at 
high drug c o n c e n t ra t io n  n i c a r d i p i n e  increased PGI2 production 
from whole blood. This may be due to  d iversion of endoperoxides 
away from TxA2 p ro du c t io n  and towards PGI2 product ion, but as 
t h i s  only occurred at high drug concentrations i t  i s  u n l i k e l y  t o  
be s ig n i f i c a n t  in v iv o .
In c o n c lu s io n ,  t h i s  study has shown n icard ip ine to  be e f fe c t iv e  
in  i n h ib i t i n g  aggregat ion i n  whole b lood .  In a d d i t i o n ,  i t  i s  
s y n e r g i s t i c  w i th  both PGI2 and a sp i r in .  The former e f fe c t  may 
explain the ant i  p la te le t  e f fe c t  of CCBs in  v i v o , whi le  the l a t t e r  
e f f e c t  may represen t  a new approach in the prevent ive treatment 
of vascular disorders associated with p la te le t  a c t i v a t io n .
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A CROSS-SECTIONAL STUDY OF IMMUNOREACTIVE PROSTACYCLIN 




P ro s ta g la n d in s  have long been known to  have phys io log ica l roles 
i n  pregnancy and p a r t u r i t i o n .  P r o s t a c y c l i n  (PGI2 ) and 
thromboxane (TXA2 ) which are powerful vasoact ive agents, can now 
be re a d i l y  assayed, and there is  increasing evidence im p l i c a t i n g  
them in  the pathophysiology of several d isorders of pregnancy. In 
pregnancy induced hypertension (PIH), several workers have shown 
a re d u c t io n  in  PGI2 production from fe ta l  (Remuzzi et , 1980; 
Downing et 1980; Walsh et al_., 1985) and maternal (Bussolino 
et a1_., 1980) vascular t i s sue ,  and low p ros tacyc l in  l i k e  a c t i v i t y  
i n  a m n io t i c  f l u i d  (Bodzenta _et ^ . , 1980) .  In i nt  ra -u te r ine  
growth re ta rd a t io n  (lUGR) PGI2 production has also been shown to  
be low (Stuar t  _et al_., 1981; J o g e e ^ a l _ . ,  1983).
Many o f  the  changes seen in  PIH and lUGR, such as p l a t e l e t  
consumption, vasoconstr ic t ion and low renin secret ion may r e s u l t  
f rom PGI2 de f ic iency ,  as PGI2 is  a potent vasod i la to r ,  p la te le t  
i n h i b i t o r  and renin secret ion s t imulant (Miyamori et al_ . ,  1979). 
More r e c e n t l y ,  PGI2 p ro d u c t io n  from umbil ica l  a r te ry  has been 
shown t o  c o r r e l a t e  w i th  u m b i l i c a l  a r te ry  blood f low (Makila et 
a l . ,  1983).
TxA2 i s  produced from a c t i v a te d  p l a t e l e t s  and i s  a PGI2 
a n ta g o n is t ,  having p l a t e l e t  aggrega to ry  and v a s o c o n s t r i c t o r  
p r o p e r t i e s  (Hamberg ^  aj_., 1975).  PGI2 and TxA2 oppose each 
o th e r  th rough r e g u la t i o n  o f  adeny la te  cyclase in  the p la te le t  
(Tateson et £ l . , 1977), t h e re fo re  TxA^ may also have a ro le  in 
these d is o r d e r s .  Both these substances are h igh ly  unstable and
are usual ly measured as t h e i r  stable metabol i tes. P ros tacyc l in 's  
major m e ta b o l i t e  i s  6-keto-PGFia , and thromboxane is  converted 
to  i t s  stable hydrat ion product thromboxane B2 (TXB2 ) .
As menationed p r e v io u s l y ,  measurement o f  PGI2 metabo l i tes  in 
p e r ip h e ra l  plasma has been, and remains a s u b je c t  o f  g rea t  
c o n t ro v e rs y .  I n i t i a l  work on 6-keto-PGFig by radioimmunoassay 
(RIA) suggested th a t  leve ls  in  normal subjects were of the o rder  
70 - 100 pg/ml ( M i t c h e l l ,  1978), and t h i s  was supported by 
gas-chromatography-mass-spectrometry (GCMS) work which suggested 
s im i la r  leve ls  (Hensby et , 1979). in 1982, however, B la i r  et 
a l . ,  publ ished work using negat ive ion GCMS which showed th a t  the 
ab so lu te  values f o r  6-keto-PGFig were below 5 pg/ml, and i t  was 
concluded tha t  PGI2 could not be a c i r c u la t in g  hormone in  man as 
previously thought (see chapter 1 . 4 ) .  T h i s ,  however, does not 
p rec lude  a r o le  f o r  PGI2 func t ion ing  as a local hormone in  the 
r e g u la t i o n  o f  pi a te l  et-vessel wall in te ra c t io n  (Patrono et a l . ,  
1984). Changes in leve ls  o f i t s  stable metabol i tes must re f l e c t  
changes in product ion, i t  is  s t i l l  there fore valuable to  measure 
these m e ta b o l i te s  to  e lu c id a t e  the  r o l e  o f  p r o s t a c y c l i n  in  
disease. RIA has also been d iscred i ted  by varying ' normal ' values 
ob ta ined by RIA, due to  d i f fe rences in methodology and antibody 
s e n s i t i v i t y  (Vinnikka and Y l iko rka la ,  1982). While RIA 's cannot 
g ive a bso lu te  va lues f o r  PGI2 m e ta b o l i t e s ,  they  can s t i l l  
produce accurate comparative values.
Much improved RIA 's  have been developed r e c e n t l y  w i th  
s e n s i t i v i t i e s  and normal leve ls  much c loser  t o  t h a t  ob ta ined  by 
GCMS. RIAs, t h e r e f o r e ,  can s t i l l  y i e l d  much v a lu a b le  and
accu ra te  data p rov ided  they  are p ro p e r l y  v a l i d a te d  (Salmon, 
1983), and have many advantages over GCMS, as they are r e la t i v e l y  
s e n s i t i v e ,  s p e c i f i c  and can cope with  large numbers of samples. 
For these reasons RIA i s  p robab ly  the  method o f  cho ice from 
rout ine measurements (Belch et , 1983; Salmon, 1983).
There i s  l i t t l e  i n f o r m a t io n  on the  normal leve ls  o f PGI2 and 
TxA2 i n  pregnancy. Since they  may be im p l i c a te d  in  disease 
processes, i t  i s  o f  va lue t o  e s t a b l i s h  the changes in  these 
le v e l s  in  normal pregnancy.  Lewis ^  a l - j  (1980) published 
leve ls  o f  6-keto-PGFxot and have shown an e levat ion in  la te  normal 
pregnancy and the  puerper ium. Bo l ton  ^ l i . j  (1981) recorded 
se r ia l  measurements throughout 12 normal pregnancies, and found a 
peak at 18 - 22 weeks g e s ta t i o n  w i th  a subsequent red uc t io n  
towards te rm .  Other  s tu d ie s  have shown no d i f f e r e n c e  in the 
l e v e l s  o f  PGI2 m e ta b o l i te s  th roughou t  normal pregnancy 
(M i t c h e l l ,  1981; Y l ikorka la  and V i i n i k k a ,  1981) . A l l  o f  these 
studies were performed p r io r  to  the work of B la i r  _et aj_., (1982), 
and suggested normal ranges of 80 - 500 pg/ml f o r  6-keto-PGFiQ. 
These studies are s t i l l  quoted as normal range despite subsequent 
advances in  knowledge and assay techn iques .  In view of these 
advances and the c o n f l i c t i n g  reports  of Lewis et (1980) and
Bolton e t  , (1981), the aim of t h i s  study was to  determine the 
compara t ive  va lues o f  PGI2 and TxA2 m e ta b o l i t e s  th roughout  
normal pregnancy and the puerperium, using a RIA which has been 
shown t o  be s e n s i t i v e ,  s p e c i f i c  and re p ro d u c ib le  f o r  PGI2 
metabol i tes (McLaren et a l . ,  1985).
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10.2 PATIENTS AND METHODS
One hundred and f i f t y  f i v e  women were s tud ied ,  44 normal non­
pregnant, 29 women in the f i r s t  t r im e s te r  o f  pregnancy, 31 in the 
second t r im e s te r ,  29 in the t h i r d  t r im e s te r ,  and 21 women on the 
t h i r d  day fo l low ing  d e l i ve ry .  A l l  pregnancies were uncomplicated 
and no sub jec t  had taken any asp i r in  or s im i l a r  preparations fo r  
at leas t  two weeks p r io r  to  sampling.
Venous blood was taken without s tas is  using a 21 gauge b u t t e r f l y  
cannula and prepared as descr ibed in  ch a p te r  4 . 1 . 3 .  Plasma 
immunoreact ive 6 -ke to-PGFia  (PGI2M) was measured by RIA as 
desc r ibed  i n  chap te r  4 . 1 . 3 .  Plasma TxB2 was also measured by 
RIA as described in  chapter 4 .1 .4 .
S t a t i s t i c a l  a n a ly s is  was by the  Wi lcoxon rank sum t e s t  f o r  
non-paired data.
10.3 RESULTS
Resu l ts  f o r  PGI2M are shown in  f i g u r e  10.1 and f o r  TxB2 in  
f i g u r e  10 .2 .  S ig n i f i c a n t l y  higher leve ls  o f PGI2M were found in  
the f i r s t  t r im e s te r  (p <0.01) when compared with the non-pregnant 
group. Whi le  th e re  were no s i g n i f i c a n t  d i f f e r e n c e s  between 
non-pregnant values and those in the second or t h i r d  t r i m e s t e r s ,  
a t re n d  towards lower  co n c e n t ra t io n s  o f  PGI2M on the  t h i r d  
p o s t - n a ta l  day was noted but t h i s  was not s t a t i s t i c a l l y  
s i g n i f i c a n t .  Levels  o f  PGI2M were s i g n i f i c a n t l y  lower in  the 
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was a p ro g re ss ive  reduct ion in plasma TxB2 concentrat ions from 
the second t r im es te r  th rough  the  t h i r d  t r i m e s t e r  and i n t o  the  
puerperium when compared to  the non-pregnant group.
Table 10.1 gives a f u l l e r  s t a t i s t i c a l  analys is .
10.4 DISCUSSION
Despite using la rger  numbers, t h i s  study did not conf irm the work 
o f  Lewis ^  al_., (1980) who showed a h ig h e r  concen t ra t ion  of 
6-ke to-PGFia  in la te  pregnancy and the puerperium, nor could i t  
confirm the work of Bolton et aj_., (1981) as peak leve ls  of PGI2M 
in  t h i s  study occurred in  the  f i r s t  t r im e s te r  and not in  mid­
pregnancy as they reported, although they d id  not record  l e v e l s  
p r io r  to  14 weeks gesta t ion.
S i g n i f i c a n t l y  h ighe r  leve ls  of PGI2M were observed in  the f i r s t  
t r im es te r  as compared to  the non-pregnant and second and t h i r d  
t r i m e s t e r s .  This e a r l y  inc rease  may be in v o lv e d  in  th e  
physio logical  vasod i la t ion  and i n s e n s i t i v i t y  to  a n g io te n s in  I I  
(Gant e t aj_., 1973) which are c h a r a c te r i s t i c a l l y  seen from the 
ear ly  stages of normal pregnancy.
I t  has r e c e n t l y  been shown t h a t  t r o p h o b la s t  from e a r l y  
pregnancies has a high c a p a c i t y  to  synthesis PGI2 , and i t  has 
been suggested tha t  c o lo n i z a t i o n  o f  maternal  b lood vesse ls  by 
t r o p h o b la s t  i s  f a c i l i t a t e d  by PGI2 , which may prevent p la te le t  
aggregates from ha l t ing  t h i s  process (Rakoczi et , 1983). This 
th e o ry  might e x p la in  our f i n d in g s  o f  e leva ted  PGI2M in ear ly  
pregnancy. F a i lu r e  o f  t h i s  response may p o s s ib ly  r e s u l t  i n
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th re a te n ed  or spontaneous abor t ion , and may even lead on to  IU6R 
in  l a t e r  pregnancy, a c o n d i t i o n  where reduced PGI2 production 
has p re v io u s ly  been recorded ( Jogee et al_., 1983; Stuart  et a l . ,
1981).
T h e o r e t i c a l l y  one might expect high l e v e l s  o f  PGI2 in la te  
pregnancy, due to  the potent ia l  f o r  increased production from the 
u te ru s  and f e t o - p l a c e n t a l  c i r c u l a t i o n  u n i t  and Goodman et a l . ,  
(1982) have documented increased u r ina ry  PGI2 metabol i tes at 
t h i s  stage in  pregnancy. However, no increase in  PGI2M was noted 
in  the  t h i r d  t r i m e s t e r  i n  t h i s  p resen t  s tu d y .  This may be 
e xp la ined  by the f ind ings of Remuzzi ^  J l * ,  (1981b) who found a 
reduced le v e l  o f  p ro s ta c y c l in -s t im u la t in g  fa c to r  in la te  normal 
pregnancy and t h i s  may represent a homeostatic mechanism. Since 
th e  c a p a c i t y  t o  produce PGI2 i s  increased, at t h i s  stage, less 
p ros tacyc l in -s t im u la t ing  fa c to r  is  required and PGI2 leve ls  would 
remain c o n s ta n t ,  as we have d e s c r ib e d .  Converse ly  when the  
a b i l i t y  to  produce PGI2 i s  low, as in  PIH, p r o s t a c y c l i n -  
s t i m u la t i n g  f a c t o r  r i s e s  in  an attempt to  increase PGI2 . This 
change has also been noted by Remuzzi et c ^ . , (1981b).
In the post-natal  group a trend towards lower leve ls  o f PGI2M was 
observed, which contradic ts  the work of Lewis et aj_., (1980), but 
is  in  keeping with the f ind ings  of Y l iko rka la  et (1981c) who 
also noted a f a l l  in PGI2 metabol i tes p o s tn a ta l l y .  The sampling 
in  t h i s  study was performed on ly  on the  t h i r d  p o s t -n a ta l  day, 
w h i l e  Lewis ^  l i * » sampled between the  f i r s t  and seventh 
post-nata l  days. I f  many of the samples were obtained soon a f te r  
d e l ive ry  they may have a high 6-keto-PGFig level due to  vascular
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i n j u r y .  A lso ,  inc reased p ro du c t io n  at 6-keto-PGFia in  v i t r o  
from sheep cerv ica l  t i ssue  taken at p a r tu r i t i o n  has been reported 
(El Iwood et ^ . , 1981). Since the fe to -p l  acental u n i t ,  which has 
enormous c a p a c i t y  t o  synthesise PGI2 , is  removed at b i r t h ,  some 
reduct ion in  6-keto-PGFia leve ls  p o s t -n a ta l ly  might be expected.
A p ro g re ss ive  f a l l  i n  plasma TxB2 c o n c e n t ra t io n s  th rough 
pregnancy and i n to  the  puerperium was observed in  t h i s  s tudy .  
This  may r e f l e c t  increased p la te le t  s t a b i l i t y ,  or the d ivers ion 
o f  TxB2 p re cu rso rs  in to  the formation of other prostaglandins, 
such as PGD2 or PGE^. Other possible explanat ions o f  t h i s  may be 
re la ted to  a change in  a c t i v i t y  o f  thromboxane syn the tase  or  
decreased s u b s t r a te  a v a i l a b i l i t y ,  but f u r t h e r  s tu d ie s  are 
required to  e luc idate  t h i s .  We noted several very high leve ls  of 
TxB2 ( f i g u re  10 .2) .  These sor t  o f  leve ls  are normal ly associated 
with traumatic  venepuncture or  haemolysis, however, we d iscarded  
a l l  samples in  which e i t h e r  o f  these problems were apparent. 
Despite a l l  precautions a minor degree o f  p la te le t  ac t iva t ion  can 
s t i l l  occur a t  venepuncture and t h i s  may e x p la in  these few 
ou t ly ing  leve ls .
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CHAPTER 11
A PROSPECTIVE LONGITUDINAL STUDY OF IMMUNOREACTIVE 




P r o s t a c y c l i n  (PGI2 ) i s  the  major p ro s ta g la n d in  produced from 
a ra c h id o n ic  ac id  v ia  the  cyc lo-oxygenase system in  vascu la r  
t i s s u e  (Moncada ^  aj_ . ,  1977). I t  i s  a po ten t  v a s o d i l a t o r  
(Armstrong ^  , 1978) and i n h i b i t o r  o f  p la te le t  aggregation
(Moncada ^  aj_., 1976) w i th  a short h a l f - l i f e  o f approximately 
th r e e  minutes at 37°C (Dusting et 1979), and is  thought to  
f u n c t i o n  as a lo c a l  hormone, p r o t e c t i n g  b lood vesse ls  from 
p l a t e l e t  d e p o s i t i o n  and subsequent damage. Product ion of PGI2 
from human vascular t issue  can be st imulated in  vivo by a va r ie ty  
o f  minor i n j u r i e s  ( R i t t e r  et aj_ . ,  1983). Fa i lu re  of the vessel 
t o  respond in  such a manner may there fore  a l low vasoconstr ic t ion , 
thrombosis and p la te le t  consumption to  take place unopposed.
Thromboxane A2 (TXA2 ) i s  the  major  cyc l  o-oxygenase product of 
arachidonic acid in  p l a t e l e t s  and i s  syn thes ised  and re leased 
when p la te le ts  aggregate (Hamberg et a1_., 1975). I t s  actions are 
d i r e c t l y  opposed t o  those o f  PGI2 as i t  i s  a potent  vasoco­
n s t r i c t o r  (Bun t ing  et ^ . ,  1976) and p la t e le t  aggregating agent 
(Hamberg ^  , 1975). I t  i s  unstable w ith  a h a l f  l i f e  of 30
seconds at 37°C. I t  has been proposed t h a t  a balance ex is ts  
between blood vessel PGI2 p ro d u c t io n  and p l a t e l e t  TxA2 
p ro d u c t i o n ,  t o  m a in ta in  va s c u la r  i n t e g r i t y  (Bun t ing  et a l . ,
1983).
PGI2 and TxA2 have r e c e n t l y  been im p l i c a te d  in  the pathophys­
io logy o f  pregnancy induced hypertension (PIH) (see Chapter 3 .7 ) .  
Several workers have shown reduced PGI2 production from fe ta l  
(Remuzzi e t a l . ,  1980; Downing ^  , 1980; Walsh et ^ . ,  1985)
180
and maternal (Bussolino ^  , 1980) vascular t i s su e .  Umbil ical
cord vesse ls  produce l a rg e  amounts o f  PGI2 (Remuzzi, 1979) and 
t h i s  may be im po r tan t  i n  the  maintenance o f  f l o w  in  the low 
pressure  f e t o - p l a c e n t a l  c i r c u l a t i o n  (Tuvemo, 1980). Makila et 
al . ,  (1983) have recent ly  shown tha t  umbi l ica l  a r te ry  blood f low 
i s  d i r e c t l y  r e la te d  to  the vessels a b i l i t y  to  produce PGI2 , and 
shown both to  be low in  p re -e c la m ps ia .  Reduct ion o f  PGI2 
p ro d u c t io n  has a lso  been documented in  i n t r a - u t e r i  ne growth 
r e t a r d a t i o n  (lUGR) ( S t u a r t  e t  al_ . ,  1981; Jogee et , 1983), 
Th is  d e f i c ie n c y  in  PGI2 p ro d u c t io n  may be in v o lv e d  in  the  
vasoconstr ic t ion and p la te le t  consumption seen in  PIH and lUGR, 
and PGI2 i n f u s io n s  have been used w i th  some success in  the  
treatment o f PIH (Belch _et _al_., 1985; Fidl  er e;t , 1981).
D esp i te  these o b se rva t io n s  in  the abnormal s i t u a t i o n ,  there is  
l i t t l e  i n f o r m a t io n  on maternal plasma PGI2 in normal pregnancy. 
In 1980 Lewis ^  , p u b l ishe d  a cross sectional study on 22
pregnancies showing t h a t  6 -ke to -PG F ia ,  the s ta b le  h y d ra t io n  
product o f  PGI2 was elevated in  la te  pregnancy and the puerperium 
as compared with  normal non-pregnant and ear ly  pregnancy groups. 
Bo l ton  et ^ . ,  (1981) in  the only prospect ive long i tud ina l  study 
of PGI2 in  12 normal pregnancies reported a peak at 18 - 22 weeks 
gesta t ion, although they did not sample in the f i r s t  t r i m e s t e r .  
Other cross sectional studies have shown no d i f fe rence (M i tchel l  
e t  1981; Y l i k o r k a l a  and V i in i k a ,  1981) in PGI2 throughout
pregnancy. The va lues g iven by these s tu d ie s ,  us ing r a d io ­
immunoassays (RIA) were between 100 and 500 pg/ml f o r  
6 -ke to -PGFia ,  and were compat ib le  w i th  va lues f o r  normal 
non-pregnant subjects ob ta ined  by RIA ( M i t c h e l l ,  1978) and by
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gas-chromatography mass-spectrometry (GCMS) (Hensby, 1979). These 
f i n d in g s  were in  keeping w i th  the  b e l i e f  t h a t  PGI2 was a
c i r c u l a t i n g  hormone in  man (Moncada e t  aj_., 1978).  In 1982,
however, B l a i r  ^  aj_., pub l ished  work using negative ion GCMS
which showed tha t  the absolute value f o r  6-keto-PGFia in  plasma 
was below 5 pg/ml, and i t  was concluded th a t  PGI2 could not be a 
c i r c u la t i n g  hormone in  man as previously thought.  This,  however,; 
does not preclude a ro le  f o r  PGI2 func t ion ing  as a local hormone 
in  the regula t ion  of p la te le t  vessel wal l in te ra c t io n  (Patrono et 
a l . ,  1984, see Chapter 4 .1 .1 ) ,  as changes in  leve ls  of i t s  stable 
m e ta b o l i t e s  must r e f l e c t  changes in  p ro d u c t io n .  I t  is  s t i l l  
there fo re  valuable to  measure these metabol i tes to  e lu c id a te  the  
ro le  o f  p ros tacyc l in  both in the normal s i tu a t io n  and in disease.
There i s  l i t t l e  i n f o rm a t io n  o f  TxA2 in  pregnancy (see chapter 
3 .7 ) .  Y l iko rka la  and V i in ikka  in  1980 described increased plasma 
concentrat ions of TxB2 in  pregnancy as compared with  non-pregnant 
control  sub jects , but could show no r e la t io n  to  g e s ta t io n ,  w h i l e  
M i t c h e l l  e t  , (1978) ,  showed increased  l e v e l s  a t term as
compared to  " la te  pregnancy" (28 -  36 weeks ges ta t ion ) .
In  view o f  advances in  knowledge and assay techniques f o r  PGI2 
and TxA2 m e ta b o l i te s  and the  c o n f l i c t i n g  re p o r t s  on these 
substances i n  normal pregnancy,  the  aim o f  t h i s  study was t o  
per fo rm a p ro s p e c t iv e  l o n g i t u d i n a l  s tudy o f  PGI2 and TxA2 
metabol i tes in  normal pregnancy.  However, o f  our i n i t i a l  14 
randomly se lec ted  s u b je c ts  s i x  became hypertensive and we were 
t h e r e f o r e  ab le  to  s tudy PGI2M and TxB2 prospect ive ly  in  both 
normal, and hypertensive pregnancy.
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11.2 PATIENTS AND METHODS
11.2.1 Pat ients
Fourteen randomly se le c te d  p a t i e n t s  were s tu d ie d ,  a l l  were 
pr imigravidae and had no h is to ry  of any hyp e r ten s ive  or  medical 
d i s o r d e r .  No s u b je c t  had taken any a s p i r i n  o r  s i m i l a r  
p re p a ra t i o n  f o r  a minimum o f  two weeks p r i o r  t o  each 
venepunc tu re .  Blood sampling was per formed in  the  f i r s t  
t r im e s te r  (9 -  12 weeks ges ta t ion ) ,  the second t r im e s te r  (17 -  24 
weeks g e s ta t i o n )  and in  the  t h i r d  t r i m e s t e r  (32 -  36 weeks 
g e s ta t io n ) .  In the  p a t i e n t s  who became h y p e r te n s iv e  f u r t h e r  
samples were obtained where possible between 36 weeks and term.
Eight p a t ie n ts  remained normotensive w h i l e  6 developed m i ld /  
moderate PIH in  the  t h i r d  t r i m e s t e r ,  d e f in e d  as a pers is ten t  
d ia s t o l i c  blood pressure on 90 mm of mercury. Five were t r e a te d  
c o n s e r v a t i v e l y ,  w h i le  one re q u i re d  t re a tm e n t  w i th  an a n t i ­
h y p e r te n s iv e  agent ( l a b e t a l o l ) .  None developed s i g n i f i c a n t  
p la t e le t  consumption or p ro te in u r ia .
A l l  pa t ients  had vaginal de l ive r ie s  e i t h e r  spontaneous or induced 
a t  te rm ,  and a l l  i n f a n t s  were healthy w ith  b i r t h  weights above 
the 10th c e n t i le  f o r  t h e i r  gestat ional  age.
The proport ion  of pat ients  who became hypertensive was unexpected 
and e x t r a o rd in a r i l y  high. There was no apparent reason f o r  t h i s  
as a l l  were a p p a re n t ly  normal p a t i e n t s  a t  a rout ine antenatal
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c l i n i c .  The inc id e nce  o f  PIH in  our p o p u la t io n  i s  between 5 
-10%, and the high inc idence  in  the  s tudy  group appears to  be 
t o t a l l y  co inc iden ta l .
11.2.2 Measurement o f PGIp Metabol i te  and TxB?
Venous blood was taken without s tas is  using a 21 gauge b u t t e r f l y  
cannula and prepared as descr ibed  in  chap te r  4 . 1 . 3 .  Plasma 
immunoreact ive 6 -ke to -PGFia  (PGI2M), the  stable  metabol i te  o f  
PGI2 , was measured by radioimmunoassay as described in  Chapter 
4 . 1 . 3 .  Plasma TxB2 was a lso  measured by radioimmunoassay as 
described in Chapter 4 .1 .4 .
A l l  assays were performed " b l i n d "  w ith  the operator unaware o f  
e i th e r  g e s ta t io n  o r  the  presence o r  absence o f  h y p e r te n s io n .  
U n f o r t u n a t e l y ,  3 specimens had to  be discarded due to  technical 
problems at the t ime o f  c e n t r i fu g a t io n ,  g iv ing  incomplete data on 
3 of the pa t ien ts .
11.2.3 S ta t i s t i c a l  Methods
s t a t i s t i c a l  analys is was by the Wilcoxon paired rank sum te s t  f o r  
analysis w i t h i n  group, and by the  Wi lcoxon rank sum t e s t  f o r  
non-pa i red  data f o r  analys is between groups. The Spearman rank 
co r re la t io n  te s t  was used f o r  co r re la t io n  of PGI2M and TxB2 .
11.3 RESULTS
R esu l ts  are shown in  f i g u r e s  11.1 and 11.2 w i t h  a f u l l e r  












Plasma PGI2M and TXB2 in  normal pregnancies (broken l i n e  
ind ica tes lower l i m i t  o f  detect ion o f  assay). Thi rd t r im e s te r  









Plasma PGI2M and TXB2 in  pregnancies complicated by PIH in  the 
t h i r d  t r im e s te r .  Two pat ients  developed PIH in  the ear ly  t h i r d  
t r im e s te r  (32-36 weeks gestat ion)  C 3( i ) ]  whi le  fou r  developed PIH 
in  the l a t e  t h i r d  t r im es te r  (37-40 weeks gesta t ion [ 3 ( i i ) ] .  No 
pa t ien t  was hypertensive whi le  PGI2M were recordable. (Broken 
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In  the  normal p a t i e n t s  PGI2M were s i g n i f i c a n t l y  higher in the 
f i r s t  than in  the second and t h i r d  t r im e s te rs ,  whi le TxB2 leve ls  
f e l l  s i g n i f i c a n t l y  in the second and t h i r d  t r imesters  as compared 
w i t h  the  f i r s t  t r i m e s t e r .  There was no s ig n i f i c a n t  d i f fe rence 
f o r  e i t h e r  PGI2M or TxB2 between the second and t h i r d  t r imeste rs 
o f  the normal group, a l though th e re  was a t r e n d  towards lower 
leve ls  o f  TxB2 in  the t h i r d  t r im e s te r .
In  the  f i r s t  and second t r i m e s t e r s ,  the  PIH group was not 
s i g n i f i c a n t l y  d i f f e r e n t  from the normal group fo r  e i t h e r  PGI2M or 
TxB2 « A l l  h yp e r ten s ive  p a t i e n t s  developed unrecordab le  
(<5 pg.ml)  leve ls  of PGI2M in the t h i r d  t r im e s te r  when they were 
h y p e r te n s iv e .  In 5 o f  the  6 PIH p a t i e n t s  hyper tens ion  had 
developed p r i o r  to  the  sample showing unreco rdab le  l e v e l s ,  
t h e r e f o r e  i t  cou ld  not be determined whether undetectable PGI2M 
leve ls  preceded the development o f  hypertension or vice-versa. In 
one p a t i e n t ,  however, a t h i r d  t r i m e s t e r  sample showed 
un reco rdab le  l e v e l s  o f  PGI2M p r i o r  t o  the  development o f  
h y p e r te n s io n ,  and they remained unreco rdab le  f o l l o w i n g  the  
development o f PIH. No normal pa t ien t  had unrecordable PGI2M at 
any stage.
Owing to  the small numbers and d i f f e r i n g  times of development o f  
PIH i t  was not p o s s ib le  t o  compare s t a t i s t i c a l l y  the t h i r d  
t r im e s te r  measurements In the PIH pat ients  with the normal group. 
The la te  (36 - 40 weeks gestat ion)  t h i r d  t r im e s te r  measurement in  
the  PIH group was s i g n i f i c a n t l y  d i f f e r e n t  from the  f i r s t  and 
second t r i m e s t e r  measurements w i t h i n  th e  group. There was a 
s i g n i f i c a n t  re d u c t io n  in  TxB2 i n  the  second and ear ly  (32 -36
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weeks ges ta t ion )  t h i r d  t r im es te r  compared to  the f i r s t  t r im es te r  
in  the  PIH group and a s ig n i f i c a n t  increase in  TxB2 was noted in  
the la te  t h i r d  as compared to  the ear ly  t h i r d  t r i m e s t e r .  There 
was no s i g n i f i c a n t  d i f fe rence  between normal and PIH groups f o r  
TxB2 , and no c o r r e l a t i o n  e x is te d  between normal and PIH groups 
f o r  TxB2 , and no c o r r e l a t i o n  ex is ted between PGI2M and TxB2 in 
e i t h e r  group.
11.4 DISCUSSION
The r e s u l t s  from t h i s  small prospective long i tud ina l  study show 
inc reased  concentrat ions of plasma PGI2M in  the f i r s t  t r im e s te r ,  
and f a l l i n g  l e v e l s  o f  plasma TxB2 i n  the  second and t h i r d  
t r im e s te r  of normal pregnancy. This confirms our previous cross 
s e c t i o n a l  study o f  155 pat ients  comparing PGI2M and TxB2 in  the 
t h i r d  t r i m e s t e r s  o f  pregnancy, th e  puerper ium, and a normal 
non-pregnant contro l  group, which also showed increased PGI2M in 
the  f i r s t  t r i m e s t e r  as compared w i th  the  second and t h i r d  
t r i m e s t e r s ,  and a lso  the  non-pregnant con t ro l  group (Greer et 
a l . ,  1985) (see Chapter 10 ) .  The f i r s t  t r im e s te r  increase in  
PGI2 may be in v o lv e d  in  the  p h y s io l o g i c a l  v a s o d i l a t i o n  and 
i n s e n s i t i v i t y  to  angiotensin I I  c h a r a c t e r i s t i c a l l y  seen in  e a r l y  
pregnancy (Gant et ^ . ,  1973).
Rakoczi ejk , (1983) have shown t h a t  t rophob las t  from early  
pregnancies has a h igh c a p a c i t y  to  produce PGI2 , and suggested 
tha t  t h i s  may f a c i l i t a t e  the  i n v a s io n  o f  maternal  vessels  by 
t r o p h o b l a s t ,  p re ve n t in g  p l a t e l e t  aggregates from ha l t ing  t h i s  
process. Th is  th e o ry  might e x p la in  our  f i n d i n g s  of e leva ted  
PGI2M in  e a r l y  pregnancy. A f a i l u r e  o f  such a p r o t e c t i v e
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mechanism might re su l t  in  spontaneous abor t ion .  This theory may 
be supported by the  f ind ings  o f  Roy et , (1984) who recent ly  
showed th a t  in t ra ve s icu la r  f l u i d  from hydat id i fo rm moles had very 
high l e v e l s  o f PGI2 metabol i tes, and t h i s  may al low the mole to  
s u c c e s s fu l l y  invade,  and escape im m o b i l i s a t i o n  by p l a t e l e t  
aggregates.
As the fe to-p lacenta l  u n i t  is  la rges t  in the t h i r d  t r im e s te r ,  one 
m igh t  expect PGI2M to  increase at t h i s  t ime due to  the potent ia l  
f o r  increased PGI2 product ion. However, we have found leve ls  to  
be decreased at t h i s  stage compared to  the f i r s t  t r im e s t e r .  Th is  
may be explained by the f ind ings  of Remuzzi ^  al_ . ,  (1981b) who 
found a reduced level o f p ro s ta cyc l in -s t im u la t in g  fa c to r  in  la te  
normal pregnancy, and th i s  may be a homeostatic mechanism. Since 
th e  c a p a c i t y  t o  produce PGI2 i s  inc reased  at t h i s  stage, less 
p r o s t a c y c l i n - s t i m u l a t i n g  f a c t o r  i s  re q u i re d  and PGI2 leve ls  
would remain constant,  as we have found .  Converse ly ,  when the  
a b i l i t y  to  produce PGI2 i s  low, as in  PIH, p r o s t a c y c l i n -  
s t i m u l a t i n g  f a c t o r  may r i s e  in  an a t tem p t  to  increase PGI2 , a 
f in d in g  which was also noted by Remuzzi et ^  . ,  (1981b).
A l l  hyper tens ive pat ients  were found to  have unrecordable leve ls  
o f  PGI2M. This i s  consistent with other  stud ies; in  1981 Lewis 
et al . ,  pub l ished  a case re p o r t  showing f a l l i n g  l e v e l s  o f  
maternal  plasma S-ke to-PGFi^  in  a p a t i e n t  w i th  severe PIH. 
However, the pat ien t  was t reated with a sp i r in  over the same t ime  
p e r io d  and i t  i s  t h e r e fo r e  d i f f i c u l t  t o  know whether t h i s  was 
associated with the disease or was an e f fe c t  of a sp i r in  act ing on 
v a s c u la r  t i s s u e  to  i n h i b i t  cyc lo -oxygenase .  More r e c e n t l y .
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s i g n i f i c a n t l y  lower plasma leve ls  o f  6-keto-PGFia have been found 
i n  women w ith  eclampsia or impending eclampsia (Moodley ^  ^  . ,  
1984) than in  normal pregnant women, and Yamaguchi and Mori 
(1985) have also reported lower leve ls  o f plasma 6-keto-PGFia in  
pregnancies complicated by PIH as compared to  normal pregnancies. 
Goodman et a l . ,  (1982) have reported lower u r inary  metabol i tes o f  
PGI2 i n  s i x  p a t i e n t s  w ith  PIH compared to  e ight normal pregnant 
contro l  pat ients  and amniotic f l u i d  has also been shown to  have 
lower leve ls  of PGI2 in  PIH (Bodzenta et , 1980; Y l iko rka la  et 
sQ,., 1981a).
The f i n d i n g  of low PGI2M in the present study is  also consistent  
w i th  the  re p o r ts  o f  reduced PGI2 production from both maternal 
and f e t a l  va scu la r  t i s s u e  in  pregnanc ies  comp l ica ted  by PIH 
(Walsh e t  , 1985; Downing et aj_., 1980; Remuzzi et ^ . ,  1980; 
Bussolino et , 1980; Makila 1983).
As one pa t ien t  in  the hypertensive group in  the present study had 
unrecordable levels  o f PGI2 p r io r  to  the development o f PIH, t h i s  
suggests t h a t  f a l l i n g  l e v e l s  o f  PGI2M may p o s s ib ly  act as a 
marker heralding the onset o f the disease.
In normal pregnancy women become very in se n s i t i ve  to  the pressor 
e f fec ts  o f  exogenous a n g io te n s in  I I  i n f u s io n s  (Chesley, 1966; 
T a l le d o  ^  al_., 1968; Gant et , 1973). This i n s e n s i t i v i t y  to  
a n g io te n s in  I I  can be abol ished i f  women are given i n h ib i t o r s  o f  
p r o s ta g la n d in  syn th e s is  such as indomethacin (Everett  et a l . ,  
1978a), and enhanced by PGI2 in fus ions (Broughton Pipkin et a l . ,
1984) .  These exper iments suggest t h a t  i n  normal pregnancy.
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angiotensin I I  may be balanced by the act ion o f  p ros tacyc l in .  In 
PIH t h i s  i n s e n s i t i v i t y  to  angiotensin I I  is  l o s t  (Chesley, 1966; 
T a l le d o  , 1968; Gant et , 1973), and t h i s  may be due to
d e f i c i e n c y  o f  PGI2 as has been documented in  the present study. 
This increased s e n s i t i v i t y  to  angiotensin I I  may also c o n t r i b u t e  
to  the pathophysiology o f  PIH.
A cause and e f f e c t  r e l a t i o n s h i p  fo r  low PGI2 and PIH cannot be 
concluded from these stud ies, however, one cou ld  specu la te  t h a t  
s ince  PGI2 i s  a po ten t  v a s o d i l a t o r  and a n t i - p l a t e l e t  agent ,  
d e f i c i e n c y  o f  t h i s  substance may cause the  s u b je c t  t o  be 
s u s c e p t ib le  t o  PIH, a l l o w in g  v a s o c o n s t r i c t i o n  and p l a t e l e t  
consumption to  occur unchal lenged, when the disease ar ises .
Thromboxane A2 d id  not seem to  be r e la t e d  to  PIH, however, a 
s ig n i f i c a n t  increase in the l a te  t h i r d  t r i m e s t e r  o f  the  hyper­
te n s i v e  group was no ted .  I t  i s  not poss ib le  to  comment as to  
whether  t h i s  was r e la t e d  to  the  d isease ,  due t o  s u b c l i n i c a l  
p l a t e l e t  aggregation, or was a normal f in d in g  as we did not have 
a la te  t h i r d  t r im es te r  sample in our normal contro l  group. This 
may, however, be a normal f e a tu re ,  as i t  would be in agreement 
w i th  the  work o f  M i tc h e l l  et (1978) who showed an increase
in  TxB2 in  the la te  t h i r d  t r im e s te r .
In c o n c lu s io n ,  these r e s u l t s  suppor t  th e  hypothesis tha t  PGI2 
de fe f ic iency  is  involved in the pathophysiology o f  PIH.
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CHAPTER 12
A CROSS-SECTIONAL STUDY OF IMMUNOREACTIVE PROSTACYCLIN 
AND THROMBOXANE METABOLITES IN PREGNANCY INDUCED 
HYPERTENSION, AND THE EFFECT OF LABETALOL TREATMENT ON 
THEIR LEVELS AND PLATELET CONSUMPTION
12.1 INTRODUCTION
Pregnancy induced h yp e r ten s io n  (PIH) i s  we l l  known to  be 
a ssoc ia ted  w i th  a c t i v a t i o n  o f  the coagulat ion system (Howie et 
a l . ,  1971; Howie et 1976) and reduced p la te le t  count (Redman 
e t  al . ,  1978; T ru d in g e r ,  1976) which have been shown to  be 
r e la t e d  to  disease seve r i t y  (Howie _et , 1976). P la te le t  l i f e  
span i s  known to  be reduced in  PIH (Rakoczi et _al_., 1979) and 
t h i s  i s  thought  t o  be secondary to  i n t r a v a s c u l a r  p l a t e l e t  
agg rega t ion  and increased adhesion t o  damaged vascu la r  
endo the l ium . There is  evidence f o r  p la te le t  a c t iva t ion  shown by 
increased g-thromboglobul in,  a p la te le t  release product (Douglas 
e t  aj_., 1982; Socol _et a]_., 1985), and decreased i n t r a - p la te le t  
s e r o to n in  leve ls  (Whigham et j ^ . , 1978). Prostacyc l in  (PGI2 ) is  
the  majo r  p ro s ta g la n d in  produced by vascular t issue  (Moncada et 
al . ,  1977) and is  a potent vasod i la to r  and i n h i b i t o r  of p la te le t  
agg rega t ion  (Moncada aj_., 1976). I t  has a short h a l f  l i f e  as 
i t  i s  u n s ta b le ,  and i s  u s u a l l y  measured as one o f  i t s  stable 
m e ta b o l i t e s ,  such as 6 -ke to -PG F ia .  Over the  past few years 
ev idence has accumulated i m p l i c a t i n g  PGI2 d e f i c i e n c y  in  the  
pa thophys io logy  o f  PIH (see chap te r  3 . 7 ) .  Reduced PGI2 
production both from maternal and f e ta l  vascular t issue  has been 
documented in  t h i s  disease (Remuzzi et al_., 1980; Downing et a l . ,  
1980; Walsh _ e t_ ^ . ,  1985) and lower leve ls  of amniotic f l u i d  PGI2 
compared to  normal pregnancy have also been noted (Bodzenta et 
al . ,  1980; Y1 i ko rka l  a _et aj_., 1981a). More r e c e n t ly  reduced 
plasma leve ls  o f PGI2 metabol i tes have been reported in eclampsia 
(Moodley et a l . ,  1984) and in  PIH (Yamaguchi and Mori , 1985)
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compared to  normal,  pregnancies and lower  u r i n a r y  PGI2 
metabol i 1 tes  have a lso  been reported (Goodman et , 1982) in  
PIH.
Thromboxane A2 (TXA2 ) i s  th e  major product o f arachidonic acid 
metabol ism i n  p l a t e l e t s  and i s  a po ten t  v a s o c o n s t r i c t o r  and 
p l a t e l e t  aggrega t ing  agent (Hamberg e t  aj_., 1975) which i s  
syn thes ised  and re leased  when p l a t e l e t s  are ac t iva ted .  I t  is  
h igh ly  unstable and is  the re fo re  u s u a l l y  measured in  plasma as 
i t s  stable  hydrat ion product TxB2 . In view of i t s  propert ies and 
th e  a s s o c ia t i o n  o f  p l a t e l e t  consumption with PIH, TxA# too may 
play a ro le  in  the pathophysi o logy o f  t h i s  d isease  and i t  has 
r e c e n t l y  been shown t h a t  ex v iv o  p l a t e l e t  TxA2 product ion is  
inc reased  in  pregnancies comp l ica ted  by PIH and i n t r a u te r in e  
growth re ta rda t ion  (Wallenburg and Rotmans, 1982), and a lso  t h a t  
TxA2 p roduc t ion  from placentas of pat ients  with  PIH is  increased 
(Walsh, 1985).
L a b e ta lo l  is  an adrenoceptor antagonist which has been used with 
some success in the treatment of PIH (Walker et , 1982; Walker 
et , 1983; Lardoux et , 1983; Symonds et a l . ,  1982; Redman,
1982). Some adrenocepto r  antagonis ts  inc lud ing labe ta lo l  have 
i n h i b i t o r y  e f f e c t s  on p l a t e l e t  f u n c t i o n  and thromboxane A2 
product ion which have been studied e a r l i e r  in  t h i s  t h e s i s  (see 
chapte rs  5, 7 and 8 ) .  Although labe ta lo l  i n h i b i t s  p la te le t  TxA2 
p ro d u c t io n ,  v a s c u la r  p ro s ta g la n d in  p ro d u c t io n  seems t o  be 
r e l a t i v e l y  spared, a t  l e a s t  a t  low drug c o n c e n t ra t io n s  (see
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chapter 6 ) .  This may be bene f ic ia l  in  PIH as f u r th e r  suppression 
o f  v a s c u la r  PGI2 p ro d u c t io n  in  t h i s  c o n d i t i o n  might be 
d e t r im e n ta l .
The aims o f  t h i s  study were t w o f o l d ,  f i r s t l y  to  perform a 
c ro s s -s e c t io n a l  study of PGI2 metabol i te  (PGI2M) and TxB2 in  PIH 
and compare t h i s  to  normal pregnancy. The second aim was t o  
s tudy the  e f f e c t  o f  t re a tm e n t  w i th  l a b e t a l o l  on p l a t e l e t  
consumption, plasma PGI2M and TxB2 in PIH.
12.2 PATIENTS AND METHODS
12.2.1 Cross Sectional Study pf PGI?M and TxB? in  PIH 
T h i r t y - s e v e n  p a t i e n t s  w i th  m i ld /m ode ra te  PIH, 6 pat ients  with 
severe PIH and 40 normal pregnant women i n  th e  t h i r d  t r i m e s t e r  
were studied,  the l a t t e r  group act ing as co n t ro ls .  Mi ld/moderate 
PIH was defined as a pers is ten t  d ia s t o l i c  blood pressure g r e a te r  
than o r  equal to  90 mm of  mercury a f t e r  3 days hospital  bed res t 
in  women who had been normotensive in  the f i r s t  t r im e s te r .  Severe 
PIH was de f ined  as a p e r s i s t e n t  d i a s t o l i c  blood pressure o f  
greater  than 110 mm of mercury on two occasions at lea s t  8 hours 
apar t ,  in  women who had been normotensive in  the f i r s t  t r im es te r .  
P ro te inu r ia  was not used i n  the  d isease c l a s s i f i c a t i o n .  The 
mi ld /modera te  PIH group and the control  group were comparable in  
terms o f  s i z e ,  p a t i e n t  age, p a r i t y  and g e s ta t i o n .  The 
c h a r a c t e r i s t i c s  o f the 3 groups are shown in  tab le  12.1. Venous 
blood was obtained without s tas is  at the t ime o f  d ia g n o s is ,  f o r  
measurement o f  plasma PGI2M and TXB2 . No pa t ien t  had taken any 
a s p i r in  or any other drug known to  i n t e r f e r e  w i th  p ro s ta g la n d in  
production f o r  at least 2 weeks p r io r  to  venepuncture.
TABLE 12.1






Mean (± SD) 
Gestat ion at 
t ime o f  f i r s t  
sample (weeks)
Number w ith  
s i g n i f i c a n t  
p ro te in u r ia  
(>0.3 g/24 h)
Number with  
lUGR*































*  lUGR: In t ra  Uter ine Growth Retardation
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12.2.2 E f fec t  of Labetalol  Treatment on PGIpM and TxB?
In o rd e r  t o  s tudy the  e f f e c t  o f  t re a tm e n t  w i th  l a b e t a l o l  on 
plasma PGI2M and TxB2 , a second blood sample was obtained one 
week a f t e r  the i n i t i a l  assessment in  17 o f  the mi ld/moderate PIH 
group who had been randomised to  receive e i t h e r  labe ta lo l  or bed 
res t  jalone, the l a t t e r  act ing as a contro l  group. A second blood 
sample was a lso  obtained one week a f t e r  s ta r t i n g  treatment in  4 
o f  th e  severe p a t i e n t s  who were a l l  t r e a te d  w i th  l a b e t a l o l .  
L a b e ta lo l  was g iven in  an i n i t i a l  dose o f  200 mg t . i . d .  and 
increased a f t e r  each 24 hour period i f  requi red.
12.2.3 Measurement of PGI?M and TxB?
Venous blood was ob ta ined w i t h o u t  s t a s i s  and prepared as 
d esc r ibed  i n  chap te r  4 . 1 . 3 .  Plasma PGI2M ( immunoreact ive 
6 -ke to -PGFia )  and TxB2 were measured as desc r ibed  in  chapter
4.1.3 and 4.1 .4  respect ive ly .
A l l  assays were performed " b l i n d "  with  the operator unaware of 
the presence or absence o f  hypertension.
12.2.4 E f fec t  o f Labetalol  on P la te le t  Count
One hundred and e ig h t  p a t i e n t s  w i th  PIH were s tu d ied  a f t e r  
informed consent had been o b ta in e d .  No p a t i e n t  had taken any 
drugs known to  a f fe c t  prostaglandin or thromboxane formation fo r  
at leas t  2 weeks p r io r  to  venepuncture .  M i ld  t o  moderate and 
severe PIH were defined as above (12 .2 .1 ) .
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Seventy pa t ien ts  with mi ld/moderate PIH were studied as fo l low s .  
The pa t ien ts  were d iv id e d  i n t o  p r im ig r a v id  and parous groups 
p r i o r  to  random isa t ion  to  re ce ive  e i t h e r  l a b e t a l o l  o r  
cont inuat ion o f  hospital  bed r e s t ,  the  l a t t e r  be ing termed the  
c o n t ro l  group. The p ro p o r t i o n s  o f  p r im ig r a v id  and parous 
p a t i e n t s  were t h e r e f o r e  com pat ib le  in  both the  c o n t r o l  and 
l a b e t a l o l  t r e a te d  groups.  The two groups were also compatible 
f o r  age and gesta t ion .  Mean age was 24.8 ± 5.2 (SD) years in  the 
c o n t ro l  group and 26.9 ± 5.9 (SD) years  in  the  l a b e t a l o l  
t reatment group; mean gestat ion was 35.1 ± 2.2 (SD) weeks, in  th e  
c o n t ro l  group and 34.9 ± 2.1 (SD) weeks in  the treatment group; 
37% of the c o n t r o l  group and 39% o f  the  l a b e t a l o l  group were 
parous. Two pat ients  in the contro l  group and 3 pat ients  in  the 
t re a tm e n t  group had s i g n i f i c a n t  p r o t e i n u r i a  (>0.3 g/24 h ) .  
L a b e ta lo l  was g iven i n  an i n i t i a l  dose o f  200 mg t . i . d .  and 
increased a f t e r  each 24 hour pe r iod  i f  s a t i s f a c t o r y  blood 
pressure contro l  was not obtained.
T h i r t y - e ig h t  pat ients  w i t h  severe PIH were s tu d ie d .  A l l  were 
t r e a te d  w i t h  l a b e t a l o l ,  the s ta r t i n g  dose was 200 mg t . i . d .  and 
the dose was increased a f t e r  each 24 hour period i f  s a t i s f a c t o r y  
c o n t ro l  was not o b ta in e d .  Mean age was 23.1 ± 3.6 (SD) years, 
mean g e s ta t i o n  was 31.6 ± 2 .6  (SD) weeks, and 8 o f  the  38 
p a t i e n t s  (21 %) were parous, t h i r t y  (79%) had s i g n i f i c a n t  
p ro te in u r ia  (>0.3 g/24 h) .
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Venous blood was taken w i t h o u t  s t a s i s  i n t o  e d e t ic  acid a n t i ­
coagulant f o r  determination o f  p l a t e l e t  count (C o u l te r  S -p lu s ,  
C o u l te r  E le c t r o n i c s  L t d . ,  UK) b e fo re  and one week a f te r  entry 
i n to  the study. The mean of 2 p l a t e l e t  counts was recorded on 
each occasion.
12.2.5 S ta t i s t i c a l  Analysis
S t a t i s t i c a l  a n a ly s is  was by th e  Wi lcoxon rank sum t e s t  f o r  
analysis between groups and by the  Wi lcoxon rank sum t e s t  f o r  
p a i re d  data f o r  ana lys is  w i th in  groups. The Spearman rank te s t  
was used to  assess c o r re la t io n  between PGI2M and TxB2 .
12.3 RESULTS
The r e s u l t s  o f  the  c r o s s - s e c t i o n a l  s tudy of PGI2M and TxB2 in 
mild/moderate and severe PIH compared to  normal t h i r d  t r i m e s t e r  
pregnancy are shown in  f igu res  12.1 and 12.2. As can be seen 19 
of the 35 pat ients  with mi ld/moderate PIH and 5 of the 6 pat ients  
w i t h  severe PIH had un reco rdab le  l e v e l s  (<5 p g /m l ) o f  PGI2M 
( f i g u r e  1 2 .1 ) .  No p a t i e n t  i n  the  normal t h i r d  t r i m e s t e r  
pregnancy group had unrecordable leve ls  o f PGI2M. The leve ls  of 
PGI2M in  both the  m i ld /m o d e ra te  and severe PIH groups were 
s i g n i f i c a n t l y  d i f f e r e n t  (p <0.001) from those in  the  normal 
group.
There was no s ig n i f i c a n t  d i f fe rence  in  TxB2 between any of the 3 
groups ( f ig u re  12.2) although th e re  was a t re n d  towards h ig h e r
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Plasma PGI2M in  mild/moderate and severe PIH compared t o  normal 
t h i r d  t r im e s te r  pregnancy. (Horizontal  bars ind ica te  the  mean 
value f o r  each group and the broken l i n e  ind ica tes  the lower 
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Plasma TxB2 i n  mi ld/moderate and severe PIH compared t o  normal 
t h i r d  t r im e s te r  pregnancy. (Horizonta l  bars ind ica te  the mean 









E f fe c t  o f  labe ta lo l  t reatment or bed res t  alone (contro l  group) 
on plasma PGI2M in  PIH. The labe ta lo l  group consisted o f  4 
pa t ien ts  with severe PIH and 7 pat ients  w ith  mi ld/moderate PIH. 
A l l  pa t ients  in  the control  group had mild/moderate PIH. "Pre" 
ind ica tes sample taken at diagnosis; "Post" ind ica tes sample 
taken a f t e r  7 days treatment.  (Horizontal  bars ind ica te  the  mean 
value f o r  each group, and the broken l i n e  ind ica tes the lower 












Effect of labetalol treatment on plasma PGI2M according to  
In i t i a l  level of PGI2M at diagnosis. "Pre” indicates sample 
taken at diagnosis; "Post" indicates sample taken following 7 
days labetalol therapy. (Horizontal bars indicate the mean 
values, and the broken line indicates the lower l im it  of 
s e n s it iv ity  fo r the assay.)
TABLE 12.2
E ffec t o f labe ta lo l treatment on plasma TxB2 in  PIH 
(A ll values are mean ± SEM)
Control group Labetalol treated group
(bed rest alone) I
Day 0 Day 7 Day 0 Day 7
PIasma
TxB2 93 ± 11.1 98.3 ± 13.4 116.2 ± 20.0 119.3 ± 24.0
(pg/ml)
10 11
The e f f e c t s  o f  l a b e ta lo l  treatment on plasma PGI2M are shown in 
f i g u re  12.3. As can be seen, th e re  was no s i g n i f i c a n t  o v e ra l l  
change in  the l a b e t a l o l  t r e a te d  group, however, f o l l o w i n g  
t re a tm e n t  no pat ient had unrecordable leve ls  o f  PGI2M. While in  
the  bed r e s t  c o n t ro l  group, a l though again  th e re  was no 
s i g n i f i c a n t  o v e ra l l  change, 1 p a t i e n t ' s  PGI2M remained 
unrecordable and a f u r t h e r  4 developed un reco rdab le  l e v e l s ,  a 
f e a t u r e  not seen in  the  l a b e ta lo l  t rea ted  group. I t  should be 
noted th a t  the labe ta lo l  t reated group contained 4 p a t ie n ts  w i th  
severe d isease ,  w h i le  the  c o n t ro l  group consisted e n t i r e l y  of 
pat ien ts  with mi ld/moderate PIH. Three o f  th e  4 p a t i e n t s  w i th  
severe d isease had i n i t i a l l y  unrecordable leve ls  o f PGI2M which 
rose fo l low ing  therapy, the other severe p a t i e n t  s t a r t e d  w i th  a 
recordable level  and t h i s  also increased.
The PGI2M response t o  l a b e t a l o l  t re a tm e n t  has a lso  been 
i l l u s t r a t e d  accord ing  to  i n i t i a l  leve ls  of PGI2M ( f ig u re  12.4).  
A l l  p a t i e n t s  who had i n i t i a l l y  unrecordab le  PGI2M le v e ls  
inc reased  t h e i r  l e v e l  o f  PGI2M f o l l o w i n g  t r e a tm e n t .  Whi le 
p a t i e n t s  w i th  i n i t i a l  leve ls  o f PGI2M above 5 pg/ml (w i th in  the 
normal range) had no p a t te rn  o f  change, a l though  none o f  them 
developed unrecordable leve ls  of PGI2M.
The r e s u l t s  f o r  the e f fe c t  of labe ta lo l  t reatment on TxB2 leve ls  
are shown in  tab le  12.2. There was no s i g n i f i c a n t  change in  TxB2 
e i th e r  in  the treatment or in  the control  group.
No co r re la t io n  was found between PGI2M and TxB2 .
TABLE 12.3
E f fe c t  o f  labe ta lo l  on p la te le t  count in  PIH (mean ± SD)
Day 0
P la te le t  count 
(x 109/1)
Day 7
P la te le t  count 
(x 109/1)
Mean change in  
P la te le t  count 
(x 109/1)
Mild/moderate PIH 





- 22 . 8++
±35.0
Mild/moderate PIH 


















P <0'005) compared to  day 0 measurement in  same group
* * *  p <0.001)
+ p <0.05 compared to  day 0 measurement in  mi ld/moderate groups
++ p <0.01 compared to  change in  mi ld/moderate PIH group t reated 














Change in  p la t e l e t  count fo l low ing  treatment w ith  la b e ta lo l  or 












Change in  p la te le t  count in  the labe ta lo l  t rea ted  mild/moderate 
PIH group compared with change in  p la t e le t  count in  the bed rest 












Change in  p la t e le t  count over one week in  pa t ien ts  w i th  severe 
PIH t rea ted  w i th  l a b e ta lo l .  (Values shown are mean ± SEM)
Resu l ts  f o r  the  e f f e c t  o f labe ta lo l  treatment on p la te le t  count 
are given in  tab le  12.3 and i l l u s t r a t e d  in  f igures 12.5 and 12.6. 
There was a small but s t a t i s t i c a l l y  s ig n i f i c a n t  f a l l  in  p la te le t  
count in  the  mi 1 d/moderate c o n t ro l  group, w h i le  th e re  was no 
change in  p l a t e l e t  count in the labe ta lo l  t reated mild/moderate 
group. The magnitude o f  change in  the c o n t r o l  group was a lso  
s i g n i f i c a n t l y  d i f f e r e n t  (p <0.01) from the magnitude o f  change in  
the labe ta lo l  t rea ted  mild/moderate group ( tab le  12.3 and f i g u r e  
1 2 .6 ) .  There was no s i g n i f i c a n t  d i f fe rence in  the basel ine or 
day 7 p la te le t  counts between these two mild/moderate PIH group.
In the  severe PIH group, b a se l ine  p l a t e l e t  count was 
s i g n i f i c a n t l y  lower than in  the mild/moderate groups.  P l a t e l e t  
count rose s i g n i f i c a n t l y  a f t e r  one week o f  t re a tm e n t  w i th  
labe ta lo l  ( tab le  12.3) and was not s i g n i f i c a n t l y  d i f f e r e n t  from 
e i t h e r  o f  th e  m i ld /m odera te  PIH groups on day 7 ( tab le  12.3) .  
This is  i l l u s t r a t e d  in  f ig u re  12.7.
12.4 DISCUSSION
This s tudy has shown th a t  low leve ls  o f  PGI2M occur in  PIH, with 
over 50% of pat ients  in  t h i s  study having unrecordable (<5 pg/ml) 
l e v e l s  o f  t h i s  m e t a b o l i t e ,  a f e a tu r e  not seen i n  any o f  the  
normal t h i r d  t r im e s te r  contro l  group. Th is  d id  not seem to  be 
r e la t e d  to  d isease s e v e r i t y  as 19 o f  35 p a t i e n t s  w i th  
mi ld/moderate disease and 5 of 6 pat ients  with severe disease had 
unrecordable leve ls .  However, many pat ients  in the mild/moderate 
group and 1 p a t i e n t  in the severe group had PGI2M levels  w i th in  
the normal range,  suggest ing  th a t  very low leve ls  of PGI2M are 
not always found in PIH.
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Th is  f i n d i n g  i s  c o n s is te n t  w i th  o th e r  s tud ies .  Yamaguchi and 
Mori (1985) recent ly  studied 15 women with PIH and found them to  
have r e l a t i v e l y  lower  levels  o f  plasma 6-keto-PGFia than normal 
pregnant women. However, the  l e v e l s  they  re p o r ted  f o r  
6 -ke to -PGFig  were very high - 318.6 (SE ± 58.0) pg/ml f o r  normal 
pregnancy and 118.8 (SE ± 16.4)  pg/ml f o r  p a t i e n t s  w i th  PIH 
b r in g in g  the  v a l i d i t y  of t h e i r  assay in to  quest ion. Moodley et 
al . ,  (1984) have a lso  repo r ted  lower  l e v e l s  o f  plasma
6 - ke to -PG F ia  i n  women w i th  ec lampsia o r  impending eclampsia 
compared to  normal pregnancy, but again they re p o r te d  ve ry  high 
l e v e l s  o f  t h i s  substance. Not a l l  r e p o r t s  on plasma PGI2 
m e ta b o l i t e s  in  PIH have been c o n s is t e n t  as Y1 ikorka la  et a l . ,  
(1981b) found no change in  22 p a t i e n t s  w i t h  PIH compared to  
normal pregnancy,  and S tr ick land ^  al_., (1984) reported higher 
leve ls  o f  6-keto-PGFia i P I H .
The f i n d in g s  o f  t h i s  present study, however, are also in keeping 
w i t h  th e  work o f  Goodman et , (1982) who studied 6 pat ients  
w i t h  PIH and found them to  have lower  l e v e l s  o f  u r in a ry  PGI2 
m e t a b o l i t e s .  The repor ts  o f reduced amniot ic f l u i d  P6 I 2 in  PIH 
(Bodzenta ejt aj_. , 1980 ; Y1 i ko rka l  a _et aj_., 1981a) and reduced 
PGI2 p ro d u c t io n  from both maternal (Bussol i no _et aj_., 1980) and 
f e t a l  (Vial sh ^  al_., 1985; Downi ng et al_, 1980) vascular t issue  
are a lso  in  keeping w i th  the  f i n d in g s  o f  the low PGI2M in PIH 
seen in  the present study.
In a d d i t i o n ,  the  r e s u l t s  o f  t h i s  cross-sect ional study confirm 
the  f i n d i n g s  o f  the p ro s p e c t i v e  s tudy o f  PGI2M descr ibed in  
chapter 11, which showed tha t  6 pat ients  who became hyper tens ive  
during pregnancy developed unrecordable leve ls  o f PGI2M.
Low leve ls  o f PGI2 may wel l play a ro le  in  the pathophysiology of
PIH, as a d e f i c ie n c y  o f  t h i s  v a s o d i l a t o r  and a n t i  p l a t e l e t
p ro s ta g la n d in  might a l lo w  the  v a s o c o n s t r i c t i o n  and p l a t e l e t  
consumption, which are c h a ra c te r i s t i c  o f PIH, to  go unchallenged.
PGI2 may a lso  be im po r ta n t  in  balancing the pressor e f fec ts  of 
angiotensin I I  in normal pregnancy (see chapte r  3 . 7 ) .  Normal ly  
pregnancy i s  assoc ia ted  w i th  a r e l a t i v e  i n s e n s i t i v i t y  to  the 
e f fec ts  o f exogenous a n g io te n s in  I I  i n f u s io n  (Ches ley ,  1966; 
T a l le d o  ^  J l . ,  1968) and t h i s  i n s e n s i t i v i t y  can be enhanced by 
PGI2 i n f u s i o n  (Broughton P ip k in  ^  aj_., 1984) and reduced by 
i n h i b i t o r s  o f  p ro s ta g la n d in  synthesis (Everett  _et a]_., 1978a). 
Th is  suggests tha t  a vasodepressor prostaglandin such as PGI2 is  
responsible f o r  t h i s  phenomenon. In  PIH th e  i n s e n s i t i v i t y  i s  
l o s t  and p a t i e n t s  become very  s e n s i t i v e  t o  th e  e f f e c t s  o f
a n g io te n s in  I I  (Gant et 1973). The reduced leve ls  o f PGI2 
in PIH seen in  the present study may explain t h i s  s e n s i t i v i t y  and 
t h i s  i s  another  mechanism by which PGI2 d e f i c i e n c y  could
contr ibu te  to  tfie disease process in PIH.
A cause and e f f e c t  r e l a t i o n s h i p  fo r  low PGI2 and PIH cannot be 
concluded from t h i s  p resent  s tudy ,  and PGI2 d e f i c i e n c y  i s  
u n l i k e l y  to  be the  pr imary cause of the disease. However, PGI2
d e f i c i e n c y  may occupy a p i v o t a l  ro le  in  the pathophysiology o f  
PIH, by in c re a s in g  v a s c u la r  s e n s i t i v i t y  and a l lo w in g  vaso­
c o n s t r i c t io n  and p la te le t  consumption to  occur unopposed.
As PGI2 d e f i c i e n c y  may be an important feature in  the pathoph­
y s i o l o g y  o f  PIH, rep lacement o f  PGI2 might be o f  value in  the 
t re a tm e n t  o f  t h i s  d ise a se .  I t  i s  now p o s s ib le  t o  give PGI2 , 
which is  commercially ava i la b le ,  and i t  has been shown to  be o f  
b e n e f i t  in  the  t re a tm e n t  o f  p e r ip h e ra l  v a s c u la r  disease, and 
Raynaud's phenomenon (Belch et aj_., 1983a; Belch _ e t ^ . ,  1983b). 
There have on ly  been two reports  o f PGI2 therapy in  PIH (F id le r  
^  , 1981; Belch et al_., 1985) and both studies looked at very
severe p a t i e n t s .  PGI2 therapy reduced p la te le t  consumption and 
helped lower blood pressure, but as both s tu d ie s  were on small  
numbers o f  very  severe p a t i e n t s  i t  i s  d i f f i c u l t  t o  know what 
impact PGI2 therapy made on outcome o f  the disease, however, the 
resu l ts  on these studies were s u f f i c i e n t l y  encouraging to  warrant 
f u r t h e r  s tu d y .  The problems o f  PGI2 the rapy  are t h a t  the  
substance i s  u ns tab le  and has to  be g iven by in t ravenous  
i n f u s i o n ,  i n  a d d i t i o n  the  dose is  l im i te d  by vasod i la to r  side- 
e f fe c ts  such as f lu sh in g ,  headache and postural  hypotension.
An a l t e r n a t i v e  to  g iv ing PGI2 would be to  use a drug which might 
reduce p la te le t  consumption and promote v a s o d i l a t a t i o n  by o th e r  
means, the reby  p o s s ib l y  compensating f o r  the lack of PGI2 . An 
adrenoceptor antagonist such as labe ta lo l  may be such a drug as 
i t  has a d i r e c t  v a s o d i l a t o r  ac t ion  through i t s  adrenoceptor 
antagonist p roper t ies ,  and has also been shown to  have in h ib i t o r y  
e f fe c ts  on p la te le t  aggregation and TxA2 product ion in  v i t r o  (see
chap te rs  5, 7 and 8) w h i le  having minimal e f fec ts  on vascular 
PGI2 p ro d u c t io n  (see ch a p te r  6 ) .  I t  has also been shown to  be 
s y n e r g i s t i c  w i th  PGI2 j_n v i t r o  (see chapte rs  6 and 7) in  
i n h i b i t i n g  p l a t e l e t  f u n c t i o n  and t h i s  may occur in  the in vivo 
s i t u a t i o n .
The r e s u l t s  o f  the  present  s tudy suggest t h a t  l a b e t a l o l  may 
inc rease  PGI2M le v e ls  i f  they are i n i t i a l l y  low.  This is  an 
unexpected f i n d i n g  as l a b e t a l o l  p robab ly  i n h i b i t s  the  
phospho l ipase enzymes (see chap te r  5) which should reduce 
a ra c h id o n ic  ac id  a v a i l a b i l i t y  and subsequent p ro s ta g la n d in  
f o r m a t i o n .  The e f f e c t  o f  l a b e t a l o l  and o th e r  adrenoceptor  
a n ta g o n is ts  on vascu la r  PGI2 product ion were studied in  Chapter 
6, and no s t imu la tory  e f fe c t  on PGI2 product ion was noted, t h i s  
suggests tha t  i f  labe ta lo l  does s t imulate PGI2 production in  vivo 
i t  i s  not by a d i r e c t  mechanism and may be secondary to  some 
other aspect o f the drugs act ion in  v i v o .
Th is  study d id  not show any increased leve ls  o f  plasma TxB2 in  
PIH, a l though there was a trend towards higher leve ls  of TxB2 in  
the mild/moderate group. This i s  i n  agreement w i t h  Yamaguchi 
and Mori (1985) and M i t c h e l l  ^ _ a l_ . ,  (1978) who studied plasma 
TxB2 i n  PIH and also found no s ig n i f i c a n t  increase. I t  has been 
shown, however, tha t  p lacen tas  from p a t i e n t s  w i th  PIH produce 
increased amounts o f  TxA2 (Walsh, 1985) and also th a t  ex vivo 
p l a t e l e t  TxA2 p ro du c t io n  i s  increased in  PIH (Wallenburg and 
Rotmans, 1982). Since t h i s  present study found no d i f f e r e n c e  in  
p e r ip h e ra l  plasma leve ls  o f TxB2 , i t  may be tha t  t h i s  increased
p ro d u c t io n  o f  TxA2 i s  apparent only at local s i tu a t ion s  such as 
in  the  p la ce n ta l  o r  renal  m ic ro v a s c u la tu re  where p l a t e l e t  
a c t i va t io n  and deposit ion are know to  occur.
In t h i s  study p la te le t  count was maintained in  the mi ld /moderate  
PIH group t r e a te d  w i th  labe ta lo l  and s i g n i f i c a n t l y  increased in 
th e  severe group t r e a te d  w i th  l a b e t a l o l .  Normal ly  in  PIH 
p l a t e l e t  count f a l l s  as g e s ta t i o n  progresses (Redman et a l . ,  
1978), as seen in  the mild/moderate contro l  group. This suggests 
th a t  labe ta lo l  therapy reduces p la te le t  consumption in  PIH. Such 
a re d u c t io n  in  p l a t e l e t  consumption may he lp  m a in ta in  utero­
placental  blood f low,  as p la te le t  aggregates are though t  to  be 
in v o lv e d  in  the  th rombot ic  occlusion of uteroplacenta l  a r te r ies  
seen in  t h i s  disease. P la te le t  a c t i v a t io n  also occurs w i th in  the 
k id n e y ,  damaging th e  m ic ro v a s c u la tu re  and im p a i r in g  renal 
func t ion .  Labetalol  has been shown to  have a p ro tec t ive  e f fe c t  on 
renal  f u n c t i o n  in  PIH (Walker  e^ aj_., 1982) and t h i s  may be a 
r e s u l t  o f  the p la te le t  p ro tec t ive  e f fec ts  o f the drug which have 
been described in  Chapters 5, 7 and 8 of t h i s  th e s is .
In  c o n c lu s io n ,  t h i s  study has provided fu r th e r  evidence showing 
t h a t  PGI2 may be reduced in  PIH, and t h i s  d e f i c ie n c y  may 
con t r ibu te  to  the vascular s e n s i t i v i t y ,  p la te le t  consumption and 
v a s o c o n s t r i c t i o n  seen in the disease. This study also suggests 
th a t  labe ta lo l  may increase PGI2M i f  leve ls  are low, however, the 
mechanism behind t h i s  is  obscure and fu r th e r  studies are required 
to  co n f i rm  o r  r e f u t e  th i s  observat ion. In add i t ion ,  t h i s  study 
has shown th a t  labe ta lo l  therapy can reduce p la te le t  consumption 
e s p e c i a l l y  in  severe PIH. This  e f f e c t  may be re la te d  to  the
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a n t i - p l a t e l e t  e f f e c t s  o f  t h i s  d rug .  Since p l a t e l e t s  play an 
important ro le  in  the pathophysiology of PIH, such an e f f e c t  may 
be o f  g rea t  va lue  in  the  t re a tm e n t  o f  t h i s  cond i t ion ,  and may 
compensate f o r  the  reduced PGI2 p ro d u c t io n  which i s  a lso  a 
fea ture  of the disease.
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CONCLUSIONS
Pregnancy induced h yp e r ten s io n  (PIH) remains a major cause of 
fe ta l  and maternal m o r ta l i t y  and m orb id i ty ,  both from the e f fec ts  
o f  th e  d isease i t s e l f  and a lso  from premature de l ive ry  o f the 
f e t u s .  I t  i s  a d isease c h a ra c te r i s e d  by v a s o c o n t r i c t i o n ,  
p l a t e l e t  a c t i v a t i o n  and consumption, and s e n s i t i v i t y  to  
angiotensin I I ,  although the precise ae t io logy  remains obscure.
In th e  l a s t  10 years two new produc ts  o f  the arachidonic acid 
cascade have been id e n t i f i e d ,  p ros tacyc l in  (PGI2 ) and thromboxane 
(TXA2 ) .  Prostacyc l in  i s  a powerful vasod i la to r  and a n t i - p l a te l e t  
prostaglandin and is the major p roduc t  o f  the  a ra ch id o n ic  ac id  
cascade in  v a s c u la r  t i s su e .  Def ic iency of such a prostaglandin 
may r e s u l t  i n  p l a t e l e t  a c t i v a t i o n ,  v a s o c o n s t r i c t i o n  and 
s e n s i t i v i t y  t o  a n g io te n s in  I I  - the  very  fe a tu re s  o f  PIH. 
Evidence is  accumulating which suggests t h a t  PIH i s  assoc ia ted  
w i th  a d e f i c ie n c y  o f  PGI2 product ion. Although t h i s  is not the 
primary cause o f  the disease i t  may play an important ro le  in the 
pathophysiology of the cond i t ion .
Thromboxane A2 i s  a powerfu l  v a s o c o n s t r i c t o r  and p l a t e l e t  
aggregating agent, i t  i s  the  major  p roduct  o f  the a ra ch id o n ic  
ac id  cascade in  p l a t e l e t s ,  and is  synthesised and released when 
p l a t e l e t s  aggregate . I t  has been suggested t h a t  no rma l ly  a 
ba lance e x i s t s  between PGI2 and TxA2 , and tha t  t h i s  balance may 
be upset in  PIH. Increased TxA2 production from placentas and 
p l a t e l e t s  has been shown to  occur i n  PIH, and t h i s  too may 
con t r ibu te  to  the pathophysiology of the disease.
In recent years adrenoceptor antagonists have been used with some 
success in  the  t re a tm e n t  o f  PIH. The aims of t h i s  thes is  were 
f i r s t l y  to  s tudy the  e f f e c t s  o f  a v a r i e t y  o f  adrenoceptor  
a n ta g o n is ts  on p l a t e l e t  f u n c t i o n ,  TxA2 and PGI2 production in  
v i t r o  and second ly ,  t o  s tudy  plasma l e v e l s  o f  PGI2 and TxA2 
metabol i tes in  normal pregnancy and PIH, and to  assess the e f fe c t  
of t reatment with an adrenoceptor antagonist on l e v e l s  o f  these 
substances and p la te le t  consumption in  PIH.
The in  v i t r o  studies described in  t h i s  thes is  using p la te le t  r i ch  
plasma have shown t h a t  th e  adrenoceptor antagonists la b e ta lo l ,  
p in d o lo l  and p ro p ra n o lo l  i n h i b i t  p la te le t  aggregation and TxA2 
g e n e r a t io n .  These e f f e c t s  may be due t o  i n h i b i t i o n  o f  
a ra c h id o n ic  ac id  re le a se  from th e  p l a t e l e t  membrane 
p h o s p h o l i p id s .  Th is  p ro p e r ty  i s  independent o f  any a or  3 
adrenocep to r  b lo c k in g  e f f e c t  as other  adrenoceptor antagonists 
such as a teno lo l ,  metoprolo l ,  t imo lo l  and p ra zos in  were w i th o u t  
e f f e c t .  The i n h i b i t o r y  a c t io n  o f  these drugs on p l a t e l e t  
f u n c t i o n  and TxA2 p ro d u c t io n  may be r e la t e d  t o  membrane 
s ta b i l i s i n g  a c t i v i t y  or l i p i d  s o l u b i l i t y ,  p r o p e r t i e s  which are 
common to  a l l  three e f fe c t i v e  agents.
Labe ta lo l ,  pindolol  and p ro p ra n o lo l  were found to  have l i t t l e  
e f f e c t  on v a s c u la r  PGI2 p ro d u c t io n ,  but acted s y n e rg is t i c a l l y  
w ith  p ros tacyc l in  to  i n h i b i t  p l a t e l e t  a g g rega t ion  in  p l a t e l e t  
r ich  plasma.
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Recently, i t  has become possible to  study p la te le t  aggregation in  
whole b lood .  This may be a more p h y s io l o g i c a l  model than 
t r a d i t i o n a l  p l a t e l e t  r i c h  plasma te ch n iq u e s ,  as i t  leaves 
p la te le ts  in t h e i r  natural  m i l ieu  with red c e l l s  and w h i te  c e l l s  
p re se n t ,  which can themselves i n f l u e n c e  p la te le t  behaviour by 
re le a se  o f  ADP and PGI2 r e s p e c t i v e l y .  Using t h i s  technique, 
adrenoceptor  a n ta g o n is ts  were found to  i n h i b i t  p l a t e l e t  
aggrega t ion  and TxA2 p ro d u c t io n  in  whole b lood ,  and were 
syne rg is t ic  with PGI2 in  i n h i b i t i n g  p la te le t  aggregat ion.
Calcium channel blocking agents have recent ly  become e s ta b l i s h e d  
in the treatment of hypertension and ischaemic heart  disease, and 
studies are beginning to  emerge on the use of these drugs in  the  
t re a tm e n t  o f  PIH. The e f f e c t  o f  a t y p i c a l  ca lc ium  channel 
block ing agent, n ica rd ip ine ,  on p la te le t  f u n c t i o n  was t h e r e f o r e  
s tu d ie d  in  v i t r o . N icard ip ine in h ib i te d  p la te le t  aggregation in  
whole b lood,  and was syn e rg is t ic  with p rostacyc l in  in  i n h ib i t i n g  
a g g re g a t io n ,  but had no e f f e c t  on TxA2 p ro d u c t io n  from whole 
blood or  on PGI2 production from vascular t i s sue .
P rev ious  in  v i t r o  s tu d ie s  have suggested tha t  calcium channel 
b lo c k in g  agents and adrenocepto r  an tagon is ts  can only i n h i b i t  
p la t e le t  funct ion  at supra-pharmacological c o n c e n t ra t io n s  which 
cannot be ob ta ined in  v i v o , y e t  both types o f  drug have been 
shown to  possess a n t i - p l  a te l  et p r o p e r t i e s  j_n v i v o . Th is  
discrepancy suggests th a t  p la te le ts  in  vivo may be more sens i t ive  
than p la te le ts  in v i t r o  to  the e f fec ts  o f  such drugs. This might 
be exp la ined  by the  synergy of these agents with  PGI2 which may 
occur in  v ivo, enhancing t h e i r  e f fec ts  on p la te le t s .
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A sp i r in  has become established as an a n t i - p l a t e l e t  agent, and has 
been used w i t h  some success in  th e  secondary p re ven t io n  o f  
myocardial i n f a r c t i o n ,  threatened stroke and more recent ly  in PIH 
and i n t r a - u t e r i  ne growth r e t a r d a t i o n .  There i s ,  however, an 
a s p i r i n  di lemma, as a l though i t  i s  a powerfu l  a n t i - p l a t e l e t  
agent, i t  also i n h ib i t s  vascular p ros tacyc l in  p ro d u c t io n ,  which 
i s  a t  l e a s t  p o t e n t i a l l y  h a rm fu l .  In an attempt to  avoid t h i s  
problem low dose asp i r in  has been used as t h i s  might s e l e c t i v e l y  
i n h i b i t  p l a t e l e t  fu n c t io n .  The e f fec ts  o f a combination of low 
dose a sp i r in  and e i t h e r  an ad renocepto r  a n ta g o n is t  o r  ca lc ium 
channel b lock ing agent were studied in  t h i s  th e s is .  At doses of 
a s p i r in  and adrenoceptor antagonist or calcium channel b lo ck in g  
agent which on t h e i r  own had minimal e f fe c t s ,  a combination of 
both drugs r e s u l t e d  in  over 50% i n h i b i t i o n  o f  p l a t e l e t  
a g g re g a t ion  in  whole b lood .  Such synergy may be useful in the 
c l i n i c a l  s i tu a t io n  a l lowing low dose a s p i r i n  to  f u n c t i o n  as an 
e f fe c t i v e  a n t i - p l a t e l e t  agent.
Whether the a n t i - p l a te l e t  propert ies of the drugs which have been 
described in  t h i s  t h e s i s  are o f  c l i n i c a l  va lue remains to  be 
e s ta b l i s h e d .  Long term c l i n i c a l  evaluat ion is  required to  study 
th e  e f f e c t s  o f  these drugs on PGI2 , TXA2 and p la te le t  behaviour 
in  v i v o , and t o  determine whether any such propert ies inf luence 
th e  d isease outcome. I f  found to  be e f fe c t i v e  these drugs would 
be of value not only in PIH but also in  other diseases associated 
w ith  p la te le t  a c t iva t ion  such as ischaemic heart disease.
A recent  s tudy has shown t h a t  a s p i r i n  can improve prognosis  
fo l low ing  myocardial i n f a r c t i o n ,  espec ia l ly  when combined with an 
adrenoceptor  a n ta g o n is t .  I t  is  tempting to  speculate th a t  t h i s  
card iopro tec t ive  e f f e c t  may be due t o  the  combined i n h i b i t o r y  
e f f e c t s  o f  a s p i r i n  and ad renocepto r  a n ta g o n is ts  on p l a t e l e t  
funct ion  which have been described i n  t h i s  t h e s i s ,  but f u r t h e r  
c l i n i c a l  evaluat ion o f  t h i s  p o s s ib i l i t y  is  requi red.
Plasma le v e ls  o f  p r o s t a c y c l i n  and thromboxane m e ta b o l i te s  in  
normal pregnancy and PIH were also studied in  t h i s  thes is .  In 
the normal s i t u a t io n  plasma prostacyc l in  m e ta b o l i te s  were found 
to  be increased in  the f i r s t  t r im e s te r ,  t h i s  may be important in 
implanta t ion, a l lowing the trophoblast to  escape im m o b i l i s a t i o n  
by p l a t e l e t  aggregates as i t  invades the  maternal u te r i n e  
c i r c u la t i o n .
In PIH plasma p ro s ta c y c l i n  metabol i tes (PGI2M) were found to  be 
reduced. This is  in keeping with previous s tud ies ,  and p rov ides  
f u r t h e r  ev idence i m p l i c a t i n g  p r o s t a c y c l i n  d e f i c i e n c y  in  the  
pathogenesis of t h i s  disease. Peripheral plasma leve ls  o f TxB2 - 
th e  s ta b le  h y d ra t io n  p roduc t  o f  TxA2 - were not s i g n i f i c a n t l y  
d i f f e r e n t  from normal pregnancy l e v e l s  in  PIH. t h i s  suggests 
t h a t  i f  TxA2 p ro d u c t io n  i s  increased in  PIH i t  may on ly  be 
detectable at s i te s  of p la te le t  a c t i v a t io n  such as the rena l  and 
p la ce n ta l  m ic ro v a s c u la tu re ,  and does not occur g e n e r a l l y  
throughout the systemic c i r c u la t i o n .
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The e f f e c t s  o f  the  ad renocepto r  antagonist labe ta lo l  on plasma 
l e v e l s  o f  PGI2M and TxB2 , and p la te le t  consumption in  PIN were 
a lso  s tu d ie d .  When i n i t i a l  plasma l e v e l s  o f  PGI2M were low 
labe ta lo l  therapy seemed to  increase l e v e l s ,  but the  mechanism 
behind t h i s  i s  un c le a r  and f u r t h e r  s tu d ie s  are re q u i re d  to  
confirm or re fu te  t h i s  o b s e rv a t i o n .  L a b e ta lo l  th e ra py  had no 
e f f e c t  on plasma TxB2 i n  PIN. However, l a b e t a l o l  the rapy  
s i g n i f i c a n t l y  reduced p la te le t  consumption e s p e c i a l l y  i n  severe 
PIN suggest ing  t h a t  th e  a n t i - p l a t e l e t  p roper t ies  o f  t h i s  drug 
which were s tu d ie d  i n v i t r o  may wel l occur in  v i v o . In view of 
th e  c o n t r i b u t i o n  o f  p l a t e l e t s  to  the  pa thophys io logy  of PIN, 
r e d u c t io n  o f  p l a t e l e t  consumption may be o f  va lue in  the  
treatment of t h i s  cond i t ion .
Fu tu re  s tu d ie s  are re q u i re d  to  examine th e  e f f e c t s  o f  
adrenoceptor antagonists and calcium channel b lo c k in g  agents on 
p l a t e l e t  f u n c t i o n  and TxA2 and PGI2 production in  v iv o , and to  
de te rm ine  whether any b e n e f i c i a l  e f f e c t s  w i l l  i n f lu e n c e  the  
natural  course of the disease in pat ients  su f fe r ing  from PIN. The 
comb ina t ion  o f  low dose a s p i r i n  and an adrenoceptor antagonist 
a lso  r e q u i re s  urgent c l i n i c a l  e v a lu a t i o n  and may o f f e r  an 
exc i t ing  new therapeut ic opt ion in  the treatment o f  PIH.
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